<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d7" for="edge" attr.name="order" attr.type="long" />
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="clusters" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="&quot;OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by excessive body fat accumulation, influenced by genetic factors such as the FTO gene variant."&lt;SEP&gt;"Obesity is a condition characterized by excessive body fat accumulation and increased health risks."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;METABOLIC SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Metabolic syndrome includes conditions such as obesity and type 2 diabetes that are linked to variants in the PPARÎ³ gene."&lt;SEP&gt;"Metabolic syndrome is a cluster of conditions that increase the risk for heart disease, stroke, and diabetes."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"A measurement of abdominal obesity that is higher in groups with abnormal blood glucose levels, indicating a risk factor for T2DM."&lt;SEP&gt;"Waist circumference measures abdominal fat and is used as an indicator of metabolic health risks."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FAT MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fat mass refers to the total amount of body fat, which can affect metabolic and cardiovascular health."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SKELETAL MUSCLE MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Skeletal muscle mass is the quantity of skeletal muscle tissue in the body, important for overall physical function."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM TOTAL CHOLESTEROL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Total cholesterol levels reflect the amount of cholesterol carried by lipoproteins in blood and are indicative of cardiovascular health risks."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;LDL CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LDL concentration measures low-density lipoprotein, a form of cholesterol associated with increased risk for heart disease."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM TRIGLYCERIDE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Serum triglycerides are fats in the blood and their high levels can indicate poor metabolic health."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM HDL CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High-density lipoprotein (HDL) concentration is a measure of good cholesterol, which helps remove bad cholesterol from arteries."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;HS-CRP CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"C-reactive protein (CRP) is an acute-phase reactant produced by the liver and its high levels indicate systemic inflammation."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;BLOOD PRESSURE (SBP/DBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Blood pressure measures the force of blood against artery walls; hypertension increases risks for heart disease, stroke, etc."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;EGFR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Estimated Glomerular Filtration Rate (eGFR) is a measure used to assess kidney function."&lt;SEP&gt;"Estimated glomerular filtration rate is a measure of kidney function and its decrease can indicate kidney damage."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ALT CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alanine transaminase concentration is an enzyme used to detect liver injury or damage."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;AST CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Aspartate aminotransferase concentration measures liver health and can indicate muscle diseases or alcohol abuse as well."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;DII (DIETARY INFLAMMATORY INDEX)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary Inflammatory Index assesses the inflammatory potential of diet based on nutrient intake patterns."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FRIED FOOD INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Frequent consumption of fried foods can increase risks for obesity and other chronic diseases due to high fat and calorie content."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SUGAR-CONTAINING FOODS INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of sugar-containing foods can contribute significantly to energy intake and play a role in weight gain or obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;KOREAN BALANCED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern that includes balanced components typical in Korean cuisine, affecting health outcomes such as obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;WESTERN-STYLE DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by high intake of processed and red meats, refined grains, and sweets associated with higher risks for chronic diseases."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A diet rich in vegetables, fruits, whole grains, nuts, seeds, and legumes, which can reduce obesity risk."&lt;SEP&gt;"Intake of plant-based diet interacts with PRS for the obesity risk; high intake can protect against obesity even in individuals with high PRS."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;ALCOHOL INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol consumption has been linked to various health outcomes including increased risk of obesity."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;CURRENT SMOKER STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Being a current smoker is considered a lifestyle factor that can affect overall health status and disease risks."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;REGULAR EXERCISE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engaging in regular physical activity as part of a healthy lifestyle, which can reduce obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;AGE&quot;">
      <data key="d0">"DEMOGRAPHIC VARIABLE"</data>
      <data key="d1">"Age is a demographic characteristic that can influence health outcomes and risk factors for various diseases."&lt;SEP&gt;"The process of aging impacts the prevalence and risk factors associated with snoring."&lt;SEP&gt;"Participant age is an environmental factor significantly associated with higher levels of social disinhibition."&lt;SEP&gt;"The age of participants was considered as a risk factor for severity of acute and delayed CINV."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;GENDER&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Gender is a biological factor affecting health risks, including obesity and metabolic syndrome."&lt;SEP&gt;"Gender, as a lifestyle factor, did not show significant association with increased risk of social disinhibition in the multivariable analysis."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of body fat based on an individual's weight in relation to their height."&lt;SEP&gt;"A measure of body fat based on height and weight, BMI is a risk factor for various diseases including snoring when adjusted in genetic studies."&lt;SEP&gt;"A measure of body fat based on height and weight; found to differ by genotype at baseline."&lt;SEP&gt;"A measure used to assess obesity levels, studied in association with genetic variants."&lt;SEP&gt;"BMI calculation reflects the interaction between genetic factors like FTO SNP and environmental influences such as education level to determine health risks."&lt;SEP&gt;"BMI measures body fat based on height and weight and is used to classify overweight or obese individuals."&lt;SEP&gt;"BMI is positively correlated with snoring prevalence, especially in both sexes when considering whole-body fat mass."&lt;SEP&gt;"A measure of body fat based on an individual's weight-to-height ratio; significantly higher in women with PCOS compared to control subjects."&lt;SEP&gt;"A measure used to assess body fat based on height and weight; increases with abnormal blood glucose levels (IFG and IGT) leading to T2DM."&lt;SEP&gt;"An indicator of body fatness that influences the association between certain SNPs and habitual coffee intake."&lt;SEP&gt;"Men show significant differences in BMI according to the rs671 polymorphism; this may be linked to variations in alcohol consumption and cortisol levels."&lt;SEP&gt;"An index calculated from a person's weight and height, used to assess the risk of obesity-related diseases."&lt;SEP&gt;"BMI is a measure of body fat based on height and weight that differed significantly between cases and controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-7ca64f92964b051cfb1c43f967f243a5&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-a34b927ed42ff0917960122b4d203f83&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engagement in physical activities can influence obesity risk, metabolic health, and cardiovascular fitness."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FAMILY HISTORY OF OBESITY&quot;">
      <data key="d0">"GENETIC TRAIT"</data>
      <data key="d1">"Having a family history of obesity increases genetic predisposition to weight gain and related conditions."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;SEC16B_RS543874&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs543874) in SEC16B, an endoplasmic reticulum export factor gene, is associated with obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;DNAJC27_RS713586&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs713586) in DNAJC27, a heat shock protein family member C27, influences the obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;CDKAL1_RS9356744&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CDKAL1 rs9356744 variant is linked to obesity risk and affects energy intake or expenditure via modulation of transcription factors."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TFAP2B_RS2206277&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant (rs2206277) in the TFAP2B gene, a transcription factor AP-2 Beta, affects obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;BDNF_RS6265&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The BDNF rs6265 variant impacts energy intake or expenditure through its influence on transcription factors and is associated with obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MYL2_RS3782889&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant (rs3782889) in myosin light chain-2 (MYL2) affects the obesity risk but does not meet statistical criteria."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;OLFM4_RS9568856&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The OLFM4 rs9568856 variant is involved in regulating energy intake or expenditure and contributes to obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;FTO_RS1421085&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs1421085) in the FTO gene acts as a hub gene influencing the obesity risk by modulating energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MC4R_RS6567160&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The MC4R rs6567160 variant functions as a hub gene that affects obesity risk through its regulation of energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;GIPR_RS1444988703&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant (rs1444988703) in the GIPR gene influences obesity risk by modulating transcription factors involved in energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulation of energy intake and expenditure through modulation of transcription factors is a key physiological process linked to obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;BODY MASS INDEX (BMI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adherence to the Mediterranean diet is associated with lower BMI levels among individuals."&lt;SEP&gt;"BMI is a measure used to assess the impact of genetic variants on obesity risk, showing an increasing trend with PRS scores."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;OBESITY RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Increased BMI and waist circumference indicate higher obesity risk, a condition closely linked with the FTO gene variant and educational level."&lt;SEP&gt;"Obesity risk is influenced by interactions between genetic factors (PRS) and environmental factors such as dietary patterns."&lt;SEP&gt;"The identified SNPs and their interactions contribute significantly to the risk of developing obesity."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;PRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polygenic risk score (PRS) for obesity interacts with age at menarche and dietary factors to influence BMI."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;EARLY MENARCHE AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of early onset of menstruation in women, which interacts with PRS to influence the obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Body Mass Index (BMI) is a measure used for adjusting analyses and assessing its influence on T2D risk associated with genetic variants."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to assess obesity risk and shows interaction with both genetic factors and dietary patterns."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to determine if an individual's weight is healthy relative to their height. It plays a role in assessing obesity and related health risks."&lt;SEP&gt;"Body Mass Index, a factor mediating pleiotropic effects of certain SNPs on cardiometabolic traits."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to assess obesity or underweight conditions; in this study, cases had slightly higher BMI compared to controls."&lt;SEP&gt;"Body Mass Index, a measure used in clinical settings to assess obesity and related health risks."&lt;SEP&gt;"Body Mass Index (BMI) is positively correlated with sUA levels and HUA risk, particularly in individuals carrying the ABCG2 rs2231142 T allele."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to assess body fat based on height and weight."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;HIGH PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals who consume a high amount of plant-based foods have lower genetic impact on BMI when compared to those with low intake and low PRS."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake of fried food interacts with PRS, where high intake is associated with higher BMI but the genetic impact (PRS) is offset in this group."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;HIGH FRIED-FOOD INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals who consume a lot of fried foods have their genetic impact on BMI mitigated, indicating that dietary choices can modify obesity risk irrespective of PRS."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LOW PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with low intake of plant-based diet show higher BMI when combined with high PRS, compared to those with high plant-based intake and high PRS."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH PRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A high polygenic risk score (PRS) indicates a higher genetic predisposition towards obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO rs1558902 genotype is a genetic variant that influences weight loss and body composition changes, particularly in response to high-protein diets."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Weight loss refers to the physiological process of reducing overall body mass, which can be influenced by dietary interventions and genetic factors such as the FTO rs1558902 genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A high-protein diet is a dietary pattern characterized by higher protein intake relative to other macronutrients, which can influence fat distribution depending on genotype."&lt;SEP&gt;"A high-protein diet is a dietary pattern characterized by increased protein intake relative to carbohydrate and fat, which can influence weight loss in individuals with certain genotypes like the FTO rs1558902 risk allele carriers."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in fat distribution are a result of interactions between genotype and environmental factors like diet over time."&lt;SEP&gt;"Changes in fat distribution refer to physiological processes involving alterations in body composition such as total adipose tissue, visceral and subcutaneous fat levels."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LINEAR MIXED MODELS ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The linear mixed models analysis is a statistical method used to assess genotype-time interactions on changes in body composition and fat distribution over time, particularly in response to dietary interventions such as protein diets."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TOTAL FAT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total fat loss involves the physiological process of reducing overall adipose tissue mass within the body."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FAT-FREE MASS (FFM) LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Loss in fat-free mass refers to a decrease in muscle and other non-fat tissues, which can be influenced by dietary protein intake and genetic factors like FTO rs1558902 genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FTO GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with obesity risk, also tied to alcohol consumption, coffee consumption, and insomnia."&lt;SEP&gt;"The FTO gene encodes a protein that is associated with the regulation of energy balance and obesity risk."&lt;SEP&gt;"The FTO gene harbors a single nucleotide polymorphism (SNP) that is associated with obesity risk."&lt;SEP&gt;"The FTO gene is a critical genetic locus associated with obesity risk and anthropometric measurements."&lt;SEP&gt;"The FTO gene is associated with obesity predisposition."&lt;SEP&gt;"The FTO gene where one of the novel SNPs (rs1558902) is located and influences CRP levels in association studies."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 14}]</data>
    </node>
    <node id="&quot;MINOR ALLELE FREQUENCY (MAF)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"MAF is a measure used to describe genetic variation within a population, indicating the proportion of a specific allele in the gene pool."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;A ALLELE (RISK ALLELE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The A allele at the rs1558902 locus is considered a risk allele for obesity and weight gain due to its influence on energy balance."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;BASELINE BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline Body Mass Index (BMI) represents an individual's initial body mass index before intervention, used as a reference point in clinical trials."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 14}]</data>
    </node>
    <node id="&quot;FM% (FAT MASS PERCENTAGE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FM%, or fat mass percentage, indicates the proportion of body mass that is fat tissue, which can change in response to diet and genetic influences."&lt;SEP&gt;"The percentage of body fat relative to total weight, affected by dietary interventions and genetic predispositions such as the FTO gene variant."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Loss of trunk fat is a reduction in adipose tissue localized around the torso area, influenced by diet and genetics."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;VISCERAL ADIPOSE TISSUE (VAT) CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in visceral adipose tissue refer to alterations in intra-abdominal fat deposits that affect health outcomes such as metabolic syndrome."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;SUBCUTANEOUS ADIPOSE TISSUE (SAT) CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in subcutaneous adipose tissue involve changes in superficial body fat deposits which are influenced by dietary and genetic factors."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;GENE-DIET INTERACTION ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An analysis method used to study the interaction between genetic variants (such as FTO rs1558902) and environmental factors (dietary protein intake), impacting physiological processes like weight loss and body composition changes."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;AA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the AA genotype for the GCKR rs780094 SNP have significantly higher TAG, TC, and apoB concentrations as well as a greater risk of hypertriacylglycerolaemia compared to GG individuals."&lt;SEP&gt;"The AA genotype is a genetic variant that influences changes in fat distribution and body composition in response to dietary interventions."&lt;SEP&gt;"The AA genotype of rs1695 polymorphism is a genetic variant with no significant association to breast cancer risk according to our study."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A low-protein diet is a dietary pattern with lower protein content compared to high-protein diets, affecting changes in fat distribution based on genotypes such as AA genotype."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fat distribution refers to the physiological process of how body fat is distributed across different regions, influenced by genetic factors and dietary patterns."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TAT (TOTAL ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"TAT represents total abdominal adipose tissue, a measure of fat distribution that can change in response to diet and genotype interactions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;SAT (SUBCUTANEOUS ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SAT refers to subcutaneous abdominal adipose tissue, which is part of the physiological process of fat distribution affected by dietary patterns and genotypes."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TOTAL FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total fat measures the overall amount of body fat, influenced by dietary intake and genetic factors like genotype-time interactions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Trunk fat refers to fat distribution around the trunk area of the body, influenced by dietary patterns and genotype-time interactions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;GENOTYPE-TIME INTERACTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genotype-time interaction refers to how genetic variants influence physiological processes in response to time-dependent factors such as dietary interventions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TOTAL FAT CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The change in total body fat is influenced by both genetic variants and dietary patterns such as low-fat diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FM% (FAT MASS PERCENTAGE) CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in the percentage of body mass that is fat tissue, affected by genotype-time interactions under different dietary conditions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in trunk fat distribution are influenced by genetic and environmental factors such as diet over time."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT-FREE MASS LOSS&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Changes in total fat are often accompanied by corresponding losses or gains in fat-free mass, indicating an overall shift in body composition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FM%&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The initial FM% provides context for how genetic factors and dietary interventions can influence the percentage of body fat over time."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 14}]</data>
    </node>
    <node id="&quot;LOW-FAT DIET&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"Genotype-time interactions on changes in fat distribution are observed under low-fat dietary conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO rs9939609 polymorphism is a genomic variant associated with anthropometric variables such as weight, BMI and waist circumference."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;ANTHROPOMETRIC VARIABLES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Anthropometric measurements like body mass index (BMI), weight, and waist circumference are physiological processes used to assess obesity risk and overall health."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;EDUCATION LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Educational background is an environmental factor influencing health outcomes such as obesity risk when interacting with genetic factors like the FTO SNP."&lt;SEP&gt;"The education level of participants was noted as lower for cases than controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 16}]</data>
    </node>
    <node id="&quot;FTO SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism in the FTO gene that is associated with obesity risk."&lt;SEP&gt;"The FTO single nucleotide polymorphism (SNP) is a genomic variant associated with increased BMI and higher obesity prevalence in certain educational groups."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 16}]</data>
    </node>
    <node id="&quot;ANTHROPOMETRIC MEASUREMENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These include weight, BMI, and waist circumference which are used to assess health status and obesity risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 14}]</data>
    </node>
    <node id="&quot;PRIMARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with primary education level show higher obesity risk when carrying the FTO rs9939609 polymorphism compared to those with university education."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;SECONDARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Similar to primary studies, individuals with secondary education also exhibit higher obesity risk associated with the FTO variant."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;UNIVERSITY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with university-level education show a lower association between the FTO rs9939609 polymorphism and anthropometric variables."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 16}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"A physiological process involving bodily movement that affects metabolism and energy expenditure, which may modify genetic effects on obesity risk when considering environmental factors like education level."&lt;SEP&gt;"The level of physical activity in an individual's lifestyle, which interacts with genetic factors like the FTO SNP to influence BMI."&lt;SEP&gt;"Physical activity is a lifestyle factor that interacts with genetic factors to modify the risk of type 2 diabetes, especially when combined with dietary interventions."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 17}]</data>
    </node>
    <node id="&quot;PREVALENCE OF OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"High prevalence of obesity is observed particularly among groups with lower education levels and specific genotypes."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Level of education can influence lifestyle choices and health outcomes, including obesity risk in relation to genetic variants like those in the FTO gene."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 16}]</data>
    </node>
    <node id="&quot;UNIVERSITY STUDIES&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engaging in university studies represents an environmental factor influencing lifestyle and health outcomes, particularly in relation to genetic variants such as the FTO SNP."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 16}]</data>
    </node>
    <node id="&quot;TCF7L2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene has SNPs that are significantly associated with BMI at baseline."&lt;SEP&gt;"The TCF7L2 gene is associated with Type 2 diabetes risk and has a specific variant rs7903146 that influences the association with disease."&lt;SEP&gt;"The TCF7L2 gene is associated with an increased risk of Type 2 Diabetes (T2D) and End Stage Renal Disease (ESRD), as indicated by the presence of a specific variant rs7903146."&lt;SEP&gt;"The TCF7L2 gene is frequently investigated for its interaction with dietary factors in the context of type 2 diabetes risk."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;GENETIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genetic variant includes specific alleles such as CC genotype and T allele, which are associated with colorectal cancer risk."&lt;SEP&gt;"Various genetic variants are associated with increased or decreased susceptibility to type 2 diabetes when interacting with environmental and lifestyle factors such as diet and physical activity."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Although not directly mentioned, dietary patterns may influence CYP24A1 activity and its variants' expression levels."&lt;SEP&gt;"Dietary patterns influence physiological processes and can interact with genotypes."&lt;SEP&gt;"Investigations into dietary patterns, including whole grain intake and fiber consumption, reveal interactions with genetic variants that influence the risk of developing type 1 or type 2 diabetes."&lt;SEP&gt;"Investigations into dietary patterns, including whole grain intake and fiber consumption, reveal interactions with genetic variants that influence the risk of developing type 2 diabetes."&lt;SEP&gt;"Patterns of dietary intake that influence metabolic processes like insulin sensitivity and secretion."&lt;SEP&gt;"There is no direct reference to dietary patterns affecting the algorithms or patient outcomes in this context."&lt;SEP&gt;"Consumption patterns of dairy products influence the expression and regulation of the LCT gene over time."&lt;SEP&gt;"Dietary patterns rich in omega-3 fatty acids can influence the metabolic pathways and inflammatory responses mediated by PPARÎ³."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6&lt;SEP&gt;chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;INTENSIVE LIFESTYLE INTERVENTION GROUP&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"An intervention group in RCTs focused on reducing weight through diet modification and increased physical activity to lower type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 17}]</data>
    </node>
    <node id="&quot;USUAL CARE CONTROL GROUP&quot;">
      <data key="d0">"CONTROL GROUP THERAPY"</data>
      <data key="d1">"A control group receiving standard care without specific lifestyle or dietary interventions, used for comparison in RCT studies."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET GROUPS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Participants randomized into two groups consuming extra-virgin olive oil or mixed nuts as part of a Mediterranean diet to assess health outcomes."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;LOW-FAT DIET GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A control group in RCTs receiving dietary advice aimed at reducing fat intake, used for comparison with intervention groups."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;WHOLE GRAIN INTAKE AND FIBER CONSUMPTION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Specific dietary factors such as whole grain consumption and fiber intake interact with genetic variants to influence type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES (T2D)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic condition characterized by high blood sugar levels over a prolonged period. The disease was assessed in relation to genetic variants associated with increased risk."&lt;SEP&gt;"A condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, influenced by genetic and environmental factors."&lt;SEP&gt;"A metabolic disorder characterized by high blood sugar levels, insulin resistance, and relative lack of insulin."&lt;SEP&gt;"A metabolic disease characterized by high blood sugar levels over an extended period due to insulin resistance or insulin deficiency, investigated for its genetic associations with CHI3LI variants."&lt;SEP&gt;"A metabolic disorder characterized by high blood sugar levels over a prolonged period due to insulin resistance or insufficient insulin production."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;NURSES' HEALTH STUDY (NHS)&quot;">
      <data key="d0">"STUDY COHORT"</data>
      <data key="d1">"A longitudinal cohort study that follows nurses from the United States over time to understand health outcomes, including diet and physical activity effects on diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;FINISH DIABETES PREVENTION STUDY (DPS)&quot;">
      <data key="d0">"RCT STUDY"</data>
      <data key="d1">"An RCT evaluating lifestyle interventions against standard care for reducing type 2 diabetes risk in high-risk individuals."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 17}]</data>
    </node>
    <node id="&quot;AMERICAN DIABETES PREVENTION PROJECT (DPP)&quot;">
      <data key="d0">"RCT STUDY"</data>
      <data key="d1">"A large-scale RCT assessing the impact of intensive lifestyle intervention on reducing the incidence of type 2 diabetes compared to usual care or metformin treatment."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;PREVENCIÃN CON DIETA MEDITERRÃNEA (PREDIMED)&quot;">
      <data key="d0">"RCT STUDY"</data>
      <data key="d1">"An RCT investigating the effects of a Mediterranean diet enriched with olive oil or nuts versus a control low-fat diet on cardiovascular disease risk factors."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;GLYCEMIC INDEX AND GLYCEMIC LOAD&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"These dietary measures reflect how quickly food is converted into glucose in the bloodstream, influencing diabetes risk when combined with genetic variants."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;TCF7L2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene is associated with type 2 diabetes (T2D) risk and modifies the effect of incretins on insulin secretion."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS7903146 CC-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genotype of the rs7903146 variant in TCF7L2 is associated with lower T2D incidence when combined with higher cereal fiber or whole-grain intake."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS7903146 RISK T-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific allele of the rs7903146 variant in TCF7L2 is associated with increased T2D incidence when combined with higher cereal fiber or whole-grain intake."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of fiber, particularly cereal fiber, interacts with genetic variants to modify the risk of type 2 diabetes (T2D)."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;WHOLE-GRAIN INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Consumption of whole grains in conjunction with certain TCF7L2 genotypes can reduce T2D incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 VARIANT RS4506565&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant, rs4506565, within the TCF7L2 gene interacts with cereal fiber and whole-grain intake to modify T2D incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 VARIANT RS12255372&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant in TCF7L2 shows interaction with dietary fiber intake but not carbohydrates, affecting T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS10923931 NOTCH2 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the NOTCH2 gene interacts with fiber intake to influence type 2 diabetes (T2D) incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;ZBED3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ZBED3 gene, involved in WNT signaling pathway, shows interaction with dietary fiber intake and a genetic variant within this gene modifies T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;IRS1 RS2943641&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the IRS1 gene associated with increased insulin sensitivity interacts with carbohydrate intake to modify type 2 diabetes (T2D) incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;GIPR RS10423928&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GIPR rs10423928 variant decreases insulin secretion and shows interaction with carbohydrate intake, influencing T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARÎ VARIANTS (RS1801282, RS3856806)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the PPARÎ³ gene show a trend for interaction with fat intake to modify type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FFAR4 VARIANT RS116454156&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant of FFAR4, involved in GÎ±q signaling, interacts with low-fat diet to increase T2D incidence among certain allele carriers."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;CAV2 VARIANT RS2270188&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variation in the CAV2 gene shows interaction with total fat and saturated fatty acids to modify type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;ADH1C *1/*2 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genotype of ADH1C modifies the association between alcohol intake and T2D risk among women but not men."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HECTD4 VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the HECTD4 gene show interaction with alcohol intake to modify type 2 diabetes (T2D) risk, observed in some studies."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE RS1799945 (H63D)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant of the HFE gene interacts with heme iron intake to increase T2D risk among women and men under different study conditions."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;SLC40A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC40A1 gene, an iron-regulated transporter, shows interaction with dietary factors like heme iron to modify type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TMPRSS6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genetic variants in the TMPRSS6 gene interact with dietary intake of heme iron to influence T2D incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS11196208 A-ALLELE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the A allele of TCF7L2 variant rs11196208 show interaction with fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS7903146 AA-GENOTYPE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the AA genotype of TCF7L2 variant rs7903146 show interaction with fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS7903146 AC-GENOTYPE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the AC genotype of TCF7L2 variant rs7903146 show interaction with fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372 CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the rs12255372 variant of TCF7L2 show interaction with dietary fiber but not carbohydrates to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS4506565 CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the rs4506565 variant of TCF7L2 show interaction with dietary fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 POLYMORPHISMS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms in the TCF7L2 gene interact with diet, modifying type 2 diabetes (T2D) incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE VARIANTS RS1799945 (H63D)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the HFE gene, specifically rs1799945 (H63D), is associated with increased T2D risk among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HFE VARIANTS RS1800562 (C282Y)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the HFE gene, specifically rs1800562 (C282Y), is associated with increased T2D risk among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC40A1 VARIANTS RS744653 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the SLC40A1 gene, specifically rs744653, interacts with heme iron intake in men."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;TMPRSS6 VARIANTS RS855791 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the TMPRSS6 gene, specifically rs855791, shows borderline significant interaction with heme iron intake in a total sample."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC30A8 VARIANTS (ZINC TRANSPORTER)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genetic variants in SLC30A8 are associated with zinc intake and T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;RS16889462, 8_118252314, AND 8_118252435 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific variants in the SLC30A8 gene are associated with zinc intake but without a clear trend for an association with T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MAGNESIUM INTAKE &quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of magnesium showed no interaction with genetic variants regarding T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;VITAMIN A INTAKE &quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of vitamin A showed no interaction with genetic variants regarding T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;RED MEAT &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"High intake of red meat increases the risk to develop T2D among men with a high GRS, but not among those with a low GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PROCESSED MEAT &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"High intake of processed meat increases the risk to develop T2D among men with a high GRS, but not among those with a low GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;OLIVE OIL &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Consumption of olive oil shows a marginally nonsignificant interaction with genetic variants such as rs10423928 in EPIC-InterAct."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Association of dairy products with T2D incidence may be modified by the lactase persistence LCT gene variant, rs4988235."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;COFFEE &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Consumption of coffee can modify T2D risk depending on genetic variants such as TCF7L2 and IGF2BP2."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;WESTERN DIETARY PATTERN &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A Western dietary pattern is associated with higher T2D risk among persons with a high T2D-GRS, but not among those with a low GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Following a Mediterranean diet lowers the incidence of T2D depending on genetic variants such as rs4580796 (CLOCK)."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of physical activity can modify T2D risk based on genetic variants like HNF1B and IRS1."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PPARÎ VARIANTS RS1801282 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the PPARÎ³ gene, such as rs1801282, are associated with changes in leisure-time physical activity (LTPA) and T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;ADRA2B GLU12-ALLELE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ADRA2B Glu12-allele shows an increase in leisure-time physical activity (LTPA) resulting in lower T2D incidence compared to others."&lt;SEP&gt;"This variant shows an increase in LTPA resulting in lower T2D incidence compared to others."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;KCNJ11 VARIANTS RS5215 CC-GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with a reduced combined prediabetes and T2D risk among coffee consumers."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;T2D-GRS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A polygenic risk score for type 2 diabetes can modify the effect of dietary patterns and physical activity on T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC39A4 VARIANTS RS1790250 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the SLC39A4 gene, specifically rs1790250, are associated with zinc intake and may influence T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;TCF7L2 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Common variants in the TCF7L2 gene are strongly associated with an increased risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;IGF2BP2 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in IGF2BP2 contribute to the development of type 2 diabetes and obesity, depending on genetic predisposition."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;FABP2 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the FABP2 gene are linked to altered lipid metabolism and can modify T2D risk based on dietary fat intake."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MYO1D VARIANTS RS6795034 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with changes in dietary fat consumption and may influence T2D incidence, particularly among individuals consuming a high-fat diet."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;IRS1 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the IRS1 gene are associated with altered insulin sensitivity and can modify the risk of developing type 2 diabetes based on lifestyle factors like diet and physical activity."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;APOE Î4-ALLELE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The APOE Îµ4-allele is linked to increased cholesterol levels and may interact with dietary fats, affecting T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;CLOCK GENE VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the CLOCK gene are associated with circadian rhythm regulation and can modify T2D risk based on dietary patterns such as adherence to a Mediterranean diet."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HNF1A VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Mutations in the HNF1A gene cause maturity-onset diabetes of the young (MODY) type 3, which is distinct from type 2 diabetes but shares genetic risk factors."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;KCNQ1 VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in KCNQ1 are associated with an increased risk for T2D and can interact with environmental factors like physical activity to modify disease risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MTNR1B VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the MTNR1B gene, which encodes a melatonin receptor, increase T2D risk through altered pancreatic beta-cell function."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PTPN11 VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms in PTPN11 may influence insulin resistance and T2D risk depending on dietary habits and physical activity levels."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PPARA VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the PPARA gene are associated with altered lipid metabolism and can interact with dietary fat intake to modify T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;WFS1 VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The WFS1 gene is implicated in both type 1 diabetes (T1D) and type 2 diabetes (T2D), particularly its variants that affect beta-cell function and glucose homeostasis."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC2A2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC2A2 gene contains multiple variants including rs5393, rs5394, rs5400, and rs5404."&lt;SEP&gt;"The SLC2A2 gene, also known as the GLUT2 transporter gene, showed associations with ketone body levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5393, RS5394, RS5400, AND RS5404&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are specific genomic variants within the SLC2A2 gene that have been investigated for their interaction with lifestyle factors like LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LTPA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LTPA refers to long-term physical activity, which may influence genetic expression and disease risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a specific variant of the TCF7L2 gene associated with type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;RS7903146 RISK TâALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This allele of rs7903146 is also linked to an increased risk for T2D, but showed lower incidence in intervention groups."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;ENPP1 RS1044498 DIABETOGENIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant within the ENPP1 gene that is associated with a higher risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;MC4R RS17066829&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant in MC4R shows a trend for interaction with weight loss interventions but no significant interaction tests were found."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;PPARÎ RS1152003 CCâGENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The PPARÎ³ gene variant rs1152003, specifically the CC genotype, shows a lower T2D incidence in intervention groups compared to controls."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;TNFÎ RS1800629 GGâGENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant of TNFÎ± is associated with reduced T2D risk in intervention groups."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;ADRA2B GLU9-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ADRA2B gene's Glu9 allele was found to have a lower incidence of type 2 diabetes upon weight loss interventions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LIPC RS2070895 AâALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant in the LIPC gene is linked with reduced risk of T2D under intervention conditions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;GENETIC VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genetic variants have a limited impact on microbial taxa variability, requiring caution when performing and interpreting causality estimation using MR analysis."&lt;SEP&gt;"Various genetic variants have been studied for their interaction with weight loss interventions in reducing type 2 diabetes risk."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Interventions aimed at promoting weight loss to reduce the risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RCT STUDY POPULATIONS&quot;">
      <data key="d0">"STUDY TYPE"</data>
      <data key="d1">"Randomized controlled trial study populations where genetic interactions with lifestyle factors are investigated."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS4506565&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs4506565 variant within the TCF7L2 gene interacts with dietary fiber and whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS12255372&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs12255372 variant within the TCF7L2 gene shows interaction with dietary fiber but not carbohydrates, affecting type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOTCH2 GENE&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"A genetic variant in the NOTCH2 gene interacts with fiber intake, influencing type 2 diabetes risk among individuals carrying a specific allele of this gene."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FFAR4 VARIANT&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Variants in PPARÎ³ show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PPARÎ VARIANTS&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Variants in PPARÎ³ show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY FACTORS&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Polymorphisms in TCF7L2 interact with various dietary factors, including fiber and whole grains, to influence type 2 diabetes incidence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"This genetic variant of TCF7L2 is significantly associated with a reduced incidence of type 2 diabetes in intervention studies compared to control groups."&lt;SEP&gt;"Type 2 Diabetes (T2D) is a disease characterized by high blood sugar levels over a prolonged period. It can be associated with obesity and is influenced by genetic factors."&lt;SEP&gt;"Type 2 diabetes (T2D) risk influenced by genetic loci and CRP levels."</data>
      <data key="d0">"DISEASE"</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;WEIGHT LOSS INTERVENTION&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d1">"While there's a trend towards interaction, the MC4R variant does not show significant interactions with weight loss interventions for reducing T2D incidence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES (T2D)&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d1">"Certain genetic variations increase susceptibility to developing type 2 diabetes, and their interaction with lifestyle factors can modify disease risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7903146 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in TCF7L2, specifically rs7903146, is significantly associated with an increased risk of Type 2 Diabetes and End Stage Renal Disease."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;WFS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The WFS1 gene has a variant, rs10010131, that shows an association with T2D in the study sample."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS10010131 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant in WFS1 (rs10010131) is associated with Type 2 Diabetes risk, according to the results of the individual SNP analysis."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CDKAL1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CDKAL1 gene includes a genetic variant rs10946398 that shows an association with T2D in both sets of case subjects and controls."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS10946398 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs10946398) within the CDKAL1 gene is significantly associated with Type 2 Diabetes, as indicated by odds ratios and confidence intervals."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;JAZF1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The JAZF1 gene harbors a genomic variant rs864745 which demonstrates association with T2D risk in both sets of cases and controls."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS864745 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant, rs864745 within JAZF1, is associated with an increased risk of Type 2 Diabetes according to the individual SNP analysis results."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;ADAMTS9 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ADAMTS9 gene has a genomic variant rs4607103 that demonstrates an association with T2D in set 1 and meta-analysis, but with a different direction compared to European samples."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS4607103 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic variant (rs4607103) within ADAMTS9 shows an association with T2D risk in set 1 of the study, but it's direction is opposite to previous reports."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;END STAGE RENAL DISEASE (ESRD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The final stage of chronic kidney disease, often requiring dialysis or transplantation. It was observed more frequently among cases with certain genetic markers for T2D."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CUMULATIVE RISK SCORE&quot;">
      <data key="d0">"METRIC"</data>
      <data key="d1">"A cumulative risk score based on genetic variants was used to assess the combined effect of multiple risk alleles in predicting Type 2 Diabetes (T2D) risk."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;LOGISTIC REGRESSION MODEL&quot;">
      <data key="d0">"MODEL/FRAMEWORK"</data>
      <data key="d1">"A statistical model used to evaluate the association between cumulative risk allele load and disease status in T2D patients and controls."&lt;SEP&gt;"A statistical model used to evaluate the relationship between cumulative risk allele load and disease status in T2D patients and controls."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS7903146&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs7903146 is a genomic variant within the TCF7L2 gene linked to Type 2 diabetes risk when adjusted for in genetic analyses."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, influenced by genetic factors such as variants within the TCF7L2 gene."&lt;SEP&gt;"A chronic disease characterized by high blood sugar due to insulin resistance or reduced insulin production; shown to have associations with specific SNPs related to ketone body metabolism."&lt;SEP&gt;"Type 2 diabetes is a metabolic disease characterized by high blood sugar levels over time."&lt;SEP&gt;"A disease outcome that was significantly associated with black and sugared coffee consumption in the study."&lt;SEP&gt;"Type 2 diabetes is a chronic condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production."&lt;SEP&gt;"Type 2 diabetes is a disease characterized by high blood sugar levels over a prolonged period, typically resulting from insulin resistance and relative insulin deficiency."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Analyzing genetic variants such as rs7903146 in the context of Type 2 diabetes risk involves examining their impact on disease susceptibility."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;TCF7L2 RISK VARIANT&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCF7LL2 RISK VARIANT&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 7 DIABETES RISK ANALYSIS&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Genetic analysis shows that adjusting for the genomic variant rs7903146 in TCF7L2 gene removes significant associations with Type 2 diabetes, suggesting its importance."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;RISK ALLELES COUNT&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The count of risk alleles is a factor influencing the association with Type 2 diabetes, particularly when considering variants like rs7903146 in TCF7L2."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE FACTOR&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"There was no evidence for interaction between age and Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEX FACTOR&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"No significant interaction with sex was found in the analysis of Type 2 diabetes risk associated with the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI FACTOR&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Body Mass Index (BMI) did not significantly interact with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEGREE OF AFRICAN ANCESTRY&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The degree of African ancestry had no significant interaction with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG/IGT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Impaired Fasting Glucose/Impaired Glucose Tolerance (IFG/IGT) refers to the physiological processes where individuals have higher than normal blood glucose levels but not high enough to be classified as diabetes. These conditions are linked to an increased risk of developing Type 2 Diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FPG measures the concentration of glucose in the blood after an overnight fast, used to diagnose prediabetes and type 2 diabetes."&lt;SEP&gt;"FPG measures the concentration of glucose in the blood after fasting, used as one indicator for diagnosing diabetes or prediabetes conditions like IFG/IGT."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TWO-HOUR PLASMA GLUCOSE (2HPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"2hPG is a test taken two hours after consuming a standard glucose drink and measures blood sugar levels, used in assessing risk for Type 2 Diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;NGT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Normal Glucose Tolerance (NGT) refers to the physiological state where an individual's blood glucose level remains within the normal range after consuming a standard glucose drink."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (SNPS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Obesity predisposing SNPs are genetic variants that influence an individualâs susceptibility to obesity and associated conditions like T2D."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;EAST ASIAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Individuals of East Asian ancestry in the EpiDREAM cohort study showed a lower prevalence of IFG/IGT and T2D compared to other ethnic groups, indicating potential genetic or environmental factors unique to this group."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;AFRICAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Individuals with African ancestry had higher rates of IFG/IGT and T2D than those with East Asian ancestry, suggesting differences in disease risk across populations."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;EUROPEAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"The prevalence of IFG/IGT and T2D among individuals of European descent was lower compared to African but higher than East Asian groups, indicating varied genetic predispositions or environmental exposures."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;NATIVE NORTH AMERICAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Subjects with Native North American ancestry had the lowest rate of IFG/IGT and a relatively low prevalence of T2D among all ethnic categories in the study."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 9}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;LATINO AMERICAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"The Latino American population exhibited higher rates of both IFG/IGT and T2D compared to East Asian individuals, indicating significant disparities in disease risk across different populations."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;SOUTH ASIAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Individuals with South Asian ancestry had high incidences of IFG/IGT (43.5%) and T2D (16.1%), highlighting the importance of genetic and environmental factors in this group."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TAL1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TAL1 gene is associated with obesity predisposition according to the text."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;LEPR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LEPR gene contains a SNP (rs1011527) that interacts with fasting plasma glucose (FPG) on baseline body mass index (BMI)."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms (SNPs) are genetic variants associated with obesity."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;GRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genotype risk score (GRS), a measure of cumulative genetic risk, is significantly associated with increased BMI at baseline."&lt;SEP&gt;"The Genetic Risk Score (GRS) is derived from polymorphisms and is associated with cognitive performance metrics in patients."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;BMI BASELINE AND CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Body mass index (BMI) at baseline and change are key physiological processes studied for their association with obesity SNPs and GRS."&lt;SEP&gt;"Body mass index at baseline and changes in BMI over time are studied for their association with obesity SNPs and GRS."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"A glycemic status trait that interacts with the rs1011527 SNP in LEPR on baseline BMI, indicating its role in modulating genetic effects on obesity."&lt;SEP&gt;"FPG is a glycemic status trait that interacts with the rs1011527 SNP in LEPR on baseline BMI."&lt;SEP&gt;"A measure of blood sugar after an overnight fast; elevated in individuals with IFG, IGT, and T2DM compared to those without abnormal glucose levels."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;SNPS IN FTO, TAL1, AND TCF7L2 GENES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific SNPs within the FTO, TAL1, and TCF7L2 genes are associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;RS9939609 SNP IN FTO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the FTO gene is significantly associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS2984618 SNP IN TAL1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the TAL1 gene is significantly associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS7903146 SNP IN TCF7L2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the TCF7L2 gene is significantly associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GRS (GENOTYPE RISK SCORE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A cumulative genetic risk measure that is significantly associated with increased BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS1011527 SNP IN LEPR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the LEPR gene interacts with fasting plasma glucose (FPG) on baseline BMI, but shows no significant main effect on BMI alone."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;OBESITY PREDISPOSING SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs associated with increased risk of obesity."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMI LEVEL AND CHANGE ASSOCIATIONS AND INTERACTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The associations between obesity predisposing SNPs, GRS, and BMI level as well as changes in BMI over time are significant areas of study."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;2HPG&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;FPG&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;BMI BASELINE AND CHANGE ASSOCIATIONS AND INTERACTIONS&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The GRS is significantly associated with increased BMI at baseline, indicating cumulative genetic risk in the context of obesity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR 1298A&gt;C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in the MTHFR gene at position 1298, associated with an increased risk of neurocognitive impairment."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MS 2756A&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in the MS gene at position 2756, linked to a higher likelihood of neurocognitive deficits."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTHFR 677C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism identified in the MTHFR gene which did not show significant associations with impaired performance on neurocognitive tests."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;SHMT 1520C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the SHMT gene that was not significantly associated with neurocognitive impairment or performance measures."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTRR 66A&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in the MTRR gene, showing no significant association with the assessed cognitive measures but impacting some fine motor skills tests."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TSER POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms within the TSER region affecting performance on attention and processing speed tests (TMTA/TMTB)."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PEGDH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Paired Associate Learning Digit Span High Load (PEGDH), a test measuring aspects of attention and memory."&lt;SEP&gt;"Test assessing fine motor skills, showing some association with genetic polymorphism effects."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;PEGNDH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Neurocognitive test for fine motor skills and executive function, revealing correlations with MTRR 66A&gt;G genotypes."&lt;SEP&gt;"Paired Associate Learning Number Digit High Load (PEGNDH) measures cognitive function under high load conditions."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;DIG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Digit Span Test (DIG), assessing working memory and attention."&lt;SEP&gt;"Working memory test that did not show associations with genetic polymorphisms or other covariates."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;CFL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Coding Figure Learning (CFL), a test for visual learning and immediate recall."&lt;SEP&gt;"Test for executive function, indicating a significant association with MTRR 66A&gt;G genotypes."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/DISEASE"</data>
      <data key="d1">"Early exposure to MTX leading to neurotoxic symptoms and later increased risk of long-term cognitive impairments."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TMTA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Test assessing focused attention and processing speed."&lt;SEP&gt;"Trail Making Test Part A (TMTA) measures visual search speed and processing speed, indicating executive function."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;TMTB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Test measuring shifting attention and processing speed."&lt;SEP&gt;"Trail Making Test Part B (TMTB) assesses cognitive flexibility, executive control, and working memory."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;DIVERGT BATTERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"A comprehensive cognitive assessment tool used to evaluate various aspects of cognitive function in patients."&lt;SEP&gt;"Battery of neurocognitive tests used to assess impairment in the study population."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;MTX&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Methotrexate (MTX) is used in the treatment of certain diseases, particularly as an intrathecal exposure in cancer therapy."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variation at the DNA sequence level that contributes to the Genetic Risk Score (GRS)."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;INTRATHECAL MTX EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The administration of methotrexate directly into the cerebrospinal fluid for treatment, affecting cognitive performance."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;CUMULATIVE IV MTX EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Total amount of intravenous methotrexate administered over time, impacting patient outcomes and genetic risk scores."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Carriers of the MTHFR 1298AC/CC genotypes are at a higher risk for neurocognitive deficits compared to those with AA genotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEGNDH SCORE DIFFERENCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MS 2756AA genotype scored lower on the PEGNDH test compared to those with AG/GG genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CFL PERFORMANCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Individuals carrying MTRR 66AA genotype showed significantly worse performance in executive function tests (CFL)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LONG-TERM NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Early MTX-induced neurotoxic symptoms were predictive of long-term cognitive deficits, despite no significant effect on all test measures."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMTB PERFORMANCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MTHFR 1298AC/CC genotypes scored significantly lower on TMTB compared to those with AA genotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMTA PERFORMANCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors carrying MS 2756AA genotype performed worse on TMTA than survivors with AG/GG genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FINE MOTOR SKILLS&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEGDH TEST&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTRR 66A&gt;G GENOTYPES&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEGNDH TEST&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIG TEST&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WORKING MEMORY&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLC30A8 RS13266634&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant SLC30A8 rs13266634 is associated with higher fasting proinsulin levels at baseline."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting proinsulin levels are significantly affected by the genetic risk allele of SLC30A8 and interventions such as lifestyle changes, metformin, or troglitazone."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;LIFESTYLE INTERVENTION GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The lifestyle intervention group showed a significant decrease in fasting proinsulin levels compared to the placebo and medication groups after one year of DPP intervention."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;METFORMIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Metformin is used as an intervention in the DPP study for reducing proinsulin levels, but its efficacy was less pronounced than lifestyle changes."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TROGLITAZONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Troglitazone was another drug used in the DPP study to reduce fasting proinsulin levels; however, it showed similar effectiveness as metformin compared to lifestyle interventions."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;C RISK ALLELE AT SLC30A8 RS13266634&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The C risk allele at the genomic variant SLC30A8 rs13266634 is associated with higher fasting proinsulin levels and does not modify treatment effectiveness in a gene-treatment interaction."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DPP COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The DPP cohort represents participants involved in a diabetes prevention program intervention study."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING INSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting insulin levels are measured and used as an adjustment factor in the analysis of proinsulin levels related to SLC30A8 risk allele and treatment effects."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;AGE, SEX, ETHNICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Demographic factors such as age, sex, and ethnicity were considered covariates for adjusting proinsulin level associations."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;PNPLA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PNPLA3 is a gene that plays a role in lipid metabolism regulation, particularly in the liver."&lt;SEP&gt;"The PNPLA3 gene is involved in lipid metabolism and its expression can be influenced by glucose levels, fatty acids, and other metabolic factors."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;SREBP1C&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SREBP1c is a transcriptional factor important for regulating genes involved in lipid metabolism."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;ACC-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ACC-1 gene encodes acetyl-CoA carboxylase, which catalyzes the formation of malonyl-CoA for fatty acid synthesis."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HIGH CARBOHYDRATE DIET (HC)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"High carbohydrate diet is a dietary pattern characterized by high intake of carbohydrates."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;LIPID EMULSION (LE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lipid emulsion is a nutritional supplement that contains lipids, providing an alternative energy source to glucose."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;STEROL REGULATORY ELEMENT BINDING PROTEIN 1C (SREBP1C)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SREBP1c regulates the expression of genes involved in lipid biosynthesis and transport as a physiological process."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HIGH-FAT DIET (HF)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern high in fat, contributing to fatty liver development when consumed chronically."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;EXERCISE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Voluntary exercise is a lifestyle factor that can modulate gene expression and physiological processes in the body."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;GLUCOSE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Glucose is a critical nutrient for cellular metabolism, particularly affecting glycolysis and lipid synthesis pathways."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;CHREBP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Carbohydrate response element binding protein (ChREBP) regulates the expression of genes involved in glucose metabolism and storage."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;FATTY ACID SYNTHASE (FAS)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAS is a gene encoding an enzyme responsible for synthesizing fatty acids from acetyl-CoA."&lt;SEP&gt;"Fatty acid synthase, a key enzyme in lipid synthesis, shows increased mRNA expression upon PNPLA3 knockdown."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;2-DEOXY-D-GLUCOSE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"2-deoxy-D-glucose is a nutrient that suppresses PNPLA3 levels and reduces lipid accumulation in cells."&lt;SEP&gt;"Non-metabolizable glucose analog used to study the effects of glycolytic inhibition on cellular processes."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;CITRATE&quot;">
      <data key="d0">"METABOLIC PATHWAY INTERMEDIATE"</data>
      <data key="d1">"Citrate, an intermediate of the Krebs cycle, increases PNPLA3 protein levels."&lt;SEP&gt;"Krebs cycle intermediate that can influence metabolic pathways, including lipid synthesis."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;PYRUVATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Pyruvate does not influence PNPLA3 levels, unlike citrate and acetate."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ACETATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Acetate does not impact PNPLA3 expression levels in cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;FAS (FATTY ACID SYNTHASE)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Fatty acid synthase, a key lipogenic enzyme, shows similar expression patterns to PNPLA3 under different metabolic conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ACC-1 (ACETYL-COA CARBOXYLASE 1)&quot;">
      <data key="d0">"GENE/PROTEIN"</data>
      <data key="d1">"The gene and protein ACC-1 show expression patterns similar to PNPLA3 in response to various metabolic stimuli."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;INSULIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A hormone produced by beta cells in the pancreas, crucial for regulating blood glucose levels and metabolism."&lt;SEP&gt;"A hormone that regulates blood glucose levels; administration can delay but not prevent type 1 diabetes progression when used prophylactically."&lt;SEP&gt;"Insulin is a hormone that does not regulate hepatic PNPLA3 expression in HepG2 cells, unlike its effects on other genes and proteins."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;GLUCAGON&quot;">
      <data key="d0">"HORMONE/NUTRIENT"</data>
      <data key="d1">"Glucagon stimulation has no effect on the expression of PNPLA3 in HepG2 cells under low glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;OLEIC ACID (OA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Oleic acid suppresses PNPLA3 gene expression and does not affect lipid accumulation when PNPLA3 is knocked down."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LINOLEIC ACID (LA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Linoleic acid decreases PNPLA3 mRNA levels under both low and high glucose conditions in HepG2 cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;Î-LINOLENIC ACID (ALA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Alpha-linolenic acid does not influence PNPLA3 expression levels compared to oleic or linoleic acids."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;EICOSAPENTAENOIC ACID (EPA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"EPA reduces the gene expression of PNPLA3 and other lipogenic factors like SREBP1c and FAS."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"DHA suppresses PNPLA3 mRNA levels under both glucose conditions, similar to EPA's effects."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;OIL RED O STAINING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METHOD"</data>
      <data key="d1">"The technique used to measure lipid accumulation in cells treated with various metabolic stimuli."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;HIGH GLUCOSE CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/METABOLIC STATE"</data>
      <data key="d1">"A high glucose environment can induce PNPLA3 expression and lipid accumulation, which is suppressed by specific fatty acids or metabolic intermediates like citrate."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LOW GLUCOSE CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/METABOLIC STATE"</data>
      <data key="d1">"A state of lower glucose availability compared to high glucose conditions, impacting metabolic pathways including PNPLA3 regulation."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;HIGH GLUCOSE LEVELS&quot;">
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d1">"Treatment with 2-deoxy-D-glucose inhibits the induction of SREBP1c and PNPLA3 by high glucose levels, indicating it disrupts metabolic pathways dependent on glucose metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Expression patterns of FAS and PNPLA3 are similar under various metabolic conditions, including high glucose levels."&lt;SEP&gt;"Fetal Alcohol Syndrome (FAS) is the most severe form of Fetal Alcohol Spectrum Disorders, characterized by pre- and postnatal growth retardation, central nervous system abnormalities, and craniofacial malformations."</data>
      <data key="d0">"DISEASE"</data>
    </node>
    <node id="&quot;PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Treatment with glucagon stimulates PC expression while having no effect on PNPLA3 mRNA levels, indicating specificity of hormonal effects."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SREBP1C, FAS, PNPLA3&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"La and oleic acid reduce the mRNA levels of SREBP1c, FAS, and PNPLA3 under both low and high glucose conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FATTY ACIDS RATIO MIX&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"The combination of OA:LA:ALA suppresses the gene expressions of SREBP1c, FAS, and PNPLA3 to a greater extent than individual fatty acids."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIPID ACCUMULATION&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Used for assessing lipid accumulation in HepG2 cells following metabolic perturbations like varying glucose conditions or exogenous fatty acid treatments."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLUCAGON, PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Under low glucose conditions, glucagon stimulation increases the expression of PC but does not affect PNPLA3 mRNA levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNPLA3 KNOCKDOWN&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"PNPLA3 knockdown results in increased mRNA levels of FAS, a key lipogenic enzyme."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNS EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to prenatal stress (PNS) causes changes in gene expression and miRNA levels in the hippocampus of adult male rats."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;HIPPOCAMPAL TRANSCRIPTOME CHANGES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"Significant modulation of 916 genes in the transcriptome of the hippocampus following PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;NEURODEVELOPMENT PATHWAYS&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Pathways involved in neurodevelopment such as Axonal Guidance Signaling, Protein Kinase A Signaling, Glutamate Receptor Signaling were affected by PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;INFLAMMATION PATHWAYS&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Pathways related to inflammation like IL-8 Signaling and STAT3 Pathway were altered in response to PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;MIRNOME CHANGES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"Significant changes in miRNA levels including 68 differentially regulated miRNAs following PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;BLOOD MRNA TRANSCRIPTOMICS CHANGES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"Differentially modulated genes (250) identified in blood samples of humans exposed to early life trauma, involved in neurodevelopment and inflammation pathways."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;GENE-PATHWAY INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Top-hit genes were both modulated by PNS exposure and targeted by miRNAs that were also altered due to stress; these interactions involve key processes such as Axonal Guidance and Glucocorticoid Receptor Signaling."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;EARLY LIFE TRAUMA EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to early life trauma leads to significant changes in blood mRNA transcriptomics, mirroring findings from PNS model studies."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;COMMON GENE OVERLAP&quot;">
      <data key="d0">"GENE INTERACTION"</data>
      <data key="d1">"22 common genes were found between the hippocampal transcriptome of PNS-exposed rats and blood transcriptomes of humans with early life trauma exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;REAL-TIME PCR VALIDATION&quot;">
      <data key="d0">"EXPERIMENTAL METHOD"</data>
      <data key="d1">"All 22 overlapping genes were validated by Real-Time PCR in both rat hippocampus and human blood samples, confirming their expression patterns."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;916 SIGNIFICANTLY MODULATED GENES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"A total of 916 genes were significantly modulated in the hippocampus following PNS exposure, with a fold change &gt;1.4 and q-value &lt;0.05."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;ISOC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Isochorismatase Domain Containing 1 (ISOC1) is a gene involved in certain metabolic processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LDLRAP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1) is a gene associated with lipid metabolism and transport."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LRRN3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Leucine-rich repeat neuronal protein 3 (LRRN3) is a gene involved in neuronal functions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;MYO1D&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Myosin ID (MYO1D) is a gene that encodes for myosin, an important motor protein involved in various cellular processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PIK3C2B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Beta (PIK3C2B) is a gene associated with phospholipid metabolism and signal transduction."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PPAP2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phosphatidic Acid Phosphatase Type 2A (PPAP2A) is a gene involved in lipid phosphate metabolism."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SAMD12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Sterile Alpha Motif Domain Containing 12 (SAMD12) is a gene with functions yet to be fully elucidated but possibly related to cellular signaling and development."&lt;SEP&gt;"Sterile Alpha Motif Domain Containing 12 (SAMD12), further noted to be involved in various biological processes, including immune responses." Changing this based on context: Sterile Alpha Motif Domain Containing 12 (SAMD12) is a gene that may play roles in cellular signaling and development, but its specific functions remain under investigation.</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SERINC5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Serine Incorporator 5 (SERINC5) is a gene involved in protein modification processes, particularly in the addition of serine residues to proteins."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TGF-Î1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Transforming Growth Factor Beta 1 (TGF-Î²1) is a gene encoding for a cytokine that regulates cell growth and differentiation, as well as immune response and tissue repair."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;A2M&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Alpha-2-Macroglobulin (A2M) is a gene involved in the regulation of proteolytic processes and innate immunity."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARID5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"AT-rich Interaction Domain Containing Protein 5B (ARID5B) is a gene associated with DNA binding and transcriptional regulation."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARRDC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Adaptor Related Gene with RhoGTPase Domain C4 (ARRDC4) is a gene involved in intracellular signaling pathways."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;EPHA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Ephrin Type-A Receptor 4 (EPHA4) is a gene that encodes for receptors involved in cell adhesion and communication processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FBXO32&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"F-box Protein 32 (FBXO32) is a gene involved in ubiquitination, a post-translational modification process crucial for protein degradation."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FOXO1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Forkhead Box O1 (FoxO1) is a gene encoding for transcription factors that regulate metabolism and stress response pathways."&lt;SEP&gt;"FoxO1 is a gene activated in hippocampal progenitor stem cells following cortisol exposure and mediates the negative effect of stress on neurogenesis."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HSF2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Heat Shock Factor Protein 2 (HSF2) is a gene involved in the regulation of cellular responses to heat shock and other forms of stress."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;GXE INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Gene-Environment Interaction (GxE) describes the interaction between genetic factors and environmental conditions that can influence phenotypic outcomes such as depression severity."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;DEPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A complex disorder influenced by multiple genes interacting through common or overlapping signaling systems."&lt;SEP&gt;"Maternal depression is a mental health condition that can have adverse effects on pregnancy outcomes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;EMOTIONAL STRESS IN CHILDHOOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental factor that interacts with genetic factors to predict depressive symptoms in adulthood."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BDI SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of the severity of depressive symptoms used for assessing individual differences in response to stress and trauma."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"B-Cell CLL/Lymphoma 2 (BCL2) is a gene involved in regulating apoptosis and cell survival."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"B-Cell CLL/Lymphoma 9 (BCL9) is a gene associated with the Wnt signaling pathway and cellular proliferation."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SOMATIC MUTATIONS IN GENES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Mutations within genes such as BCL2 and BCL9 can influence their interaction with environmental factors like stress."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific genomic variants or SNPs were used in the MR Egger and IVW analyses to detect causal effects of nutrients on physiological outcomes."&lt;SEP&gt;"Specific variations in DNA sequences studied, including those in the FADS gene cluster."&lt;SEP&gt;"Specific variations in the DNA sequence that occur at a single nucleotide position, affecting gene expression or function."&lt;SEP&gt;"Three minor alleles for SNPs (rs1998220, rs9534511, and rs4938056) were associated with increased risk of social disinhibition while three others (rs16116, rs16870286, and rs1003921) showed protective effects."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;CHILDHOOD SEXUAL ABUSE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental factor contributing to GxE interactions with genes such as TGF-Î²1 and A2M."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PHYSICAL ABUSE IN CHILDHOOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A type of environmental stress influencing gene expression, particularly for genes like FoxO1."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;EMOTIONAL ABUSE IN CHILDHOOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Another form of childhood trauma interacting with multiple genes to predict adult depression severity."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;CORTISOL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cortisol is a human stress hormone that induces FoxO1 upregulation and reduces neuronal proliferation in vitro."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;AS1842856&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"AS1842856 is an inhibitor of FoxO1 used to test the functional relevance of FoxO1 in cortisol-induced reduction of neuronal proliferation."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SGK-1 is a stress-responsive gene elevated in both hippocampus and blood under conditions of stress, mediating some glucocorticoid effects on brain function."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEUROGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neurogenesis refers to the process by which new neurons are generated, negatively affected by cortisol through FoxO1 signaling pathway."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;GLUCOCORTICOID EFFECTS ON BRAIN FUNCTION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This pathway includes processes like SGK-1 upregulation in response to stress and glucocorticoids, affecting brain function such as neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with emotional abuse has been identified."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HIPPOCAMPUS&quot;">
      <data key="d0">"ANATOMICAL LOCATION"</data>
      <data key="d1">"The hippocampus is a brain region where FoxO1 expression is altered following stress exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"This cell line, established from human fetal tissue, serves as an in vitro model for studying the effects of cortisol on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CHILDHOOD TRAUMA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Childhood trauma is associated with upregulation of FoxO1 expression in blood samples."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;PROGENITOR STEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These cells are found in the hippocampus and show altered FoxO1 activity following cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of neuronal proliferation is reduced by cortisol, mediated through FoxO1 signaling pathway."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;STRESSED RATS&quot;">
      <data key="d0">"ANIMAL MODEL"</data>
      <data key="d1">"Rats exposed to stress show elevated levels of SGK-1 in the hippocampus."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;DEPRESSED PATIENTS&quot;">
      <data key="d0">"PATIENT GROUP"</data>
      <data key="d1">"Blood samples from depressed patients exhibit elevated levels of SGK-1, indicating a link with brain function alterations."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR (EMOTIONAL STRESS IN CHILDHOOD)&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"The interaction between FoxO1 gene variants and early emotional stress predicts depressive symptoms in adulthood, as observed in two independent clinical cohorts."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4771122&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs4771122) associated with long-term weight loss after bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PRE-SURGICAL BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Pre-surgical body mass index, a measure of obesity before bariatric surgery that influences post-operative outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;LONG-TERM WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of weight loss over an extended period after bariatric surgery, influenced by genetic factors like rs4771122."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;BARIATRIC SURGERY&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"A surgical procedure performed to treat obesity and associated health conditions, impacting long-term weight loss and physiological processes post-surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;WEIGHT OBSERVATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurements of body weight taken at various times after bariatric surgery to assess the effectiveness of weight loss over time."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;TRAJECTORY GROUP MEMBERSHIP&quot;">
      <data key="d0">"DISEASE RISK FACTOR"</data>
      <data key="d1">"Classification based on patterns of weight change post-surgery, indicating different trajectories in weight management outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;NADIR WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The maximum percentage of initial body weight lost after bariatric surgery, an important marker for long-term success and health benefits."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;TWO YEAR PERCENT WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Weight loss measured at two years post-surgery, used to assess the immediate efficacy of bariatric surgery on weight reduction."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;GCK GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GCK gene is associated with maturity-onset diabetes of the young (MODY), a monogenic form of diabetes caused by mutations in specific genes involved in glucose metabolism."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SANGER SEQUENCING AND MODY GENE PANEL TESTING METHODS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are methods used for identifying genetic variations, particularly pathogenic variants, within the GCK gene that lead to GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The specific mutations in the GCK gene identified through sequencing which are associated with causing or potentially causing GCK-MODY according to ACMG guidelines."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;ACMG GUIDELINES FOR GENOMIC VARIANT INTERPRETATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A set of criteria used by geneticists and clinicians to determine the clinical significance of genomic variants, especially in the context of diagnosing genetic disorders like GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK-MODY (DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of monogenic diabetes resulting from mutations in the glucokinase gene leading to altered glucose sensing and regulation."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SEQUENCING ANALYSIS OF GENETIC VARIANTS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which genetic variations are detected and analyzed for their potential impact on health, particularly in relation to GCK-MODY and other monogenic diabetes conditions."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CO-SEGREGATION WITH DIABETES PHENOTYPE TESTING &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A method used to confirm the relationship between a specific genetic variant (like those found in the GCK gene) and the manifestation of type 2 diabetes in family members, providing evidence for causation."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK GENE VARIANTS (VUS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genetic variants identified in the GCK gene that have an uncertain clinical significance according to ACMG guidelines."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PARENTAL/EXTENDED FAMILY DNA TESTING &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process where family members of probands with suspected GCK-MODY undergo testing for specific genetic variations to confirm co-segregation patterns and assess disease risk."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;IN-SILICO PREDICTION TOOLS &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Tools used computationally to predict the impact of genetic variants on protein function, aiding in their classification as pathogenic or benign."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;FASTING HYPERGLYCEMIA LEVELS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure indicating elevated blood glucose levels after fasting, which is used to assess metabolic health and disease risk."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;HBA1C TESTING &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A test measuring the average blood sugar level over a period of 2-3 months, providing insight into long-term diabetes management."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANTS (VUS)&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Testing family members for VUS helps confirm co-segregation with disease phenotype, aiding in variant classification."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Adherence to the Mediterranean diet was observed among individuals with various characteristics such as lower BMI, higher education levels, and physical activity."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;TAG CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Triglyceride (TAG) concentration is a metabolic marker that shows significant differences in adherence categories of the Mediterranean Diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;HDL-C CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"High-density lipoprotein cholesterol (HDL-C) concentration is another lipid metabolic pathway indicator that is affected by the Mediterranean diet adherence level."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The apolipoprotein B to apolipoprotein A-I ratio, a measure of cardiovascular risk, is influenced by adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;HBA1C CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Haemoglobin A1c (HbA1c) concentration reflects long-term blood sugar control and is affected by dietary patterns such as the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GLUCOKINASE REGULATORY PROTEIN SNP (GCKR RS780094)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GCKR rs780094 single nucleotide polymorphism affects TAG, total cholesterol (TC), and apolipoprotein B concentrations."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by high levels of triglycerides in the blood, associated with both genetic factors like the GCKR rs780094 SNP and dietary patterns."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;GG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homozygous GG genotype of rs1695 is associated with an increased risk of developing breast cancer compared to other genotypes."&lt;SEP&gt;"Individuals carrying the GG genotype for the GCKR rs780094 SNP have lower TAG concentrations compared to those with AA genotypes."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GA genotype is associated with increased risk of hypertriacylglycerolaemia compared to the GG genotype."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;RS1260326 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism in high linkage disequilibrium with the GCKR rs780094 SNP, affecting TAG levels similarly."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;LDL-C CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Low-density lipoprotein cholesterol (LDL-C) concentration is another lipid metabolic pathway indicator influenced by adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;SYSTOLIC BLOOD PRESSURE (SBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Systolic blood pressure levels are affected by dietary patterns such as the Mediterranean diet, indicating its influence on cardiovascular health."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;DIASTOLIC BLOOD PRESSURE (DBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Diastolic blood pressure is another physiological process indicator influenced by adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The degree of insulin resistance can be influenced by adherence to dietary patterns like the Mediterranean diet."&lt;SEP&gt;"The reduced sensitivity of cells to insulin, exacerbated by HFD leading to more pronounced phenotypes in SENP1-aP2KO mice compared to control."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;SMOKING STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Smoking status is a lifestyle factor considered in the multivariate linear regression models to understand its impact on the association between alcohol consumption and cortisol levels."&lt;SEP&gt;"Smoking status is an environmental factor that includes smoker and non-smoker categories."&lt;SEP&gt;"The smoking status of individuals can influence their behavior in alcohol consumption and response to medications like naltrexone."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;TAG LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"TAG levels refer to the measurement of triglycerides in blood, indicative of lipid metabolism status."&lt;SEP&gt;"TAG levels refer to the physiological process or measurement related to triglyceride concentrations in blood."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An individual's genetic makeup (genotype) influences various physiological processes and traits such as TAG levels."&lt;SEP&gt;"Genotype refers to a specific variant of genes within an individual's genetic makeup that can influence traits like TAG levels."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;MEDITERRADIAN DIET ADHERENCE (MD)&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"Higher adherence to the Mediterranean diet is associated with lower HbA1c concentrations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GCKR RS780094 SNP&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"The GCKR rs780094 single nucleotide polymorphism is positively associated with TAG levels in individuals carrying the AA genotype compared to GG genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"A lifestyle factor that influences blood cortisol levels, its effect is adjusted for during multivariate linear regression analysis."&lt;SEP&gt;"Individuals who are physically active tend to have higher adherence to the Mediterranean diet."&lt;SEP&gt;"Participants with less physical activity had a higher risk for colorectal cancer, according to the study's findings."</data>
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"Dietary patterns interact with genotypes to modify physiological processes such as lipid metabolism.")&lt;SEP&gt;"Interactions between dietary patterns (such as milk product consumption) and specific genotypes modulate microbial abundances in the gut."</data>
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;ABCC8 MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutations identified in the ABCC8 gene among patients with congenital hyperinsulinism (CHI)."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Three different heterozygous mutations were identified in the GLUD1 gene in five patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;KCNJ11 MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No mutations found in KCNJ11 among CHI patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GCK GENE VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No variants identified in GCK gene for any patient."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by excessive insulin secretion leading to hypoglycemia. Patients are categorized based on diazoxide responsiveness and treatment methods such as dietary management."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition characterized by abnormally low blood glucose levels, managed through various treatments including diet and medications such as diazoxide."&lt;SEP&gt;"Condition where blood glucose levels drop below normal, a common symptom in CHI patients."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;INSULIN HORMONE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A hormone that regulates blood sugar levels; its plasma level is measured in diagnosing hypoglycemia and HI."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment for CHI patients, especially those who are diazoxide-responsive."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;18F-DOPA PET/CT SCAN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Imaging technique used to detect focal lesions in the pancreas of CHI patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;KATP CHANNEL GENE MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutations identified in KATP channel genes, including ABCC8 and KCNJ11."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 GENE MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutations found in the GLUD1 gene among patients with CHI."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE-UNRESPONSIVE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A group of CHI patients who do not respond to diazoxide treatment."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE-RESPONSIVE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A group of CHI patients who respond positively to diazoxide treatment."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;MACROSOMIC PATIENTS&quot;">
      <data key="d0">"PATIENT CONDITION"</data>
      <data key="d1">"Patients with significantly higher birth weight than average, often linked to genetic factors or environmental influences such as maternal diabetes."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;NEONATAL PERIOD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The initial period shortly after birth when symptoms of CHI may first appear in some patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;INFANCY PERIOD (1-12 MONTHS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Period during the first year of life where CHI symptoms can manifest, especially for diazoxide-responsive patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CHILDHOOD (&gt;12 MONTHS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Later period when CHI symptoms may appear in a subset of patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;EPILEPSY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurological condition observed more frequently in diazoxide-responsive Group 2 compared to the diazoxide-unresponsive group."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIC BRAIN INJURY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain damage resulting from prolonged periods of hypoglycemia, often associated with CHI patients who do not receive timely treatment."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;FREQUENT FEEDINGS AND DIETARY MANAGEMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A dietary approach to manage blood glucose levels in CHI patients by frequent feeding and nutritional intake."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;18F-DOPA PET/CT SCAN FOR FOCAL LESIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Imaging technique used to diagnose focal pancreatic lesions, aiding in surgical decision-making."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GLUD1 gene is associated with hypoglycaemia, hyperinsulinism (HI), and mild hyperammonemia (HA) syndromes."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG322HIS MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutation in the GLUD1 gene has been identified in three patients and is inherited autosomally dominantly from their father, who was an asymptomatic carrier."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Found in one patient with HI/HA due to a GLUD1 genetic defect."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Identified in another patient with HI/HA syndrome linked to a GLUD1 gene mutation."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET (1.5 G/KG/DAY)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern prescribed for patients diagnosed with HI/HA syndrome due to GLUD1 genetic defects."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE TREATMENT&quot;">
      <data key="d0">"THERAPY/MOLECULAR INTERACTION"</data>
      <data key="d1">"Used to manage hypoglycemia in patients with HI/HA syndrome; however, it has side effects like gastrointestinal disturbances and hypertrichosis."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;OCTREOTIDE TREATMENT&quot;">
      <data key="d0">"THERAPY/MOLECULAR INTERACTION"</data>
      <data key="d1">"A treatment used for hypoglycaemic patients unresponsive to diazoxide, but only one patient was responsive while two had severe diarrhoea as a side effect."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SURGICAL PROCEDURE"</data>
      <data key="d1">"A surgical procedure performed on 10 patients who were not responsive to drug treatments, involving partial removal of the pancreas due to diffuse disease or atypical form conditions."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPERTRICHOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE"</data>
      <data key="d1">"A side effect experienced by a significant number (55%) of patients during diazoxide treatment, characterized by abnormal hair growth."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A metabolic disorder characterized by high blood sugar levels over a prolonged period. It may influence serum uric acid levels indirectly through its impact on kidney function or medications."&lt;SEP&gt;"Developed in some cases following surgical intervention for hypoglycaemia management; insulin therapy was required in these cases."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;MALABSORPTION SYMPTOMS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE"</data>
      <data key="d1">"Observed in two patients after surgery, one of whom needed regular feedings to manage mild hypoglycemia post-surgery."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;GLUD1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The GLUD1 gene transcript is affected by mutations leading to hypoglycaemia, hyperinsulinism (HI), and mild hyperammonemia (HA) syndromes."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SERUM AMMONIA CONCENTRATION (85-184 ÎMOL/L)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE MARKER"</data>
      <data key="d1">"A biochemical marker indicating the presence of GLUD1 gene-related hypoglycaemic conditions due to high ammonia levels."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;NAUSEA AND VOMITING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SIDE EFFECT"</data>
      <data key="d1">"Gastrointestinal side effects common among patients treated with diazoxide for managing hypoglycaemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SEVERE GASTROINTESTINAL UPSET&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SIDE EFFECT"</data>
      <data key="d1">"A serious adverse reaction to diazoxide treatment, leading to the need for nasogastric feeding in some cases."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;POOR APPETITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SIDE EFFECT"</data>
      <data key="d1">"Another common side effect experienced by patients receiving diazoxide therapy."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d0">"DISEASE/SIDE EFFECT"</data>
      <data key="d1">"A serious condition requiring the cessation of diazoxide treatment in one patient due to its severity."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d0">"SURGICAL PROCEDURE"</data>
      <data key="d1">"The most common surgical intervention for managing hypoglycemia unresponsive to drug treatments, involving partial removal of the pancreas."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;INSULIN TREATMENT&quot;">
      <data key="d0">"THERAPY/MOLECULAR INTERACTION"</data>
      <data key="d1">"Used in cases where patients develop diabetes mellitus after pancreatectomy due to surgery-induced insulin deficiency."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Patients who do not respond to diazoxide treatment often show diffuse rather than focal pancreatic lesions upon surgical examination."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL PERIOD AND INFANCY PERIOD (1-12 MONTHS)&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Frequent feeding is often initiated early after birth or during infancy to manage blood glucose levels in CHI patients, especially for those with hypoglycemia detected shortly after birth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Effective treatment strategy for many CHI patients, reducing the frequency of hypoglycemic episodes and improving overall health outcomes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAC AND BHB LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of AcAc and BHB are physiological processes that significantly change in individuals with different glucose tolerance states."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;TWO-HOUR POST-PRANDIAL GLUCOSE (2HPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"2hPG is measured two hours after a meal and is used to assess glucose tolerance in individuals with normal FPG levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLYCAEMIA (IFG)&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"A condition where fasting blood sugar levels are higher than normal but not high enough for a diagnosis of diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition characterized by impaired response to ingested glucose; linked to higher risk of developing T2DM and specific genetic factors like rs10886471.")&lt;SEP&gt;"An intermediate stage between normal glucose tolerance and type 2 diabetes, characterized by elevated postprandial blood glucose levels."&lt;SEP&gt;"A condition where blood sugar levels are higher than normal but not high enough to be classified as diabetes after a glucose tolerance test."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;METSIM STUDY&quot;">
      <data key="d0">"STUDY"</data>
      <data key="d1">"The METSIM study is a prospective research project focusing on metabolic syndrome and its risk factors."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;HYPERGLYCEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by high blood glucose levels, observed to onset earlier (at age 8 weeks) under HFD conditions compared to normal diet in SENP1-aP2KO mice."&lt;SEP&gt;"An elevated level of glucose in the bloodstream, often a symptom or indicator of type 2 diabetes and other metabolic disorders."&lt;SEP&gt;"An increase in blood sugar above the normal range, often seen as an early indicator of diabetes or prediabetes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY (ISI)&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"A measure indicating how effectively insulin lowers blood glucose levels; decreased sensitivity can lead to type 1 or type 2 diabetes."&lt;SEP&gt;"A measure indicating how effectively insulin lowers blood glucose levels; decreased sensitivity can lead to type 2 diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which the pancreas releases insulin into the bloodstream, crucial for regulating blood sugar levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms that are associated with an increased risk of type 2 diabetes or hyperglycemia."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;FOLATE METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Folate metabolism is crucial for DNA synthesis and repair, affecting cardiovascular health through its interaction with MTHFR variants.")&lt;SEP&gt;"Not directly mentioned but relevant to nutrient metabolism."&lt;SEP&gt;"The metabolic process involving the synthesis, conversion and utilization of folate in various biochemical pathways."&lt;SEP&gt;"The process by which folic acid is converted into its active forms for use in various physiological processes such as DNA synthesis."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Factors such as diet, physical activity, smoking, and BMI which influence glucose tolerance and diabetes risk."&lt;SEP&gt;"Genetic background and ancestral admixture (measured by AIMs) are environmental factors influencing pharmacogenomics algorithms."&lt;SEP&gt;"Unspecified environmental factors may influence CYP24A1 expression and contribute to disease susceptibility."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;GCKR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene associated with CRP levels and cardiometabolic phenotypes."&lt;SEP&gt;"The GCKR gene is involved in glucose metabolism and has risk SNPs associated with elevated BHB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;RS780094&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific SNP (rs780094) of the GCKR gene is linked to higher BHB levels, indicating a genetic influence on ketone body metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FADS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FADS1 gene influences fatty acid desaturation and has been found to have significant associations with AcAc or BHB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ANK1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ANK1 is a gene involved in blood clotting and was associated with the levels of AcAc or BHB."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GIPR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GIPR gene, which encodes the glucagon-like peptide-1 receptor, showed significant associations with ketone body levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGA2 is a high-mobility group AT-hook 2 protein gene and was found to have an association with BHB or AcAc levels."&lt;SEP&gt;"High Mobility Group AT-Hook 2, a gene associated with height variation and number of teeth."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FFAS (FREE FATTY ACIDS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Free fatty acids are a nutrient involved in energy metabolism and correlate positively with AcAc and BHB levels during fasting conditions."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CPT1A gene encodes an enzyme that plays a crucial role in fatty acid oxidation by transporting long-chain acyl-CoAs into mitochondria for beta-oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS1 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1, SOLUBLE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HMGCS1 gene is involved in ketogenesis and the synthesis of ketone bodies from acetyl-CoA."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGCS2 encodes an enzyme that catalyzes a rate-limiting step in ketogenesis and is localized to the mitochondria."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ACAT1 gene encodes an enzyme crucial for the final step of ketone body breakdown, producing two molecules of acetyl-CoA from acetoacetyl-CoA."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BDH1 (BHB DEHYDROGENASE, TYPE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BDH1 is involved in BHB metabolism and was found to have inverse correlations with glucose AUC and insulin secretion while positively correlating with Matsuda ISI."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;OXCT1 (3-OXOACID COA TRANSFERASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The OXCT1 gene regulates the ketolysis process, converting acetoacetyl-CoA to acetyl-CoA and is correlated with insulin sensitivity and glucose metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACSS2 (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ACSS2 gene encodes an enzyme involved in the activation of fatty acids for subsequent beta-oxidation and has been found to correlate with insulin sensitivity."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Ketone bodies, such as BHB and AcAc, are produced during fasting or low carbohydrate intake and their levels are associated with genetic variations and metabolic conditions like type 2 diabetes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FATTY ACIDS OXIDATION (FFA OXIDATION)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of breaking down fatty acids to produce energy; correlated with ketone body levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KETOGENESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway responsible for the synthesis of ketone bodies from acetyl-CoA during periods of fasting or low carbohydrate intake."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KETOLYSIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway involved in breaking down ketone bodies back into acetyl-CoA and other metabolites."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HYPERGLYCEMIA AND INCIDENT DIABETES&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"The METSIM study tracks participants over time to identify factors that increase the risk of hyperglycemia and incident diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"Folate metabolism is part of broader nutrient-related physiological processes.")&lt;SEP&gt;"The text does not mention nutrients directly but suggests that genetic background influences therapeutic dose prediction."</data>
      <data key="d0">"NUTRIENT"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs associated with cardiometabolic phenotypes and serum CRP levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CRP GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"GWAS for C-Reactive Protein (CRP) levels in the context of cardiometabolic traits."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;APOC1 GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the APOC1 locus associated with CRP and inversely related to cholesterol, LDL-cholesterol, and triglyceride levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HNF1A GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the HNF1A locus linked to CRP but inversely correlated with cholesterol and LDL-cholesterol levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GCKR GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the SNPs located near or within the GCKR gene associated with cardiometabolic traits including CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL6R GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP in the IL6R locus, showing significant association with CRP but differing lead SNP compared to other cardiometabolic GWAS for this locus."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PPAR REGULATED LIPID METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Metabolism regulated by PPAR which may interact with genetic variants affecting CRP and lipid levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CRP LEVELS&quot;">
      <data key="d0">"CLINICAL PARAMETER"</data>
      <data key="d1">"C-reactive protein levels are elevated in individuals who develop diabetes, particularly those with type 1 diabetes mellitus (T1DM)."&lt;SEP&gt;"Levels of C-Reactive Protein, a biomarker for systemic inflammation associated with cardiometabolic diseases."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CHOLESTEROL METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway involved in cholesterol synthesis and regulation, affected by SNPs identified in the GWAS."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A metabolic disease characterized by hyperglycemia; GWAS for CRP show significant deviations in p-values indicating potential genetic overlap with this condition."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CORONARY ARTERY DISEASE (CAD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular disease where atherosclerotic plaques narrow coronary arteries; GWAS of CRP SNPs indicate associations with CAD."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CRP SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific single nucleotide polymorphisms (SNPs) associated with CRP levels in various cardiometabolic conditions."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;RS1558902 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located within the FTO gene, showing a significant association with CRP levels and representing one of the novel associations identified in the GWAS for CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 14}]</data>
    </node>
    <node id="&quot;RS2867125 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another SNP near TMEM18 on chromosome 2, also significantly associated with CRP levels as part of the GWAS findings."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TMEM18 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene near which a significant SNP (rs2867125) was found, contributing to the understanding of CRP associations with cardiometabolic traits."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PLTP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PLTP locus has associated SNPs impacting CRP levels as part of GWAS studies for cardiovascular and metabolic conditions."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;MC4R GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene upstream where a SNP (rs571312) is significantly linked to higher CRP, contributing insights into cardiometabolic phenotypes."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;LDL-CHOLESTEROL METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathways involved in the synthesis and regulation of LDL-cholesterol, affected by genetic variants identified in GWAS for CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HDL-CHOLESTEROL METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic processes regulating HDL cholesterol levels are influenced by genomic loci related to CRP levels as seen in the GWAS."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TRIGLYCERIDE REGULATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Genetic factors influencing triglyceride metabolism, demonstrated through associations with CRP SNPs identified in cardiometabolic studies."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene identified in association studies for CRP and cardiometabolic traits, not previously reported in GWAS."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PPP1R3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene showing pleiotropic effects on CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene influencing CRP levels and cardiometabolic phenotypes, notably T2D risk."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PABPC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene involved in pleiotropy with effects on CRP and metabolic parameters."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;BCL7B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene associated with changes in HDL cholesterol after adjustment for CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF1A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1183910 is located within the HNF1A gene, influencing coronary artery disease (CAD) risk and CRP levels."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;APOC1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs4420638 near APOC1 affects T2D risk and serum CRP levels."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;IL6R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene showing pleiotropic effects on CRP without significant effect size diminishment after adjustment for BMI, cholesterol, or HbA1C."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MC4R&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs near MC4R showed no significant association with CRP levels in the WGHS."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PLTP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs near PLTP showed no significant association with CRP after correction for multiple testing."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CRP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"C-reactive protein (CRP) levels influenced by genetic loci and cardiometabolic phenotypes."&lt;SEP&gt;"The CRP gene encodes a protein that serves as an acute-phase reactant during inflammatory processes."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CAD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Coronary Artery Disease is a condition associated with heart disease due to blockages in the arteries supplying blood to the heart."&lt;SEP&gt;"Coronary artery disease, risk associated with SNP rs1183910 in HNF1A."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CHOLESTEROL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Serum cholesterol levels influence genetic associations with CRP and metabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HBA1C&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Haemoglobin A1c, a marker of average blood glucose level over time, influences CRP associations in cardiometabolic studies."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;FXR/RXR ACTIVATION PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway significantly enriched by pleiotropic genes influencing CRP and cardiometabolic traits."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;LXR/RXR ACTIVATION PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Significantly enriched metabolic pathway related to the effects of pleiotropic loci on CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MATURITY ONSET DIABETES OF THE YOUNG (MODY)&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"Pathway significantly enriched by genes involved in pleiotropy affecting CRP levels and metabolic traits."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HEPATIC CHOLESTASIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Significantly enriched pathway linked to genetic loci influencing CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;ACUTE PHASE RESPONSE SIGNALING&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;GLYCEMIC PHENOTYPES&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"SNPs in the HNF1A gene affect fasting glucose levels, illustrating genetic influence on metabolic conditions such as diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATION REGULATION&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"Variants near IL6R are linked to inflammatory responses measured by CRP and may modulate cardiovascular risks.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS NOT REPORTED&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"IL1F10 was not previously reported in GWAS for the specific phenotype, indicating novel associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRP AND METABOLIC PHENOTYPES&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"PPP1R3B gene shows pleiotropic effects on CRP levels and multiple cardiometabolic traits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D RISK&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"HNF4A influences risk of T2D and CRP levels, showing biological pleiotropy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Association between BCL7B and HDL cholesterol decreases considerably after adjustment for CRP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAD RISK&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNPs in HNF1A are associated with an increased risk of coronary artery disease (CAD).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDIATOR OF PLEIOTROPIC EFFECTS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Body Mass Index is a key mediator in the pleiotropy observed between certain SNPs and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;CRP ASSOCIATIONS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Levels of cholesterol influence genetic associations with CRP and cardiometabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC PLEIOTROPY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway enriched by genes showing pleiotropic effects on CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC EFFECTS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MODY SIGNALING&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEPATIC CHOLESTASIS PATHWAY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway significantly enriched by genetic loci influencing CRP and cardiometabolic traits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACUTE PHASE RESPONSE SIGNALING PATHWAY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC INFLUENCES&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in miR-34b/c region that has been genotyped for IA patients and controls."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An Arginine to Proline substitution at position 72 of the TP53 gene, which was also genotyped in the study."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by a bulge or balloon-like dilation of an artery wall within the skull that can potentially lead to hemorrhage if it ruptures."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide variation at a specific location in the genome that can influence genetic traits."&lt;SEP&gt;"A type of genetic variation that involves a change in a single nucleotide at a specific position within the genome."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A principle used to check for random mating and non-evolving populations in genetic studies."&lt;SEP&gt;"A principle used to test if genotype frequencies in a population are inherited randomly without natural selection, mutation, or other disruptive mechanisms."&lt;SEP&gt;"Refers to the state where genotype frequencies in a population remain constant from generation to generation due to random mating and no other evolutionary influences."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;OR (ODDS RATIO)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"OR is a measure indicating the strength of association or correlation between an exposure and a result. In this context, it's being used to determine how strongly T2DM is associated with specific alleles."&lt;SEP&gt;"The odds ratio is a measure of association between an exposure and health outcome."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9&lt;SEP&gt;chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;95% CI (CONFIDENCE INTERVAL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A range estimate for the measure of effect, in this case, the Odds Ratio, providing the reliability of the observed effect."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;GENOTYPE FREQUENCY DISTRIBUTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The proportion or frequency of different genotypes within a population."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;INADL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene where a nonsynonymous SNP (rs1056513; G1178S) was found to be near genome-wide significant for weight, BMI, FFM, FM, trunk FM, and hip circumference."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;COL4A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 13 where an intronic variant (rsID not provided) showed association with weight z-score change."&lt;SEP&gt;"An intronic variant in this gene on chromosome 13 showed association with weight z-score change."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TSEN34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 19 where a variant in the 5â²UTR region was associated with linear growth (height change)."&lt;SEP&gt;"A variant in the 5â²UTR region of TSEN34 on chromosome 19 is associated with linear growth (height change)."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MTNR1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant within MTNR1B on chromosome 11 was strongly associated with fasting glucose."&lt;SEP&gt;"An intronic variant within this gene on chromosome 11 is strongly associated with fasting glucose."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;APOA5-ZNF259 REGION&quot;">
      <data key="d0">"GENOMIC VARIANT, GENE"</data>
      <data key="d1">"This genomic area harboring APOA5 and ZNF259 genes includes variants linked to triglycerides."&lt;SEP&gt;"This genomic region encompasses the APOA5 and ZNF259 genes on chromosome 11, harboring intronic and 3â²UTR variants linked to triglycerides."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;PCSK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in PCSK2 on chromosome 20 is associated with total antioxidants in the body."&lt;SEP&gt;"An intronic variant within this gene on chromosome 20 is associated with total antioxidants in the body."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RNASE1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 14 where a 3â²UTR region variant is linked to urinary nitrogen excretion."&lt;SEP&gt;"A gene on chromosome 14 where a flanking 3â²UTR region harbors a variant linked to urinary nitrogen excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ASS1P11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 7 with its flanking 3â²UTR containing a variant associated with creatinine excretion."&lt;SEP&gt;"A gene on chromosome 7 with its flanking 3â²UTR harboring a variant associated with creatinine excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GCH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP in GCH1 on chromosome 14 was identified for urinary dopamine:creatinine ratio."&lt;SEP&gt;"An intronic SNP in this gene on chromosome 14 was identified for urinary dopamine:creatinine ratio."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;KLKB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 4 with a nonsynonymous SNP (rs3733402; S143T) linked to serum free IGF-1."&lt;SEP&gt;"A nonsynonymous SNP (rs3733402; S143T) within KLKB1 on chromosome 4 is associated with serum free IGF-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MPRIP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP in MPRIP on chromosome 17 is linked to serum IGFBP-3 levels."&lt;SEP&gt;"An intronic SNP within this gene on chromosome 17 is associated with serum IGFBP-3 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;XPA/FOXE1 (TTF-2)&quot;">
      <data key="d0">"GENOMIC VARIANT, GENE"</data>
      <data key="d1">"A block of twenty-three SNPs in the flanking 5â²UTR region of XPA/FOXE1 on chromosome 9 is highly associated with serum TSH."&lt;SEP&gt;"A block of twenty-three SNPs in the flanking 5â²UTR region of this gene on chromosome 9 are highly associated with serum TSH and found to be in strong linkage disequilibrium."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DARC&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Contains coding variants linked to MCP-1, including a nonsynonymous SNP (rs12075; G42D) and an intronic SNP."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GREB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 2 with a variant identified for MCP-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DFNB31&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 9 where coding variants are associated with MCP-1 levels."&lt;SEP&gt;"A gene on chromosome 9 where coding variants were found to be associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CCR3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A 3â²UTR variant in this gene was highly associated with MCP-1 and IL-6."&lt;SEP&gt;"Variants in the 3â²UTR region of CCR3 and an intronic SNP are highly associated with MCP-1 and IL-6."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RASGEF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP within RASGEF1A is significantly associated with MCP-1 levels."&lt;SEP&gt;"An intronic SNP within this gene is significantly associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ABO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Contains a variant in the intronic region strongly linked to IL-6."&lt;SEP&gt;"Variants in the intronic region of ABO are strongly linked to IL-6."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TMEM229B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 14 where an intronic variant is associated with ad libitum energy intake at dinner."&lt;SEP&gt;"An intronic variant within TMEM229B on chromosome 14 is associated with ad libitum energy intake at dinner."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP in ARHGAP11A on chromosome 15 showed significant association with sleep duration."&lt;SEP&gt;"An intronic variant within this gene on chromosome 15 showed significant association with sleep duration."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;C21ORF34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Contains an SNP in the intronic region linked to respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SERUM FREE IGF-1, SERUM IGFBP-3, SERUM TSH, FASTING GLUCOSE, TRIGLYCERIDES, TOTAL ANTIOXIDANTS, 24-H URINARY NITROGEN EXCRETION, CREATININE EXCRETION, 24-H URINARY DOPAMINE:CREATININE RATIO, MCP-1, IL-6, AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION&quot;">
      <data key="d0">"ENDOMETABOLIC TRAITS, INFLAMMATION MARKERS, DIET, ENERGY EXPENDITURE, SUBSTRATE UTILIZATION AND PHYSICAL ACTIVITY"</data>
      <data key="d1">"Various endometabolic traits, inflammation markers, dietary habits, energy expenditure, substrate utilization, and physical activity levels are associated with specific genetic variants identified in the study."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;LINEAR GROWTH (HEIGHT CHANGE)&quot;">
      <data key="d0">"TRAIT"</data>
      <data key="d1">"A trait measured as linear growth (height change) that is associated with a variant in TSEN34 on chromosome 19."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;FASTING GLUCOSE, TRIGLYCERIDES, TOTAL ANTIOXIDANTS, 24-H URINARY NITROGEN EXCRETION, CREATININE EXCRETION, 24-H URINARY DOPAMINE:CREATININE RATIO, MCP-1, IL-6&quot;">
      <data key="d0">"ENDOMETABOLIC TRAITS AND INFLAMMATION MARKERS"</data>
      <data key="d1">"These traits are significantly associated with genetic variants identified in the endometabolic and inflammation marker sections."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP, ACCELEROMETER-MEASURED LIGHT ACTIVITY&quot;">
      <data key="d0">"DIETARY HABITS, ENERGY EXPENDITURE, SUBSTRATE UTILIZATION, PHYSICAL ACTIVITY"</data>
      <data key="d1">"These dietary habits and activity measures are associated with genetic variants identified in the respective sections."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A INTRONIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in ARHGAP11A was associated with sleep duration."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;C21ORF34 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RPL7P3 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant was identified for accelerometer-measured light activity in the 5â²UTR region of RPL7P3."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CTCFL VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant was identified for sedentary-light activity in the 3â²UTR region of CTCFL."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;MATK GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Highly significant variants were identified for total energy expenditure associated with MATK gene."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CHRNA3 GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Significant genetic associations detected for sleeping energy expenditure linked to CHRNA3 gene."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEP DURATION &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A factor that correlates with the occurrence of snoring, although not extensively covered in this text."&lt;SEP&gt;"Sleep duration is a physiological process that has been shown to be influenced by genomic variants such as those in ARHGAP11A."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The respiratory quotient during sleep measures metabolic efficiency and energy use, influenced by genetic factors such as C21orf34."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;LIGHT ACTIVITY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Accelerometer-measured light activity is a measure of physical behavior patterns linked to genomic variants in RPL7P3."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sedentary-light activity during sleep measures low-intensity movements influenced by genetic factors such as CTCFL."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE &quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The total energy expenditure is a key metabolic pathway linked to genomic variants in MATK, indicating its role in overall metabolism."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE &quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Sleeping energy expenditure is part of the basal metabolic rate during sleep, influenced by genetic factors such as CHRNA3."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;WEIGHT Z-SCORE CHANGE&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic variant in COL4A1 on chromosome 13 is associated with changes in weight z-score."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FASTING GLUCOSE&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in MTNR1B on chromosome 11 is strongly linked to fasting glucose levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRIGLYCERIDES&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants within this genomic area significantly affect triglyceride levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL ANTIOXIDANTS&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in PCSK2 on chromosome 20 is associated with total antioxidants in the body."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RNASE1, ASS1P11&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;URINARY NITROGEN EXCRETION, CREATININE EXCRETION&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;24-H URINARY DOPAMINE:CREATININE RATIO&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in GCH1 on chromosome 14 influences the ratio of 24-hour urinary dopamine to creatinine."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KLKB1, MPRIP&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FREE IGF-1, SERUM IGFBP-3&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM TSH&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"A group of SNPs in the flanking region of XPA/FOXE1 on chromosome 9 are highly associated with serum thyroid-stimulating hormone levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DARC, GREB1, DFNB31, CCR3, RASGEF1A, ABO&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCP-1, IL-6&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMEM229B, ARHGAP11A, C21ORF34&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEP DURATION&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"This variant is associated with sleep duration, indicating a genetic influence on this physiological process."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"This variant is associated with accelerometer-measured light activity, implying a genetic effect on physical behavior patterns."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The variant in the 3â²UTR of CTCFL is linked to sedentary-light activity during sleep, indicating an influence on daily movement patterns through genetic variation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Highly significant variants for total energy expenditure were identified in the MATK gene, suggesting a strong genetic association with overall metabolic rate."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Genetic associations detected for CHRNA3 linked to sleeping energy expenditure, indicating this gene's role in basal metabolism during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ARHGAP11A INTRONIC VARIANT &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The intronic variant in ARHGAP11A is associated with sleep duration, indicating a direct genetic influence on this physiological process."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C21ORF34 SNP &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The SNP in C21orf34 influences the respiratory quotient during sleep, suggesting a significant impact of genetic variation on metabolic efficiency."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RPL7P3 VARIANT &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Genetic variation in RPL7P3 is associated with accelerometer-measured light activity, indicating its role in physical behavior patterns."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTCFL VARIANT &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The CTCFL variant affects sedentary-light activity during sleep, reflecting the genetic influence on low-intensity movements."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOBR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"APOBR is a gene studied for its role in obesity through sequence variant analysis."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;RS74949322, RS151233, RS149271, RS3833080, RS368546180, RS180743, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are sequence variants identified in the coding region of APOBR."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS3833080: P.GLY369_ASP370DEL9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This variant is a deletion that affects the amino acid sequence of APOBR and has no predicted function."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;RS180743: P.PRO428ALA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A non-synonymous SNP affecting the amino acid sequence of APOBR, located in a conserved position among species."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This refers to individuals suffering from obesity who were part of the study population."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, ENSEMBL, PROVEAN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These are bioinformatics tools used for predicting the functional impact of genetic variants on proteins and genes."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;GENETIC VARIANT RISK ALLELES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Risk alleles identified in APOBR associated with obesity risk."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;RS368546180: P.THR321_GLY329DEL9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A deletion variant in APOBR affecting an amino acid sequence, identified in a heterozygous state."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS151233, RS149271, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are additional sequence variants identified in the coding region of APOBR that do not affect amino acid sequences."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;C.1036_1062DEL27&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A common deletion variant affecting a transcript in the repeat region of APOBR with no predicted function."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS180743 G-ALLELE, RS3833080 DELETION ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These alleles are associated with obesity as identified through case-control studies."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS368546180: P.ALA328_GLY329DEL9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A variant resulting in an in-frame shortened amino acid sequence of the repeat region of APOBR."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, MUTATION TASTER, PROVEAN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Bioinformatics tools for predicting the impact of genetic variations on proteins and genes."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS142786317: C.*118_*119DELCA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a genomic variant that causes changes in splicing enhancer and silencer binding sites, affecting the transcription of SULT1A1."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding sulfotransferase family 1A member 1, which plays roles in various physiological processes involving sulfur conjugation with substrates for detoxification purposes."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;MET1VAL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A non-synonymous variant in SULT1A1 that cannot be explained by other members of the SULT1 gene family and could not be replicated using independent genotyping methods, suggesting it might be an artifact."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;P.PRO200 = (RS3176926)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous variant in SULT1A1 predicted to change the binding domains of splicing regulators and transcription factor AML-1, potentially affecting gene expression regulation."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding sulfotransferase family 1A member 2, which is closely related to SULT1A1 in sequence but represents a distinct protein with its own wild-type allele and functional differences."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4149403: P.ILE7THR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Non-conservative amino acid exchange detected in the coding region of SULT1A2, predicted to have no significant effect on function based on in silico analysis."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS10797300: P.PRO19LEU&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Detected non-conservative SNP with potential functional modification as per PolyPhen2 and PANTHER, indicating possible impact on protein function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS145008170: P.SER44ASN&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Conservative amino acid exchange close to the binding pocket of SULT1A2; in silico analysis suggests non-neutral or deleterious impact on function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4987024: P.TYR62PHE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Non-conservative missense variant with potential to affect protein functionality, though the degree of functional change is not uniformly agreed upon by prediction tools."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS142241142: P.ALA164VAL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Non-conservative amino acid exchange located away from the binding pocket; predictions suggest lower likelihood of significant functional impact compared to other variants."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS1059491: P.ASN235THR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Conservative SNP predicted to be functionally relevant by multiple tools including PolyPhen2, SNAP and SIFT; indicative of probable protein alteration."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS1690407: P.SER8 = &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Known synonymous variant in SULT1A2 with predicted changes to transcription factor binding sites or splicing enhancer/silencer sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;TUFM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TUFM is a gene that harbors multiple variants affecting splicing regulator or transcription factor binding sites."&lt;SEP&gt;"The gene encoding mitochondrial thymidine kinase 1, involved in nucleotide metabolism within mitochondria and associated with regulatory elements impacting expression."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;C.3536C&gt;G &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant detected in the 3â untranslated region of TUFM; predicted to alter splicing regulator or transcription factor binding sites, potentially affecting gene regulation."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS7187776: C.-55T&gt;C, RS4788099: C.500â19T/C, RS8061877: C.248â18G&gt;A, AND RS61737565: C.922+29C&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A series of non-coding intronic variants in TUFM predicted to lead to changes in transcription factor binding sites or splicing regulatory elements."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS61737565: C.922+29C&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant in TUFM is predicted to alter splicing regulator or transcription factor binding sites, potentially affecting gene expression and regulation."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Disruption of transcription factor binding sites can affect gene regulation through altered interactions with DNA."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SRY, HFH 2, HMG-IY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"These are proteins involved in transcription factor activity and their binding to the DNA is crucial for proper gene expression."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;G.28854194C/G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant within TUFM's non-coding 3â UTR affects splice enhancer and silencer sites, potentially impacting mRNA processing."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICE SITES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in splice sites can lead to aberrant splicing events which may result in protein dysfunction or loss of function mutations."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;RS8061877&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant disrupts transcription factor binding sites, affecting gene regulation and expression."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICE ENHANCER BINDING SITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in splice enhancer binding sites can influence splicing patterns and mRNA processing."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICING SILENCER SITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in splicing silencer sites affect the stability and translation of mRNA."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-7ca64f92964b051cfb1c43f967f243a5&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"A genomic variant near the LCT gene influences lactase persistence, a condition related to the ability to digest lactose into adulthood."&lt;SEP&gt;"A genomic variant within the FADS1/2 gene cluster influences AA concentrations in the colon."&lt;SEP&gt;"These bioinformatics tools predict functional effects of genetic variations identified in the study."&lt;SEP&gt;"Genomic variants could influence dose prediction and patient outcomes in the context of pharmacogenomics, though specific variants weren't detailed."&lt;SEP&gt;"Novel and reported mutations within exon 5 of the LPL gene have been identified in a case study."&lt;SEP&gt;"Variants in the PPARÎ³ gene are associated with conditions like metabolic syndrome, obesity, and type 2 diabetes."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
    </node>
    <node id="&quot;APOBR TRANSCRIPT&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"A common deletion variant affecting a transcript, with no predicted function on protein structure."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS180743 G-ALLELE AND RS3833080 DELETION ALLELE&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"These genetic variants were associated with obesity in case-control studies of extremely obese children and adolescents."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;P.PRO19LEU (RS10797300)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"Detected in SULT1A2, this variant shows potential functional modification based on prediction tools, indicating a possible impact on protein function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.SER44ASN (RS145008170)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"This conservative amino acid change in SULT1A2 near the binding pocket of xenobiotics is predicted to have a 'non-neutral' or 'deleterious' impact on function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.TYR62PHE (RS4987024)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"This non-conservative missense variant in SULT1A2 is predicted by various tools to have a higher probability of functional changes, though results are mixed."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.ALA164VAL (RS142241142)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"The non-conservative exchange in SULT1A2 away from the binding pocket is predicted to have less significant functional impact compared to other variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.ASN235THR (RS1059491)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"This conservative SNP in SULT1A2 is predicted by PolyPhen2, SNAP and SIFT as likely to be functionally relevant, indicating probable alterations to the protein."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALOX15 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALOX15 is an inflammation-related gene whose minor alleles of SNPs are associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;ALOX5 GENE (ARACHIDONATE 5-LIPOXYGENASE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALOX5 is a gene in which minor allele of SNP rs1864414 is significantly associated with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CCL2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A CCL2 gene variant is analyzed but not found to be significantly associated with the risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CRP GENE (C-REACTIVE PROTEIN)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CRP gene is among those whose minor alleles of SNPs are assessed for association with ovarian cancer risk, though no strong associations are reported."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL18 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL18 is an inflammation-related gene where the minor allele frequency does not significantly associate with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1A GENE (INTERLEUKIN 1 ALPHA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL1A, particularly SNP rs17561 and rs4848300, shows a significant association with decreased risk of ovarian cancer, especially in specific histological subtypes."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B GENE (INTERLEUKIN 1 BETA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs7596684 at the IL1B gene suggests an association with ovarian cancer risk but lacks consistency across different phases of study."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1RN GENE (INTERLEUKIN 1 RECEPTOR N)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in the IL1RN gene is not significantly associated with ovarian cancer risk according to findings described here, although it was part of the analysis."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL6 GENE (INTERLEUKIN 6)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The minor alleles of SNPs at the IL6 gene are evaluated but do not show a significant association with increased or decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3 GENE (NITRIC OXIDE SYNTHASE 3)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs743507 within the NOS3 gene is significantly associated with decreased risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS1 GENE (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs2282169 SNP at PTGS1 gene suggests an association with ovarian cancer risk, but results are inconsistent across different phases of study."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS2 GENE (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The minor alleles of SNPs in the PTGS2 gene did not show significant associations with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;TLR2 GENE (TOLL-LIKE RECEPTOR 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP variants in TLR2 do not suggest significant association with increased or decreased risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;TNF GENE (TUMOR NECROSIS FACTOR)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant associations were found between TNF gene SNP variants and the risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;RS1864414 GENOMIC VARIANT IN ALOX5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is located within intron 1 of the ALOX5 gene, showing a significant association with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;RS743507 GENOMIC VARIANT IN NOS3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP associated with reduced risk of ovarian cancer found near the NOS3 gene."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1A GENE TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of IL1A gene is highlighted for analysis due to its significant association with reduced ovarian cancer risk, especially in specific histological subtypes."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3 PROTEIN (NITRIC OXIDE SYNTHASE 3)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by the NOS3 gene shows a minor allele SNP rs743507 associated with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;OVARIAN CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by the uncontrolled growth of ovarian cells."&lt;SEP&gt;"A type of malignancy that develops from cells in the ovary, and its risks can be influenced by genetic variations including those in inflammation-related genes like ALOX15, ALOX5, IL1A, IL1B, NOS3."&lt;SEP&gt;"Ovarian cancer is a type of cancer that forms in tissues of the ovary, usually the epithelial cells lining the outer layer of the ovary. It can be influenced by genetic variants such as rs11568820 and rs731236."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;INFLAMMATION-RELATED GENE PRODUCTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Inflammatory processes mediated by gene products such as IL18, CRP, PTGS1, and TLR2 are investigated for their potential role in ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL6R GENE (INTERLEUKIN 6 RECEPTOR)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant associations were found between IL6R gene SNP variants and the risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;STAT3 GENE (SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs1053023 in STAT3 is assessed but not significantly associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the IL1B gene (rs7596684) has been suggested to be associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;PTGS1 RS2282169&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the PTGS1 gene (rs2282169) has been suggested to be associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Ovarian cancer is a disease that has been studied for its association with genetic variants such as FokI, ApaI, and BsmI."&lt;SEP&gt;"The risk of developing ovarian cancer, a disease influenced by genetic variants such as IL1B rs7596684 and PTGS1 rs2282169."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL1B gene encodes interleukin-1 beta, a cytokine involved in immune response."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;PTGS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PTGS1 gene encodes prostaglandin-endoperoxide synthase 1 (cyclooxygenase-1), which plays a role in inflammation and pain."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;ALOX15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALOX15 gene encodes arachidonate 5-lipoxygenase, an enzyme involved in the synthesis of leukotrienes."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;CCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CCL2 gene encodes chemokine (C-C motif) ligand 2, which is involved in immune cell recruitment and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL18 gene encodes interleukin-18, which is involved in the regulation of immune responses and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL6 gene encodes interleukin-6, a cytokine that plays important roles in immune response and inflammatory processes."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;HISTOLOGICAL SUBTYPE OF OVARIAN CANCER&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL1B, PTGS1&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOS3 RS3918186&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"NOS3 rs3918186 is a SNP associated with increased risk of developing childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 RS1051266&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SLC19A1 rs1051266 is a SNP that shows less evidence in the data for association with childhood ALL compared to NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs of MTHFD2 gene were identified in the initial screening but did not proceed to final analysis due to posterior probability inclusion less than 0.2."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs of BHMT2 gene were identified in the initial screening but did not proceed to final analysis due to posterior probability inclusion less than 0.2."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NOS3 gene is associated with childhood ALL risk, specifically through SNP rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC19A1 gene has a SNP (rs1051266) that shows less evidence in the data for association with childhood ALL compared to NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Childhood acute lymphoblastic leukemia is a disease studied for genetic associations, specifically involving folate metabolic genes."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The study focuses on 16 folate metabolic genes to identify SNPs associated with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFD2 gene is one of the folate metabolic genes studied for SNPs associated with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BHMT2 gene is another folate metabolic gene identified in the study, showing some SNP associations but not proceeding to final analysis."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 RS3918186 RISK FACTOR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP of NOS3 gene increases the risk of childhood ALL by 2.16 times for each copy of the minor allele."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 RS1051266 RISK FACTOR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP of SLC19A1 gene is associated with a slightly lower risk of childhood ALL compared to NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BAYES FACTORS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bayes factors are used in statistical analysis to determine the association strength between SNPs and disease, indicating posterior odds against prior odds."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;POSTERIOR PROBABILITY OF INCLUSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This is a measure indicating whether an SNP has sufficient evidence for further analysis based on its probability after initial screening."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD ALL PARTICIPATION RATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The participation rate for the study was 85%, reflecting high compliance among families recruited from Texas Childrenâs Cancer Center."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FADS1/FADS2 HAPLOTYPE GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FADS1/2 genes are part of a cluster that influences polyunsaturated fatty acid metabolism."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET GROUP AND MEDITERRANEAN DIET GROUP DIETARY PATTERNS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Two dietary patterns examined: Healthy Eating group (n=54) and Mediterranean diet group (n=54)."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Refers to the dietary intake of long-chain omega-3 fatty acids such as EPA and DHA, and their concentrations in serum or colonic mucosa."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;ARACHIDONIC ACID (AA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A polyunsaturated fatty acid that plays a role in inflammation and other physiological processes."&lt;SEP&gt;"Arachidonic acid is a type of polyunsaturated fatty acid that shows significant interaction with genotype and diet interventions, particularly affecting its concentration in the colon."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE SERUM AA CONCENTRATION MEASUREMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurement of the baseline serum concentration of arachidonic acid in study participants."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LINEAR REGRESSION ANALYSIS FOR FATTY ACID INTAKE AND BASELINE SERUM AA CONCENTRATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis to determine if dietary intake predicts baseline serum AA concentrations."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE COLONIC ARACHIDONIC ACID (AA) MEASUREMENT IN PARTICIPANTS WITH OR WITHOUT MINOR ALLELES IN THE FADS GENE CLUSTER&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measurement of colonic arachidonic acid levels in relation to genetic factors."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;FADS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene within the FADS gene cluster involved in fatty acid desaturation."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FADS2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene within the FADS gene cluster, also involved in fatty acid metabolism."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;GENOTYPE DISTRIBUTION OF SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The distribution and frequency of genetic variations among participants."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE AA CONCENTRATION MEASUREMENT IN SERUM AND COLON&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measurement of arachidonic acid concentration at the beginning of the study."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;DIETARY INTAKE OF LONG CHAIN N-3 FATTY ACIDS AND BASELINE CONCENTRATION PREDICTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis to predict baseline long chain n-3 fatty acid concentrations based on dietary intake."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BMI DIFFERENCE BETWEEN MINOR ALLELE CARRIERS AND NON-CARRIERS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Difference in BMI among participants with or without minor alleles of FADS genes."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;AGE AS A COVARIATE IN GENOTYPE ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Age retained as a covariate for statistical analysis despite no significant difference between groups."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SERUM AND COLON FATTY ACID CONCENTRATIONS BY GENOTYPE GROUP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measurement of fatty acid concentrations in serum and colon based on genotype."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 PUFA DIETARY INTAKE INCREASE IN HEALTHY EATING GROUP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increase in long chain omega-3 polyunsaturated fatty acids after the dietary intervention."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SFA (SATURATED FATS) AND MUFA (MONOUNSATURATED FATS) REDUCTION IN HEALTHY EATING AND MEDITERRANEAN GROUPS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Reduction of saturated fats and increase in monounsaturated fats observed post-intervention."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;POLYUNSATURATED FAT:SATURATED FAT RATIO INCREASE AFTER DIETARY INTERVENTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Ratio improved in both diet groups, indicating healthier lipid profile."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FADS1/2 GENE CLUSTER&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FADS1/2 gene cluster influences fatty acid metabolism and levels of arachidonic acid (AA) in the colon."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;POLYUNSATURATED FAT: SATURATED FAT RATIO&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"This ratio increased non-significantly from 0.72 to 0.77 in the Mediterranean group over time."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MUFA (MONOUNSATURATED FATTY ACIDS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"MUFA significantly increased in the Mediterranean arm only, indicating a dietary influence on fatty acid levels."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;N-3 PUFA (OMEGA-3 POLYUNSATURATED FATTY ACIDS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Both n-3 PUFA and MUFA significantly increased in the Mediterranean arm only."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;COLON AA CONCENTRATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The interaction between genotype and diet showed significant changes in colon concentrations of 20:4, n-6 (AA) for subjects with no minor alleles in the FADS1/2 gene cluster."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"This dietary pattern had a significant effect on AA concentration in the colon compared to the Mediterranean diet for individuals without minor alleles in the FADS1/2 gene cluster."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Mediterranean diet showed different effects on AA concentrations in the colon compared to the Healthy Eating diet, particularly in individuals with no minor alleles in the FADS1/2 gene cluster."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;SERUM 18:2 N-6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The level of serum 18:2 n-6 significantly decreased (p=0.02) in response to the Mediterranean dietary intervention."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;EPA (EICOSAPENTAENOIC ACID)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"EPA is a type of omega-3 polyunsaturated fatty acid that was found not to have significant genotype-by-diet interactions."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;GENOTYPE DISTRIBUTION OF SNPS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Used to verify random mating and genetic equilibrium in SNP distribution among participants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FATTY ACID METABOLISM PATHWAY&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Baseline arachidonic acid levels serve as an important marker for metabolic pathways."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM AND COLON FATTY ACID CONCENTRÃÃES BY GENOTYPE GROUP&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Age retained as covariate for more accurate fatty acid concentration analysis based on genotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUFA&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"The Mediterranean diet significantly increased MUFA levels, indicating its impact on fatty acid metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;N-3 PUFA&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Both long-chain n-3 PUFA and MUFA significantly increased in the Mediterranean arm only, showing a dietary pattern's effect on omega-3 polyunsaturated fatty acids."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EPA&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"No significant genotype-by-diet interactions were found for EPA, indicating that EPA levels are less influenced by genetic variants in the FADS1/2 gene cluster."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNORING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Snoring is a condition characterized by loud, disruptive breathing during sleep."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SEX (MALE/FEMALE)&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Gender differences influence snoring prevalence, with males having a higher reported rate."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;SLEEP APNOEA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by pauses in breathing during sleep, more prevalent among those who snore."&lt;SEP&gt;"A sleep disorder characterized by pauses in breathing during sleep."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SOCIOECONOMIC STATUS (SES)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Lower SES was associated with increased risk of snoring in males specifically."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SMOKING FREQUENCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Smoking more frequently correlates positively with higher prevalence of snoring, particularly among females."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION FREQUENCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Increased alcohol consumption frequency is associated with elevated risk of snoring, predominantly in males."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;WHOLE-BODY FAT MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of total body fat, including both essential and nonessential fat."&lt;SEP&gt;"Fat mass was correlated with snoring prevalence as determined by various studies."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A method used to identify genetic variants associated with snoring and other traits."&lt;SEP&gt;"A study that scans the entire genome looking for genetic variations associated with a particular trait, such as a disease condition or response to medication."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GENOMIC VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Identified through GWAS, these variants are significant in the context of snoring risk factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SNP HERITABILITY (H2SNP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure indicating the proportion of phenotypic variance attributable to genetic effects."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;GENETIC CORRELATIONS &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis revealing associations between snoring and other traits based on shared genetics."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SELF-REPORTED SLEEP APNOEA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Highly genetically correlated with habitual snoring, indicating a strong genetic relationship."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;OXYGEN HEMOGLOBIN SATURATION (SPO2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Indicators like minimum and percent under 90% SpO2 are significant in the context of sleep-disordered breathing related to snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;BMI, WHOLE-BODY FAT MASS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Both factors positively correlate with snoring, influencing genetic associations after adjustment."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;FTO LOCUS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic location impacting obesity that changes significantly in effect size upon BMI adjustment."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SCHIZOPHRENIA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A psychiatric disorder negatively genetically correlated with snoring, suggesting differing genetic underpinnings."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;GENOMIC RISK LOCI &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genomic regions identified through GWAS that contain variants significantly associated with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;TOP 15 RISK LOCI &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific loci among the top genetic associations found for snoring, indicating significant risk factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;AVERAGE SPO2 &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The average level of oxygen hemoglobin saturation during sleep, reflecting changes in ventilation but not necessarily related to sleep apnoea."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;PERC90 (PERCENT OF SLEEP WITH OXYHEMOGLOBIN SATURATION UNDER 90%) &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure indicating the percentage of time during sleep when oxyhemoglobin saturation is below 90%, a proxy for sleep-disordered breathing."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;CORONARY ARTERY DISEASE &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genetically correlated with habitual snoring, suggesting shared genetic risk factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;HEART ATTACK &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Traits related to heart attack were no longer genetically associated with snoring after adjusting for BMI."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;HYPERTENSION &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"After adjustment for BMI, hypertension was not found to be genetically correlated with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;MOOD SWINGS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition showing moderate genetic correlation with habitual snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;WHOLE-BODY FAT MASS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"As a trait, it correlates phenotypically and genetically with snoring before adjustment for BMI."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;FLUID INTELLIGENCE SCORE &quot;">
      <data key="d0">"PSYCHOLOGICAL TRAIT"</data>
      <data key="d1">"Negative genetic correlation indicates distinct underlying genetic factors between these traits and habitual snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT &quot;">
      <data key="d0">"SOCIAL DETERMINANT OF HEALTH"</data>
      <data key="d1">"A trait that remains genetically correlated with snoring even after adjusting for BMI, indicating shared genetic influences."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SCHIZOPHRENIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A mental disorder characterized by symptoms such as hallucinations, delusions, and disordered thinking."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The level of education achieved by an individual or group."&lt;SEP&gt;"There was a significant association between educational attainment and milk drinking habits across all countries studied."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SODIUM IN URINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The concentration of sodium within the urine."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;EXCESSIVE DAYTIME SLEEPINESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Feeling very sleepy during the daytime, often as a result of poor nighttime sleep."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NOCTURNAL HYPOXIA MEASURES (MINIMUM SPO2, AVERAGE SPO2 AND PERC90)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measures indicating low blood oxygen levels at night."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GENETIC CORRELATION WITH SNORING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The genetic correlation between nocturnal hypoxia measures and snoring after adjusting for BMI."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;DLEU7 GENE ON CHROMOSOME 13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at position 13q21.3 and known to be associated with snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MSRB3 GENE ON CHROMOSOME 12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at position 12p13.32 and associated with snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;BCL11B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in transcription regulation, previously linked to smoking and alcohol consumption."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SMG6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in RNA surveillance, associated with musculoskeletal traits such as height and heel bone mineral density."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ROBO2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in axon guidance, previously linked to chronotype and snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NSUN3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with alcohol consumption and coffee consumption, also involved in snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNAP91 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with sleep disorders such as narcolepsy."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;LMO4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Linked to insomnia, contributing to the genetic architecture of snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;RNA5SP471 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with alcohol consumption and insomnia, also relevant in relation to narcolepsy and sleep regulation."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ANAPC4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in cell cycle control, associated with musculoskeletal traits such as height and heel bone mineral density."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;KCNQ5 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with various neurological disorders, also relevant to snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;CEP120 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in centrosome organization and mitotic progression, associated with snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MACF1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with musculoskeletal traits such as height and heel bone mineral density, also linked to snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;PULSE RATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The rate at which the heart beats, measured per minute."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MAJOR CORONARY HEART DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Heart disease characterized by atherosclerosis in the coronary arteries."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;HEART ATTACK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Sudden cardiac event caused by an abrupt loss of blood flow to part of the heart muscle due to a blocked artery."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SEX-STRATIFIED GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A study conducted separately in males and females to identify genetic factors contributing to snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;RS199797821&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A lead SNP identified in GWAS analyses for snoring in males."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RS200391180&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A lead SNP identified in GWAS analyses for snoring in females."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SEX-STRATIFIED GWAS ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GWAS analysis stratified by sex to identify genetic variants associated with snoring in males and females."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 15}]</data>
    </node>
    <node id="&quot;PGS (POLYGENIC SCORE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Derived from GWAS summary statistics, PGS is used to predict the likelihood of recent snoring in an independent sample from AGDS."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 15}]</data>
    </node>
    <node id="&quot;RECENT SNORING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by habitual loud breathing during sleep, often associated with increased risk for OSA and cardiovascular diseases."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;PROBABLE OSA (OBSTRUCTIVE SLEEP APNEA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disorder where the upper airway repeatedly collapses during sleep, leading to breathing pauses and can be indicated by snoring severity."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SNORING SEVERITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The degree to which an individual snores, often measured by frequency or loudness."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;CROSS-SEX GENETIC CORRELATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A measure indicating the genetic correlation between sexes regarding a trait (in this case, snoring), reflecting shared genetic influences across genders."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;TOP HITS IN GWAS&quot;">
      <data key="d0">"GENE/GENOMIC VARIANT"</data>
      <data key="d1">"The most significant genetic variants identified through genome-wide association studies for a particular trait or condition."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 15}]</data>
    </node>
    <node id="&quot;SLEEP APNOEA &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNORING &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION FREQUENCY &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SMOKING FREQUENCY &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI ADJUSTMENT ANALYSIS &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"After controlling for BMI in the GWAS analysis, heart attack is no longer genetically associated with snoring."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROBABLE OSA&quot;">
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d1">"Severe cases of recent snoring may indicate probable obstructive sleep apnea, a serious health condition requiring medical attention."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VITAMIN D STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Vitamin D status refers to the level of vitamin D in individuals, which is crucial for calcium homeostasis and bone health."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"VDBP polymorphisms refer to genetic variations in the Vitamin D Binding Protein gene that can influence vitamin D status and metabolism."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neonatal vitamin D status refers to the level of vitamin D in neonates, which is important for early life health outcomes such as bone development and immune function."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Maternal height is an environmental factor that may influence prenatal care and pregnancy outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI PRE-PREGNANCY (KG/M2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"BMI pre-pregnancy refers to the body mass index before conception, which can impact maternal health during pregnancy and neonatal outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI TERMINAL (KG/M2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"BMI terminal is the body mass index at term of pregnancy, reflecting changes in weight throughout gestation that may affect maternal-fetal conditions."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;UVB EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"UVB exposure is an environmental factor influencing vitamin D synthesis through sunlight absorption by the skin."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;GESTATION PERIOD (WEEKS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The gestation period refers to the time from conception to birth, during which maternal and neonatal health are critically influenced."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;25(OH)D CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"25-hydroxyvitamin D (25(OH)D) is a metabolite of vitamin D that serves as a marker for vitamin D status in the body, playing a role in various physiological processes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;CC GENOTYPE (RS2298850)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype at rs2298850 is a specific genetic variation within VDBP that may influence vitamin D metabolism and status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;CC GENOTYPE (RS4588)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype at rs4588 is another genomic variant in the VDBP gene, affecting the binding capacity of Vitamin D Binding Protein and impacting maternal 25(OH)D concentrations during delivery."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL CUT-OFFS (â¥50 NMOL/L VS. â¤50 NMOL/L)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neonatal cut-offs for vitamin D levels categorize neonates based on their 25(OH)D concentrations, providing insights into early life vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL CUT-OFFS (â¤25 VS. â¥25 NMOL/L)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Maternal cut-offs for vitamin D levels categorize mothers based on their 25(OH)D concentrations, reflecting maternal vitamin D sufficiency or deficiency."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;STATISTICAL ANALYSIS (ANCOVA)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"ANCOVA is a statistical method used to adjust for covariates in comparisons of means among groups, evaluating the influence of various factors on neonatal and maternal vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VITAMIN D BINDING PROTEIN (VDBP)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"VDBP is a protein that binds vitamin D and influences its metabolism and transport within the body."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;GENOTYPE DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The distribution of genotypes in a population or group can influence genetic traits and associated health outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific genetic variations in maternal VDBP that may impact vitamin D levels during pregnancy."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genetic variations in neonatesâ VDBP gene that could affect their vitamin D status and metabolism."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BIRTH BIOCHEMICAL DATA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Biochemical measurements taken at birth to assess neonatal health conditions, such as vitamin D levels."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;ONE-WAY ANALYSIS OF COVARIANCE (ANCOVA)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A statistical method used for analyzing differences among related groups while controlling for covariates."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT (CM)&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Maternal height may interact with the duration of gestation affecting prenatal care and neonatal outcomes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The CC genotype at rs2298850 is associated with higher maternal 25(OH)D concentrations, indicating a positive impact on vitamin D status."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VEGFA GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The VEGFA gene is involved in the regulation of angiogenesis, which is important for various physiological processes including reproductive health."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS3025020 (-583T&gt;C)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) located at position -583 in the VEGFA gene, with an increased minor allele frequency in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS2010963 (-634C&gt;G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) located at position -634 in the VEGFA gene, with a trend towards higher minor allele frequency in controls compared to women with PCOS."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGF SERUM LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The levels of vascular endothelial growth factor (VEGF) circulating in the blood plasma are significantly altered among genotype carriers of specific VEGFA SNPs, reflecting their impact on angiogenesis and possibly other physiological processes such as insulin resistance."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;POLYCYSTIC OVARY SYNDROME (PCOS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A common endocrine disorder characterized by a cluster of symptoms including ovarian dysfunction, hyperandrogenism, and metabolic disturbances, affecting women's reproductive health."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE INDEX HOMA-IR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"HOMA-IR is an index used to assess insulin resistance in the body, which has significantly higher levels among women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE TESTOSTERONE&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"Free testosterone refers to the biologically active form of testosterone circulating in blood plasma; its levels are elevated in women with PCOS compared to control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A marker for inflammation, hs-CRP levels correlate positively with the minor allele of VEGFA SNP rs3025020 in women with PCOS, indicating a link between this genetic variant and inflammatory processes."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;ERYTHROCYTE SEDIMENTATION RATE (ESR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A marker for inflammation; ESR levels correlate negatively with the minor allele of VEGFA SNP rs2010963 in women with PCOS, suggesting a protective role against inflammation."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TOTAL TESTOSTERONE LEVELS&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"The total amount of testosterone circulating in the blood plasma, which does not show significant differences between women with PCOS and controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;LH (LUTEINIZING HORMONE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A hormone produced by the pituitary gland that stimulates ovulation; levels are comparable between women with PCOS and control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FSH (FOLLICLE-STIMULATING HORMONE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A hormone produced by the pituitary gland that stimulates follicular growth in ovaries; levels are comparable between women with PCOS and control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;SHBG (SEX HORMONE BINDING GLOBULIN)&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"A protein that binds sex hormones like testosterone, significantly lower in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TSH (THYROID-STIMULATING HORMONE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A hormone produced by the pituitary gland that stimulates thyroid function; levels are higher but within reference range in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE ANDROGEN INDEX (FAI)&quot;">
      <data key="d0">"NUTRIENT/METABOLITE/BIOMARKER"</data>
      <data key="d1">"An index used to assess the proportion of free testosterone relative to SHBG, which is elevated in women with PCOS compared to control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;BIOACTIVE TESTOSTERONE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/NUTRIENT METABOLITE"</data>
      <data key="d1">"The active form of testosterone circulating in blood plasma, showing a progressive increase among rs3025020 genotype carriers and a reduction in rs2010963 genotype carriers."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;IL-10 (INTERLEUKIN-10)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"An anti-inflammatory cytokine; its levels are not correlated with VEGFA SNPs rs3025020 or rs2010963."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;IL-6 (INTERLEUKIN-6)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A pro-inflammatory cytokine; its levels do not correlate with the VEGFA SNPs rs3025020 or rs2010963."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TNFÎ (TUMOR NECROSIS FACTOR-ALPHA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A pro-inflammatory cytokine; its levels do not correlate with the VEGFA SNPs rs3025020 or rs2010963."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE TESTOSTERONE LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"The presence of rs2010963 genotype is inversely correlated with free testosterone levels, indicating a protective role against hyperandrogenism characteristic of PCOS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PCOS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"While total testosterone levels are comparable between women with PCOS and controls, the bioactive forms of these hormones show differences that correlate with disease pathology."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LH/FSH RATIO&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"The ratio of LH to FSH is elevated in women with PCOS compared to control subjects, indicating a key hormonal imbalance characteristic of this condition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHBG LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Significantly lower SHBG levels are observed in women with PCOS compared to controls, contributing to increased free androgens."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TSH LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"While TSH levels are higher but within normal range in women with PCOS compared to controls, this may reflect a subtle thyroid dysfunction or metabolic alteration."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HS-CRP LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATION&quot;">
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response."&lt;SEP&gt;"NF-ÎºB activation leads to enhanced proinflammatory phenotype observed in adipose tissue of SENP1-deficient mice."</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;ANTI-INFLAMMATORY EFFECT&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ESR LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VEGFA SNPS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6 LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between IL-6 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNFÎ LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between TNFÎ± levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VAL CARRIER GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The val carrier genotype is a variant in relation to the response bias and shock intensity selection."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;ISO HOMOZYGOTE GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The iso homozygote genotype represents another genetic variation that contrasts with the val carrier genotype in terms of behavioral outcomes."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;RESPONSE BIAS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Behavioral measure indicating preference or tendency towards a specific stimulus based on reward history. Changes in this are indicative of cognitive and emotional processes influenced by stress."&lt;SEP&gt;"Response bias refers to a cognitive process where participants modify their responses based on reinforcement contingencies."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SHOCK INTENSITY SELECTION&quot;">
      <data key="d0">"BEHAVIORAL PROCESS"</data>
      <data key="d1">"Participants' selection of shock intensity levels reflects individual differences in aversion tolerance and stress response."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;STAI SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASURE"</data>
      <data key="d1">"State-Trait Anxiety Inventory scores measure anxiety levels at different times during the study."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;PANAS NA (NEGATIVE AFFECT)&quot;">
      <data key="d0">"PSYCHOMETRIC SCALE"</data>
      <data key="d1">"The PANAS negative affect scale measures emotional distress such as anger, sadness, and fear."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;POSITIVE AFFECT (PANAS PA)&quot;">
      <data key="d0">"PSYCHOMETRIC SCALE"</data>
      <data key="d1">"The PANAS positive affect scale assesses pleasant emotions like joy, interest, and alertness."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;SKIN CONDUCTANCE RESPONSES (SC RESPONSES)&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASURE"</data>
      <data key="d1">"Measure of emotional arousal through changes in skin conductance due to sweat gland activity."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;VAL CARRIERS&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Individuals who carry the val variant of the COMT gene, associated with changes in response bias under stress conditions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;ISO HOMOZYGOTES&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Individuals homozygous for the isoleucine (iso) allele of the COMT gene, typically showing less pronounced effects of stress on response bias compared to val carriers."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CONDITION (STRESS VS NO-STRESS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Environmental condition manipulating levels of psychological stress to observe effects on cognitive and physiological responses, particularly concerning response bias."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;DISCRIMINABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measure of the ability to discriminate between stimuli in a task; it can be influenced by factors such as block number or experimental conditions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SHOCK INTENSITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The level of physical stimulus used, which might influence stress responses and therefore behavioral outcomes like response bias."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SKIN CONDUCTANCE RESPONSES (SCR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measure reflecting autonomic arousal in response to stimuli; elevated SCRs indicate heightened physiological activity often associated with stress or emotion."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CRHR1 SNPS (RS12938031, RS10445364, RS4076452)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific single nucleotide polymorphisms in the CRHR1 gene, recently linked to stress-induced reward learning deficits."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;MR GENOTYPE (COMT GENE VARIANTS)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genotype at the catechol-O-methyltransferase (COMT) gene locus, consisting of val and iso alleles, influences response bias in stressful conditions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CRHR1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The corticotropin-releasing hormone receptor 1 (CRHR1) gene, which regulates the body's response to stress through its receptor proteins. Variations in this gene are associated with differences in stress-induced reward learning deficits."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;TIME Ã CONDITION Ã GENOTYPE INTERACTION&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"There was a trend showing that STAI scores increased over time and condition differently across genotypes, suggesting genetic modulation of stress response."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION Ã TIME Ã GENOTYPE TREND&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PANAS NA&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SC RESPONSES&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TIME Ã GENOTYPE INTERACTION&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Polymorphisms in the CRHR1 gene are linked to variations in reward learning deficits induced by stress, indicating a genetic basis for differential susceptibility to stress effects on cognitive processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP is a single nucleotide polymorphism that can be associated with specific phenotypes or diseases."&lt;SEP&gt;"Single Nucleotide Polymorphism (SNP) is a type of genetic variation that involves a change in a single nucleotide at a specific position within the genome."&lt;SEP&gt;"Single Nucleotide Polymorphism (SNP) is a type of genomic variant that refers to a variation at a single position in a DNA sequence."&lt;SEP&gt;"Single nucleotide polymorphisms tested in the study did not reach statistical significance after multiple testing adjustments."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;BMP4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BMP4 gene, also known as Bone Morphogenetic Protein 4, plays roles in the development and maintenance of various tissues including dentition."&lt;SEP&gt;"The BMP4 gene plays a role in the development and maintenance of oral structures and is associated with variations affecting age at first tooth and number of teeth."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;CACNB2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CACNB2 gene encodes a voltage-dependent calcium channel beta subunit that is involved in neuronal function, among other processes."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CDON GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CDON (Cell adhesion molecule with Ig and Dome domain) gene plays roles in embryonic development including the specification of facial structures like teeth."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;AJUBA/C14ORF93 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"AJUBA gene is associated with cellular interactions and developmental signaling, contributing to tissue differentiation."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;TEX14/RAD51C GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TEX14/RAD51C gene is involved in DNA repair mechanisms, which can influence developmental outcomes."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;KCNJ160&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with tooth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FAM155EâEDA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with the FAM155E-EDA region, linked to craniofacial development and number of teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BMP4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Bone Morphogenetic Protein 4 (BMP4), a gene involved in tooth development and craniofacial shape formation."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;IGF2BP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1), linked to tooth development and craniofacial shape."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;KCNJ2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Potassium inwardly-rectifying channel, subfamily J, member 2, associated with craniofacial phenotypes."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;MSRB3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Methionine Sulfoxide Reductase B3, a gene linked to tooth development and mid-brow prominence."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ADK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Adenosine Kinase (ADK), associated with nose width and earlier tooth eruption."&lt;SEP&gt;"Adenosine Kinase (ADK), associated with nose width measures in craniofacial studies."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;AJUBA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LIM Domain Containing 7 Protein (LMO7, also known as AJUBA), involved in mid-brow height and prominence."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HEIGHT&quot;">
      <data key="d0">"PHYSICAL TRAIT/BODY MEASUREMENT"</data>
      <data key="d1">"Height is positively associated with specific genetic variants such as rs35866622 near the FUT1/FUT2 locus."&lt;SEP&gt;"The process of growing taller, influenced by genetic factors like HMGA2 and BMP4."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;TOOTH ERUPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The biological process where teeth emerge through the gum line, influenced by multiple genes including HMGA2."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;CRANIOFACIAL DEVELOPMENT&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"Developmental pathway that includes growth and formation of craniofacial structures, linked to genetic loci like BMP4 and HMGA2."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;DENTAL PHENOTYPE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The development and maintenance of teeth throughout a lifetime, influenced by genes such as MSRB3 and BMP4."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS2520397&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the KCNJ160 gene associated with tooth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1951867&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant near BMP4, linked to craniofacial measures and number of primary teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1472259&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in HMGA2 associated with both tooth development and craniofacial phenotypes."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS8069452&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant near IGF2BP1, linked to number of teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS9788982&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Associated with tooth development and craniofacial measurements."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;CACNB2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Voltage-dependent calcium channel subunit beta-2, linked to tooth number at 6-14 years old."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RAD51L1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RecombinaseRAD51-like1 (RAD51L1), associated with earlier tooth eruption and tooth count."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HEIGHT INCREASER ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An allele that increases height also influences faster tooth eruption or more teeth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;TOOTH ERUPTION SPEED&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The rate at which teeth emerge through the gum line, influenced by genetic factors like HMGA2 and RAD51L1."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HMGA2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HMGA2 gene is involved in regulating biological pathways related to dental health and may influence age at first tooth and number of teeth."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH SCORE (PMETA = 0.0012)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant score constructed from significant SNPs for 'Age at first tooth' shows a moderate association with height, but this evidence is largely driven by HMGA2 and BMP4 variants."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR NUMBER OF TEETH SCORE (PMETA = 9.8 Ã 10â4)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant score constructed from significant SNPs for 'Number of teeth' also shows a moderate association with height, driven by HMGA2 and BMP4 variants."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;HEIGHT TRAIT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of growth leading to adult height may be influenced by genetic factors such as those in HMGA2 and BMP4 genes."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The pathway analysis for 'age at first tooth' revealed significant overrepresentation of pathways, suggesting biological relevance to the phenotype."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;PATHWAY ANALYSIS RESULTS (NUMBER OF TEETH)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"No significant over-representation of pathways was found in the 'number of teeth' GWAS analysis, indicating limited pathway-level biological impact."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;ALLIGATOR SOFTWARE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A software tool used for pathway analysis to identify gene sets significantly associated with phenotypes like age at first tooth and number of teeth."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;SIGNIFICANT SNPS FOR NUMBER OF TEETH PATHWAY ANALYSIS RESULTS (NONE SIGNIFICANT)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The pathway analysis results indicating no significant over-representation of pathways in the 'number of teeth' GWAS, suggesting a lack of clear genetic influence on this trait compared to 'age at first tooth'."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;DENTAL DEVELOPMENT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variants in CACNB2 are found to be linked to variations in age at first tooth, suggesting a role in the timing of tooth development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH MORPHOGENESIS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNP rs4937076 near CDON gene is associated with phenotypes related to dental morphogenesis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CALU/OPN1SW GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation in this region affects oral health parameters like age of first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORAL HEALTH&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation in this region affects oral health parameters like age of first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DENTAL PHENOTYPES&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs997154 near AJUBA gene is associated with phenotypic variation in dental development traits."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADK GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORAL DEVELOPMENT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH COUNT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs412000 near TEX14/RAD51C is associated with variation in the count of teeth at one year."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DENTAL TRAITS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DLEU7 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KCNJ2 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH DEVELOPMENT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MSRB3 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs1956529 in MSRB3 region is associated with phenotypic variation related to dental traits."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IGF2BP1 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORAL DEVELOPMENT TRAITS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DENTAL MORPHOGENESIS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in EDA region are associated with phenotypic variations in dental morphology and development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EDA GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in EDA region are associated with phenotypic variations in dental morphology and development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HMGA2 REGION&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH COUNT VARIABILITY&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LINC01278 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variants around LINC01278 gene are linked to oral developmental traits such as the timing of first tooth eruption."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOSE WIDTH&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Adenosine Kinase (ADK) variants are associated with measures of nose width in craniofacial studies."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEIGHT AND CRANIOFACIAL PHENOTYPES&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"LIM Domain Containing 7 Protein (AJUBA) is involved in mid-brow height increase, possibly linked to height."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH TRAIT&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"The GWAS investigates genetic variants associated with when an individual first develops teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;">
      <data key="d2">chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"A GWAS is used to identify genetic variations associated with complex traits, like the relationship between SNP and type 2 diabetes."&lt;SEP&gt;"The GWAS investigates genetic variants associated with when an individual first develops teeth."</data>
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
    </node>
    <node id="&quot;NUMBER OF TEETH TRAIT&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"The GWAS also explores genetic factors influencing the number of permanent teeth in adults, though less significant pathways were found compared to 'age at first tooth'."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10RÎ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-10 receptor alpha gene, which plays a role in immune regulation and is selectively deleted in T cells or myeloid cells to study its effects on colitis development."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;T CELL TRANSFER-COLITIS MODEL&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"A model used for inducing colitis by transferring naive CD4+CD25âCD45RBhi T cells into Rag1â/â recipients, used to evaluate the impact of IL-10 signaling."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10 SIGNALING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Signaling through the interleukin 10 receptor leading to inhibition of pro-inflammatory cytokines such as IL-1Î²."&lt;SEP&gt;"The process through which interleukin 10 (IL-10) mediates its effects on immune cells such as T cells and macrophages, impacting inflammation and colitis severity."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;DSS COLITIS MODEL&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"A model of acute colitis induced by dextran sulfate sodium (DSS), used to study the impact of IL-10 signaling on disease development in a T cell-independent context."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RÎTDEL MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice with selective deletion of IL-10 receptor alpha gene specifically in T cells, used for studying lineage-specific effects of IL-10 signaling."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RÎDCDEL AND IL-10RÎMDEL MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice with selective deletion of the IL-10 receptor alpha gene in dendritic cells (IL-10RÎ±DCdel) or macrophages (IL-10RÎ±Mdel), used to study immune responses in T cell transfer-mediated colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inflammatory condition affecting the colon, exacerbated in the presence of a specific genetic modification (IL-10RÎ±Mdel) which impairs macrophage response to IL-10."&lt;SEP&gt;"Inflammation of the colon that can be induced by various genetic mutations or environmental factors such as diet and stress."&lt;SEP&gt;"Inflammation of the colon, studied through various models including T cell transfer and DSS-induced inflammation."&lt;SEP&gt;"Colitis is an inflammation of the colon that can be exacerbated in mice lacking the CARD9 protein."&lt;SEP&gt;"Colitis is an inflammatory bowel disease characterized by inflammation of the colon. In this context, it is influenced by genetic factors such as CARD9 deficiency and environmental factors like gut microbiota composition."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;TH1 CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Helper T cells that produce interferon-gamma (IFN-Î³), associated with immune responses to intracellular pathogens and cell-mediated immunity."&lt;SEP&gt;"T helper 1 cells that play a role in immune responses against intracellular pathogens and are involved in certain types of autoimmune diseases, though not directly mentioned as affected by IL-10 signaling in this text."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;FOXP3+ T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Regulatory T cells (Tregs) expressing Foxp3 protein which help to maintain immune tolerance and regulate inflammatory responses, though not directly addressed in the effects of IL-10 signaling on colitis development."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MACROPHAGES (MÎ¦)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Immune cells that play a crucial role in phagocytosis and regulation of inflammation; specific deletion of IL-10RÎ± in macrophages intensifies the severity of T cell transfer colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CX3CR1-DRIVEN CRE TRANSGENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic construct used to selectively delete genes such as IL-10RÎ± in a subset of cells, including Ly6C+ monocytes and tissue-resident macrophages, linked with spontaneous colitis development."&lt;SEP&gt;"A genetic construct used to selectively delete genes such as IL-10RÎ± specifically in cells expressing CX3CR1, leading to spontaneous colitis development."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;LYS-M-CRE TRANSGENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic construct used for specific deletion of IL-10RÎ± gene in granulocytes and macrophages, impacting the severity of T cell transfer-mediated colitis."&lt;SEP&gt;"A transgenic construct used to delete the IL-10 receptor alpha specifically in granulocytes and macrophages, impacting T cell transfer-mediated colitis when compared to controls."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-10 gene plays a role in immune modulation and has been studied for its rs1800896 A/G polymorphism, showing significant associations with reduced CRC risk."&lt;SEP&gt;"The gene encoding interleukin 10 (IL-10), a cytokine that regulates immune responses and inflammation, crucial for understanding the protective role of IL-10 in colitis."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RÎFL/FL MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice with a floxed IL-10 receptor alpha gene, used in combination with various Cre recombinase drivers to study the effects of IL-10 signaling."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NEUTROPHILS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of white blood cell that is part of the innate immune system, playing a role in inflammation and phagocytosis. Neutrophil depletion studies indicate their minimal impact on disease exacerbation in IL-10RÎ±MdelRag1â/â mice."&lt;SEP&gt;"Granulocytes that play a role in immune responses and can influence colitis severity when specific pathways are disrupted."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RÎâ/â RAG1â/â MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice lacking the IL-10 receptor alpha gene in a germline deletion, used to assess the overall impact of IL-10 signaling on colitis development."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;RECTAL PROLAPSE&quot;">
      <data key="d0">"DISEASE SYMPTOM"</data>
      <data key="d1">"A symptom observed in severe cases of colitis where inflammation and tissue damage lead to protrusion of the rectum, commonly seen in IL-10RÎ±Mdel mice."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RÎMDELRAG1â/â&quot;">
      <data key="d0">"GENE/DISEASE"</data>
      <data key="d1">"A genetic condition or experimental model where the Î± subunit of the IL-10 receptor is deleted specifically in myeloid cells, resulting in heightened immune responses and exacerbated disease states."&lt;SEP&gt;"This term describes a genetic modification where the IL-10 receptor alpha chain (IL-10RÎ±) is deleted in the context of Rag1 deficiency, affecting immune responses and cytokine signaling."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LAMINA PROPRIA MACROPHAGES (LPMÎ¦S)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/PROTEIN"</data>
      <data key="d1">"Macrophages residing in the lamina propria of the intestine that play a critical role in immune regulation. They are characterized by specific surface markers such as CD11bhi, CD11câ/lo/mod, F4/80+, Ly6Gâ/lo, SiglecFâ and CD64+. These cells exhibit elevated activation markers including CD40, CD80, and CD86."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE"</data>
      <data key="d1">"Interleukin 10 (IL-10) is a gene encoding a protein that functions to suppress inflammation by inhibiting pro-inflammatory cytokine production and enhancing anti-inflammatory responses."&lt;SEP&gt;"Interleukin-10 (IL-10) is a cytokine that suppresses pro-inflammatory responses, including the maturation of IL-1Î² and activation of caspase-1 in macrophages."&lt;SEP&gt;"Interleukin-10 is a cytokine that plays an important role in immune regulation and inflammation. Its signaling into macrophages can affect the generation and maintenance of regulatory T cells, but its specific impact on IL-10RÎ±MdelRag1â/â mice remains to be elucidated."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;T REGULATORY CELLS (TREGS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A subset of CD4+ T cells that are critical for suppressing excessive immune responses and maintaining self-tolerance. In the context of IL-10RÎ±MdelRag1â/â mice, their suppressive activity remains intact despite impaired signaling through IL-10."&lt;SEP&gt;"Specialized immune cells involved in suppressing overactive immune responses and maintaining self-tolerance."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;RAG1â/â&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic background or model where Rag1 is deleted, resulting in mice lacking mature T cells and B cells."&lt;SEP&gt;"A genetic variant where Rag1 gene function is disrupted or absent (Rag1â/â), affecting the development of T and B lymphocytes."&lt;SEP&gt;"A genomic variant associated with Rag1 deficiency, which affects immune cell development."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;CD4 T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"T helper cells that play a crucial role in immune responses by secreting cytokines such as IL-2, IL-4, and IFN-gamma. They are involved in the proliferation and differentiation of B cells and CD8+ cytotoxic T lymphocytes."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;DENDRITIC CELLS (DCS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Professional antigen-presenting cells that link innate and adaptive immunity by uptaking antigens, processing them, and presenting them to T cells via MHC molecules."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;LY6G&quot;">
      <data key="d0">"GENE/PROTEIN"</data>
      <data key="d1">"A gene encoding a surface protein (Ly6G) expressed on neutrophils. Antibodies targeting Ly6G are used for selective depletion of neutrophils in experimental settings."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD11BHICD11Câ/LO/MODF4/80+LY6Gâ/LOSIGLECFâ&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/PROTEIN"</data>
      <data key="d1">"A specific phenotype defining lamina propria macrophages (LPMÏs) based on their surface markers, indicating their role in immune regulation within the intestinal mucosa."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;FOXP3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene that encodes a transcription factor essential for regulatory T cell development and function. Its upregulation marks the transition of naive CD4+ T cells into Foxp3+ regulatory T cells (Tregs)."&lt;SEP&gt;"FOXP3 is a gene encoding a transcription factor important for the differentiation, maintenance, and function of regulatory T cells (Tregs)."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RÎâ/âRAG2â/â&quot;">
      <data key="d0">"GENE/DISEASE"</data>
      <data key="d1">"A genetic model where both IL-10 receptor beta subunit and Rag2 are deleted, leading to defects in immune cell development and function."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;ITREG&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Induced regulatory T cells that develop from naive CD4+ T cells under specific conditions, such as the presence of appropriate cytokines like TGF-Î² and IL-6. They play a key role in maintaining immune homeostasis."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;MESENTERIC LYMPH NODES (MLNS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/PROTEIN"</data>
      <data key="d1">"Lymphoid tissues located along the mesentery that serve as sites for immune cell interactions, particularly relevant to intestinal immunity. They are involved in mounting and regulating adaptive immune responses against intestinal pathogens."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;SPLEEN&quot;">
      <data key="d0">"ANATOMY/DISEASE"</data>
      <data key="d1">"A secondary lymphoid organ where immune cells interact with antigens from the blood, leading to the generation of immune responses including antibody production and T cell activation."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RÎMDELRAG1â/â MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A genetic model of colitis characterized by a mutation in IL-10 receptor alpha with Rag1 knockout."&lt;SEP&gt;"A genetic model of colitis characterized by a mutation in IL-10 receptor alpha, with Rag1 knockout."&lt;SEP&gt;"These are mice with a specific genetic modification that leads to increased susceptibility to inflammatory bowel disease, specifically colitis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A type of white blood cell that plays a central role in adaptive immunity, including those producing IL-22."&lt;SEP&gt;"T cells are immune cells involved in adaptive immunity and play a role in regulating immune responses through the production of cytokines such as IL-10."&lt;SEP&gt;"T cells are a type of white blood cell that play an essential role in the adaptive immune system."&lt;SEP&gt;"T cells are a type of white blood cell that play a central role in adaptive immunity by recognizing and responding to specific antigens."&lt;SEP&gt;"T cells are immune cells whose maintenance is influenced by STAT5B, with reductions often observed in patients lacking functional STAT5B protein."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;MÎ¦ IL-10 RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which macrophages respond to Interleukin 10 (IL-10) leading to the regulation of inflammatory responses."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;PRO-INFLAMMATORY CYTOKINE PRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Production of cytokines such as IL-1Î², IL-6, TNF-Î±, MCP-1, IL-17, and IFN-Î³ by immune cells which promote inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-10RÎMDEL LPMÎ¦S&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A specific type of macrophages (LPMÏ) from mice with a genetic modification in the IL-10 receptor alpha chain, showing altered cytokine production profiles."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TH17 CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Differentiation of T helper cells into Th17 effector cells involved in promoting inflammation and autoimmune conditions such as colitis."&lt;SEP&gt;"Helper T cells characterized by the production of IL-17, involved in promoting inflammation and tissue repair."&lt;SEP&gt;"T helper 17 cells are a subset of CD4+ T lymphocytes that play a key role in the pathogenesis of autoimmune diseases like colitis."&lt;SEP&gt;"T helper 17 (TH17) cells are a subset of CD4+ T cells that produce interleukin-17 (IL-17). They play roles in immune defense against extracellular pathogens and tissue inflammation. In the context provided, TH17 cell IL-22 production was not affected by CARD9 deficiency."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Interleukin 6 (IL-6) is a cytokine that plays a role in immune responses, including the regulation of acute-phase reactions and hematopoiesis."&lt;SEP&gt;"Interleukin-6 (IL-6) is a cytokine involved in the maturation of Th17 cells and immune responses; its signaling can be modulated by various factors."&lt;SEP&gt;"Interleukin-6 is a cytokine known to induce Th17 cell differentiation and support their activity during inflammation."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TNF-Î&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Tumor Necrosis Factor alpha (TNF-Î±) is a pro-inflammatory cytokine involved in systemic inflammation and the induction of fever."&lt;SEP&gt;"Tumor necrosis factor alpha (TNF-Î±) is a cytokine that plays a key role in the inflammatory response and immune system activation. Adalimumab targets TNF-Î± to treat inflammatory diseases, but paradoxical psoriasis can occur as a side effect."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;MCP-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Monocyte Chemoattractant Protein 1 (MCP-1) is a chemokine that attracts monocytes and other immune cells to sites of inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-17&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 17 (IL-17) is a cytokine involved in the regulation of inflammatory responses, particularly those associated with tissue destruction and repair."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IFN-Î&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interferon gamma (IFN-Î³) is a cytokine that plays a critical role in immune defense against intracellular pathogens and tumor surveillance."&lt;SEP&gt;"Interferon-gamma (IFN-Î³) is a cytokine that plays a critical role in the immune response and inflammation."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-1Î&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A pro-inflammatory cytokine involved in innate immune responses, including the development of Th17 cells during colitis."&lt;SEP&gt;"Interleukin 1 beta (IL-1Î²) is a pro-inflammatory cytokine involved in the induction of fever, acute-phase reactions, and the regulation of immune responses."&lt;SEP&gt;"Interleukin-1 beta (IL-1Î²) is a pro-inflammatory cytokine that plays a critical role in immune responses, often regulated by caspase-1 activation."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;INOS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Inducible nitric oxide synthase (iNOS) enzyme that catalyzes the production of nitric oxide from L-arginine, contributing to inflammatory processes and host defense mechanisms."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;ARGINASE&quot;">
      <data key="d0">"ENZYME"</data>
      <data key="d1">"An enzyme involved in the metabolism of arginine into ornithine and urea, playing a role in immune regulation and inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-23P19&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 23 p19 subunit (IL-23p19) is a gene involved in the production of IL-23, a cytokine that promotes Th17 cell differentiation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;CD4+IL-17A+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Helper T cells expressing both CD4 and IL-17A, indicative of Th17 cell phenotype."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;RORÎT-GFP REPORTER T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Transgenic T cells that express RORÎ³T (a transcription factor important for Th17 differentiation) tagged with GFP for visualization purposes in experiments."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;ARGINASE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which macrophages increase the production of Arginase, an enzyme involved in metabolic pathways and immune regulation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;INOS EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Macrophage activation results in increased iNOS (inducible nitric oxide synthase) activity leading to enhanced pro-inflammatory functions."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;CD163&quot;">
      <data key="d0">"PROTEIN MARKER"</data>
      <data key="d1">"A protein expressed on the surface of macrophages that serves as a marker for anti-inflammatory MÏs, indicating their regulatory function in inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;RORÎT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A transcription factor that promotes the development of Th17 cells by binding to regulatory regions of genes involved in the differentiation of these cells."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6RÎâ/â T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"T cells lacking IL-6 receptor alpha subunit, which have diminished clinical and histological measures of colitis."&lt;SEP&gt;"T cells lacking the IL-6 receptor alpha subunit, unable to directly respond to IL-6 but may still contribute to inflammation through other pathways."&lt;SEP&gt;"T cells lacking the IL-6 receptor alpha subunit, which are unable to respond directly to IL-6 but may still contribute to inflammation through other pathways."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;RAG1â/â MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mice lacking recombination activating gene 1, resulting in a severe combined immunodeficiency due to an inability to generate adaptive immunity properly."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-1Râ/â T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"T cells lacking the interleukin-1 receptor, which results in decreased responsiveness to IL-1 signaling and reduced ability to induce colitis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;FOXP3+ CD4+ T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulatory T cells that play a role in maintaining immune tolerance by suppressing activation of other immune cells."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-1&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Interleukin-1 is a cytokine involved in the regulation of inflammatory responses and cell proliferation."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6RÎ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene for the interleukin 6 receptor alpha subunit, which plays a role in immune responses and can influence disease severity."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-1R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene for the interleukin 1 receptor, involved in signaling pathways that regulate inflammation and autoimmune diseases."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-10RÎMDEL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A genetic modification involving the interleukin 10 receptor alpha subunit, leading to altered immune responses and disease susceptibility."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;COLONIC INFLAMMATION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammation within the colon, often associated with autoimmune disorders or infections leading to symptoms like diarrhea and abdominal pain."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-1Î PRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of generating interleukin 1 beta from its precursor pro-IL-1Î² in immune cells during inflammation responses."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;CASPASE-1 CLEAVAGE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A proteolytic interaction that activates the caspase-1 enzyme, cleaving and activating pro-IL-1Î² into active IL-1Î²."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;INFLAMMASOME STIMULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Activation of the inflammasome complex in immune cells leading to cleavage of pro-IL-1Î² by caspase-1, initiating inflammatory responses."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;LPMÎ¦S (LINâCD11B+ CD11Câ/LO F4/80HI LY6Gâ SIGLECFâ)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of macrophage cell found in the lamina propria of the intestine, known to produce IL-1Î² during inflammation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;PRO-IL-Î&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Pro-interleukin-1 beta (pro-IL-Î²) is the precursor form of the pro-inflammatory cytokine IL-1Î², which becomes mature and active after processing by caspase-1."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;MÎ¦S&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Macrophages (MÏs) are immune cells that play a role in phagocytosis and inflammation, with their activity modulated by various cytokines including IL-10."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;CASPASE-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Caspase-1 is an enzyme involved in the maturation of pro-inflammatory cytokines such as IL-1Î²; its activation can be regulated by signaling pathways like those involving IL-10."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-1RÎMDEL&quot;">
      <data key="d0">"GENOMIC VARIANT, MOLECULAR INTERACTION"</data>
      <data key="d1">"A genetic modification where a component of the IL-1 receptor is altered or deleted, affecting cytokine signaling and immune responses."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TH17 CELL MATURATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which naive T cells differentiate into Th17 helper T cells in response to specific stimuli like IL-6 and transforming growth factor beta (TGFÎ²)."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LPMÎ¦S&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS, PROTEIN INTERACTION"</data>
      <data key="d1">"Liver sinusoidal endothelial cells (LSEC), which are also known as liver-derived macrophages or LPMÏs, play a role in the regulation of immune responses and can influence T cell maturation."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RÎMDELRAG1â/â MÎ¦S&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"Macrophages (MÏs) derived from mice with an IL-10 receptor alpha chain deletion in the context of Rag1 deficiency, showing altered cytokine signaling compared to normal macrophages."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-6Râ/â T CELL TRANSFER&quot;">
      <data key="d0">"EXPERIMENTAL MODEL, DISEASE"</data>
      <data key="d1">"A model where T cells lacking the IL-6 receptor are transferred into mice for studying the role of IL-6 in immune responses and disease development."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LPS AND ATP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Lipopolysaccharide (LPS) and adenosine triphosphate (ATP) are environmental factors that stimulate macrophages to produce inflammatory cytokines like IL-1Î²."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TGFÎ&quot;">
      <data key="d0">"PROTEIN, NUTRIENT, ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Transforming growth factor beta (TGFÎ²) is a protein involved in cell differentiation and immune regulation; it can promote Th17 cell maturation when combined with other cytokines like IL-6."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;NAÃVE T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS, PROTEIN INTERACTION"</data>
      <data key="d1">"Naive T cells are lymphocytes that have not yet been exposed to specific antigens and can differentiate into various T helper cell subsets, such as Th17 cells."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;DISEASE DEVELOPMENT&quot;">
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d1">"Selective deletion of IL-10RÎ± specifically in T cells does not significantly influence disease development or severity in a T cell transfer-mediated colitis model.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLITIS SEVERITY&quot;">
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d1">"Deletion of the IL-10 receptor alpha specifically in macrophages intensifies disease severity, suggesting a protective role for IL-10 signaling within this cell type.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPONTANEOUS COLITIS&quot;">
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d1">"The CX3CR1-driven Cre transgene leads to spontaneous colitis when used to delete IL-10RÎ± in a subset of immune cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUTROPHIL ROLE&quot;">
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d1">"Deletion of IL-10RÎ± using Lys-M-Cre transgene in neutrophils and macrophages shows a complex effect on colitis severity, indicating the need for further studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE MODELS&quot;">
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d1">"Mice with floxed IL-10 receptor alpha gene are used in various models to understand the cell-specific effects of IL-10 signaling on colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE OUTCOME&quot;">
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d1">"Rectal prolapse is a severe symptom observed in mice with high disease severity, indicating advanced stages of colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;16S RRNA GENE V4 REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 16S rRNA gene V4 region is a variable segment of the bacterial genome used for microbiome analysis."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;16S RRNA GENE V3-V4 REGIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The V3 and V4 hypervariable regions of the 16S rRNA gene are targeted in genomic analyses to study microbial diversity."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;16S RRNA GENE V1-V2 REGIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"V1 and V2 variable regions of the 16S rRNA gene, which are used for sequencing studies."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;BACTEROIDES GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The Bacteroides genus is a bacterial group commonly found in human gut microbiota that contributes significantly to microbial composition diversity and health."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;FAECALIBACTERIUM GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A genus of bacteria within the Firmicutes phylum known for its role in producing butyrate, an important short-chain fatty acid for intestinal health."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;BLAUTIA GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The Blautia genus is a group of bacteria involved in carbohydrate metabolism and fermentation processes in the gut."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ALISTIPES GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Bacteria within the Bacteroidetes phylum, often associated with dysbiosis in some disease states."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;RUMINICLOSTRIDIUM GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A bacterial genus that produces short-chain fatty acids and contributes to gut health through its metabolic activities."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;FUSICATENIBACTER GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A member of the Clostridia class, known for producing butyrate and other beneficial metabolites in the gut microbiota."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;BUTYRICICOCCUS GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Bacteria that produce butyrate, an important short-chain fatty acid with anti-inflammatory effects in the colon."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;EUBACTERIUM GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A bacterial genus within the Firmicutes phylum associated with beneficial functions in gut microbiota health."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;DNA EXTRACTION METHOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The method used to extract DNA from samples, which can influence the observed microbial composition and diversity."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;TWINSUK COHORT TWIN PAIRS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A twin cohort used in genetic studies that helps estimate heritability of gut microbiome traits through MZ and DZ comparisons."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;NETHERLANDS TWIN REGISTRY (NTR) COHORT TWIN PAIRS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A twin cohort consisting of monozygotic twins used for replicating intraclass correlation coefficients in genetic studies."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;HERITABILITY ESTIMATION OF GUT MICROBIOME COMPOSITION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The study involves estimating the heritable component (H2) of gut microbiota composition based on twin data and genetic association statistics."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Heritability estimation from genome-wide summary statistics using LD score regression to assess genetic contribution to microbial taxa variation."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MIDDLE-EASTERN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"A cohort with samples from Middle-Eastern individuals."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;EAST ASIAN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"A cohort comprising East Asian ethnic background participants."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;AMERICAN HISPANIC/LATIN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"A cohort consisting of American Hispanic and Latin individuals."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;AFRICAN AMERICAN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"A specific cohort including African Americans in the study."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MULTI-ANCESTRY COHORTS&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"Four cohorts that included samples from multiple ethnic backgrounds."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ADOLESCENT AND ADULT INDIVIDUALS COHORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cohorts consisting of adult or adolescent participants, used for microbiome analysis."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;CHILDREN COHORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Two cohorts that specifically included children for microbial composition study."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;16S RRNA GENE VARIABLE REGIONS V4-V5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variable regions of the 16S rRNA gene used in microbiome sequencing studies."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;RUMINOCLOSTRIDIUM GENUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A bacterial genus known for its role in gut health and production of short-chain fatty acids."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;HERITABILITY ESTIMATION OF GUT MICROBIOTA ALPHA DIVERSITY METRICS (SHANNON, SIMPSON, INVERSE SIMPSON)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Estimations showing lack of heritability for alpha diversity metrics such as Shannon, Simpson, and inverse Simpson in the gut microbiome."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;HERITABILITY ESTIMATION OF 159 BACTERIAL TAXA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The estimation process that identifies 19 bacterial taxa with evidence for heritability among 159 studied bacterial taxa."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;RUMINICLOSTRIDIUM GENUS AND PEPTOSTREPTOCOCCAEAE FAMILY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Two specific microbial taxa showing SNP-based heritability in the gut microbiome study."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;LCT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LCT gene encodes lactase-phlorizin hydrolase, an enzyme critical for lactose digestion."&lt;SEP&gt;"The LCT gene is associated with the abundance of Bifidobacterium and shows heterogeneity in its effects across different ethnicities and ages."&lt;SEP&gt;"The LCT gene is involved in cell-type specific expression and is associated with lactase non-persistence."&lt;SEP&gt;"The LCT gene is responsible for the production of lactase, an enzyme that breaks down lactose in milk and other dairy products."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;FUT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Encodes alpha-1,2-fucosyltransferase involved in mucus glycans secretion in gastrointestinal mucosa; non-secretors lack ABO antigens on intestinal mucosa due to mutation."&lt;SEP&gt;"Functionally relevant variants, such as those in FUT2, are included among loci that influence gut microbiota composition."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM&quot;">
      <data key="d0">"GENOMIC VARIANT/METABOLIC PATHWAY/ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Bifidobacterium abundance is influenced by the LCT gene and dietary factors, especially milk product consumption in individuals with specific genotypes."&lt;SEP&gt;"Bifidobacterium is a genus of bacteria belonging to Actinobacteria class that shows a potential protective effect on ulcerative colitis, as shown by MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GENOMIC VARIANT RS182549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs182549) located within the LCT gene is significantly associated with Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;MILK PRODUCTS INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of milk products correlates positively with Bifidobacterium abundance in individuals homozygous for a specific LCT haplotype."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;AGE AND ETHNICITY HETEROGENEITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The interaction between age, ethnicity, and genetic variants affects the relationship between LCT gene polymorphisms and Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANT RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs4988235) within the LCT gene correlates with Bifidobacterium abundance and is functionally significant."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANT RS182549 (PROXY FOR RS4988235)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in linkage with the functional LCT variant, showing significant association with Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;LCT HAPLOTYPE CC (RS182549)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This haplotype is associated with higher Bifidobacterium abundance in adults but not in younger individuals."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;SIMPSON, INVERSE SIMPSON, AND SHANNON DIVERSITY INDICES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These indices were used to measure alpha diversity but did not show significant genetic hits after meta-GWAS analysis."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;TWINSUK COHORT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The TwinsUK cohort showed strong heritability evidence for certain bacterial taxa, which correlates with genome-wide significance in mbTLs."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;COPSAC2010 COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"This cohort contributed significantly to the heterogeneity observed in LCT gene associations with Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GEM_V12 AND GEM_ICHIP SUBCOHORTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"These subcohorts showed a significant SNP-age interaction on the level of Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;GEM_V24 COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Mainly composed of Israeli subethnicities, this cohort did not show an mbQTL effect despite genetic influences observed in other cohorts."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;RS182549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant that influences the abundance of Bifidobacterium in adult individuals but not in younger ones."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;LCT MBQTL EFFECT SIZE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The effect size of LCT (lactase) genetic variants on microbiome traits varies across different ethnic and age groups, particularly lower in Israeli adults."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2-FUT1 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A locus associated with the abundance of Ruminococcus torques genus group due to a stop-codon mutation introduced by SNP rs601338 in FUT2 gene."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;R. TORQUES GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Ruminococcus torques group is influenced by genetic variation at the FUT2 locus and correlates with fruit intake."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS SP.&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Bacteria specialized in degrading complex carbohydrates, impacting the gut microbiome composition and metabolism."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FRUIT INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of fruit is correlated with reduced abundance of R. torques group due to genetic variation at FUT2 locus."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;ALLISONELLA ABUNDANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abundance of Allisonella associated with SNPs in 9q21 locus (PCSK5, RFK, GCNT1 genes) involved in riboflavin phosphorylation and glycosyltransferase activities."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PEPTOSTREPTOCOCCACEAE ABUNDANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abundance of Peptostreptococcaceae affected by genetic variants at CUBN gene, related to cobalamin absorption and metabolism."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COBALAMIN ABSORPTION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The process of vitamin B12 (cobalamin) absorption regulated by genes like RFK and GCNT1 involved in host-microbiota interactions within the intestine."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;B12-DEFICIENT ANEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease resulting from cobalamin deficiency affecting intestinal epithelium expression of CUBN gene, leading to albuminuria and anemia."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE FAMILY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Family of bacteria negatively associated with stool levels of gut inflammation markers like chromogranin A and calprotectin due to genetic variants."&lt;SEP&gt;"Family of bacteria negatively correlated with gut inflammation markers like chromogranin A and calprotectin, influenced by genetic variants."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;9Q21 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at the 9q21 locus associated with abundance of Allisonella family due to influence on riboflavin phosphorylation and glycosyltransferase activities."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;CUBN GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Encodes cubilin, a receptor for cobalamin complexes necessary for vitamin B12 absorption; linked to albuminuria and B12 deficiency anemia."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;SNP RS7574352&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP associated with stool levels of gut inflammation markers chromogranin A and calprotectin and ulcerative colitis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE&quot;">
      <data key="d0">"TAXON"</data>
      <data key="d1">"A family of bacteria negatively associated with stool levels of gut inflammation markers such as chromogranin A and calprotectin, and with ulcerative colitis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CHROMOGRANIN A&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"Gut inflammation marker negatively correlated with the presence of certain microbial taxa like Peptococcaceae."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CALPROTECTIN&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"A proteinaceous gut inflammation marker negatively associated with the abundance of specific bacterial families such as Peptococcaceae."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inflammatory bowel disease negatively correlated with certain microbial taxa and positively linked to genetic variants such as SNPs."&lt;SEP&gt;"Ulcerative colitis is an inflammatory bowel disease for which higher abundance of gut microbial taxa such as Bifidobacterium and Actinobacteria may have a protective effect."&lt;SEP&gt;"Another form of inflammatory bowel disease (IBD), distinct from Crohn's disease, affecting the colon and rectum."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IRF1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in insulin resistance and susceptibility to type 2 diabetes located near a genomic variant associated with gut microbiota composition."&lt;SEP&gt;"Interferon regulatory factor 1 gene whose expression level can be influenced by genetic variants such as rs4788084[T] and missense SNP rs181206[G]."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;LCT GENE (RS182549)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Lactase gene, polymorphisms of which are associated with multiple dietary and metabolic phenotypes including obesity and Type 2 Diabetes Mellitus."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;FUT1/FUT2 LOCUS (RS35866622)&quot;">
      <data key="d0">"LOCUS"</data>
      <data key="d1">"A locus containing FUT1/FUT2 genes, associated with fish intake, height, cholelithiasis risk and Crohnâs disease risk."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;FISH INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"An aspect of dietary pattern positively associated with the FUT1/FUT2 locus and negatively correlated with certain diseases like cholelithiasis and Crohn's disease."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/METABOLIC PATHWAY"</data>
      <data key="d1">"Microbial abundance correlated with dietary intake patterns and metabolic traits such as lactose intolerance, obesity, and Type 2 Diabetes Mellitus."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS (T2DM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease associated with certain genetic variants such as rs182549 in the LCT gene, showing positive correlation with T2DM diagnosis."&lt;SEP&gt;"A disease characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, linked with specific genomic variants like rs10886471."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;LACTOSE INTOLERANCE&quot;">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"A condition characterized by the inability to digest lactose due to low levels or absence of lactase enzyme."&lt;SEP&gt;"A physiological condition predisposing individuals to a higher risk of Type 2 Diabetes Mellitus and obesity."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;RAW VEGETABLE INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"An aspect of dietary pattern that shows nominal correlation with Bifidobacterium abundance, but not significant after multiple testing correction."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;METABOLIC TRAITS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Traits such as BMI and cholesterol levels associated with genetic loci like LCT and FUT1/FUT2 via gene-based PheWAS analysis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS182549)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in the LCT gene associated with multiple dietary and metabolic phenotypes."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS FAMILY HISTORY (PATERNAL)&quot;">
      <data key="d0">"DISEASE/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The genetic predisposition to Type 2 Diabetes Mellitus, specifically passed from the paternal side."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS FAMILY HISTORY (MATERNAL)&quot;">
      <data key="d0">"DISEASE/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genetic predisposition to Type 2 Diabetes Mellitus, specifically inherited from the maternal lineage."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;SIBLINGS' TYPE 2 DIABETES MELLITUS RISK&quot;">
      <data key="d0">"DISEASE/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Risk of siblings developing Type 2 Diabetes Mellitus based on familial genetic factors."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS35866622)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant near the FUT1/FUT2 locus associated with various nutritional and health outcomes."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;FUT1/FUT2 LOCUS GENETIC VARIANTS&quot;">
      <data key="d0">"LOCUS/VARIANT"</data>
      <data key="d1">"Genetic variants at this locus influence dietary patterns, height, and disease risks such as cholelithiasis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;OILY FISH INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The consumption of oily fish is associated with genetic loci like FUT1/FUT2 in various nutritional phenotypes."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;MEAN PLATELET VOLUME&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BLOOD MARKER"</data>
      <data key="d1">"A blood marker linked to immune and metabolic functions, showing associations with the FUT1/FUT2 locus."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CHOLELITHIASIS&quot;">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"The formation of gallstones, associated with genetic variants at the FUT1/FUT2 locus."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;HIGH CHOLESTEROL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC CONDITION"</data>
      <data key="d1">"A metabolic condition positively correlated with certain genetic loci like FUT1/FUT2."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;ACTINOBACTERIA&quot;">
      <data key="d0">"GENOMIC VARIANT/METABOLIC PATHWAY/ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Actinobacteria is a class of bacteria found in the gut microbiome that may have a protective effect on ulcerative colitis, as indicated by MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;OXALOBACTERACEAE&quot;">
      <data key="d0">"GENOMIC VARIANT/METABOLIC PATHWAY/ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Higher abundance of the family Oxalobacteraceae has been observed to offer protection against rheumatoid arthritis, as indicated by MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;RHEUMATOID ARTHRITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Rheumatoid arthritis is an autoimmune disease where higher gut microbial taxa abundance in certain families such as Oxalobacteraceae might provide protective effects."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;MICROBIAL TAXA VARIABILITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/METABOLIC PATHWAY"</data>
      <data key="d1">"Variability in the composition of gut microbiome due to genetic factors or environmental influences needs careful interpretation in MR analyses."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;DIETARY PREFERENCES&quot;">
      <data key="d0">"NUTRIENT/DIETARY PATTERN"</data>
      <data key="d1">"No evidence was found for causal relationships between dietary preferences and gut microbial taxa abundance, as identified through sensitivity analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;MR ANALYSIS (MENDELIAN RANDOMIZATION)&quot;">
      <data key="d0">"METHODOLOGICAL PROCESS"</data>
      <data key="d1">"A statistical method used to identify potential causal links between gut microbial taxa and phenotypes such as diseases and nutritional traits."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISEASES&quot;">
      <data key="d0">"DISEASE CATEGORY"</data>
      <data key="d1">"A category of diseases resulting from an immune response by the body against substances and tissues normally present in it, including Type 1 Diabetes."&lt;SEP&gt;"Group of diseases where the immune system attacks healthy cells in the body, considered along with other disease categories for MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A cluster of conditions that affect the heart and blood vessels, one category analyzed for causal links to gut microbial taxa."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;METABOLIC DISEASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Conditions characterized by disturbances in metabolism, including diabetes or obesity, part of phenotypes examined through MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;PSYCHIATRIC DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mental health conditions such as depression and schizophrenia, among others, included within the scope of MR analysis for identifying causal links with gut microbiota."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;RS4988235 T/T GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs4988235 T/T genotype is a genetic variant associated with higher milk intake and altered dietary patterns."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;LP (T) ALLELES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LP (T) alleles refer to the presence of certain alleles related to lactase persistence, impacting various health factors such as blood pressure and diet."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MILK INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Milk intake is a dietary pattern that varies between countries and influences plasma C15:0 levels."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;PLASMA C15:0 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Plasma C15:0 levels are physiological markers influenced by milk consumption and genotypes of rs4988235."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIABETES RISK FACTORS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Diabetes risk factors include genetic predisposition from the LP (T) alleles and dietary patterns such as potato intake."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"HDL cholesterol levels are affected by the genotype of rs4988235, showing a modestly lower level in carriers."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake of dairy products is influenced by LP (T) alleles and includes milk, but not other dairy products."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;POTATOES INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of potatoes is higher in individuals with more LP (T) alleles, contrary to fruits and vegetables."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;CEREALS INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake of cereals is lower in individuals carrying the rs4988235 T allele."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;FRUITS INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of fruits decreases with an increase in LP (T) alleles, contrary to potatoes and dairy products."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;NON-ALCOHOLIC BEVERAGES INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake of non-alcoholic beverages is lower among individuals carrying the rs4988235 T allele."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;WINE CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of wine decreases with an increase in LP (T) alleles, contrary to milk consumption."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;RISK OF DEVELOPING DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Despite associations with dietary patterns and physiological processes, the rs4988235 genotype does not significantly influence the risk of developing diabetes."&lt;SEP&gt;"The risk of developing diabetes is not associated with the rs4988235 genotype or milk intake."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MULTIVARIABLE ADJUSTMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Multivariable adjustment for dietary intakes and genotypes shows varied associations with health outcomes such as HDL cholesterol levels."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;RS4988235 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs4988235 genotype is associated with variations in milk intake, dietary patterns, and physiological processes."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;HOMOZYGOUS LP (T/T)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Individuals homozygous for the LP (T/T) allele show increased milk consumption and altered baseline characteristics such as higher systolic blood pressure."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MILK CONSUMPTION VARIABILITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The variability in milk consumption across different countries indicates the influence of environmental factors on dietary habits."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;GENETIC DEVIATION FROM HWE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Deviation from Hardy-Weinberg equilibrium (HWE) for rs4988235 genotypes was observed in several European countries, indicating potential population-specific influences on genotype distribution."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIETARY INTAKE OF DAIRY PRODUCTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Individuals with the LP allele have higher dietary intake of dairy products such as milk and milk beverages, but not other dairy products."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;INTAKE OF NON-DAIRY FOODS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The genotype rs4988235 is also associated with altered intakes of non-dairy foods such as potatoes and cereal products."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;PLASMA C17:0 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Although not statistically significant, plasma C17:0 levels show a trend similar to C15:0 levels in relation to the LP genotype."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL VARIABILITY&quot;">
      <data key="d0">"DISEASE RISK FACTOR"</data>
      <data key="d1">"The rs4988235 genotype is associated with lower HDL cholesterol levels, contributing to diabetes risk factors."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;BASELINE HBA1C LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The baseline HbA1c levels are not influenced by the LP genotype or milk intake, indicating no direct genetic link for glycemic control."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;CHOLINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A critical nutrient for fetal brain development, often insufficient in maternal diets."&lt;SEP&gt;"Choline is an essential nutrient involved in many biological processes, including lipid metabolism and neurotransmitter synthesis."&lt;SEP&gt;"Dietary choline intake is a nutrient crucial for fetal development and maternal health."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Heavy alcohol consumption during pregnancy can negatively impact fetal growth and neurodevelopment."&lt;SEP&gt;"The process of consuming alcoholic beverages that is influenced by genetic factors such as CNR1 variation and medication treatments like olanzapine."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;SMOKING&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Maternal smoking, even at low levels, can affect fetal growth and development."&lt;SEP&gt;"Smoking is an additional lifestyle factor that showed nominal associations with milk consumption in some populations, particularly the Czech Republic."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;ILLICIT DRUGS (METHAMPHETAMINE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Use of illicit drugs during pregnancy can have adverse effects on the fetus's health."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FETAL ALCOHOL SPECTRUM DISORDERS (FASD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"FASD is a group of conditions that can occur in a person whose mother drank alcohol during pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;EYEBLINK CONDITIONING (EBC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of neurodevelopment and learning, particularly relevant to assessing effects of prenatal exposure to environmental factors."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;GESTATIONAL AGE (GA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gestation period refers to the time from conception until birth; it's crucial for fetal development."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SOMATIC GROWTH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of physical growth during pregnancy and early infancy, influenced by genetic and environmental factors."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FETAL ALCOHOL GROWTH RESTRICTION (FAGR)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by poor fetal growth due to maternal alcohol consumption."&lt;SEP&gt;"A condition where the fetus fails to grow adequately due to maternal alcohol consumption."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NOVELTY PREFERENCE SCORES IN FTII TEST&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Indicates visual recognition memory function in infants, used as a measure of cognitive development."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The level of education among mothers can influence their understanding of health risks during pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PERCEIVED STRESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High perceived stress levels in pregnant women may affect fetal development and maternal well-being."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;VERBAL AND NONVERBAL INTELLECTUAL COMPETENCE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"These measures indicate the cognitive abilities of participants, which may be influenced by dietary patterns."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CALORIC INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The amount of calories consumed is a key indicator of nutritional status during pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CIGARETTES PER DAY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Maternal smoking habits can impact the health and growth of the fetus."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE USE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Use of methamphetamine during pregnancy poses significant risks to fetal development."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;GESTATIONAL AGE AT BOOKING, SCREENING, OR RANDOMIZATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The timing of initial clinical assessments is important for tracking gestational age and planning interventions."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;WEEKS GESTATION AT RANDOMIZATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This measure indicates the stage of pregnancy when treatment allocation occurs."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DURATION OF CHOLINE SUPPLEMENTATION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The length of time choline was supplemented during pregnancy is a key variable in assessing its impact."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SEX OF INFANT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The sex ratio can provide insights into the effects of interventions on fetal development."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;INFANT AGE AT ASSESSMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Age at which infants are assessed for developmental milestones and neurodevelopmental outcomes."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PERCENT CRS IN EBC SESSIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The percentage of conditioned responses observed during eyeblink conditioning sessions."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PROTOCOL ADHERENCE AND PERCENT CRS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Adherence to the choline supplementation protocol correlates with neurodevelopmental outcomes measured by percent CRs."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;BIRTH WEIGHT (&lt;2500 G)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Low birth weight is a measure of growth restriction often associated with poor pregnancy health."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;BIRTH SIZE AND PERCENTILES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measures indicating the physical dimensions of newborns, influenced by prenatal conditions."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CATCH-UP GROWTH IN WEIGHT AND HEAD CIRCUMFERENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The phenomenon where infants show improved growth rates after initial restriction, influenced by nutritional interventions."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FAGAN TEST OF INFANT INTELLIGENCE (FTII)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A test used to assess visual recognition memory and processing speed in infants."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NOVELTY PREFERENCE SCORES ON FTII TEST&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Scores reflecting the ability of infants to recognize new stimuli, indicating cognitive development."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FASD DIAGNOSIS (FETAL ALCOHOL SYNDROME (FAS), PARTIAL FETAL ALCOHOL SYNDROME (PFAS))&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Conditions resulting from prenatal alcohol exposure, affecting physical and neurodevelopmental outcomes."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FASD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fetal Alcohol Spectrum Disorders (FASD) is a range of conditions that can occur in a person whose mother drank alcohol during pregnancy."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PFAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Partial Fetal Alcohol Syndrome (PFAS) involves some but not all diagnostic criteria for Fetal Alcohol Syndrome."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PEMT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phosphatidylethanolamine N-methyltransferase (PEMT) gene encodes a protein that catalyzes the conversion of phosphatidylethanolamine to phosphatidylcholine, an essential component in cell membranes."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;RS12325817&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic variant within the PEMT gene associated with reduced choline synthesis capacity."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;P=0.393&quot;">
      <data key="d0">"P-VALUE"</data>
      <data key="d1">"The p-value of 0.393 from the statistical test indicates that there is no statistically significant association between maternal dietary choline intake and FAS/PFAS outcomes."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Maternal dietary intake of choline during pregnancy, which can impact infant health outcomes but did not show a significant difference in this study."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;Î§Â²(1)=0.73&quot;">
      <data key="d0">"STATISTICAL TEST RESULT"</data>
      <data key="d1">"A statistical test result indicating no significant difference in FAS/PFAS diagnosis between the choline-treated arm and placebo arm."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE STATUS&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Proper caloric intake is necessary to support adequate choline status during pregnancy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTOCOL ADHERENCE&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Timing of initial assessments influences the feasibility and adherence to treatment protocols.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE SUPPLEMENTATION EFFECTIVENESS&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"The effectiveness of choline supplementation may vary based on gestational age at initiation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GESTATIONAL AGE AND SOMATIC GROWTH&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"The sex of the infant can influence growth patterns observed during gestation and after birth.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CATCH-UP GROWTH&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Higher adherence to choline supplementation protocols correlates with better neurodevelopmental outcomes, including catch-up growth patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEMT GENE EXPRESSION&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The rs12325817 variant of the PEMT gene affects choline synthesis capacity and may alter maternal dietary requirements for adequate nutrition during pregnancy."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL DIETARY STATUS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"Mothers' dietary choline intake status is an environmental factor that can significantly impact infant health outcomes, especially in relation to FASD risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAS/PFAS DIAGNOSIS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The study's findings suggest that maternal dietary choline status does not significantly impact the diagnosis of FAS or PFAS in infants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL DIETARY CHOLINE STATUS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The study's findings suggest that maternal dietary choline status does not significantly impact the diagnosis of FAS or PFAS in infants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10886471 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at rs10886471 is associated with intronic (CA)n repeats that play a role in gene splicing and are linked to the risk of prediabetes and T2DM."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;GRK5 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GRK5 gene has intronic CA repeat sequences polymorphisms that influence its expression and are associated with prediabetes and T2DM risk."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;(CA)17 ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An allele of the (CA)n repeats, (CA)17, is the most common in the NFG group and used as a reference for estimating association strength."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;(CA)16 ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The (CA)16 allele is used as a reference in studies involving genomic variants related to T2DM and other blood glucose abnormalities."&lt;SEP&gt;"The (CA)16 allele shows significantly higher frequencies in IFG, IGT, and T2DM groups compared to the NFG group, indicating increased risk of prediabetes and T2DM."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLUCOSE (IFG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition characterized by high blood glucose levels measured in the morning before eating, before diabetes is diagnosed."&lt;SEP&gt;"A condition where fasting glucose is higher than normal but not high enough to be classified as diabetes; associated with increased risk of T2DM and genomic variants."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;SBP (SYSTOLIC BLOOD PRESSURE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The highest pressure exerted on the walls of the arteries during heart contraction; increased in individuals with prediabetes and T2DM compared to those without abnormal glucose levels."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;DBP (DIASTOLIC BLOOD PRESSURE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The lowest pressure in the arteries when the heart is resting between beats; elevated in groups with impaired fasting glucose, glucose tolerance, and Type 2 Diabetes Mellitus compared to normal glucose-tolerant individuals."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;2H PG (2-HOUR POSTPRANDIAL GLUCOSE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"A measure of blood sugar two hours after consuming a meal; increases in individuals with impaired glucose tolerance and Type 2 Diabetes Mellitus compared to those without abnormal glucose levels."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;GRK5 (CA)N REPEATS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms within the GRK5 gene involving CA repeat sequences that influence genetic predisposition towards prediabetes and T2DM."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;T2DM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 Diabetes Mellitus (T2DM) is a chronic disease characterized by high blood sugar levels over an extended period."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)N ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"(CA)n alleles are genomic variants that have been studied in relation to the risk of developing T2DM, IFG, and IGT conditions."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IFG (IMPAIRED FASTING GLUCOSE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Impaired Fasting Glucose (IFG) is a condition characterized by higher than normal fasting blood glucose levels but not high enough to be classified as diabetes."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IGT (IMPAIRED GLUCOSE TOLERANCE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Impaired Glucose Tolerance (IGT) refers to a condition where the body's ability to handle glucose is diminished, yet it does not meet the criteria for full-blown diabetes."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)15, (CA)17, (CA)18, (CA)19 ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These multiple alleles are classified together as a single variant in studies examining their association with IFG, IGT, and T2DM."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;NFG GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The NFG group refers to individuals with Normal Fasting Glucose, used as a control in studies comparing different dietary patterns and their impact on blood glucose levels."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;2H PG&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Polymorphisms within GRK5's CA repeat sequences are linked with higher postprandial glucose levels in individuals moving from normal glucose tolerance to IGT and T2DM, suggesting a genetic component in impaired glucose metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;IFG&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The multiple alleles (excluding (CA)16) show a significant negative correlation with IFG, indicating a protective effect against this condition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IGT&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"There is a significant negative association between the studied alleles and IGT, suggesting these variants reduce the risk of impaired glucose tolerance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="(&quot;CA)N ALLELES&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The (CA)15, (CA)17, (CA)18, and (CA)19 alleles are classified together as a multiple allele in contrast to the reference (CA)16 allele."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG, IGT, T2DM GROUPS&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The NFG group serves as the control for comparing against groups with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and Type 2 Diabetes Mellitus (T2DM)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;(CA)N ALLELES, T2DM&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The odds ratio is used to measure the association between specific alleles (such as (CA)n variants) and the risk of developing conditions like Type 2 Diabetes Mellitus."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OR&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The odds ratio is used to measure the association between specific alleles (such as (CA)n variants) and the risk of developing conditions like Type 2 Diabetes Mellitus."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELENIUM&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium is a trace element that plays a role in various physiological processes and can be found in supplements and dietary sources."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLORECTAL CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by the growth of cancer cells in the colon or rectum, influenced by genetic and environmental factors."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;GPX4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GPX4 gene encodes glutathione peroxidase 4, an enzyme involved in antioxidant defense mechanisms against reactive oxygen species (ROS)."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;RS8178974&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) located within the GPX4 gene associated with colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;NSAIDS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Nonsteroidal anti-inflammatory drugs used to manage pain and inflammation, which did not show significant association with colorectal cancer in this study."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;POSTMENOPAUSAL HORMONE USE&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"The use of hormone replacement therapy among postmenopausal women; lower usage was observed in cases compared to controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;CALCIUM INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of calcium was found to be lower in colorectal cancer cases than in controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;DIETARY FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of dietary fiber was also found to be lower in cases compared to controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;SMOKING HABIT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Higher smoking rates were observed in cases compared to controls, indicating an association with increased risk of colorectal cancer."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;META-ANALYSIS RESULTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A comprehensive analysis that summarizes the findings from multiple studies, suggesting a protective effect of selenium against colorectal tumor development."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;WHI OBSERVATIONAL STUDY&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"An observational cohort study within the Women's Health Initiative (WHI) that investigates risk factors and outcomes related to colorectal cancer among women."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SERUM SELENIUM CONCENTRATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The concentration of selenium in participants' blood serum, found not to be significantly associated with colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLORECTAL ADENOMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A benign tumor that is a precursor lesion to colorectal cancer; the meta-analysis showed stronger inverse associations between selenium and adenomas compared to cancers."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SELENIUM INTAKE&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"Both selenium and calcium intakes were noted to differ between cases of colorectal cancer and controls, indicating possible nutritional influences on disease susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;CARD9 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CARD9 gene plays a critical role in shaping the bacterial and fungal gut microbiota, particularly in controlling fungal microbiota expansion in colitis."&lt;SEP&gt;"The Card9 gene plays a role in regulating the immune response and susceptibility to DSS-induced colitis."&lt;SEP&gt;"The Card9 gene plays a role in the immune response and recovery from colitis induced by dextran sulfate sodium."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;WT MICE TRANSCRIPTOME&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcriptome of wild-type (WT) mice shows a different response to colitis compared to Card9â/â mice, with differences in immune-related pathways and cell proliferation genes."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3G GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Reg3g encodes REGIII-Î³ protein which is induced by IL-22 and plays a role in the antimicrobial response during colitis recovery."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Reg3b gene expresses the REGIII-Î² protein, involved in the immune defense against pathogens during colitis recovery."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;IL1B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 1 beta (Il1b) is induced and plays a role in inflammatory responses related to colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-22 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-22 protein mediates recovery from DSS-induced colitis through induction of antimicrobial proteins such as REGIII-Î³ and REGIII-Î²."&lt;SEP&gt;"Interleukin-22 (IL-22) is involved in promoting local IL-22 production and contributes to protection against intestinal inflammation."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;DEXTRAN SULFATE SODIUM (DSS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DSS is a chemical used to induce colitis in experimental models by damaging the colon's epithelial layer."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;FUNGAL MICROBIOTA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The fungal microbiota composition differs between WT and Card9â/â mice, with increased instability in Card9â/â mice during colitis induction."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;BACTERIAL MICROBIOTA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline bacterial microbiota differences exist between WT and Card9â/â mice, and stability is compromised more in Card9â/â mice during DSS-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;DSS-INDUCED COLITIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Colitis induced by Dextran Sulfate Sodium (DSS), a condition characterized by inflammation of the colon."&lt;SEP&gt;"DSS-induced colitis is a model of inflammatory bowel disease used to study immune responses in mice."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;KI67 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Ki67 protein is a marker for cell proliferation and its staining decreases in Card9â/â mice indicating reduced epithelial cell proliferation during DSS-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CASPASE 3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Cleaved caspase 3 is an indicator of apoptosis, which increases in Card9â/â mice during DSS-induced colitis, suggesting increased cell death."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-17A PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-17A protein acts in concert with IL-22 to provide a protective role during DSS-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3G TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of Reg3g gene is induced and differentially expressed between Card9â/â and WT mice, indicating its role in immune response during colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3B TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of Reg3b gene is induced and differentially expressed between Card9â/â and WT mice, indicating its role in immune response during colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-1BETA TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of Il1b gene is upregulated in the colon tissue of mice during DSS-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL22 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Colonic expression of Il22 decreases on day 12 in Card9â/â mice, suggesting a diminished immune response."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;NKP46+ CELLS&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"Cells expressing NKp46 protein have altered proportions and activity levels between WT and Card9â/â mice during DSS-induced colitis, indicating their role in immune responses."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;CD3âCD4âNKP46â SUBSET&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"This subset of cells decreases on day 12 in Card9â/â mice compared to WT mice, highlighting the importance of CARD9 and IL-22 in mediating immune responses."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;GUT MICROBIOTA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The community of microorganisms living in the gastrointestinal tract, which can influence tryptophan metabolism and AHR activation."&lt;SEP&gt;"The gut microbiota refers to the collection of microorganisms residing in the gastrointestinal tract. It plays a crucial role in health and disease, particularly influencing immune responses and intestinal homeostasis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IL-22 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-22 is an inflammation-associated gene that encodes for IL-22 protein, which mediates innate antimicrobial resistance in the gut and contributes to mucosal healing during colitis recovery."&lt;SEP&gt;"The IL-22 gene contains two polymorphisms (rs1179251 C/G and rs2227485 C/T) investigated for their influence on the susceptibility of colorectal cancer development."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTRAEPITHELIAL ÎÎ T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A population of immune cells located within the epithelium, including those that produce IL-22 and IL-17."&lt;SEP&gt;"These are immune cells found within the epithelial lining of various tissues including the gut. They contribute to immune responses but were not altered in IL-22 production between WT and Card9â/â mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;TH22 CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"T helper 22 (TH22) cells are a subset of CD4+ T cells that produce interleukin-22 (IL-22). They contribute to mucosal barrier integrity and repair. IL-22 production by TH22 cells was decreased in Card9â/ââGF mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INNATE LYMPHOID CELLS (ILCS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A group of immune cells that include ILC1, ILC2, and ILC3 subtypes. They play roles in immunity and inflammation without undergoing antigen-specific selection. The study indicates a decrease in IL-22 production by NKp46+ ILCs in Card9â/ââGF mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;NATURAL KILLER (NK) CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Immune cells that are part of the innate immune system and can kill virus-infected or tumor cells. In this context, no difference was observed in IL-22 production by NKp46+ ILCs between Card9â/ââGF mice and WT controls."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;REG3G AND REG3B GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These genes encode for regenerating islet-derived proteins (REG) 3G and REG3B, which are involved in innate immunity. Their expression levels were reduced in Card9â/ââGF mice compared to WT controls."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTERLEUKIN-22 (IL-22)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A cytokine produced by immune cells including TH17 and ILCs, involved in mucosal homeostasis. The study highlights decreased IL-22 expression levels in Card9â/ââGF mice compared to WT controls."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTERLEUKIN-6 (IL-6)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A cytokine that plays a role in inflammation and immune responses. No differences were observed in the amounts of IL-6 between Card9â/ââGF mice and WT controls."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTERFERON-GAMMA (IFN-Î)&quot;">
      <data key="d0">"PROPTOEN"</data>
      <data key="d1">"An important cytokine involved in host defense against intracellular pathogens. In this context, no difference was observed in IFN-Î³ amounts between Card9â/ââGF mice and WT controls."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTERLEUKIN-10 (IL-10)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A cytokine that inhibits inflammation and promotes immune tolerance. No differences were noted in IL-10 levels between Card9â/ââGF mice and WT controls."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DEFENSIN BETA 1 (DEFB1) GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding an antimicrobial peptide involved in innate immunity. The expression of Defb1 was not altered in the context provided when comparing Card9â/ââGF mice with WT controls."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The process through which tryptophan is metabolized into various products, such as kynurenine and indole derivatives."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IDO1 (INDOLEAMINE 2,3-DIOXYGENASE 1) GENE/PROTEIN&quot;">
      <data key="d0">"GENE/PROTEIN"</data>
      <data key="d1">"IDO1 gene encodes the enzyme responsible for catalyzing the first and rate-limiting step in tryptophan catabolism to kynurenine."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR (ARYL HYDROCARBON RECEPTOR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"An intracellular receptor that mediates cellular responses to environmental factors, particularly dioxins and other xenobiotics, as well as tryptophan metabolites like indole-3-acetic acid."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;INDOLE DERIVATIVES (IAA)&quot;">
      <data key="d0">"MOLECULAR INTERACTION/NUTRIENT"</data>
      <data key="d1">"Indoles are aromatic compounds derived from the amino acid tryptophan and can act as ligands for AHR, promoting local IL-22 production in the gut."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;KYNURENINE (KYN)&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"A metabolite of tryptophan produced via the action of IDO1 enzyme, involved in immune regulation and inflammation control."&lt;SEP&gt;"A metabolite of tryptophan that increases in fecal samples from IBD patients, indicating defective AHR activation due to impaired gut microbiota metabolism."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;LACTOBACILLUS STRAINS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/BACTERIA"</data>
      <data key="d1">"Probiotic bacteria that can be used to rescue susceptibility to colitis by enhancing AHR activation and IL-22 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IL-17 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin-17 (IL-17) is a cytokine involved in promoting inflammation."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INTESTINAL DENDRITIC CELLS/MACROPHAGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/CELL TYPE"</data>
      <data key="d1">"Immune cells in the intestine that play a role in producing IL-23 to stimulate IL-22-producing cells."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IL-23 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin-23 (IL-23) is involved in immune responses and stimulates the production of IL-22 by T cells and ILCs."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;ILC (INNATE LYMPHOID CELL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/CELL TYPE"</data>
      <data key="d1">"Immune cells similar to T-helper 17 and T-regulatory cells but are innate immune cells that produce cytokines like IL-22."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;FECZ (6-FORMYLINDOLO(3,2-B)CARBAZOLE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION/DRUG"</data>
      <data key="d1">"An agonist for the Aryl Hydrocarbon Receptor (AHR), used in experiments to activate AHR and reduce colitis severity."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;CARD9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CARD9 is a gene involved in immune signaling pathways and susceptibility to colitis."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IL-22&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin 22 (IL-22) is a cytokine involved in immune response, particularly in epithelial barrier integrity and protection against pathogens."&lt;SEP&gt;"Interleukin-22 (IL-22) is a cytokine that plays a role in the production of AHR ligands by the gut microbiota."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;TRYPTOPHAN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Tryptophan is an essential amino acid involved in tryptophan metabolism, which influences AHR activation and colitis susceptibility."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IDO1&quot;">
      <data key="d0">"ENZYME/PROTEIN"</data>
      <data key="d1">"Indoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that metabolizes tryptophan to produce Kynurenine (Kyn), affecting AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AHR LIGAND PRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of producing ligands for the Aryl Hydrocarbon Receptor (AHR), which are crucial for immune regulation and colitis resistance."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CARD9â/â MICE&quot;">
      <data key="d0">"ANIMAL MODEL"</data>
      <data key="d1">"Knockout mice lacking CARD9 gene, used to study susceptibility to colitis due to impaired IL-22 signaling pathway and tryptophan metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;INDOLE-3-CARBINOL (I3C)&quot;">
      <data key="d0">"NUTRIENT/AHR LIGAND"</data>
      <data key="d1">"An AHR agonist found in cruciferous vegetables, which can effectively counter defects in AHR activation observed in IBD patients."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;INFLAMMATORY BOWEL DISEASE (IBD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic inflammatory condition of the gastrointestinal tract including Crohn's disease and ulcerative colitis, associated with impaired tryptophan metabolism and reduced AHR activity."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;GENOMIC VARIANT WITHIN CARD9 (RS10781499)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single-nucleotide polymorphism in the CARD9 gene linked to increased susceptibility to inflammatory bowel disease by affecting AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CROHNâS DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A form of inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;NOD2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with increased risk of developing Crohnâs disease due to mutations leading to impaired innate immune response."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;ATG16L1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Autophagy-related 16-like 1 (ATG16L1) is a gene implicated in the development of inflammatory bowel diseases, particularly Crohnâs disease.""</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;LRRK2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Leucine-rich repeat kinase 2 (LRRK2) is another genetic variant associated with increased susceptibility to Parkinson's disease and may also influence IBD risk."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;FECAL SAMPLES&quot;">
      <data key="d0">"BIOLOGICAL SAMPLE"</data>
      <data key="d1">"Samples collected from the gastrointestinal tract of patients, used in this study to assess AHR activation by gut microbiota-produced metabolites."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CARD9â/ââGF MICE&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"In mice lacking CARD9 (Card9â/ââGF), there is a significant downregulation of IL-22, which affects the immune response and mucosal repair during colitis recovery."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN-17A (IL-17A)&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"TH17 cells produce IL-17A, but in this context, there were no observed differences in IL-17 production between Card9â/ââGF mice and WT controls."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDO1 GENE/PROTEIN&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">"IDO1 mediates tryptophan metabolism into kynurenine, which is involved in immune regulation and can influence AHR activation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR ACTIVATION&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">"Supplementation with Lactobacillus strains rescues AHR activation in Card9â/â mice, suggesting their importance for gut health."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-22 PRODUCTION&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">"Î³Î´ T cells contribute to IL-22 production, which is involved in immune regulation and protection against intestinal inflammation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDO1 ENZYME ACTIVITY&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Increased IDO1 activity promotes the production of Kynurenine from tryptophan, indicating defective AHR activation in inflammatory bowel disease (IBD)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KYNURENINE LEVELS&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Increased IDO1 activity promotes the production of Kynurenine from tryptophan, indicating defective AHR activation in inflammatory bowel disease (IBD)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The risk allele within CARD9 is associated with reduced ability of fecal microbiota to activate AHR in vitro assays from patients with IBD."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Î2M&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Beta-2-microglobulin (Î²2M) is a protein that has been associated with hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by persistently elevated blood pressure, which can contribute to cardiovascular disease and hyperuricemia risk."&lt;SEP&gt;"Hypertension is a disease characterized by persistently high blood pressure."&lt;SEP&gt;"Hypertension is adjusted for in the multivariate linear regression analysis, showing no significant effect on altering the relationship between daily alcohol intake and blood cortisol level."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3 EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SH2B3 expression is a physiological process that affects Î²2M levels and hypertension risk."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ANGIOTENSIN II&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Angiotensin II is an environmental factor that induces hypertensive responses in mice."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;CIS GENETIC VARIATION WITHIN SH2B3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A cis genetic variation within the SH2B3 gene affects its expression and function, influencing Î²2M levels and hypertension risk."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3â/â MOUSE MODEL&quot;">
      <data key="d0">"BIOLOGICAL MODEL"</data>
      <data key="d1">"The Sh2b3 knockout mouse model is used to study the effects of reduced SH2B3 function on Î²2M expression and hypertensive responses."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS3184504)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with plasma Î²2M levels and SH2B3 expression."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SH2B3 gene encodes for the SH2B3 protein which is involved in regulating blood pressure and kidney function."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ALBUMINURIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Albuminuria is a physiological process characterized by the presence of albumin in urine, indicating potential kidney damage."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;CLINICAL MODEL&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A clinical model that includes baseline covariates such as age, sex, BMI, diabetes status, smoking habits, cholesterol levels, and blood pressure for predicting new-onset hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;KIDNEY FUNCTION&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"Low eGFR indicates reduced kidney function, often seen in hypertensive patients."&lt;SEP&gt;"The process by which the kidney regulates water and electrolyte balance, blood pressure, acid-base balance, waste products, etc."</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;NEW-ONSET HYPERTENSION PREDICTION&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"The clinical model improves the prediction of new-onset hypertension when combined with Î²2M levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFD1 SNP RS2236224&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An MTHFD1 single nucleotide polymorphism located at position rs2236224, associated with an increased risk of neural tube defects in infants when compared to the CC genotype in higher folate intake groups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFD1 SNP RS2236225&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An MTHFD1 single nucleotide polymorphism located at position rs2236225, associated with an increased risk of neural tube defects in infants when compared to the CC genotype in higher folate intake groups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFD1 SNP RS11627387 AG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"An MTHFD1 single nucleotide polymorphism located at position rs11627387 with the AG genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;FOLATE INTAKE&quot;">
      <data key="d0">"NUTRIENT (DIETARY PATTERN)"</data>
      <data key="d1">"The daily dietary intake of folate is an important factor in reducing the risk of neural tube defects, showing differential effects based on genetic variations such as those found in MTHFD1 and other genes mentioned."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR SNP RS1476413&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the MTHFR gene at position rs1476413, where heterozygous mothers have a decreased risk of an NTD-affected pregnancy compared to common homozygous mothers when they have low folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR SNP RS1801131&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the MTHFR gene at position rs1801131, where heterozygous mothers have a decreased risk of an NTD-affected pregnancy compared to common homozygous mothers when they have low folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR SNP RS1801133&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the MTHFR gene at position rs1801133, where heterozygous mothers have a decreased risk of an NTD-affected pregnancy compared to common homozygous mothers when they have low folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS669340 CG&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the SHMT1 gene at position rs669340, where heterozygous mothers have a reduced risk of an NTD-affected pregnancy compared to those with the CC genotype."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS12939757 AG&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the SHMT1 gene at position rs12939757, where infants have a higher risk of NTDs compared to those with the AA genotype when they are in the low folate intake group."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS SNP RS502396&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the TYMS gene at position rs502396, associated with a reduced risk of NTDs for mothers in the low folate intake group when compared to those in the high folate intake group."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS SNP RS699517&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the TYMS gene at position rs699517, associated with a reduced risk of NTDs for mothers in the low folate intake group when compared to those in the high folate intake group."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS SNP RS2847153 AG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the TYMS gene at position rs2847153 with the AG genotype, showing a protective interaction effect against NTDs for infants compared to those with the GG genotype when they are in high folate intake groups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;NEURAL TUBE DEFECT (NTD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A birth defect resulting from abnormal development of the neural tube during gestation, influenced by genetic and environmental factors such as maternal folate intake and specific gene variants."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR SNP RS1801131 TT GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the MTHFR gene at position rs1801131 with the TT genotype, associated with an increased risk of neural tube defects when compared to the CT or CC genotypes in high folate intake groups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS4997765 AA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the SHMT1 gene at position rs4997765 with the AA genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS SNP RS2847153 CG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the TYMS gene at position rs2847153 with the CG genotype, showing a protective interaction effect against NTDs for infants compared to those with the GG genotype when they are in high folate intake groups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFD1 SNP RS6966057 AG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"An MTHFD1 single nucleotide polymorphism located at position rs6966057 with the AG genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS3787486 AA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT (PROTEIN)"</data>
      <data key="d1">"A single nucleotide polymorphism in the SHMT1 gene at position rs3787486 with the AA genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;RS10399931&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located in the CHI3LI gene, found to have no significant association with Type 2 Diabetes (T2D) but shows a borderline protective association with Impaired Glucose Tolerance (IGT)."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;RS4950928&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the CHI3LI gene, found to have no significant association with Type 2 Diabetes (T2D) and other quantitative traits."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;CHI3LI GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CHI3LI gene harbors several tgSNPs that were investigated for their potential associations with T2D but showed no significant linkage after adjustments for age, sex, BMI, and glucose tolerance."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;T2D QUANTITATIVE TRAITS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Quantitative traits associated with Type 2 Diabetes (T2D), including serum C-peptide concentration, which shows a borderline significant association with rs10399931."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;SERUM C-PEPTIDE CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process measured as the level of serum C-peptide after 2 hours, showing a borderline significant association with genomic variant rs10399931."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;TGSNPS OF CHI3LI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A set of tag single nucleotide polymorphisms (tag SNPs) associated with the CHI3LI gene, which were analyzed for their association with Type 2 Diabetes (T2D) but showed no significant linkage after adjustments."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;HAPLOTYPE BLOCKS OF CHI3LI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Two identified haplotype blocks within the CHI3LI gene that were studied for their potential associations with Type 2 Diabetes (T2D) but showed no significant linkage."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d1">"Body Mass Index (BMI) was multiadjusted and associated with T2D-related quantitative traits, though no significant associations were found."&lt;SEP&gt;"The process of DNA replication and transcription is involved in the amplification and genotyping of CYP24A1 gene variants."</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;CFH Y402H RISK ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CFH Y402H risk allele is a genetic variant that increases the odds of developing AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;A69S RISK ALLELE (ARMS2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The A69S risk allele in ARMS2 gene increases the odds of developing AMD when combined with poor lifestyle scores."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;RS641153 (CFB/C2) G ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homogeneity for the G allele of rs641153 is associated with increased odds of AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The HLS score reflects a healthy lifestyle and dietary pattern that influences risk factors for AMD, such as diet stability."&lt;SEP&gt;"The healthy lifestyle score is a measure that includes dietary patterns and other health behaviors."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by progressive damage to the macula, increasing the odds of developing with certain genetic variants like Y402H and A69S alleles."&lt;SEP&gt;"Age-related macular degeneration is a condition that affects the central part of the retina, leading to loss of vision in older individuals."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;OMEGA-3 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A dietary nutrient, omega-7 fatty acids, may influence PPARÎ³ activity through molecular interactions reducing inflammation."&lt;SEP&gt;"A type of polyunsaturated fatty acid that can reduce triglyceride levels when consumed as part of a fat-restricted diet, showing promising results in managing hypertriglyceridemia."&lt;SEP&gt;"Omega-3 fatty acids are nutrients that were explored for their role in explaining the association between HLS and AMD but found not to influence interaction terms."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LOW/LOW LZ (LUTEIN/ZEAXANTHIN)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process involving low intake of lutein and zeaxanthin which was adjusted for in analyses with HLS and AMD risk, potentially explaining some associations."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;DIETARY INTAKE OF LUTEIN/ZEAXANTHIN (LZ)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of LZ nutrients is a factor explored to explain the association between HLS and AMD risk in high genetic risk individuals."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;CFH GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CFH gene harbors the Y402H variant which is associated with increased risk of AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;ARMS2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ARMS2 gene contains the A69S allele, a genetic variant linked to an increased risk of developing AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;C3 (COMPLEMENT COMPONENT 3)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in C3 did not show main effect within CAREDS study, but was mentioned as a gene of interest."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;CFI GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CFI gene does not have a main effect on AMD risk within the CAREDS dataset."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;RS10033900 (CFI)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the CFI gene did not show an impact on AMD risk as observed in CAREDS study."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;LUTEIN AND ZEAXANTHIN INTAKE LEVELS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Levels of dietary intake of lutein and zeaxanthin (LZ) were explored for their role in explaining the association between HLS and AMD risk."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;ARMS2 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ARMS2 genotype refers to genetic variations within the ARMS2 gene, which are associated with increased risk for age-related macular degeneration."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;COMPLEMENT PATHWAY GENES (CFB/C2, C3, AND CFI)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These genes encode proteins involved in the complement pathway of the immune system, which is implicated in several diseases including AMD."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;SYNERGY INDEX (SI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"The Synergy Index is a measure used to determine whether the combined effect of two factors (such as genetic risk and lifestyle) is more than additive or less than expected multiplicatively."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;ODDS RATIO (OR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/STATISTICAL MEASURE"</data>
      <data key="d1">"Odds ratio is a statistical tool used in epidemiology to quantify the strength of an association between a variable and a disease, reflecting how much higher the odds are for those with versus without exposure to risk factors."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;COMPLEMENT PATHWAY GENES (CFB/C2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These genes encode proteins involved in the complement pathway, which plays a role in immune response and inflammation, potentially influencing disease susceptibility including AMD."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;SNP C3 RS2230199&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2230199 is a single nucleotide polymorphism (SNP) located within the complement pathway gene C3, which may influence risk for age-related macular degeneration."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;SNP CFI RS10033900&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs10033900 is a single nucleotide polymorphism (SNP) located within the complement pathway gene CFI, which may influence risk for age-related macular degeneration."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;AMD&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"The A69S risk allele in ARMS2 gene increases odds for AMD when combined with poor lifestyle scores."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AMD RISK IN HIGH GENETIC RISK WOMEN&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"Adjusting for low dietary intake of lutein and zeaxanthin attenuates the association between HLS and AMD risk in women with high genetic risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OMEGA-3 FATTY ACIDS INTAKE&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"Intake of omega-3 fatty acids does not influence the interaction terms explaining HLS and AMD risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;A69S ALLELE&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"The ARMS2 gene harbors an A69S allele that increases AMD risk when combined with poor lifestyle scores."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CFH AND ARMS2 GENES&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"While C3 does not show a main effect, it's considered in the context of other genetic factors influencing AMD risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LUTEIN/ZEAXANTHIN INTAKE LEVELS&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"Higher dietary intake levels of lutein and zeaxanthin can partially explain some associations between HLS and AMD risk in high genetic risk individuals."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Y402H VARIANT IN CFH GENE&quot;">
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d1">"CFI gene status does not interact significantly with Y402H variant in CFH to influence AMD risk as much as other factors like HLS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Variants in the complement pathway genes are associated with the risk of AMD through their role in immune response and inflammation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HECTD4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at one of the genomic variants identified in the GWAS related to habitual coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;ACAD10 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at one of the genomic variants identified in the GWAS associated with habitual coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;MYL2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at one of the genomic variants found to be significant in the study on habitual coffee intake."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;CUX2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene situated at a significant SNP identified through GWAS for habitual coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SNP RS2074356&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the three genotyped SNPs found to be highly correlated and relevant to habitual black coffee intake."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SNP RS11066015&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another one of the three genotyped SNPs considered as coffee-related genetic variants in the GWAS study."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SNP RS12229654&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A third genotyped SNP identified to be associated with habitual black coffee consumption and used for calculating genetic risk scores."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SNP RS11065828&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An imputed SNP selected as a key variant in relation to habitual coffee consumption based on high correlation with genotyped SNPs."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SNP RS79105258&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another imputed SNP chosen for genetic risk score calculations due to its strong association with habitual coffee intake."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;PREDIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An intermediate state of glucose metabolism characterized by elevated blood sugar levels but not high enough for a diabetes diagnosis, linked to habitual coffee intake."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The habit of drinking coffee regularly was found to influence the risk of developing type 2 diabetes and prediabetes over time."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;BLACK COFFEE INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern associated with a reduced risk of prediabetes and type 2 diabetes compared to non-consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SUGARED COFFEE CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"An additional dietary habit linked to lower risks of developing prediabetes and type 2 diabetes in the study."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC RISK SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A calculated score based on genetic variants influencing coffee consumption and risk for prediabetes/type 2 diabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;PRDM16 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at a genomic variant identified in GWAS for habitual coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GCKR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene situated near one of the significant SNPs associated with habitual black and sugared coffee intake."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;HLA-DQB1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located at a genomic variant linked to both black and sugared coffee consumption in GWAS studies."&lt;SEP&gt;"The HLA-DQB1 gene, along with the HLA-DRB1 gene, forms haplotypes important for immune responses and disease susceptibility."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;ALLELE FREQUENCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The frequency of an allele within a population can influence genetic risk factors for diseases such as type 2 diabetes."</data>
      <data key="d2">chunk-b803830d07bff8ae14550f6458048707</data>
    </node>
    <node id="&quot;SENP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SENP1 gene plays a critical role in regulating inflammation and diabetes through its expression in adipocytes."&lt;SEP&gt;"SENP1 is a gene that regulates the activation of NF-ÎºB and cytokine production in adipocytes."&lt;SEP&gt;"SENP1 is a gene whose expression levels are associated with the progression of type 1 diabetes and immune cell infiltration."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An adipocyte-specific deletion of the SENP1 gene was introduced into mice to investigate the function of SENP1 in inflammation and diabetes."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOQ-CRE, PDGFRÎ-CRE, AP2/FABP4-CRE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Specific Cre recombinase-driven promoters (Adipoq, PdgfRÎ±, and aP2/Fabp4) were used to generate adipocyte-specific SENP1 knockout mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein product of the SENP1 gene was reduced in isolated adipocytes from different fat tissues but not in macrophages or pancreatic islets."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;DIABETES MELLITUS, TYPE 1 (T1DM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"SENP1-deficient mice exhibit a type-1-like diabetic phenotype characterized by high blood glucose levels and reduced insulin secretion."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GLUCOSE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increased age-dependent glucose levels were observed in SENP1-deficient mice compared to controls, indicating the development of diabetes."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INSULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Plasma insulin levels decline with increasing age in SENP1-AdipoqKO and SENP1-aP2KO mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GLUCOSE TOLERANCE TEST (GTT)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"GTT showed prolonged hyperglycaemia in SENP1-deficient mice compared to control mice, indicating impaired glucose tolerance."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INSULIN TOLERANCE TEST (ITT)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"ITT revealed no significant difference between SENP1-deficient and control mice, suggesting normal insulin responsiveness despite the diabetic phenotype."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GLUCOSE-STIMULATED INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Glucose-stimulated insulin secretion from islets was significantly reduced in SENP1-deficient mice compared to controls."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;AUTOIMMUNE MEDIATED DAMAGES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Damages caused by the body's immune system attacking its own tissues, particularly in the context of diabetes mellitus."&lt;SEP&gt;"SENP1 deficiency leads to autoimmune-mediated damage, likely contributing to the development of diabetes mellitus type 1."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;T-CELL-MEDIATED DESTRUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Diabetes in SENP1-deficient mice is associated with T-cell mediated destruction of pancreatic Î² cells."&lt;SEP&gt;"The process by which activated cytotoxic T cells attack and destroy insulin-producing pancreatic islet Î² cells in Type 1 Diabetes Mellitus (T1DM)."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;SENP1-ADIPOQKO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific knockout variant of the SENP1 gene in mice with adipocyte-specific deletion driven by Adipoq-Cre."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1-PDGFRÎKO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific knockout variant of the SENP1 gene in mice with adipocyte-specific deletion driven by PdgfRÎ±-Cre."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1-AP2KO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with alterations in peri-pancreatic adipocyte function and increased cytokine production."&lt;SEP&gt;"A specific knockout variant of the SENP1 gene in mice with adipocyte-specific deletion driven by aP2/Fabp4-Cre."&lt;SEP&gt;"SENP1-aP2KO is a genetic model where the SENP1 gene interacts with aP2 knockout leading to altered adipose tissue characteristics and metabolic phenotypes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;SMOOTH MUSCLE CELLS/PERICYTES (SM22Î-CRE)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Specific transcript associated with the deletion of SENP1 in smooth muscle cells and pericytes using SM22Î±-Cre."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;VASCULAR ENDOTHELIAL CELLS (VE-CADHERIN-CRE)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Specific transcript associated with the deletion of SENP1 in vascular endothelial cells using VE-cadherin-Cre."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPONECTIN, PDGFRÎ, AP2/FABP4 GENE PROMOTER&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Gene promoters used to drive Cre recombinase expression for adipocyte-specific deletion of SENP1 gene."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INTERSCAPULAR BROWN ADIPOSE TISSUE (IBAT)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tissue where SENP1 expression was diminished in isolated adipocytes from SENP1-deficient mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;WHITE ADIPOSE TISSUE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tissue where SENP1 expression was decreased leading to glucose intolerance and insulin resistance."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;BODY WEIGHT AND BODY MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Reduced body weight in SENP1-deficient mice compared with control mice after the onset of diabetes."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL), HIGH-DENSITY LIPOPROTEIN (HDL), TRIGLYCERIDE (TG), FREE FATTY ACID (FFA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Normal lipid profiles up to 14 weeks in SENP1-deficient mice but slightly reduced cholesterol and TG levels after age of 18 weeks."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;WATER CONSUMPTION, FOOD INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Increased water consumption with similar food intake observed in SENP1-aP2KO mice compared to control mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SENP1 gene is responsible for producing the SENP1 protein which, when deficient, can lead to type-1-like diabetic phenotypes."&lt;SEP&gt;"The SENP1 gene plays a critical role in regulating cytokine production and autoimmune responses observed in mice."&lt;SEP&gt;"The SENP1 gene plays a critical role in the regulation of cytokine production and autoimmune responses observed in mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC SENP1 DEFICIENCY&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant leading to adipocyte-specific deficiency of the SENP1 gene contributes to the development of autoimmune-mediated damages and diabetes mellitus in mice."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 1)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by T-cell mediated destruction of insulin-producing pancreatic islet Î² cells leading to a loss of functional Î² cells and autoimmunity."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;Î-CELLS AND ISLETS DESTRUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process involving the destruction of pancreatic islet Î² cells due to autoimmune attack leading to type 1 diabetes mellitus (T1DM)."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;AUTOANTIBODIES, INSULIN AUTOANTIBODY (IAA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The production of autoantibodies targeting insulin and Î² cells in the pre-diabetic phase preceding T1DM."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;BETA-HYDROXYBUTYRATE LEVELS&quot;">
      <data key="d0">"CLINICAL PARAMETER"</data>
      <data key="d1">"Levels of beta-hydroxybutyrate, a ketone produced when the body loses its ability to absorb glucose properly, are elevated in individuals who develop diabetes."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;IMMUNE SYSTEM CHARACTERIZATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The characterization of immune cell populations and responses in SENP1-deficient mice, including skin transplantation studies to assess immune function."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;PANCREATIC ISLET Î CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Insulin-producing cells located within pancreatic islets that are targeted and destroyed by T-cells in Type 1 Diabetes Mellitus (T1DM)."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;INSULITIS&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"The infiltration of immune cells into the pancreatic islet Î² cells, causing inflammation and destruction."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CD8+ T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A subset of T cells that recognize antigens presented by HLA class I molecules and play a crucial role in the adaptive immune system's cytotoxic function."&lt;SEP&gt;"A type of cytotoxic T cell that plays a crucial role in attacking and destroying infected or abnormal cells, including pancreatic Î² cells in T1DM."&lt;SEP&gt;"A type of immune cell involved in directly killing infected or cancerous cells. Differential splicing and gene expression are detectable in CD8+ T cells."&lt;SEP&gt;"CD8+ T cells are cytotoxic T lymphocytes that destroy virus-infected or cancerous cells by releasing perforin and granzyme, leading to apoptosis of target cells."&lt;SEP&gt;"Cytotoxic T lymphocytes responsible for direct destruction of virus-infected or cancerous cells, modulated by gene expression changes."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CD4+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of immune cell involved in regulating immune responses. These cells can be influenced by genetic variants leading to differential gene expression."&lt;SEP&gt;"CD4+ T cells are immune cells that play critical roles in regulating adaptive immunity, including differentiation into distinct subsets such as naÃ¯ve, memory, and regulatory (Treg) cells."&lt;SEP&gt;"Helper T cells that play a regulatory role in the immune system by activating other immune cells and are involved in autoimmune responses."&lt;SEP&gt;"CD4+ T cells, also known as helper T cells, assist other immune cells during an immune response. They produce cytokines involved in the activation of B cells and macrophages."&lt;SEP&gt;"T helper cells that play a central role in the immune response by regulating other cell types through cytokine secretion and cell surface interactions."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;TH1 (IFN-Î+CD4+) AND TH17 (IL-17+CD4+) EFFECTOR T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Subsets of helper T cells that promote inflammation and contribute to the autoimmune response seen in type 1 diabetes mellitus."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;REGULATORY T CELLS (TREGS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A subset of CD4+ T cells involved in maintaining immune tolerance by suppressing activation of other immune cells, their reduction contributes to autoimmunity."&lt;SEP&gt;"Tregs are a subset of T cells whose numbers and function may be reduced over time in STAT5B deficient patients due to impaired FOXP3 expression maintenance."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;ACTIVATED DENDRITIC CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Dendritic cells that have been activated and are capable of presenting antigens to T-cells, initiating an immune response."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;NRP-V7-POSITIVE CD8+ T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Specific type of cytotoxic T cells targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), involved in autoimmune responses against pancreatic Î²-cells."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;NRP-V7 POSITIVE CD8+ T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These cells target a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein, indicating an involvement in autoimmune response against pancreatic Î²-cells."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN (IGP1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This protein is the target of autoantigen NRP-V7 positive CD8+ T cells, indicating its role in autoimmune response."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An autoimmune disease characterized by immunological destruction of pancreatic Î²-cells leading to insulin deficiency."&lt;SEP&gt;"An autoimmune disease in which the immune system destroys insulin-producing beta cells in the pancreas leading to high blood sugar levels."&lt;SEP&gt;"Autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES IL-6, TNF-Î AND IL-1Î&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These cytokines are significantly elevated in the SENP1-deficient mice before diabetes onset, suggesting a role in initiating autoimmune responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PATS (PERI-PANCREATIC ADIPOSE TISSUES)&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"Produces high levels of proinflammatory cytokines to induce local pancreatic inflammatory response and diabetic phenotype."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CHEMOKINE CCL5 (RANTES)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Upregulated in pancreatic islets and contributes to the recruitment of immune cells, playing a role in type-1 diabetes development."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC MACROPHAGES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Infiltrate into pancreases at later phases and express high levels of proinflammatory cytokines contributing to tissue damage."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CYTOKINE TNF-Î, IL-6, AND IL-1Î&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These cytokines are secreted by peri-pancreatic adipose tissues leading to local inflammatory responses in the pancreas."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC ISLETS&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"Pancreatic islets are affected directly by adipocyte-derived cytokines leading to Î²-cell death and pancreatic disruption."&lt;SEP&gt;"Upregulation of CCL5 and other chemokines occurs here, contributing to immune cell recruitment and Î²-cell damage."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IMMUNE CELL RECRUITMENT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Recruitment into pancreas due to increased levels of chemokine CCL5 expression in islets under the influence of proinflammatory cytokines from PATs."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IL-6, TNF OR IL-1Î&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"These are proinflammatory cytokines that can be neutralized by antibodies to reduce their effects on CCL5 expression and Î²-cell death."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CYTOKINE SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of secretion of cytokines such as IL-6, TNF, or IL-1Î² from adipocytes affects pancreatic islet function."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CCL5 EXPRESSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A marker for inflammation and immune response, particularly relevant to pancreatic islets during diabetes progression."&lt;SEP&gt;"Expression of CCL5 in the pancreas can be induced by high levels of local proinflammatory cytokines and contributes to immune cell recruitment."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;NF-ÎB DEPENDENT INFLAMMATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The activation of NF-ÎºB leads to the upregulation of inflammatory genes such as IL-6, TNF-Î±, and IL-1Î² in adipose tissues."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PPARÎ SUMOYLATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SUMOylation of PPARÎ³ does not significantly contribute to reduced adipogenesis or increased cytokine production in SENP1-deficient mice."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PHOSPHORYLATION OF IKK, IÎBÎ AND NF-ÎB P65/RELA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Phosphorylation events lead to the activation of the NF-ÎºB pathway in adipose tissues of SENP1-aP2KO mice."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;ADIPOCYTE DIFFERENTIATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differentiation markers such as fatty acid synthase, lipoprotein lipase, and others are reduced in peri-pancreatic adipocytes from SENP1-aP2KO mice."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;MACROPHAGE INFILTRATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Immune cell recruitment into the pancreas is influenced by elevated levels of CCL5 expression due to high local concentrations of cytokines from peri-pancreatic adipocytes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NF-ÎB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"NF-ÎºB is a critical activator of genes for inflammation and immune regulation."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IKK, IÎBÎ AND NF-ÎB P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"These proteins are involved in the phosphorylation events leading to the activation of the NF-ÎºB pathway."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;FABP4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Adipocyte-specific marker used for identifying adipocytes during staining and analysis."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IL-6, IL-1Î AND TNF-Î PROMOTERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Promoter regions of these cytokine genes show increased NF-ÎºB binding in SENP1-deficient cells."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;3T3-L1 PREADIPOCYTES&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Mouse cell line used for differentiation into mature adipocytes to study the effects of SENP1 knockdown."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;SENP1 KNOCKDOWN&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Reduction in SENP1 expression leads to increased NF-ÎºB activation and cytokine production in adipocytes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;F4/80&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Macrophage marker used for distinguishing macrophages from other cell types during staining analysis."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CHIP ASSAYS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Chromatin immunoprecipitation assays are used to determine the binding of NF-ÎºB p65/RelA to cytokine promoters."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IKK&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IKK (IÎºB Kinase) is a protein complex critical for activating NF-ÎºB signaling pathway."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IÎBÎ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IÎºBÎ± is a protein that inhibits the nuclear translocation of the NF-ÎºB transcription factor complex by binding to it in the cytoplasm."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NF-ÎB P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"p65/RelA, also known as RelA, is a subunit of the NF-ÎºB protein family involved in regulating immune responses and inflammatory processes."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IL-6, TNF-Î, IL-1Î&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Interleukin 6 (IL-6), Tumor Necrosis Factor alpha (TNF-Î±), and Interleukin 1 beta (IL-1Î²) are pro-inflammatory cytokines that contribute to immune responses."&lt;SEP&gt;"These are proinflammatory cytokines expressed at high levels in PATs of SENP1-aP2KO mice even before the onset of diabetes. They play a role in islet disruption and contribute to insulin resistance."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;SUMOYLATION OF IKK SUBUNIT NEMO AND NF-ÎB P65/RELA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process by which SUMO proteins covalently attach to IKK subunit NEMO and NF-ÎºB p65/RelA proteins, modifying their activity."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SENP2 is a protein that can deSUMOylate NEMO and inhibit NF-ÎºB activation in 293T cells."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NEMO SUMOYLATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process by which SUMO proteins covalently attach to the IKK subunit NEMO, modulating its activity."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;FLAG-NEMO&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A form of NEMO tagged with Flag for detection and isolation purposes in experiments."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NEMO K277R OR K309R MUTANTS&quot;">
      <data key="d0">"GENE VARIANT"</data>
      <data key="d1">"Mutant forms of the gene coding for NEMO that have lysine to arginine substitutions at specific sites, affecting SUMOylation."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NF-ÎB-DEPENDENT CYTOKINE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which NF-ÎºB regulates the transcription and expression of pro-inflammatory cytokines such as IL-6, TNF-Î±, and IL-1Î²."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP1-AP2KO MICE&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"Mouse model with adipocyte-specific SENP1 deletion used for studying inflammatory responses."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP1 GENE KNOCKOUT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic alteration in the Senp1 gene leading to its absence or non-functionality."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;PANCREATIC ADIPOCYTES (PATS)&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"Adipose tissue cells located around the pancreas, studied for their role in inflammation and insulin resistance."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SUMO1â3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A family of SUMO proteins including SUMO1, SUMO2, and SUMO3 that participate in various cellular processes."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP3 AND SENP5&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Members of the second family of SENPs with specificity for SUMO2/3 substrates."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP6 AND SENP7&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Members of the third family of SENPs, also preferentially deSUMOylating SUMO2/3 substrates."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;ETOPOSIDE VP16&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A DNA-damaging agent used to induce stress responses and evaluate cellular pathways involved in inflammation."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NOD MICE&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"Non-obese diabetic (NOD) mouse model for studying Type 1 Diabetes Mellitus (T1DM)."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NOD MOUSE MODEL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A mouse strain used as a model for studying type 1 diabetes, characterized by late-onset spontaneous diabetes and specific genetic traits."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process involving cytokine production that is elevated in type 1 diabetes patients and associated with inflammation."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;IFN-Î (INTERFERON GAMMA)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An interferon gamma molecule involved in the induction of insulitis and leukocyte infiltration leading to pancreatic islet disruption."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;NF-ÎB ACTIVATION INHIBITOR JSH-23&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used to inhibit NF-ÎºB activation, showing efficacy in reducing blood glucose levels and islet damage in diabetic mice models."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HIGH-FAT DIET (HFD)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental factor that influences the development of diabetes and inflammation by affecting adipocyte morphology."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPOCYTE&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of cell found in adipose tissue that stores energy as fat."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;Î-CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Pancreatic cell type responsible for producing insulin and other hormones to maintain proper blood sugar levels."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ISLET CELLS (ISLETS OF LANGERHANS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Clusters of cells in the pancreas that include beta cells, alpha cells, delta cells, etc., involved in hormone secretion."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;NF-ÎB PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A signaling pathway involved in inflammatory responses and cell survival mechanisms that plays a role in the development of type 1 diabetes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HFD&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"High-fat diet (HFD) is a dietary pattern that leads to increased fat weight in various depots, including epididymal fat and peri-inguinal adipose tissues (PATs), as well as contributing to inflammatory cytokine production and insulin resistance."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;ADIPOGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of adipocyte development or fat cell formation, which is stimulated by HFD in PATs of SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;T1DM AND T2DM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM), both conditions are exacerbated by HFD in the context of SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;LIVER INSULIN RESISTANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition marked as a hallmark of obesity-linked T2DM development, observed to be more pronounced under HFD conditions in SENP1 knockout (KO) mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;ADIPOSE DEPOT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An anatomical site for fat storage, including epididymal fat and peri-inguinal adipose tissues (PATs), where HFD increases fat weight."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;FAT WEIGHT INCREASE&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"The condition characterized by an increase in fat mass within adipose depots due to dietary changes like HFD."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;CELL SIZE REDUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A reduction in the size of adipocytes (fat cells) observed in PATs from SENP1-aP2KO mice under both normal chow and HFD conditions."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;CELL NUMBER INCREASE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An increase in cell numbers within adipose tissues, particularly noted in PATs of SENP1-aP2KO mice compared to control adipocytes."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;ISLET STRUCTURE DISRUPTION&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"A condition observed where HFD causes disruption of islet structures in the pancreas of SENP1-aP2KO mice, contributing to diabetes development."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;HYPERGLYCEMIA ONSET&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which blood glucose levels rise above normal, starting earlier (at age 8 weeks) under HFD conditions compared to standard chow in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;BASAL AND GLUCOSE-STIMULATED INSULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The measurement of insulin levels both at rest (basal) and after glucose stimulation, significantly reduced in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;INSULIN RESPONSE&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"Reduced sensitivity to insulin observed in both SENP1-deficient mice and control under standard chow conditions, but exacerbated by HFD leading to more severe phenotypes."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;INTRAPERITONEAL TOLERANCE TEST (ITT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A test used to assess the ability of insulin to lower blood glucose levels in response to an intraperitoneal injection of glucose, showing induced insulin resistance under HFD conditions."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;SENP1-SMKO AND SENP1-ECKO&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"Mice with smooth muscle cells/pericytes or vascular endothelial cells-specific deletion of the SENP1 gene do not develop high glucose levels despite similar Cre-mediated expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRE-DIABETIC PHASE&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"During the pre-diabetic phase preceding T1DM, autoantibodies such as IAA are directed against Î² cells indicating an autoimmune response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES DIAGNOSIS&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"Elevated CRP levels in the blood serve as a clinical parameter aiding in the diagnosis of diabetes, particularly T1DM.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLUCOSE METABOLISM DYSFUNCTION&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"Increased beta-hydroxybutyrate levels indicate impaired glucose metabolism and can be used to diagnose diabetes, reflecting a loss in the body's ability to absorb glucose properly.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Î-CELLS DESTRUCTION&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"Activated CD8+ T cells infiltrate pancreatic islets destroying insulin-producing Î²-cells in individuals with Type 1 Diabetes Mellitus (T1DM).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AUTOIMMUNE RESPONSE&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"Helper T cells such as Th1 and Th17 promote inflammation and contribute to the autoimmune destruction of pancreatic islet Î² cells in type 1 diabetes mellitus.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE TOLERANCE&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"Reduction in regulatory T cells leads to a loss of immune tolerance, exacerbating autoimmune responses and contributing to the destruction of pancreatic islet Î²-cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AUTOIMMUNE RESPONSE INITIATION&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"Activated dendritic cells present antigens to T-cells initiating an immune response, leading to autoimmunity in Type 1 Diabetes Mellitus (T1DM).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IGP1 PROTEIN&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Autoantigen NRP-V7 positive CD8+ T cells target IGP1 protein in pancreatic lymph nodes and spleen, indicating an autoimmune response targeting this protein.")&lt;SEP&gt;"These cells target IGP1 protein, indicating a direct role in the autoimmune response against pancreatic Î²-cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T1DM&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Elevation of these cytokines is associated with an increased risk of developing T1DM through their inflammatory roles.")&lt;SEP&gt;"High levels of these cytokines are associated with the onset of T1DM through mechanisms involving immune cell expansion and inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CCL5 (RANTES)&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Upregulation of CCL5 in islets recruits immune cells into pancreas, causing damages to Î²-cells and contributing to T1DM progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE CELLS&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Upregulation of CCL5 in islets recruits immune cells into pancreas, causing damages to Î²-cells and contributing to T1DM progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TISSUE DAMAGE&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Infiltration and expression of high levels of proinflammatory cytokines by macrophages cause damage to pancreatic tissues at later stages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 REGULATION&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"SENP1 plays a crucial role in regulating inflammatory responses within pancreatic adipocytes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUMO2/3 DESUMOYLATION&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"SENP3 and SENP5 contribute to the removal of SUMO2/3 from target proteins."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NF-ÎB ACTIVATION&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Stress induction by Etoposide VP16 leads to enhanced NF-ÎºB activity in adipocytes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T1DM DEVELOPMENT&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"The NOD mouse model is utilized to study the pathogenesis and progression of T1DM."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HFD (HIGH-FAT DIET)&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"The NF-ÎºB pathway is involved in mediating the effects of high-fat diet on adipocyte inflammation and diabetes progression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1-KO&quot;">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">"The loss of SENP1 gene function leads to liver insulin resistance under basal conditions, which is exacerbated under high-fat diet (HFD) conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOKI (RS2228570 OR RS10735810)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FokI variant is associated with an increased risk of ovarian cancer."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;APAI (RS7975232)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ApaI variant does not show a significant association with ovarian cancer risk according to the fixed-effect model."&lt;SEP&gt;"The ApaI variant does not show significant association with ovarian cancer risk according to the fixed-effect model."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;BSMI (RS1544410)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The BsmI variant is not significantly associated with an increased risk of ovarian cancer when using a fixed effect model, but genotype distribution in controls from some subgroup studies deviates from Hardy-Weinberg equilibrium."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A principle stating that the allele and genotype frequencies in a population remain constant from generation to generation in the absence of evolutionary influences."&lt;SEP&gt;"The Hardy-Weinberg equilibrium is a principle that predicts the genetic variation in a population and is often used as a baseline for evaluating departures from expected genotype frequencies due to factors such as mutation, selection, or migration."&lt;SEP&gt;"The equilibrium where allele and genotype frequencies remain constant from generation to generation under certain conditions, used here to validate SNP data consistency."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;META-ANALYSIS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"A meta-analysis is a statistical method of combining data from multiple studies to obtain a more precise estimate of effect size. It was used in this text to evaluate the association between genetic variants and ovarian cancer risk."&lt;SEP&gt;"A statistical method combining results from different studies to provide more precise estimates compared to those derived from individual studies."&lt;SEP&gt;"A statistical method that combines data from multiple studies to increase sample size and improve the precision of estimates."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;FIXED-EFFECT MODEL&quot;">
      <data key="d0">"MODEL TYPE"</data>
      <data key="d1">"A model used in meta-analysis where it is assumed that the effect size is consistent across all studies."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;DOMINANT GENETIC MODEL&quot;">
      <data key="d0">"GENETIC INHERITANCE PATTERN"</data>
      <data key="d1">"A genetic inheritance pattern where a single copy of an allele is enough for an organism to express a particular phenotype."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;RECESSIVE GENETIC MODEL&quot;">
      <data key="d0">"GENETIC INHERITANCE PATTERN"</data>
      <data key="d1">"A genetic inheritance pattern where two copies of the recessive allele are needed for an individual to exhibit a trait."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;CAUCASIANS&quot;">
      <data key="d0">"DEMOGRAPHIC GROUP"</data>
      <data key="d1">"A broad term referring to individuals with European ancestry, used here as a demographic subgroup in studies."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;CDX-2 GENE (RS11568820)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"The Cdx-2 gene is a genomic variant associated with the risk of ovarian cancer. The rs11568820 variant has been studied in relation to its effect on ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;TAQI GENE (RS731236)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"The TaqI gene is a genomic variant associated with the risk of ovarian cancer. The rs731236 variant has been studied in relation to its effect on ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;GENETIC MODEL (DOMINANT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A genetic model used to assess how specific gene variants influence disease risk. In this case, it is applied to evaluate the rs11568820 variant of Cdx-2 and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;AA/GA GENOTYPE (CDX-2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The AA or GA genotypes are variations in the Cdx-2 gene, where A represents an allele associated with increased risk for ovarian cancer compared to GG carriers."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;GG GENOTYPE (CDX-2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GG genotype is a reference genotype used as a control group when studying the association of other genotypes like AA or GA in the Cdx-2 gene with ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;JAPANESE SUBGROUP (LURIE ET AL.)&quot;">
      <data key="d0">"DIETARY PATTERN, ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A specific subgroup within a study population focusing on individuals of Japanese descent. This subgroup was found to depart from Hardy-Weinberg equilibrium in the context of Cdx-2 and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NECC SUBGROUP (TWOROGER ET AL.)&quot;">
      <data key="d0">"DIETARY PATTERN, ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A specific subgroup within a study population focusing on individuals within the Nurses' Health Study II cohort. This subgroup also departed from Hardy-Weinberg equilibrium in the context of Cdx-2 and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NORTHERN SWEDEN SUBGROUP (CLENDENEN ET AL.)&quot;">
      <data key="d0">"DIETARY PATTERN, ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A specific subgroup within a study population focusing on individuals from Northern Sweden. This subgroup departed from Hardy-Weinberg equilibrium in the context of TaqI and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;PUBLICATION BIAS TEST (EGGER'S TEST)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A test used to detect publication bias in meta-analyses, which assesses whether smaller studies with less precise estimates are more likely to be published. It was applied here for evaluating the association of gene variants and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;SENSITIVITY TEST&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Statistical analysis used to evaluate how robust the results of a meta-analysis or other statistical analyses are when individual studies are removed one at a time, ensuring that no single study disproportionately influences the overall result."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;OVARIAN CANCER RISK STUDIES&quot;">
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d1">"The genotype distribution of controls in several subgroup studies for ApaI and BsmI variants deviated from Hardy-Weinberg equilibrium, affecting the validity of these genetic associations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;META-ANALYSIS (CDX-2 GENE)&quot;">
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d1">"Sensitivity tests were conducted on the meta-analysis of Cdx-2 gene to assess its robustness against individual studies' influence, confirming the overall findings are not significantly influenced by any single study."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;META-ANALYSIS (TAQI GENE)&quot;">
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d1">"Sensitivity tests were conducted on the meta-analysis of TaqI gene to assess its robustness against individual studies' influence, confirming the overall findings are not significantly influenced by any single study."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The VDR gene is a focus of analysis for its polymorphisms' influence on susceptibility to infection by T. cruzi and the development of chronic Chagas cardiomyopathy (CCC)."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS731236, RS7975232, RS1544410 GENOMIC VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These three SNPs in VDR showed a high linkage disequilibrium and were analyzed for their influence on the susceptibility to T. cruzi infection and CCC development."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS2228570 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor allele of rs2228570*A was significantly associated with a reduced risk of developing CCC and a trend towards protective effect against T. cruzi infection, even after correction for multiple testing."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T. cruzi causes Chagas disease, which can lead to chronic Chagas cardiomyopathy (CCC). The study explores the role of VDR polymorphisms in susceptibility to T. cruzi infection."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;CHRONIC CHAGAS CARDIOMYOPATHY (CCC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CCC is a complication of Chagas disease, and the study investigates the association between VDR SNPs and the risk of developing CCC."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS731236 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the VDR gene was analyzed for its influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS7975232 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the VDR gene was analyzed for its influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS1544410 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the VDR gene was analyzed for its influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;IL-1A -889C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The IL-1A -889C&gt;T variant is a genetic polymorphism that was studied in relation to the risk of having Hypnopompic Hallucinations and/or Narcolepsy (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A 238G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TNF-A 238G&gt;A variant is a genetic polymorphism that was studied in relation to the risk of having Hypnopompic Hallucinations and/or Narcolepsy (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR TAQI RS731236&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The VDR TaqI variant is a genetic polymorphism that was studied in relation to the risk of having Hypnopompic Hallucinations and/or Narcolepsy (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HNP is a condition characterized by experiencing vivid, often frightening hallucinations while in the transitional state between sleeping and waking."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;IL-1A (RS1800587)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-1A gene harbors a polymorphism rs1800587 which was studied for its association with Hypnopompic Hallucinations and/or Narcolepsy (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A (RS361525)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TNF-A gene harbors a polymorphism rs361525 which was studied for its association with Hypnopompic Hallucinations and/or Narcolepsy (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR (RS731236)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The VDR gene harbors a polymorphism rs731236 which was studied for its association with Hypnopompic Hallucinations and/or Narcolepsy (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;B12&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"B12 is a vitamin that plays a critical role in maternal and fetal health."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A nutrient essential for DNA synthesis and repair, often found in dietary supplements."&lt;SEP&gt;"Folate is a key nutrient involved in the analysis of causal effects on B12 levels and offspring birthweight."&lt;SEP&gt;"Folate is another essential nutrient, crucial for pregnancy outcomes."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL SERUM B12 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Serum levels of B12 in pregnant women are influenced by genetic variants and dietary intake."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MATERNAL FOLATE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Folate levels in pregnant women affect fetal development, particularly birthweight."&lt;SEP&gt;"Maternal folate levels are examined for their influence on offspring birthweight without mediating through B12 levels."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;BIRTHWEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Birthweight is a measure of newborn health and developmental outcomes."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;GWAS VARIANTS FOR B12 LEVELS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These variants are associated with maternal serum B12 levels."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;GWAS VARIANTS FOR FOLATE LEVELS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These genomic variants explain variation in maternal serum folate levels."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MMACHC GENE (RS12272669)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MMACHC gene variant is implicated in B12 metabolism, with a lesser effect on pregnant women's B12 levels."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FUT2 GENE (RS602662)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FUT2 genetic variation influences B12 serum concentrations and may have pleiotropic effects."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MTHFR GENE (RS1801133)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFR gene variant is significant in the analysis of maternal folate levels on birthweight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FETAL B12 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"B12 levels during fetal development influence growth and health outcomes."&lt;SEP&gt;"Fetal B12 levels are analyzed for their effect on gestational duration, but no evidence of causal relationship is found."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;B12 (COBALAMIN)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"B12, also known as Cobalamin, is a nutrient analyzed for its causal effect on folate levels and offspring birthweight."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL B12 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Maternal B12 levels are examined for their influence on offspring birthweight and gestational duration."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Offspring birthweight is a physiological process measured to assess the impact of maternal nutrient levels such as B12 and folate."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;GESTATIONAL DURATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gestational duration is a physiological process examined in relation to maternal and fetal nutrient levels without finding any significant causal effects."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MR EGGER ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A statistical analysis method, MR Egger, was applied to assess potential biases from genetic instruments in studies involving folate and B12 levels."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;IVW ANALYSIS (INVERSE VARIANCE WEIGHTED)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An IVW analysis detected a small causal effect of folate on B12 levels within the Danish cohorts."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;DANISH COHORTS&quot;">
      <data key="d0">"DIETARY PATTERN, ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The study involves two Danish cohorts used to analyze the impact of maternal nutrient levels on offspring health outcomes."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;FOLATE LEVELS&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"An IVW analysis detected a small but significant effect of folate levels on B12 levels within the Danish cohorts, indicating a molecular interaction between these nutrients."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR C677T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant located at position 677 in the MTHFR gene, often associated with changes in folate metabolism and cardiovascular disease risk."&lt;SEP&gt;"The MTHFR C677T variant is a genetic polymorphism associated with changes in methionine metabolism and elevated homocysteine levels, potentially leading to increased cardiovascular risk."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;MTHFR A1298C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genetic variant within the MTHFR gene, differing from C677T at position 1298, affecting similar metabolic pathways."&lt;SEP&gt;"The MTHFR A1298C variant is another common genetic polymorphism that can affect folate metabolism and methionine synthesis, impacting cardiovascular health."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;PAI-1 -675 4G/5G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in the promoter region of PAI-1, influencing thrombosis risk and cardiovascular health."&lt;SEP&gt;"The PAI-1 -675 4G/5G variant is a polymorphism associated with increased plasminogen activator inhibitor type 1 activity, which can lead to hypercoagulability and thrombotic disorders."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;PAI-1 A844G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant within the PAI-1 gene affecting platelet aggregation and clotting factors."&lt;SEP&gt;"The PAI-1 A844G variant is a genetic polymorphism that affects the activity of plasminogen activator inhibitor type 1, playing a role in thrombosis and fibrinolysis."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic alteration in prothrombin, increasing thrombosis risk due to elevated levels of circulating prothrombin."&lt;SEP&gt;"The Prothrombin G20210A variant is a genetic polymorphism that leads to an increase in prothrombin levels, potentially contributing to hypercoagulability and thrombotic events."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;FACTOR V G1691A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism within the Factor V gene that impacts blood coagulation factors and clotting efficiency."&lt;SEP&gt;"The Factor V G1691A variant results in resistance to activated protein C (APC), leading to an increased risk of venous thromboembolism (VTE)."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;LV (LIVEDO RETICULARIS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by a mottled skin appearance due to underlying vascular or autoimmune issues."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;CARDIOVASCULAR HEALTH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Maintaining heart health through regulation of blood flow, vessel integrity, and prevention of cardiovascular diseases."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PCR (POLYMERASE CHAIN REACTION)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A laboratory technique used to amplify DNA sequences, commonly utilized for detecting and analyzing SNPs."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;HIND III RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A method used in molecular biology to detect genetic variations by cutting DNA at specific recognition sites."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;SEQUENCING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process of determining the precise order of nucleotides within a DNA molecule, often used for genotyping and analyzing SNPs."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Leiomyoma Venosa is a rare vascular disease characterized by the development of benign tumors in veins, often associated with genetic predispositions such as certain genomic variants."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;METHIONINE METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Methionine metabolism involves the conversion of methionine to homocysteine and further breakdown or remethylation to form other metabolites, affected by MTHFR variants."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;THROMBOSIS RISK&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"The PAIâ1 â675 4G/5G variant is directly linked to increased thrombotic tendencies and cardiovascular disease risk."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;PLATELET AGGREGATION&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"This genetic variant within PAI-1 affects platelet function and can lead to abnormal clot formation patterns."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;BLOOD COAGULATION&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"The factor V variant impacts coagulation factors, contributing to altered clotting efficiency and increased thrombosis risk."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;VITAMIN B12 (COBALAMIN)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A vitamin important for nerve function, DNA synthesis, and red blood cell production."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;THCY (TOTAL HOMOCYSTEINE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"The total concentration of homocysteine in the serum, an amino acid that can be harmful when present in excess. It is involved in methylation reactions and its metabolism is dependent on folate and B12."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;RCF (REDUCED CYSTATHIONINE/FOLATE RATIO)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"A ratio indicating the balance between reduced cystathionine and folate levels, suggesting a role in homocysteine metabolism."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE (PEMT) M175V GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant associated with male infertility when homozygous for the minor V allele."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;TRANSCOBALAMIN RECEPTOR GENE TCBLR (CD320) RS173665 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the B12 transcobalamin receptor gene, associated with male infertility when heterozygous."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;MTHFR 1298A&gt;C MINOR C ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the methylenetetrahydrofolate reductase (MTHFR) gene that impacts folate metabolism and is associated with male infertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;FOLIC ACID-CONTAINING VITAMIN SUPPLEMENTS&quot;">
      <data key="d0">"DIETARY PATTERN/NUTRIENT"</data>
      <data key="d1">"Vitamin supplements containing folic acid, used for their nutritional benefits and to potentially reduce the risk of certain diseases or conditions like male infertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;MALE INFERTILITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by difficulty in achieving conception despite unprotected intercourse over a prolonged period."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;MTHFR 677C&gt;T GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the methylenetetrahydrofolate reductase (MTHFR) gene, which is not associated with male infertility in this study population."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;DIETARY PATTERN OF FOLIC ACID SUPPLEMENT USE&quot;">
      <data key="d0">"DIETARY PATTERN/NUTRIENT"</data>
      <data key="d1">"The dietary pattern involving the use of supplements containing folic acid."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;INFERTILE MEN&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"B12 levels were found to be lower in infertile men compared to fertile controls but did not reach statistical significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLATE AND B12 LEVELS&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"Subjects who reported taking vitamin supplements had higher folate and B12 concentrations compared to non-users, suggesting a role in maintaining optimal nutrient levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHMT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SHMT1 gene encodes an enzyme that catalyzes the reversible conversion of serine to glycine, transferring methyl groups to tetrahydrofolate (THF) which is converted into 5,10-methylenetetrahydrofolate (5,10-CH2-THF)."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS1979277&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in the SHMT1 gene that results in a change from leucine to phenylalanine at position 435."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS638416&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism located in the promoter region of SHMT1 (5'-UTR) linked to an increased risk for TMD patients."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;MTHFD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFD1 gene encodes a protein with three distinct enzymatic activities: 5,10-methylenetetrahydrofolate dehydrogenase, cyclohydrolase, and synthetase."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS2236225&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A transition from G to A in the MTHFD1 gene that results in an alteration of ARG-653-GLN, associated with neural tube defects sensitive to folates."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GSTM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GSTM1 gene encodes mu-class glutathione S-transferase which plays a role in detoxifying electrophilic compounds such as carcinogens and drugs."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GSTM1-NULL POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A deletion of the GSTM1 gene associated with an increase of cancer and male infertility due to greater susceptibility to environmental toxins and carcinogens."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;MTRR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTRR gene is responsible for the regeneration of Methionine Synthase (MTR) through reductive methylation using SAM as a methyl donor."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS1801394&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A substitution from A to G in the encoding region of MTRR gene leading to an Ile22Met change, affecting enzyme efficiency and substrate affinity."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;DRD4-48BPTR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The 48-bp VNTR in exon 3 of the DRD4 gene encodes for dopamine receptor D4 with varying repeat lengths between 2 to 11, affecting genotype frequencies."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;S-DRD4&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism characterized by 2 to 5 repeats in the exon 3 of the DRD4 gene."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;L-DRD4&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism with 6 or more repeats in the exon 3 of the DRD4 gene, not found in individuals with TMD."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;TETRAHYDROFOLATE (THF)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"THF is a form of folate involved in one-carbon metabolism and the synthesis of purines and thymidylates."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;5,10-METHYLENETETRAHYDROFOLATE (5,10-CH2-THF)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A derivative of THF important for methylation reactions in the body."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;PYRIMIDINE SYNTHESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which pyrimidines are synthesized from amino acids, involving methyltransferases like SHMT1."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;NEURAL TUBE DEFECTS (NTDS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Congenital malformations characterized by defects in the development of the brain and spinal cord due to problems with neural tube closure during early embryogenesis."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;TMD (TEMPOROMANDIBULAR DISORDERS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A set of conditions that affect the temporomandibular joint, muscles, or other tissues involved in jaw movement."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;CARCINOGENS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Substances capable of causing cancer through interaction with DNA and cellular mechanisms."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;THF&quot;">
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d1">"Tetrahydrofolate undergoes methylation to produce 5,10-methylenetetrahydrofolate which is essential in many metabolic pathways."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDC MBA METHOD&quot;">
      <data key="d0">"TECHNIQUE/METABOLIC PATHWAY ANALYSIS TOOL"</data>
      <data key="d1">"The CDC MBA method measures serum folate levels and compares with HPLC-MS/MS to assess agreement and accuracy."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC HPLC-MS/MS METHOD&quot;">
      <data key="d0">"TECHNIQUE/METABOLIC PATHWAY ANALYSIS TOOL"</data>
      <data key="d1">"A highly accurate technique used for measuring serum folate, providing precise data compared to the CDC MBA method."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;IH-CAL (INTERNAL HOMOGENEOUS CALIBRATION)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/LABORATORY PROCEDURE"</data>
      <data key="d1">"Refers to the use of different types of internal calibrators among participating laboratories, affecting measurement precision and accuracy."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;FOLIC ACID&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folic acid is a B-vitamin crucial for DNA synthesis and repair, especially important during pregnancy."&lt;SEP&gt;"Folic acid, also known as vitamin B9, is an essential nutrient involved in numerous physiological processes including DNA synthesis and repair, red blood cell formation, and amino acid metabolism."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC REAGENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"CDC reagents refer to the standard materials provided by the Centers for Disease Control (CDC) used for laboratory testing and calibration purposes."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;IH REAGENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"IH reagents are specific materials or standards used in laboratories, differing from CDC reagents in their composition or source."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;MICROORGANISM CALIBRATOR (CDC-MO)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The microorganism calibrator provided by the CDC is a standard reference material used for calibration purposes in laboratory settings to ensure accurate and consistent testing results."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CALIBRATOR (CDC-CAL)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A calibrator provided by the CDC is a standardized substance or sample used to calibrate instruments, ensuring their accuracy and consistency across different laboratories."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;WB-FOL &amp; S-FOL TESTING CONDITIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Conditions for testing WB-FOL (whole blood folate) and S-FOL (serum folate), representing the procedures and environmental factors affecting the measurement of these substances in clinical settings."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY TEST HARMONIZATION CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Harmonized laboratory test conditions involve standardizing reagents, calibrators, and protocols to ensure consistency and comparability across different laboratories when measuring analytes like folate levels."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC MBA TARGET VALUE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The target value established by the CDC for folate measurements, representing a standard against which laboratory results are compared."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;S-FOL (SERUM FOLATE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurement of serum folate levels in blood, indicating folic acid status in circulation."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;WB-FOL (WHOLE BLOOD FOLATE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurement of whole blood folate levels, providing a comprehensive measure of circulating and intracellular folate."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;CDC ROUND-ROBIN KIT (CDC-MO &amp; CDC-CAL)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A standardized kit provided by the CDC containing microorganism and calibrator to ensure uniform testing conditions across different laboratories."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY #6 AND LABORATORY #9 RESULTS ANOMALIES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These laboratories exhibited inconsistent results compared with the CDC MBA target value, indicating potential issues in calibration or measurement protocols."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;S-FOL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Both measurements reflect the metabolic pathways of folate in serum and whole blood respectively, influencing nutritional assessment."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WB-FOL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Both measurements reflect the metabolic pathways of folate in serum and whole blood respectively, influencing nutritional assessment."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT METABOLISM&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Folic acid undergoes metabolism within the body involving various physiological processes such as DNA synthesis and amino acid metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LABORATORY CALIBRATION&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"CDC reagents are used to calibrate laboratory instruments, ensuring accurate measurements of analytes like folate levels across different testing conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CALIBRATION ACCURACY&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"The microorganism calibrator provided by the CDC ensures accurate calibration of laboratory instruments, contributing to precise measurements across different conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LABORATORY STANDARDS&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"The CDC-provided calibrators are critical for maintaining consistent standards in folate testing among various laboratories."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLIC ACID MEASUREMENT&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"These conditions are essential for the accurate measurement of whole blood and serum folate levels, influencing health assessments related to folic acid intake and metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTER-LABORATORY COMPARABILITY&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Harmonizing laboratory test conditions improves comparability and consistency in the measurements of folate levels across different laboratories."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLIC ACID CALIBRATOR&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"The folic acid calibrator ensures accurate measurements of serum folate levels across different laboratory settings."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;LABORATORY STANDARDIZATION&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"This kit ensures uniform calibration across different laboratories, enhancing comparability in folic acid measurement protocols."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CALIBRATION ISSUES&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"The inconsistencies observed in these laboratories suggest potential problems with their calibration processes or adherence to standard protocols."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1695 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs1695 polymorphism is associated with an increased risk of breast cancer, specifically for homozygote genotype GG."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;BREAST CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by uncontrolled cell growth in the tissues of the breast. Increased risk due to genetic factors such as rs1695 polymorphism."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;RS1138272 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs1138272 polymorphism does not show a significant association with increased risk of breast cancer, based on genotype analysis."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GSTP1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein studied for its function and potential influence due to single nucleotide polymorphisms such as Ile105Val SNP."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ILE105VAL POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific single nucleotide polymorphism in GSTP1 that decreases the amyloid propensity of the enzyme, according to WALTZ analysis."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;AG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The AG genotype of rs1695 polymorphism also does not show a significant association with the increased risk of breast cancer."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;CC GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype is a specific genetic variant associated with an increased occurrence of colorectal cancer."&lt;SEP&gt;"The CC genotype of rs1138272 polymorphism is the most common among both control and case groups, showing no association with breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e&lt;SEP&gt;chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;CT GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous CT genotype of rs1138272 does not demonstrate a significant impact on breast cancer susceptibility based on our analysis."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;TT GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The homozygous TT genotype of rs1138272 has been evaluated but shows no association with an increased risk for breast cancer, despite its low frequency among controls and cases."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ALLELE G (RS1695)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The allele G variant of rs1695 polymorphism is associated with an increased risk of breast cancer compared to the A allele based on statistical analysis."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ILE105VAL SNP ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis of Ile105Val SNP shows that this single nucleotide change does not affect protein aggregation tendency or chaperone binding but decreases amyloid formation propensity."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;P.R778L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A pathogenic genomic variant in China that is associated with haplogroups A, B, and C."&lt;SEP&gt;"p.R778L is a prevalent pathogenic variant among WD patients, with an allelic frequency of 31.7% across the entire patient group."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;P.P992L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A pathogenic genomic variant that is associated with a more complex spectrum of six different haplogroups."&lt;SEP&gt;"p.P992L is another prevalent pathogenic variant among WD patients, with an allelic frequency of 15.7% in total and higher in certain regions like Jiangxi."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;P.T935M&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A pathogenic genomic variant characterized by only one kind of haplogroup (J) on WD chromosomes with high significance compared to controls."&lt;SEP&gt;"p.T935M is a rare but significant pathogenic variant among WD patients, especially prevalent in Fujian province compared to other regions."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;WD PATIENTS GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The WD patients group includes individuals with Wilson's disease, characterized by the presence of certain pathogenic variants like p.R778L, p.P992L and p.T935M."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;GEOGRAPHICAL REGIONS (SOUTHEASTERN CHINA)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The geographical regions in southeastern China are an environmental factor influencing the distribution of pathogenic variants among WD patients."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;FUJIAN PROVINCE, ZHEJIANG, JIANGSU, SHANGHAI, JIANGXI&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"These provinces and cities account for a significant proportion of WD patients carrying p.R778L, p.P992L, or p.T935M variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM ANALYSIS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Analyzes how often certain gene variants are inherited together more than would be expected by chance."&lt;SEP&gt;"Linkage disequilibrium analysis is used to study the association between specific genetic markers and pathogenic variants among WD patients."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;HAPLOTYPE ASSOCIATION STUDY&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"A haplotype association study elucidates the relationship between genetic haplotypes and prevalent disease-causing variants in WD patients."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;D13S314, D13S301, D13S316&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Microsatellite markers used in the study to analyze linkage disequilibrium with pathogenic variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;HAPLOGROUP A&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"A haplotype group predominantly associated with the p.R778L variant in WD patients."&lt;SEP&gt;"The most common haplogroup associated with the p.R778L variant, mostly found on WD chromosomes compared to controls."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;WD CHROMOSOMES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Chromosomal material carrying pathogenic variants like p.R778L, p.P992L and p.T935M in WD patients."&lt;SEP&gt;"Chromosomes found to be associated with specific pathogenic variants in individuals with a particular condition."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT A1 (10-7-7)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant within haplogroup A that is the most prevalent among all haplotypes related to p.R778L."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUPS B AND C&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Less common haplogroups associated with the p.R778L variant compared to haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP E (10-9-5)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The most common haplogroup in the p.P992L group, significantly represented on WD chromosomes compared to controls."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT E1 (10-9-5)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant within haplogroup E that occupies a significant part of the spectrum related to p.P992L."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP J, VARIANTS J1 AND J2&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The unique haplogroup associated with the p.T935M variant that is found exclusively in WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;CONTROL ONES (CHROMOSOMES)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Chromosomes from control subjects used for comparison against those with pathogenic variants."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP D (9-7-5)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A rare haplogroup associated with the p.P992L variant, found sporadically on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP F (10-9-8)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Another rare haplogroup related to the p.P992L variant, appearing infrequently on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP G (10-11-5)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A less common haplogroup in the spectrum of p.P992L, found at a 3.4% frequency on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP H (12-4-5; 12-5-5)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This rare haplogroup related to the p.P992L variant is also present in a small percentage of WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP I (12-5-8)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A less frequent haplogroup found within individuals with the p.P992L variant, showing low representation on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT E2 (10-9-6)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is part of haplogroup E but is much rarer than variant E1 in the context of p.P992L."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT J1 (12-4-8)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant within haplogroup J that shows high prevalence among WD chromosomes related to the p.T935M variant."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT J2 (12-5-8)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant within haplogroup J but found less commonly than variant J1 in relation to p.T935M."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;FUJIAN PROVINCE&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"The p.T935M variant shows particularly high prevalence in patients from Fujian province compared to other regions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (P.R778L)&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"This analysis reveals significant linkage disequilibrium between the p.R778L variant and specific microsatellite markers."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOGROUP J (VARIANTS J1 AND J2)&quot;">
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d1">"The genomic variant p.T935M is uniquely associated with haplogroup J, representing a significant difference in genetic information on WD chromosomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOGROUPS F, G, H AND I&quot;">
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d1">"These rare haplogroups are sporadically represented among WD chromosomes associated with p.P992L.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP2C9*2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*8&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*11&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1799853&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1057910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371686&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS7900194&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371685&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;WARFARIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An anticoagulant medication used to prevent blood clots in patients at risk of deep vein thrombosis or pulmonary embolism."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;DVT/PE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), conditions frequently treated with warfarin."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS9923231&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP with a minor allele frequency of 0.06, affecting warfarin dose prediction."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;HWE (HARDY-WEINBERG EQUILIBRIUM)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The principle used to assess deviations in genetic variation frequencies."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9 STAR VARIANT GROUP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A combination of CYP2C9 variants due to their low individual frequency but combined impact on drug metabolism."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"An IWPC pharmacogenomics algorithm is used to predict therapeutic doses in patients, showing an inverse correlation with percent WAA among those requiring high doses."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC CLINICAL ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"The IWPC clinical algorithm correctly assigned 2% of high-dose patients compared to the novel AA algorithm that detected 53%."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NOVEL AA ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"A novel AA algorithm outperformed IWPC algorithms in detecting high-dose patients and predicting doses closer to observed values."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;AIMS (ANCESTRY INFORMATIVE MARKERS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The availability of AIMs has made it possible to accurately measure admixture among African Americans (AAs)."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;WAA (WHOLE ANCESTRAL ADMIXTURE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The whole ancestral admixture is a factor that influences the performance of different algorithms in predicting therapeutic doses."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;SELF-REPORTED RACE FOR AAS &quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Self-reporting race for African Americans is not a strong proxy for genetic background, highlighting the importance of genetic markers like AIMs."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes are implied to be part of pharmacogenomics algorithms, but specific gene names were not mentioned."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The expression levels or mutations in transcripts might be part of algorithms used to predict therapeutic doses, but specifics are not provided."&lt;SEP&gt;"The transcript of the LPL gene is expressed primarily by myocytes and adipocytes."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Proteins involved in drug metabolism and response could affect the efficacy of pharmacogenomics algorithms, though specific proteins were not mentioned."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"CYP24A1 is part of metabolic pathways involving vitamin D metabolism and calcium homeostasis."&lt;SEP&gt;"Drug metabolism pathways are implied by pharmacogenomics but specific pathways were not detailed."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Interactions between molecules, such as drug-protein interactions, may influence dose prediction but weren't specified in the text."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The disease context implied by the study involves patients requiring HU treatment, suggesting conditions like sickle cell anemia or beta-thalassemia."&lt;SEP&gt;"The text discusses therapeutic doses which could be relevant to managing diseases but does not specify particular diseases."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;WARFARIN DOSE PREDICTION&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The CYP2C9*2 variant influences the predicted dose of warfarin based on its effect on drug metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WARFARIN TREATMENT&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Patients with DVT or PE are commonly treated with warfarin to prevent blood clots."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT ANALYSIS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Used to evaluate deviations in SNP frequencies for genomic studies and drug response predictions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WARFARIN DOSAGE PREDICTION&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The combination of CYP2C9 variants affects the prediction models for warfarin dosages based on genetic factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WAA&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"Our novel AA algorithm did not show association with WAA because population-specific variables are incorporated, accounting for admixture effects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AIMS&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"Ancestry Informative Markers (AIMs) enable accurate measurement of ancestral admixture among African Americans, influencing the efficacy of pharmacogenomics algorithms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP27B1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CYP27B1 gene encodes an enzyme involved in vitamin D metabolism."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CYP24A1 gene is associated with the metabolism of 25(OH)D and plays a role in colorectal adenoma recurrence."&lt;SEP&gt;"The CYP24A1 gene is associated with the metabolism of vitamin D and plays a role in calcium homeostasis."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS927650&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant within the CYP24A1 gene is associated with vitamin D concentrations and colorectal adenoma recurrence."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS35051736&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in CYP24A1 that influences advanced adenoma recurrence risk."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;RS2296241&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant within the CYP24A1 gene is associated with increased odds of recurrent adenomas with villous histology."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VITAMIN D METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The pathway involved in converting vitamin D into its active forms, influenced by genes like CYP27B1 and CYP24A1."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;COLORECTAL ADENOMA RECURRENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition involving the recurrence of colorectal adenomas, which is influenced by genetic factors such as SNPs in CYP24A1."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;ADVANCED ADENOMA RECURRENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of advanced adenoma recurrence, characterized by specific histological features and influenced by genetic variants like rs35051736."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VITAMIN D CONCENTRATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of vitamin D in the body that play a role in colorectal health, particularly regarding adenoma recurrences."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;25(OH)D&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A circulating form of vitamin D, also known as calcifediol."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;1,25(OH)2D&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The active form of vitamin D in the body, also known as calcitriol."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;VILLOUS ADENOMA RECURRENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition involving the recurrence of adenomas with villous histology."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;SNP GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genotype for a specific single nucleotide polymorphism (SNP)."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;ADVANCED LESION RECURRENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease involving the recurrence of colorectal adenomas with advanced features."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1 SNP GENOTYPE&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"Genetic variants within the CYP24A1 gene are linked to a higher risk of advanced lesion recurrence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C.428_430DELAAG VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant involves the deletion of AAG nucleotides at positions 428-430, leading to altered CYP24A1 gene expression and function."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;C.1186Câ&gt;âT VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant involves the substitution of a T for a C at position 1186 in the CYP24A1 gene, affecting its coding sequence."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS777676129 AMPLICON&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The amplicon related to rs777676129 is used for genotyping and includes the c.428_430delAAG variant."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS114368325 AMPLICON&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The amplicon related to rs114368325 is used for genotyping and includes the c.1186Câ&gt;âT variant."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;SANGER SEQUENCING&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Sanger sequencing is a method used to confirm HRMA results by directly analyzing DNA sequences."&lt;SEP&gt;"Used to validate HLA-DQ haplotypes determined by Real-time PCR genotyping."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;IIH (IDIOPATHIC INTRACRANIAL HYPERTENSION)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IIH, or idiopathic intracranial hypertension, is a condition that may be associated with genetic variants, such as those in the CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;CYP24A1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of CYP24A1 is subject to genotyping for variants such as c.428_430delAAG and c.1186Câ&gt;âT."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;HRMA&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"Sanger sequencing confirms HRMA results by providing direct DNA sequence data."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1 GENE&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">"CYP24A1 is involved in metabolic pathways that process vitamin D and maintain calcium homeostasis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P1001L MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The P1001L mutation is a genomic variant confirmed in the probandâs genomic DNA, contributing to mosaicism."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;ATP7A EXON 7&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"ATP7A exon 7 serves as a control for completeness of BsmAI digestion in quantitative real-time PCR experiments."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;COPPER DEPENDENCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The deficiency of dopamine-b-hydroxylase activity, which is copper-dependent, reflects biochemical findings inconsistent with Menkes disease in the proband."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MENKES DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Classical Menkes disease is characterized by specific cerebrospinal fluid (CSF) copper and catecholamine ratios within established ranges for this condition."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CATECHOLAMINES&quot;">
      <data key="d0">"NUTRIENT/METABOLIC PATHWAY PRODUCT"</data>
      <data key="d1">"Plasma catecholamine ratios reflect deficient activity of dopamine-b-hydroxylase, an enzyme dependent on copper, not consistent with Menkes disease in the proband."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;DENVER DEVELOPMENTAL SCREENING TEST II&quot;">
      <data key="d0">"DIETARY PATTERN/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Denver Developmental Screening Test II is used to assess developmental skills levels including gross motor, fine motor, language, and personal-social skills."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BRAIN MRI&quot;">
      <data key="d0">"DIAGNOSTIC TOOL/METABOLIC PATHWAY"</data>
      <data key="d1">"A brain MRI at 20 months of age showed atrophy and delayed myelination in the patient, indicating neurodevelopmental issues."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"Clinical neurophysiology studies measured median nerve compound motor action potentials to assess peripheral nervous system function."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The velocity of the median nerve conduction was 50 m/s, within normal range for infants aged 1-2 years."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"Sensory action potentials were measured to assess peripheral sensory function; in this case, it was 36 Î¼V, above the lower limit of normal for infants aged 1-2 years."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;DOPAMINE-B-HYDROXYLASE ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The deficiency of dopamine-b-hydroxylase activity is copper-dependent and reflects biochemical findings inconsistent with Menkes disease in the proband, indicating a physiological process that may influence neurodevelopmental outcomes."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;FIBROBLASTS&quot;">
      <data key="d0">"PROTEIN/DIETARY PATTERN"</data>
      <data key="d1">"Primary fibroblast cultures from skin biopsies were used to analyze tissue-specific mosaicism of the P1001L mutation."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"The cerebrospinal fluid (CSF) copper and catecholamine ratios fall within ranges established for classical Menkes disease, providing diagnostic criteria."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEVELOPMENTAL SKILLS ASSESSMENT&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"This test measures developmental skills levels which are significantly delayed compared to age-appropriate milestones in the patient."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEURODEVELOPMENTAL ISSUES&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"MRI findings of atrophy and delayed myelination indicate neurodevelopmental issues in the patient."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERIPHERAL NERVOUS SYSTEM FUNCTION&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Clinical studies measured motor action potentials to assess peripheral nervous system function, which were within normal ranges for infants aged 1-2 years."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUROPHYSIOLOGICAL ASSESSMENT&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Velocity measurement is a part of neurophysiological assessment, indicating the patient's conduction velocity was within normal range for age."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERIPHERAL SENSORY FUNCTION&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Sensory action potentials were measured to assess peripheral sensory function in the patient, showing results above the lower limit of normal."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CACO-2 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A human intestinal epithelial cell line used to investigate how lncRNA LOC100507600 influences LCT mRNA levels."&lt;SEP&gt;"Caco-2 cells are a human colon adenocarcinoma cell line used for studying intestinal absorption and transport of nutrients."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;DEIODINASE GENE (DIO)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The deiodinase gene is not expressed at detectable levels by enzyme assay in Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;RAT IDI CODING SEQUENCES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rat IDI coding sequences are used for transfecting Caco-2 cells with either the T (IDI-T) or C (IDI-C) variant of rs713041."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 3â²UTR&quot;">
      <data key="d0">"TRANSCRIPT FEATURE"</data>
      <data key="d1">"The GPX4 3â² untranslated region is used to link rat IDI coding sequences in transfection experiments with Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;IDI-T AND IDI-C TRANSCRIPTS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"IDI-T (T variant) and IDI-C (C variant) transcripts are generated following transfection of Caco-2 cells with rat IDI coding sequences linked to the GPX4 3â²UTR."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GAPDH TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT REFERENCE GENE"</data>
      <data key="d1">"Relative transcript levels of IDI-T and IDI-C are measured against GAPDH transcripts as a reference gene for normalization."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE (T-BHP)&quot;">
      <data key="d0">"CHEMICAL COMPOUND"</data>
      <data key="d1">"Tert-butylhydroperoxide is used to challenge cells in oxidative stress experiments, with varying concentrations applied depending on cell culture conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Glutathione peroxidase (GPx) activity is a measure of the antioxidant defense capacity against oxidative stress in cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;ROS LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Reactive oxygen species levels are measured to assess the impact of IDI-T and IDI-C on cellular oxidative stress response."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENIUM (SE)&quot;">
      <data key="d0">"NUTRIENT ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Selenium is an essential micronutrient that plays a critical role in selenoprotein synthesis, including antioxidant enzymes like GPx4."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX1 MRNA LEVELS&quot;">
      <data key="d0">"TRANSCRIPT EXPRESSION LEVEL"</data>
      <data key="d1">"Glutathione peroxidase 1 (GPX1) mRNA levels are measured to assess the impact of IDI-T and IDI-C on selenoprotein hierarchy under different Se supply conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN H MRNA LEVELS&quot;">
      <data key="d0">"TRANSCRIPT EXPRESSION LEVEL"</data>
      <data key="d1">"Selenoprotein H mRNA levels serve as an indicator for differential expression under varying selenium supplies in transfected Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;T VARIANT (IDI-T)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The T variant of rs713041 is one form of the IDI gene that was transfected into Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;C VARIANT (IDI-C)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C variant of rs713041 is another form of the IDI gene used in transfection experiments with Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;RS713041&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP is located within the 3â²UTR region of the IDI gene and affects transcript levels when transfected into Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 MRNA LEVELS&quot;">
      <data key="d0">"TRANSCRIPT EXPRESSION LEVEL"</data>
      <data key="d1">"Glutathione peroxidase 4 (GPX4) mRNA levels are measured to evaluate changes in antioxidant enzyme expression under different conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TR1 PROTEIN LEVELS&quot;">
      <data key="d0">"PROTEIN EXPRESSION LEVEL"</data>
      <data key="d1">"Thioredoxin reductase 1 (TR1) protein levels are assessed to understand the impact of IDI-T and IDI-C variants on selenoprotein hierarchy."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE (SELENIUM)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium is a trace element essential for the synthesis of selenoproteins, including GPx4."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX4 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript encoding glutathione peroxidase 4 (GPx4), which plays a role in antioxidant defense against oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A transcript whose expression levels are similar to GPx1 and GPx4 under both Se-depleted and supplemented conditions but significantly lower for selenoprotein H mRNA in IDI-C cells compared to IDI-T cells."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The gene encoding glutathione peroxidase 1, which along with TR1 shows similar levels under both Se-depleted and supplemented conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENOPROTEIN H MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A transcript whose expression is significantly lower in IDI-C cells compared to IDI-T cells regardless of selenium supply."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcriptional level of the IDI gene that differs between IDI-T and IDI-C clones, affecting GPx activity and ROS levels post oxidative challenge."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE (TBHP)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An oxidant used to assess cell viability in serum-free conditions under varying selenium concentrations."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process induced by the presence of reactive oxygen species, which can be influenced by selenium levels and selenoprotein expression."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-C CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Cells in which IDI gene expression leads to higher GPx activity but lower cell viability under low Se conditions compared to IDI-T cells."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-T CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Cells in which IDI gene expression has less impact on endogenous GPx activity and ROS levels compared to IDI-C cells, showing greater sensitivity to oxidative stress when selenium is limited."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;ROS (REACTIVE OXYGEN SPECIES)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A byproduct of cellular metabolism that can cause oxidative damage but also signals for repair mechanisms involving selenoproteins like GPx4."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX4 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Glutathione peroxidase 4 (GPx4) protein, involved in antioxidant defense against oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENOPROTEIN H PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A selenoprotein whose expression is affected by selenium supply and varies between IDI-C and IDI-T cells."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SE-DEPLETED MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Medium lacking sufficient selenium, affecting cell viability and ROS levels in experiments involving oxidative stress challenges."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SE-SUPPLEMENTED MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Medium containing adequate amounts of selenium, which influences cell viability and selenoprotein expression under oxidative conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SERUM-FREE CONDITIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Conditions used to deplete cells of selenium before oxidative stress challenges."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SE-SUPPLY CONDITIONS&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Levels of GPX4 mRNA do not differ significantly between IDI-T and IDI-C cells under both depleted and supplemented selenium conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SE SUPPLY&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"The expression of selenoprotein H mRNA is significantly lower in IDI-C cells compared to IDI-T cells under both Se-depleted and supplemented conditions, indicating a differential response to selenium levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELENIUM DEPLETION&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Cells grown under serum-free conditions experience selenium depletion, affecting their response to oxidative challenges and selenoprotein expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHAT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CHAT is a gene that undergoes mutations leading to missense and nonsense variations."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.VAL136MET&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense mutation (p.Val136Met) identified in the CHAT gene, affecting three patients."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ALA557THR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another missense mutation (p.Ala557Thr) detected in five patients and homozygous in one patient."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;CHAT TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The CHAT transcript expresses two protein isoforms of 70 kDa and 74 kDa from alternative start sites in the spinal cord (S-type)."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;WILD-TYPE CHAT PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The wild type of ChAT protein expressed at a higher level compared to most missense mutants, indicating its significance in expression levels."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MISSENSE MUTANTS CHAT PROTEINS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Several missense mutations lead to lower expression levels and altered kinetic parameters of the CHAT proteins."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;KINETIC PROPERTIES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The kinetic properties of wild-type and mutant ChATs were evaluated, revealing changes in activation rate constants for some mutants."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;THERMAL STABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Mutations affect the thermal stability of CHAT proteins, with two mutations significantly compromising this property."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;BOSC 23 CELLS AND E. COLI &quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cells and bacterial cultures used in expressing and purifying wild-type and mutant ChATs for analysis."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.TRP421SER&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense mutation (p.Trp421Ser) identified in CHAT gene with altered expression levels."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.SER498PRO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Missense mutation (p.Ser498Pro) affecting the expression level of ChAT protein."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.THR553ASN&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense mutation (p.Thr553Asn) identified in CHAT gene with reduced expression levels."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MET202, TRP421, THR553, AND ALA557&quot;">
      <data key="d0">"CONSERVED RESIDUES"</data>
      <data key="d1">"These residues are conserved across multiple species indicating their functional importance."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;DROSOPHILA AND C. ELEGANS &quot;">
      <data key="d0">"MODEL ORGANISMS"</data>
      <data key="d1">"Species used to identify conserved residues in CHAT gene for comparative analysis."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PATIENT 8&quot;">
      <data key="d0">"INDIVIDUAL WITH MUTATION"</data>
      <data key="d1">"Homozygous for p.Ala557Thr mutation, showing a specific phenotype."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PATIENT 10&quot;">
      <data key="d0">"INDIVIDUAL WITH MUTATION"</data>
      <data key="d1">"Carries a nonsense mutation on one allele and is homozygous for p.Ala557Thr."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PATIENT 11&quot;">
      <data key="d0">"INDIVIDUAL WITH MUTATION"</data>
      <data key="d1">"Born to consanguineous parents, homozygous for p.Ile689Ser mutation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;HISTIDINE-TAGGED CHAT CDNAS&quot;">
      <data key="d0">"PROTEIN CONSTRUCT"</data>
      <data key="d1">"His-tagged constructs of wild-type and mutant ChATs used in kinetic studies."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;NI-NTA COLUMN&quot;">
      <data key="d0">"TECHNIQUE FOR PROTEIN PURIFICATION"</data>
      <data key="d1">"Used to purify His-tagged CHAT proteins from bacterial lysates."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;FAST PROTEIN LIQUID CHROMATOGRAPHY (FPLC)&quot;">
      <data key="d0">"TECHNIQUE FOR PROTEIN ANALYSIS"</data>
      <data key="d1">"Instrument used in purification and analysis of ChAT mutants."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;DNA METHYLATION PATTERNS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Changes in DNA methylation patterns near the LCT and MCM6 genes are critical for regulating lactose digestion ability over a person's lifetime, linking genetic variation with nutritional metabolism."&lt;SEP&gt;"The DNA methylation patterns at specific genomic sites (CpGs) are associated with markers of oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS MARKERS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Oxidative stress markers are indicators of the physiological process related to oxidative stress."&lt;SEP&gt;"Oxidative stress markers such as TGSH, GSH, GSSG, HCY, oxLDL, OLAB, CD, BCD-LDL and TAOC are used to measure the oxidative state of an individual."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28&lt;SEP&gt;chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;TGSH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total glutathione (TGSH) is a marker for measuring total levels of reduced glutathione in biological systems."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GSH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Glutathione (GSH), the reduced form, acts as an antioxidant and its level indicates the oxidative state of cells."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GSSG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Glutathione disulfide (GSSG) is the oxidized form of glutathione used to measure oxidative stress in biological systems."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;HCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Homocysteine (HCY) levels are associated with cardiovascular disease and methylation patterns may influence this association."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;OXLDL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Oxidized low-density lipoprotein (oxLDL) is a marker for lipid peroxidation and oxidative stress in the vascular system."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Copper-dependent lysyl oxidase activity (CD) measures products of lipid peroxidation indicating oxidative damage to LDL."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;BCD-LDL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bilirubin-copper-dependent low-density lipoprotein (BCD-LDL) is another marker for assessing lipid peroxidation and oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GLUTATHIONE BALANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The balance between reduced glutathione (GSH) and oxidized glutathione (GSSG) reflects the redox status of a cell or tissue."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;BCL2L11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL2-like 11 gene is associated with methylation patterns linked to oxidative stress markers TGSH and GSH."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;NDUFS7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NADH dehydrogenase Fe-S protein 7 (NDUFS7) shows methylation levels associated with oxidative stress marker TGSH or GSH."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;EIF3J&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Eukaryotic translation initiation factor 3, subunit J (EIF3J), is a gene linked to methylation patterns related to oxidative stress markers TGSH and GSH."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ZNF761&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Zinc finger protein 761 (ZNF761) shows significant methylation levels associated with the ratio of oxidized to reduced glutathione (GSSG/GSH)."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;PSMG3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Proteasome assembly chaperone 3 (PSMG3), is a gene whose promoter region methylation level is strongly associated with GSSG/GSH ratio."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;SEMA6A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Sema domain, transmembrane and cytoplasmic domain protein 6A (SEMA6A) has methylation patterns significantly correlated with oxidized LDL levels."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;TAPBP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tap binding protein (TAPBP), is a gene whose 3'-UTR region methylation level correlates with copper-dependent lysyl oxidase activity (CD)."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RGL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Ral guanine nucleotide dissociation stimulator-like 2 (RGL2) shows promoter region methylation associated with CD."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CKAP5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cytoskeleton-associated protein 5 (CKAP5), is a gene linked to BCD-LDL through its CpG site methylation levels."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FOSL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FOS-like antigen 2 (FOSL2) exhibits significant methylation patterns associated with BCD-LDL marker of oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FAM20C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Family with sequence similarity 20, member C (FAM20C), has CpG site methylation levels significantly linked to BCD-LDL."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FRMD6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FERM domain containing 6 (FRMD6) is a gene whose CpGs are associated with the oxidative marker BCD-LDL."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;OXIDATIVE DAMAGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Oxidative stress leads to oxidative damage in biological systems, affecting various cellular components and processes."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT J (EIF3J)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EIF3J is involved in protein synthesis regulation and its methylation patterns correlate with oxidative stress markers TGSH and GSH."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;NADH DEHYDROGENASE FE-S PROTEIN 7 (NDUFS7)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NDUFS7 is a component of the mitochondrial respiratory chain, and its methylation level is associated with oxidative stress marker TGSH or GSH."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;E2F1 GENE/PROTEIN&quot;">
      <data key="d0">"GENE, PROTEIN"</data>
      <data key="d1">"E2F1 is a gene and protein with potential roles in atherosclerosis and coronary heart disease (CHD)."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLAND SHORES&quot;">
      <data key="d0">"GENOMIC LOCATION, REGULATORY ELEMENT"</data>
      <data key="d1">"CpG island shores are genomic locations enriched in phenotype-associated CpGs and have potential regulatory functions."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PROMOTERS&quot;">
      <data key="d0">"REGULATORY ELEMENT"</data>
      <data key="d1">"Promoters are regions of DNA where transcription factors bind to initiate gene expression; phenotype-associated CpGs are more likely located near them than other CpGs."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TF BINDING SITES (JASPAR DATABASE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION, REGULATORY ELEMENT"</data>
      <data key="d1">"TF binding sites identified using JASPAR database are potential regulatory elements that influence gene expression."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PHOSPHORYLATION AND PHOSPHATE/PHOSPHOROUS METABOLIC PROCESSES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These processes relate to functional annotations of genes clustered into terms such as phosphorylation and phosphate/phosphorus metabolism, which are associated with oxidative stress markers."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;MEQTLS (METHYLATION QUANTITATIVE TRAIT LOCI)&quot;">
      <data key="d0">"GENOMIC VARIANT, MOLECULAR INTERACTION"</data>
      <data key="d1">"MeQTLs refer to genetic sequence variants contributing to DNA methylation variation across different genomic locations."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CIS-MEQTL SNPS&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"SNPs associated with cis-meQTL, indicating the relationship between genotype and DNA methylation levels at a nearby CpG site."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CHD (CORONARY HEART DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CHD is a condition related to coronary heart disease which can be influenced by genetic factors like SNPs associated with oxidative stress markers."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;T2D (TYPE 2 DIABETES)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T2D, or Type 2 diabetes, may have associations mediated through epigenetics and specific genetic variants linked to methylation at CpG sites."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CARDIOGRAM CONSORTIUM&quot;">
      <data key="d0">"RESEARCH ORGANIZATION"</data>
      <data key="d1">"The CARDIoGRAM consortium is a research organization focused on identifying genetic risk factors for coronary heart disease (CHD)."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;DIAGRAM CONSORTIUM&quot;">
      <data key="d0">"RESEARCH ORGANIZATION"</data>
      <data key="d1">"DIAGRAM consortium is dedicated to studying genetic determinants of type 2 diabetes (T2D) through genome-wide association studies."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;BCL2L11 GENE CPG SITE (CG07547695)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant site within the BCL2L11 gene, specifically cg07547695, associated with methylation level and linked to SNP rs726430."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CEP55 GENE CPG SITE (CG24371383)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant site within the CEP55 gene, specifically cg24371383, associated with methylation level and linked to SNP rs12782691."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CPB1 GENE CPG SITE (CG04072156)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant site within the CPB1 gene, specifically cg04072156, associated with methylation level and linked to SNP rs16861015."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;INTERGENIC SITE ON CHROMOSOME 4 (CG14532755)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intergenic site on chromosome 4, specifically cg14532755, associated with methylation level and linked to multiple SNPs including rs1665364."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HISTONE CLUSTER 1 H4D (HIST1H4D) CPG SITE (CG08170869)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A CpG site in the 3'-UTR of histone cluster 1, H4d gene, associated with methylation level and linked to Type 2 Diabetes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;DISHEVELLED-1 (DVL1) CPG SITE (CG03465880)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A CpG site in the body of DVL1 gene, associated with methylation level and linked to Type 2 Diabetes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ZNF341 CPG SITE (CG11842944)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A CpG site within the ZNF341 gene body, associated with methylation level and linked to cardiovascular disease, particularly heart failure."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS PHYSIOLOGICAL PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Oxidative stress is a physiological process involving an imbalance between the production of reactive oxygen species (ROS) and the ability of cells to detoxify them."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE (CVD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A class of diseases that involve the heart and blood vessels, often resulting from poor blood flow leading to heart attack, stroke, or peripheral artery disease."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;MYOCARDIAL INFARCTION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition where part of the myocardium dies due to an extended lack of oxygen supply."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HEART FAILURE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic condition wherein the heart muscle is unable to pump enough blood to meet the body's needs."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ISCHAEMIC STROKE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of stroke that occurs when a major artery in the brain becomes blocked, leading to an insufficient supply of oxygen and nutrients to brain tissue."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;BCL2L11 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in apoptosis regulation."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CEP55 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene that encodes a centrosomal protein essential for cell division and cytokinesis."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CPB1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in the regulation of calcium signaling pathways."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ZNF341 GENE PRODUCT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein product encoded by ZNF341, involved in transcriptional regulation."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;DVL1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A signaling molecule that functions as a critical link between cell surface receptors and intracellular signal transduction pathways, particularly Wnt signaling."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HIST1H4D PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein product encoded by histone cluster 1, H4d gene, involved in chromatin structure and transcriptional regulation."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS PATHWAY&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"Cellular processes involving the production of reactive oxygen species (ROS) and their detoxification by antioxidant mechanisms."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;TRANSCRIPTIONAL REGULATION PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulation of gene expression at the transcription level."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;GENE EXPRESSION REGULATION&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"Phenotype-associated CpGs located near promoters suggest their potential regulatory influence over gene expression through transcriptional control mechanisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY ELEMENT FUNCTIONALITY&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"Identified TF binding sites provide evidence for the functionality of specific regulatory elements in influencing gene expression patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTIONAL ANNOTATION CLUSTERING&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"These processes cluster into functional annotations based on their enrichment scores, implying a biological significance related to oxidative stress markers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIATION AND DNA METHYLATION REGULATION&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"The presence of meQTLs suggests that genetic variation can significantly impact DNA methylation levels, a key epigenetic modification involved in gene regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHD RISK GENES&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"Specific SNPs associated with cis-meQTL show modest associations with CHD risk genes identified through GWAS data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS DATA ANALYSIS FOR CHD&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"This consortium contributes to the analysis of GWAS data aimed at identifying genetic risk factors specific to coronary heart disease (CHD).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D GENETIC RISK FACTORS IDENTIFICATION&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"The DIAGRAM consortium facilitates research into understanding genetic risk factors contributing to type 2 diabetes (T2D), enhancing our knowledge of the condition's heritability and biological basis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MT-ATP6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MT-ATP6 gene is located in mitochondrial DNA and codes for a protein subunit of ATP synthase, which plays a crucial role in the electron transport chain."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a de novo mutation in the MT-ATP6 gene resulting in an amino acid change from Leucine to Arginine at position 156 of the protein."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;LEIGH SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurodegenerative disorder affecting the central nervous system, caused by mutations in mitochondrial DNA or nuclear genes involved in oxidative phosphorylation pathways."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COMPLEX V (ATP SYNTHASE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The final complex of the electron transport chain that uses energy from electrons to synthesize ATP from ADP and Pi."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NDUFV1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding a protein involved in mitochondrial oxidative phosphorylation, specifically subunit 8 of NADH dehydrogenase (ubiquinone), which is part of complex I of the electron transport chain."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.736G&gt;A, P.GLU246LYS VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense variant in NDUFV1 gene that results in an amino acid change from Glutamic Acid to Lysine at position 246 of the protein."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.349G&gt;A, P.ALA117THR VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense variant in NDUFV1 gene that results in an amino acid change from Alanine to Threonine at position 117 of the protein."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COMPLEX I (NADH DEHYDROGENASE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The first complex of the electron transport chain involved in transferring electrons from NADH to ubiquinone, with concomitant proton pumping across the mitochondrial membrane."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;EXOME SEQUENCING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A technique used to sequence only the exons (protein-coding regions) of the genome, which helps in identifying genetic variants associated with diseases."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;GSNAP ALIGNMENT TOOL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An alignment tool that maps sequencing reads to a reference genome and is used to identify variant calls."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;HETEROPLASMIC VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants present in some but not all mitochondrial DNA copies within the same cell, indicating a mix of mutated and normal mtDNA sequences."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;RFLP ASSAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A technique used to detect specific DNA sequences by cutting them with restriction enzymes and then separating the resulting fragments using gel electrophoresis."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COMPLEX V DEFICIENCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The lack of proper function in ATP synthase (complex V) that can result from mutations affecting its components, leading to impaired ATP production."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A series of redox reactions involving complexes I through IV and the mobile electron carriers ubiquinone (CoQ) and cytochrome c, culminating in complex V (ATP synthase)."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COQ2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The COQ2 gene encodes a protein involved in coenzyme Q10 biosynthesis."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.437G&gt;A (SER146ASN)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a genomic variant located at position c.437 of the COQ2 gene, causing an amino acid change from Serine to Asparagine."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q10 DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease caused by mutations in the COQ2 gene or other genes involved in coenzyme Q10 biosynthesis."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COQ2 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by the COQ2 gene, which is involved in the synthesis of coenzyme Q10."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MT-ND1 GENE (MITOCHONDRIAL)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A mitochondrial gene encoding a subunit of complex I of the electron transport chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;3754C&gt;A MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a novel genomic variant found in the MT-ND1 gene, causing heteroplasmic changes in the mtDNA sequence."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;SUBUNIT 1 (MT-ND1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"One of seven subunits encoded by mitochondrial DNA and part of complex I of the electron transport chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;LEBER OPTIC ATROPHY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease caused by mutations in the MT-ND1 gene, resulting in optic nerve dysfunction."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disorder due to mutations affecting complex I of the electron transport chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MELAS SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A mitochondrial disease characterized by a wide range of symptoms including neurological and myopathic features, often caused by mutations in mtDNA."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NADH DEHYDROGENASE COMPLEX (COMPLEX I)&quot;">
      <data key="d0">"PROTEIN/MOLECULAR INTERACTION"</data>
      <data key="d1">"A large protein complex involved in the electron transport chain that uses NADH to reduce ubiquinone."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;UBIQUINONE&quot;">
      <data key="d0">"MOLECULE/NUTRIENT"</data>
      <data key="d1">"A molecule that accepts electrons from NADH dehydrogenase complex (Complex I) as part of oxidative phosphorylation."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;FMN BINDING SITE&quot;">
      <data key="d0">"PROTEIN FEATURE"</data>
      <data key="d1">"An essential binding site on the NADH dehydrogenase protein for flavin mononucleotide, involved in electron transfer."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;ELONGATED ACIDIC PROTEIN (EAP)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A hypothetical acidic protein that may be involved in the regulation of complex I activity or electron transport chain functions."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;PERIPHERAL BLOOD CELLS DNA EXTRACTION AND SEQUENCING PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The process by which genomic DNA is isolated from peripheral blood cells, enriched for exome content, and sequenced to analyze genetic variants."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NUCLEAR EXOME&quot;">
      <data key="d0">"GENOMIC FEATURE/METABOLIC PATHWAY"</data>
      <data key="d1">"A subset of the nuclear genome that encodes proteins involved in various cellular functions including mitochondrial biogenesis."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MTDNA COVERAGE&quot;">
      <data key="d0">"METABOLIC PATHWAY/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Coverage obtained from sequencing the mitochondrial DNA, which is crucial for studying genetic variants related to mitochondrial disorders."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;VARIANT CLASSIFICATION (RUNES)&quot;">
      <data key="d0">"MOLECULAR INTERACTION/DISEASE"</data>
      <data key="d1">"A bioinformatics tool used to classify genomic variants into categories based on their potential impact and frequency in a database."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;CATEGORY 1-3 VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Highly impactful genetic variations classified by RUNES as potentially deleterious to health or function."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q2 HOMOLOG, PRENYLTRANSFERASE (COQ2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding a protein involved in the biosynthesis of coenzyme Q10, which is essential for mitochondrial electron transport chain function."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.1159C&gt;T VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant introduces a premature stop codon at position 387, potentially disrupting COQ2 protein function and leading to coenzyme Q10 deficiency."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL GENOME-ENCODED NADH DEHYDROGENASE SUBUNIT 1 (MT-ND1)&quot;">
      <data key="d0">"GENE/METABOLIC PATHWAY"</data>
      <data key="d1">"A gene encoding one of seven subunits necessary for the proper functioning of complex I in mitochondria, crucial for ATP synthesis."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;3754C&gt;A VARIANT IN MT-ND1 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT/MOLECULAR INTERACTION"</data>
      <data key="d1">"A novel heteroplasmic variant identified within the mitochondrial DNA-encoded NADH dehydrogenase subunit 1 gene."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.437G&gt;A VARIANT AND C.1159C&gt;T VARIANT&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Mutations in the COQ2 gene can result in coenzyme Q10 deficiency and are associated with specific genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OPRM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The OPRM1 gene is a focus in the text regarding genotype differences in drinking variables and pharmacogenetic effects on alcohol craving and subjective response."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALDH2 (RS671)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant of ALDH2 used as a covariate to control for in analyses related to OPRM1 genotype group differences."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ADH1B (RS1229984)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant of ADH1B also controlled for in the same manner as ALDH2's rs671."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;NALTREXONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A medication tested for its effect on alcohol craving and subjective response, notably associated with side effects like drowsiness and ringing in ears."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;PLACEBO&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Used as a control in the study to compare against naltrexone's effects."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DROWSINESS&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"A significant medication association found during analyses, more prevalent with naltrexone than placebo use."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;RINGING IN THE EARS&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"Another significant side effect observed specifically for participants on naltrexone compared to placebo users."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALCOHOL CRAVING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An outcome measured during alcohol infusion sessions, analyzed based on OPRM1 genotype and medication effects."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;SUBJECTIVE RESPONSE TO ALCOHOL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Includes sedation and stimulation levels experienced by participants in response to alcohol consumption, examined across genotypes and drug conditions."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;BRAC LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Blood alcohol concentration level used as an important factor influencing subjective responses during the study."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;AUDIT SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"AUDIT score is a measure used in drinking variables comparisons among OPRM1 genotype groups."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;NUMBER OF DRINKING DAYS&quot;">
      <data key="d0">"DISEASE RISK FACTOR"</data>
      <data key="d1">"The number of days participants engaged in drinking alcohol over the past 30 days was compared across OPRM1 genotype groups as part of baseline and demographic comparisons."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure used to compare alcohol consumption patterns between different genotypes during the study period."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPE (RS671)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant was controlled for in analyses of OPRM1's effects on drinking variables and subjective responses, alongside ADH1B."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ADH1B GENOTYPE (RS1229984)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Like ALDH2 rs671, this variant was included as a covariate in analyses to understand its influence on drinking behavior and subjective alcohol responses."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;AUQ VALUES&quot;">
      <data key="d0">"BASELINE MEASURE"</data>
      <data key="d1">"AUQ values are baseline measures of alcohol use that were significant covariates influencing the study results."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;CURRENT CIGARETTE SMOKING STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"This status was considered in analyses to determine its role as a moderator of effects related to OPRM1 genotype and medication."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ALDH2 genotype is a genetic variant that influences alcohol metabolism and consumption behavior."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ASP40 CARRIER GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Asp40 carriers have a specific genetic variation affecting their response to alcohol compared to Asn40 homozygotes."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ASN40 HOMOZYGOTE GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals with the Asn40 homozygous genotype exhibit different behavior in alcohol consumption and metabolism as opposed to Asp40 carriers."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NALTREXONE MEDICATION&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Naltrexone is a medication that affects opioid receptors, used here to study its effects on alcohol self-administration compared to placebo."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALCOHOL SELF-ADMINISTRATION BEHAVIOR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This process refers to the voluntary intake of alcohol under controlled conditions, which is influenced by genetic factors such as ALDH2 genotype and medication effects."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;OPRM1 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The OPRM1 genotype is a genetic variant that influences opioid receptor function and may impact alcohol consumption behavior."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;BASELINE STIMULATION VALUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline stimulation values refer to the initial level of brain activity or other physiological measures before experimental manipulation."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;BRAC (BREATH ALCOHOL CONCENTRATION)&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASUREMENT"</data>
      <data key="d1">"BrAC is a measure used to determine alcohol concentration in breath, reflecting recent alcohol consumption."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;NICOTINE SMOKING STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"The status of whether an individual smokes nicotine-containing cigarettes and its impact on physiological processes like alcohol consumption."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 RS671 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ALDH2 rs671 genotype is a genetic variant that influences daily alcohol consumption and blood cortisol levels, with GG genotype individuals consuming the highest amount of alcohol."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;DAILY ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Daily alcohol consumption varies significantly by ALDH2 genotypes; men with GG genotypes consume more than those with GA or AA genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;CORTISOL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Blood cortisol levels show variation based on ALDH2 genotypes, particularly in men where the GA group has lower levels compared to others."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;AGE DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The distribution of age varies significantly across different ALDH2 genotypes, with the GA genotype group being older than other groups in both sexes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Adjusting for diabetes status in multivariate analysis does not significantly alter the association between alcohol consumption and cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;EDUCATION STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Educational attainment is a lifestyle factor that, when adjusted for, does not change the relationship between daily alcohol intake and blood cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GENETICALLY PREDICTED ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The genetically predicted amount of alcohol consumption influences blood cortisol level positively in men but shows no significant association in women according to multivariate linear regression models."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;ALDH2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALDH2 gene is associated with alcohol metabolism, particularly through its rs671 polymorphism which affects daily alcohol consumption."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISM (RS671)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs671 genetic polymorphism in the ALDH2 gene influences daily alcohol intake and cortisol levels, showing significant differences among genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;MEN&quot;">
      <data key="d0">"SEXUAL GROUP"</data>
      <data key="d1">"Men show higher baseline characteristics of alcohol consumption compared to women, with significant variations across different genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;WOMEN&quot;">
      <data key="d0">"SEXUAL GROUP"</data>
      <data key="d1">"Women display a lower daily alcohol intake and less variation in cortisol levels compared to men based on ALDH2 genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;CORTISOL METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cortisol metabolism is influenced by ALDH2 genotypes, showing differential patterns across sexes and genotypic groups."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;CONFIDENCE INTERVAL (CI)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Used in the sensitivity analysis to determine the association between genetically predicted alcohol consumption and blood cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;UNIVARIATE LINEAR REGRESSION MODEL&quot;">
      <data key="d0">"BIOSTATISTICAL METHOD"</data>
      <data key="d1">"This model assesses the direct relationship between daily alcohol consumption and blood cortisol levels without adjusting for confounders."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;MULTIVARIATE LINEAR REGRESSION MODEL&quot;">
      <data key="d0">"BIOSTATISTICAL METHOD"</data>
      <data key="d1">"Adjusts for factors such as age, physical activity, smoking status, hypertension, diabetes, and education to understand the true association between variables."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;MENDELIAN RANDOMIZATION (MR)&quot;">
      <data key="d0">"BIOSTATISTICAL TECHNIQUE"</data>
      <data key="d1">"Used in sensitivity analysis to establish a causal relationship between genetically predicted alcohol consumption and blood cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;ABCG2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ABCG2 is a gene associated with uric acid levels and hyperuricemia (HUA) risk."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SLC2A9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC2A9 is a gene involved in the regulation of uric acid transport and its variants are linked to increased sUA levels and HUA risk."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SLC22A12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC22A12 is a gene associated with uric acid metabolism, but its role in increasing sUA levels or HUA risk may be gender-dependent."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;RS3733591 SLC2A9 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant of the SLC2A9 gene is associated with higher serum uric acid (sUA) levels and increased risk of hyperuricemia, particularly in females."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;RS2231142 ABCG2 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant of the ABCG2 gene significantly increases sUA levels and HUA risk across both genders."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;RS893006 SLC22A12 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with increased sUA levels in males but not necessarily with an elevated HUA risk."&lt;SEP&gt;"This variant of the SLC22A12 gene is associated with increased serum uric acid levels, particularly in males."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SERUM URIC ACID (SUA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Serum uric acid level is a physiological process that reflects the balance between urate production and excretion."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HYPERURICEMIA (HUA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by abnormally high levels of serum uric acid, which can lead to gout and other health issues."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SERUM CREATININE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An indicator of kidney function reflecting the level of creatinine in blood serum."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;TG (TRIGLYCERIDES)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A type of lipid present in the bloodstream, indicating fat metabolism and storage."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;LDL (LOW-DENSITY LIPOPROTEIN)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A cholesterol-carrying lipoprotein that is associated with cardiovascular health risks when elevated."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HDL (HIGH-DENSITY LIPOPROTEIN)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A lipoprotein that plays a role in cholesterol metabolism and is generally associated with lower cardiovascular disease risks when high."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SLC2A9 RS3733951&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SLC2A9 gene variant rs3733951 is associated with serum uric acid (sUA) levels."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;ABCG2 RS2231142&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ABCG2 gene variant rs2231142 influences hyperuricaemia (HUA) risk and serum uric acid (sUA) levels, especially in the presence of cardiovascular risk factors."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;SLC22A12 RS893006&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SLC22A12 gene variant rs893006 does not show significant association with sUA levels, except in male carriers of the C/C genotype."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;SUA LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"sUA (serum uric acid) levels are influenced by genetic variants and cardiovascular risk factors such as obesity, hypertension, and lipid profile anomalies."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;GENETIC RISK SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A score reflecting the number of alleles associated with high sUA levels is positively correlated with actual sUA levels in both males and females."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Factors such as obesity, hypertension, higher triglycerides (TG), lower HDL cholesterol levels are linked to increased HUA risk when combined with specific genetic variants."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;HYPERURICAEMIA (HUA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by high uric acid levels in the blood which can lead to gout and kidney stones, influenced by genetic predisposition and lifestyle factors."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;SLC2A9 C/C GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SLC2A9 C/C genotype is associated with higher serum uric acid (sUA) levels compared to T/T carriers."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;TG LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Higher triglyceride (TG) levels are associated with increased serum uric acid (sUA) levels and higher hyperuricaemia (HUA) risk in individuals carrying the ABCG2 rs2231142 T allele."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;LDL LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Higher low-density lipoprotein cholesterol (LDL) levels are associated with increased serum uric acid (sUA) levels and higher hyperuricaemia (HUA) risk in individuals carrying the ABCG2 rs2231142 T allele."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;HDL LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Lower high-density lipoprotein cholesterol (HDL) levels are associated with increased serum uric acid (sUA) levels and higher hyperuricaemia (HUA) risk in individuals carrying the ABCG2 rs2231142 T allele, but not significantly for females."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;RS2231142 T ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs2231142 T allele is a genetic variant associated with increased uric acid levels and hyperuricemia risk."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;URIC ACID METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of metabolizing uric acid in the body, which is influenced by genetic factors like rs2231142 T allele."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;HYPERURICEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by high levels of uric acid in the blood, often associated with certain genetic variants and risk factors."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;SLC2A9 VARIANT&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The rs3733591 variant of SLC2A9 is significantly associated with increased risk for hyperuricemia, particularly in female subjects."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT ABCG2&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"Variants of the ABCG2 gene affect serum uric acid levels across both genders and populations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM URIC ACID LEVELS&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"Variants of the ABCG2 gene affect serum uric acid levels across both genders and populations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LRP2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LRP2 gene is associated with kidney function and identified through genome-wide association studies."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NFATC1 gene is linked to kidney function, discovered in GWASs of individuals with European ancestry."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;EGFR-DECREASING ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific allele variant associated with a decrease in estimated glomerular filtration rate (eGFR), indicating potential risk for chronic kidney disease."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;CKD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chronic Kidney Disease is defined by eGFR &lt; 60 mL/min/1.73 m2 and/or incidence of ESRD, influenced by genetic factors such as the lead SNPs identified in the study."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;UNCX GENE VARIANT (RS62435145)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant within the UNCX gene showing significant association with chronic kidney disease risk."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ALMS1 GENE (RS7587577)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"The ALMS1 gene and its associated SNP are linked to chronic kidney disease risk as indicated by genome-wide association studies."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;PDILT-UMOD GENE VARIANTS (RS77924615)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant in the PDILT-UMOD locus showing significant linkage to chronic kidney disease and eGFR, identified through whole-genome sequencing and long-range haplotype imputation."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;PRKAG2 GENE VARIANTS (RS7463059)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"The PRKAG2 gene variant is associated with changes in eGFR in individuals with diabetes, indicating a role in kidney function regulation."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;T2D AND T1D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Diabetes types 2 (T2D) and 1 (T1D) contribute to the risk of chronic kidney disease and influence eGFR as indicated by genetic studies."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;LRP2 GENE (RS57989581)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"The LRP2 gene variant rs57989581 is associated with kidney function in individuals across different ancestry groups."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1 GENE (RS8096658)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"The NFATC1 gene variant rs8096658 has been linked to an increased risk of kidney function impairment according to genome-wide studies."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;PDILT-UMOD GENE (RS77924615)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in the PDILT-UMOD locus associated with chronic kidney disease and significant impact on eGFR."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;SLC34A1 GENE VARIANTS (RS7805792)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"Variants within the SLC34A1 gene linked to changes in estimated glomerular filtration rate (eGFR) and kidney function."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;GCKR GENE VARIANTS (RS1260326)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"The GCKR gene variant rs1260326 is associated with changes in eGFR and has been localized through fine mapping studies."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;DCDC5-MPPED2 GENE VARIANTS (RS7944877)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"Variants within the DCDC5-MPPED2 locus associated with changes in eGFR and chronic kidney disease risk."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NFATC1 is a gene that plays a central role in inducible gene transcription during immune response."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;SLC34A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC34A1 is involved in kidney function and is associated with variants impacting eGFR levels."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;GCKR P.PRO446LEU (RS1260326)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This missense variant has been shown to result in increased de novo triglyceride and cholesterol synthesis, decreased plasma glucose concentrations, and associated with risk of CKD."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;DHSS FOR 145 CELL TYPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"DNase I Hypersensitive Sites (DHSs) are DNA regions where chromatin is more accessible to DNase I digestion."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;CHIP-SEQ BINDING SITES FOR 165 TRANSCRIPTION FACTORS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These refer to the genomic locations where specific transcription factors bind, which can regulate gene expression."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;HDAC8 BINDING SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Histone Deacetylase 8 (HDAC8) binding sites are critical for kidney function and development."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RGS14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Regulator of G protein signaling family member, modulates downstream effects of GÎ± subunits, with unknown function in kidneys."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;NFATC1 GENE EXPRESSION REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This process involves the regulation and transcriptional activity driven by NFATC1 gene."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITES (TFBS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These are specific DNA sequences where transcription factors bind to regulate gene expression."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;HISTONE DEACETYLASES (HDACS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HDACs are a family of enzymes involved in modifying histones, affecting chromatin structure and transcriptional regulation."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;CYCLOSPORINE A&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An immunosuppressant drug that targets NFATC1 as part of its mechanism of action."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;EQTLS FOR NFATC1 AND RGS14&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Expression Quantitative Trait Loci (eQTL) influencing the expression levels of NFATC1 and RGS14 genes in multiple tissues."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;IONIC REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process involving maintaining ion concentrations within biological systems, particularly relevant to kidney function."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;SALT SENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This describes the sensitivity of organisms to dietary salt intake and its impact on health conditions like hypertension or heart disease."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;OSMOTIC REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulation that involves maintaining balance between water concentration inside cells and outside, critical for cell survival."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;CKD (CHRONIC KIDNEY DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A long-term condition in which the kidneys lose their ability to filter blood effectively."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;NFATC1 VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants at the NFATC1 locus are associated with changes in gene expression regulation."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;SLC34A1 VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants at SLC34A1 locus impact eGFR levels and regulatory chromatin state in kidney cells."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;FETAL KIDNEY CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These cells are involved in developmental processes and play a role in understanding gene regulation during early development."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These cells are crucial for kidney function and studies show that DHSs in RPTECs influence the posterior probability of driving association signals with eGFR."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RENAL CORTICAL EPITHELIAL CELLS (HRCES)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells important for kidney physiology, especially in renal function and disease mechanisms."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RGS14 VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants at the SLC34A1 locus are also eQTLs for RGS14 in multiple tissues, indicating its role in eGFR regulation."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCO LOSS-OF-FUNCTION VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These variants in Drosophila melanogaster reduce expression of the loco gene and are associated with improved survival under salt stress conditions."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;TRANSPLANT IMMUNOSUPPRESSION DRUG (CYCLOSPORINE A)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used for suppressing immune responses, particularly relevant in organ transplantation, targeting NFATC1 as a downstream target."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCO GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The loco gene has a role in resistance to salt stress in Drosophila mutants."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NFATC1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NFATC1 is a protein whose renal mRNA expression decreases significantly during high-salt exposure and chronic kidney disease (CKD)."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;RGS14 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"RGS14 is a protein whose renal mRNA expression also shows significant reduction in high-salt diet conditions and trends towards reduction in CKD."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HIGH-SALT DIET&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental factor that alters the gene expression of NFATC1 and RGS14 in mice, contributing to kidney dysfunction."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CHRONIC KIDNEY DISEASE (CKD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease condition induced by sub-total nephrectomy, associated with changes in renal mRNA expression of NFATC1 and RGS14."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;GLOMERULOSCLEROSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process related to kidney function that is exacerbated by salt sensitivity in mice."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;LOCO MUTANTS (Y1W1; LOCOD06164/+ AND Y1W1; LOCOEY-P283/+) &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific genomic variants of the loco gene in Drosophila that exhibit resistance to salt stress."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;ISOGENIC CONTROLS (Y1W1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genetically identical control strains used for comparison with LoCo mutants to study the effects of genetic modifications on salt stress resistance."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HYBRID HETEROGENIC STRAINS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Strains resulting from crossbreeding different genetic backgrounds, used for studying the role of loco gene in salt resistance."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;129S6 MOUSE STRAIN &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific mouse strain known to be salt-sensitive and susceptible to glomerulosclerosis, used as a model for studying kidney disease."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NFATC1 GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene that encodes the NFATC1 protein, which is involved in regulating renal mRNA expression during high-salt diet exposure and CKD."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;RGS14 GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene that codes for RGS14 protein, whose renal mRNA levels are altered under conditions of salt stress and chronic kidney disease."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SUB-TOTAL NEPHRECTOMY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A surgical procedure that involves the removal of a part of one or both kidneys, used to induce chronic kidney disease (CKD) in experimental models."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NACL &quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Sodium chloride, an environmental factor and dietary salt component that influences gene expression in renal tissue when administered in high concentrations."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CKD, EGFR&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"Variants within the PDILT-UMOD locus, notably rs77924615, impact both chronic kidney disease risk and estimated glomerular filtration rate."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE RISK&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"The GCKR missense variant is associated with metabolic changes that increase the risk of cardiovascular diseases, such as CKD."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KIDNEY FUNCTION REGULATION&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Binding of HDAC8 to specific genomic regions may regulate kidney function and development through chromatin modification."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE EXPRESSION IN TISSUES&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"These variants are eQTLs for RGS14 and NFATC1 in multiple tissues, indicating their regulatory roles."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC REGULATION&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Studies on DHSs in fetal kidney cells suggest that these cells play a role in early gene regulation during development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE REGULATION MECHANISMS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"These cells indicate that DHSs play a crucial role in the posterior probability of driving association signals with eGFR."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE RESPONSE&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"The gene RGS14, influenced by variants at SLC34A1 locus, is involved in immune responses and regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SALT SENSITIVITY REGULATION&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"These variants reduce expression of loco gene, improving survival under salt stress conditions in Drosophila."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SALT STRESS RESISTANCE&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"The loco gene plays a role in conferring resistance against salt stress, especially evident in mutant strains of Drosophila when supplemented with NaCl."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ISOGENIC CONTROLS&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"When compared with isogenic controls under non-NaCl conditions, loco mutants show no significant differences in viability, indicating the specific role of NaCl supplementation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYBRID HETEROGENIC STRAINS&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"In hybrid heterogenic strains, loco mutants exhibit salt-resistance similar to their isogenic counterparts, excluding effects due to inbreeding depression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOCO MUTANTS&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"In hybrid heterogenic strains, loco mutants exhibit salt-resistance similar to their isogenic counterparts, excluding effects due to inbreeding depression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;129S6 MOUSE STRAIN&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"The 129S6 mouse strain serves as a model for studying the regulation of NFATC1 gene expression under conditions of high salt intake and CKD."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RGS14 GENE&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"Renal mRNA levels of RGS14 are significantly reduced after exposure to a high-salt diet, indicating its role in kidney dysfunction under stress conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CKD MODEL&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"The procedure of sub-total nephrectomy induces chronic kidney disease in mice models, leading to alterations in renal mRNA expression of RGS14 and NFATC1 genes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUB-TOTAL NEPHRECTOMY&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"The procedure of sub-total nephrectomy induces chronic kidney disease in mice models, leading to alterations in renal mRNA expression of RGS14 and NFATC1 genes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAMPYLOBACTER INFECTIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A bacterial infection caused by Campylobacter species, commonly affecting gastrointestinal health."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE RESISTANCE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant resulting in resistance to quinolone antibiotics in Campylobacter strains."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;ERYTHROMYCIN RESISTANCE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant leading to resistance against erythromycin, an antibiotic used for bacterial infections."&lt;SEP&gt;"A specific genetic mutation leading to erythromycin resistance, observed primarily in C. coli isolates."&lt;SEP&gt;"Erythromycin resistance is a genomic variant present in some Campylobacter jejuni and C. coli isolates that confers resistance to the antibiotic erythromycin."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;TRAVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Foreign travel was associated with a higher prevalence of quinolone-resistant Campylobacter infections, indicating the influence of environment on disease susceptibility."&lt;SEP&gt;"Foreign travel was associated with a higher prevalence of quinolone-resistant Campylobacter isolates, highlighting the influence of environment on disease susceptibility."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;C. COLI AND C. JEJUNI INFECTIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Infections caused by two species of Campylobacter bacteria differing in their geographical origin and resistance patterns."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;DURATION OF ILLNESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The duration patients experience symptoms from a disease, which can vary based on the type of infection (quinolone-resistant vs. quinolone-sensitive)."&lt;SEP&gt;"The period during which a patient experiences symptoms from an infection, varying with the type of bacterial strain (quinolone-resistant vs. quinolone-sensitive)."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;C. JEJUNI AND C. COLI INFECTIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Infections caused by two species of Campylobacter bacteria differing in their geographical origin and resistance patterns."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern associated with increased risk of quinolone-resistant Campylobacter infections."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;SWIMMING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Engaging in swimming as an activity that increases the risk for quinolone-resistant C. jejuni infections."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;AGE GROUP&quot;">
      <data key="d0">"DEMOGRAPHIC FACTOR"</data>
      <data key="d1">"The age of patients affected by Campylobacter infections, with no significant difference found between younger and older groups (younger or older than 15 years) in terms of resistance patterns."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;FLUOROQUINOLONES&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A class of antibiotics that includes quinolone drugs used to treat bacterial infections."&lt;SEP&gt;"Fluoroquinolones are antibiotics used in the treatment of campylobacteriosis; however, resistance against fluoroquinolones was observed among some isolates."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;CASE-COMPARISON STUDY&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"A method to identify risk factors for specific types of infections by comparing cases with similar characteristics."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;CAMPYLOBACTER JEJUNI&quot;">
      <data key="d0">"GENE (INDIRECT)"</data>
      <data key="d1">"Campylobacter jejuni is a bacterial pathogen that can cause campylobacteriosis and may contain genes related to resistance against antimicrobial agents."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;NALIDIXIC ACID RESISTANCE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Nalidixic acid resistance is a genomic variant that confers resistance to the antibiotic nalidixic acid in Campylobacter jejuni isolates."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;FRESH POULTRY OTHER THAN CHICKEN AND TURKEY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of fresh poultry other than chicken and turkey was found to be associated with a higher likelihood of domestically acquired quinolone-resistant Campylobacter infections."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;MACROLIDES&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Macrolides represent another class of antibiotics used for treating campylobacteriosis, with a lower prevalence of resistance compared to fluoroquinolones."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CAMPYLOBACTERIOSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Campylobacteriosis is an infection caused by Campylobacter bacteria that can lead to gastroenteritis and may be treated with antimicrobial agents."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;C. COLI&quot;">
      <data key="d0">"GENE (INDIRECT)"</data>
      <data key="d1">"Campylobacter coli is a bacterial pathogen that can cause campylobacteriosis similar to Campylobacter jejuni."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;RETAIL FOOD PRODUCTS AND BROILER CHICKENS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Isolates from retail food products, including chicken, turkey, pork, and broiler chickens, were compared with human isolates for resistance patterns and origin analysis."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;GEOGRAPHIC AREA AND TIME PERIOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The geographic area and time period of both human and animal isolations are critical factors in comparing infection sources and origins."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;DOMESTICALLY ACQUIRED QUINOLONE-RESISTANT INFECTIONS&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Consumption of fresh poultry other than chicken and turkey is associated with a higher risk of domestically acquired quinolone-resistant Campylobacter infections."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9534511&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located on HTR2A gene that is significantly associated with social disinhibition."&lt;SEP&gt;"The minor allele for rs9534511 is associated with an increased risk of social disinhibition, with a parameter estimate of 0.32 (95% CI = 0.14â0.50, P &lt; 0.001)."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;HTR2A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Serotonin receptor 2A gene, which has a SNP (rs9534511) linked to an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS4938056&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located on HTR3B that is significantly associated with social disinhibition."&lt;SEP&gt;"The minor allele for rs4938056 is associated with an increased risk of social disinhibition."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;HTR3B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Serotonin receptor 3B gene, which has a SNP (rs4938056) linked to an increased risk of social disinhibition."&lt;SEP&gt;"Serotonin receptor 3B gene, which has an additional SNP (rs7514628) linked to an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1998220&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in the intronic region of OPRM1 gene that is significantly associated with social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;OPRM1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Opioid receptor mu 1 gene, which has an intronic SNP (rs1998220) linked to an increased risk of social disinhibition."&lt;SEP&gt;"Opioid receptor mu 1 gene, which has another intronic SNP (rs3025971) linked to an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1003921&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the intronic region of KCNC1 gene that is significantly associated with social disinhibition."&lt;SEP&gt;"The minor allele for rs1003921 is associated with a strong protective effect against social disinhibition, with a parameter estimate of â0.64 (95% CI = â1.13 to â0.15, P = 0.011)."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;KCNC1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Potassium voltage-gated channel subfamily C member 1, which has an intronic SNP (rs1003921) linked to an increased risk of social disinhibition."&lt;SEP&gt;"Potassium voltage-gated channel subfamily C member 1, which has another intronic SNP (rs12830955) linked to an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16116&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the intergenic region downstream of NPY that is significantly associated with social disinhibition."&lt;SEP&gt;"The minor allele for rs16116 is associated with a protective effect against social disinhibition, with a parameter estimate of â0.29 (95% CI = â0.48 to â0.09, P = 0.004)."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;NPY GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Neuropeptide Y gene, which has an intergenic SNP (rs16116) linked to an increased risk of social disinhibition."&lt;SEP&gt;"Neuropeptide Y gene, which has another intergenic SNP (rs16867458) linked to an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16870286&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP part of LINC00518 that is significantly associated with social disinhibition."&lt;SEP&gt;"The minor allele for rs16870286 is associated with a protective effect against social disinhibition."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;LINC00518 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Long intergenic non-protein coding RNA 518, which has a SNP (rs16870286) linked to an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure reflecting the extent to which youth deviate from social norms and engage in risky behaviors, influenced by demographic characteristics, psychosocial factors, and genetic variants."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;PARENTAL EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Level of education attained by parents is an environmental factor that influences social disinhibition but was not significantly associated in the final model."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;LINGUISTIC ACCULTURATION SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A score reflecting the degree to which youth are assimilated into a new cultural environment, positively correlated with higher levels of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;TAS AND DAS SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Transactional Assessment System (TAS) and Depressive Anhedonia Scale (DAS) scores were significantly associated with increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS3025971&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in the intronic region of OPRM1 gene that is significantly associated with social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16867458&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in the intergenic region downstream of NPY that is significantly associated with social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS12830955&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the intronic region of KCNC1 gene that is significantly associated with social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Social disinhibition is a condition or behavior trait that can be influenced by genetic factors such as specific SNPs."&lt;SEP&gt;"Social disinhibition is influenced by genetic factors such as specific SNPs."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;RS9534511 AND RS4938056&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"These SNPs are part of the group associated with an increased risk of social disinhibition, compared to protective effects shown by other SNPs."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS16116, RS16870286, AND RS1003921&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"These SNPs are associated with a protective effect against social disinhibition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION (PROTECTIVE)&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"These SNPs are associated with a protective effect against social disinhibition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1998220, RS9534511, AND RS4938056&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"These SNPs are associated with an increased risk of social disinhibition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION (RISK)&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"These SNPs are associated with an increased risk of social disinhibition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CNR1 gene codes for cannabinoid receptor 1, which is involved in modulating mesocorticolimbic neurocircuitry and is associated with drug-seeking behavior."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;RS2023239 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs2023239 is a genetic variant located upstream of exon 3 in the CNR1 gene, described as an alternative promoter that influences CB1 receptor levels and binding."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CB1 RECEPTOR BINDING LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The level of CB1 receptors in postmortem human prefrontal cortex (PFC) is influenced by genetic variation in the CNR1 gene, such as rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;MESOCORTICOLIMBIC NEUROCIRCUITRY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The mesocorticolimbic neurocircuitry involves brain regions modulated by CB1 receptor levels and activity that is linked to drug-seeking behavior, particularly in the context of alcohol addiction."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;NEUROIMAGING STUDY ON BRAIN ACTIVATION &quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A neuroimaging study investigates the differential activation of brain structures during exposure to alcohol cues in individuals with different genotypes at rs2023239, showing greater activation in NAcc, VMPFC, VTA, and OFC for CT genotype compared to TT genotype."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL USE DISORDER SCORE (AUDIT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The AUDIT score measures alcohol use disorder severity and correlates with brain activation in the ventromedial prefrontal cortex (VMPFC) in individuals with the CT genotype at rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;URGE TO CONSUME ALCOHOL (AUQ SCORE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The total AUQ score measures alcohol craving and correlates significantly with left and right orbitofrontal cortex activation in those with the CT genotype, indicating a link between genetic variation and subjective craving experiences."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;SHORT-TERM EFFECTS OF ALCOHOL ON REWARD SENSITIVITY &quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Individuals carrying the rs2023239 CT or CC genotypes report significantly greater reward sensitivity after consuming alcohol compared to those with TT genotype, based on repeated-measures ANOVA."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;TOBACCO SMOKING&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Smoking tobacco is a lifestyle factor that was considered in the study but did not show significant differences between genotypes at rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PAST-MONTH QUANTITY OF ALCOHOL USE &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The past-month quantity of alcohol use was measured using a 30-day timeline follow-back method and showed no significant difference between individuals with TT or CT/CC genotypes at rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;BREATH ALCOHOL LEVELS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Breath alcohol levels after consumption of three drinks did not differ significantly by genotype (TT vs CT/CC) in the study on short-term effects of alcohol on reward sensitivity."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;RS2023239 GENOMIC VARIANT - EXON REGION &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs2023239 is found in the region upstream of exon 3 of CNR1, which has been described as an alternative promoter."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;BRODMANN AREAS 9 AND 10 &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CB1 receptor binding levels influenced by rs2023239 are particularly relevant in Brodmann areas 9 and 10 of the prefrontal cortex, indicating localized effects on neural function."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;NUCLEUS ACCUMBENS (NACC) &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The NAcc is a brain region activated differentially between CT and TT genotypes during alcohol exposure, suggesting genetic modulation of reward processing."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;VENTRAL MIDBRAIN PREFRONTAL CORTEX (VMPFC) &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"VMPFC activation correlates with AUDIT scores in individuals carrying the rs2023239 CT genotype, linking genetic variation to brain function during alcohol craving."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;VENTRAL TEGMENTAL AREA (VTA) &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"VTA is one of the regions showing differential activation between TT and CT genotypes in response to alcohol exposure, indicating its role in reward processing mediated by CNR1 gene variation."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ORBITOFRONTAL CORTEX (OFC) &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Activation in both left and right OFC correlates with AUQ scores in individuals carrying the rs2023239 CT genotype, linking genetic influence to alcohol craving."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUDIT SCORE &quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"The AUDIT score measures alcohol use disorder severity and is used as an indicator of behavioral impact of CNR1 gene variation."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUQ SCORE &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total AUQ score measures the subjective urge to consume alcohol, which correlates with brain activation patterns in specific regions like OFC in individuals carrying CT genotype at rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;RS2023239&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the CNR1 gene identified by its rs number, linked to differential responses to alcohol consumption and olanzapine treatment."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CNR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CNR1 gene is involved in cannabinoid signaling that influences reward pathways and may interact with genotypes and medications such as olanzapine."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;OLANZAPINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An antipsychotic medication that targets the dopamine system, used to treat mental health conditions and studied for its interaction with CNR1 gene variations."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used as an active control in studies examining interactions between genotypes and medications on alcohol consumption responses."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;PLACEBO TREATMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A treatment condition used in clinical trials where participants are given a substance with no active pharmacological effect to assess the efficacy of an intervention, such as olanzapine, on cue-elicited craving and drinking behavior."&lt;SEP&gt;"Used as a comparison in assessing colesevelam's differential effects on AC t1/2, GC24, and CT."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070&lt;SEP&gt;chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;ACTIVE CONTROL MEDICATION (CYPROHEPTADINE)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A medication used in studies as a comparison against olanzapine for its effects on alcohol consumption and reward pathways in individuals with specific CNR1 genotypes."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;DOPAMINE SYSTEM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A neural system involved in regulating reward, motivation, and motor functions; targeted by medications like olanzapine which can interact with genetic factors such as CNR1 variations."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CUE-ELICITED DRINKING BEHAVIOR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Behavioral responses to environmental cues that trigger alcohol consumption, influenced by genotypes and medication treatments."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CB1 RECEPTOR BINDING LEVELS &quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"CNR1 gene variants like rs2023239 affect mesocorticolimbic neurocircuitry by altering CB1 receptor levels, influencing drug-seeking behavior."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MESOCORTICOLIMBIC NEUROCIRCUITRY &quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"CNR1 gene variants like rs2023239 affect mesocorticolimbic neurocircuitry by altering CB1 receptor levels, influencing drug-seeking behavior."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOBACCO SMOKING &quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"Both tobacco smoking and past-month quantity of alcohol use were considered as factors in the study but showed no significant differences related to genotypes at rs2023239, suggesting no confounding effects."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1 GENE &quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"The genetic variant rs2023239 is located upstream of exon 3 in the CNR1 gene, suggesting its role as an alternative promoter affecting CB1 receptor expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REWARD&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"Individuals with the CT genotype report significantly greater reward from drinking alcoholic beverages compared to other genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELF-REPORTED HIGH&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"The drug olanzapine interacts with self-reported high measures, showing different effects based on participant genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CUE-ELICITED CRAVING&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"Individuals receiving placebo treatment showed increased cue-elicited craving compared to those treated with olanzapine in the context of specific CNR1 genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LPL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LPL gene encodes for lipoprotein lipase (LPL), an enzyme crucial in lipid metabolism by catalyzing the hydrolysis of triglycerides in chylomicrons and very-low-density lipoproteins (VLDL). Mutations in this gene can lead to severe hypertriglyceridemia."&lt;SEP&gt;"The LPL gene is involved in lipid metabolism, specifically the hydrolysis of chylomicrons."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPOPROTEIN LIPASE (LPL)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LPL is a protein responsible for the hydrolysis of chylomicrons and other lipids."&lt;SEP&gt;"LPL protein plays a critical role in lipid metabolism through hydrolysis of chylomicrons."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;DIETARY FAT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary fat is packaged into chylomicrons and undergoes processing by LPL for further metabolism."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MEDIUM-CHAIN TRIGLYCERIDES (MCT)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"MCTs are a form of dietary fat that does not require LPL activity for metabolism."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;CHYLOMICRONS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Chylomicrons are lipoprotein particles synthesized in the small intestine to transport dietary triglycerides."&lt;SEP&gt;"Large lipoprotein particles secreted into the blood from the intestine after a meal rich in fats, which transport dietary triglycerides to adipose and muscle tissues for storage or energy use."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPEMIA RETINALIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A clinical feature associated with LPL deficiency, characterized by lipid deposition in the eye due to high levels of blood triglycerides."&lt;SEP&gt;"A condition where retinal veins appear white due to lipoprotein particles in the blood leading to fat deposition and vessel occlusion, typically observed at triglyceride levels over 2500 mg/dl."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ERUPTIVE XANTHOMAS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An acute skin eruption consisting of small yellow papules typically appearing on shoulders, buttocks and limbs due to high levels of triglycerides (TG) exceeding 2000 mg/dl."&lt;SEP&gt;"Yellow papules on skin caused by cholesterol-rich deposits under the epidermis, a symptom of hypertriglyceridemia."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GPIHBP1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A molecule responsible for transporting LPL to capillary lumen for lipid metabolism."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition characterized by abnormally high levels of triglycerides in the blood, often resulting from genetic mutations like those found in the LPL gene."&lt;SEP&gt;"An abnormal elevation of triglycerides in the blood, often seen in patients with LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LPL DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A rare autosomal recessive disorder caused by mutations in the LPL gene leading to decreased lipoprotein lipase activity."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PUERTO RICAN DESCENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental or genetic factor influencing disease prevalence, specifically noted for this case study patient."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;CHYLOMICRON HYDROLYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which lipoprotein lipase (LPL) breaks down chylomicrons into free fatty acids and monoglycerides."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;FASTING LIPID PROFILE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A test measuring levels of various lipids in the blood after a period without food, used to diagnose lipid metabolism disorders such as LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ENFAPORT LIPIL FORMULA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Special dietary formula with high MCT content designed for patients with certain metabolic conditions."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MEDIUM-CHAIN TRIGLYCERIDES (MCT) FAT CONTENT IN ENFAPORT LIPIL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A component of the diet tailored to avoid lipoprotein lipase activity and manage hypertriglyceridemia effectively."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HOMOZYGOUS LPL DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Condition where both copies of the LPL gene are mutated, leading to severe lipid metabolism impairment."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS LPL DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A less severe but still debilitating form of LPL deficiency where two different mutations in one allele cause disease symptoms."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MUTATION P.G215E (C.644G&gt;A)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Reported mutation in the LPL gene leading to a substitution of glycine to glutamic acid at position 215, causing functional impairment."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MUTATION P.Q240H (C.721G&gt;T)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Novel mutation identified in exon 5 of the LPL gene, leading to a substitution of glutamine to histidine at position 240."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GENOMIC VARIANT: P.Q240H MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A novel genomic variant, specifically a missense mutation at position 240 changing glutamine (Q) to histidine (H), in the LPL gene identified in a patient presenting with severe hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPOPROTEIN LIPASE PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The lipoprotein lipase protein, encoded by the LPL gene, is essential for lipid metabolism by breaking down triglycerides into free fatty acids and monoacylglycerols."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HYPERVISCOSITY SYNDROME&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition caused by excessive thickening of bodily fluids due to high lipid content, often associated with elevated triglycerides leading to abdominal pain and gastrointestinal hemorrhage."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PANCREATITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammation of the pancreas commonly occurring in patients with LPL deficiency and hypertriglyceridemia, risk increases as triglyceride levels rise above 1000 mg/dl."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;MCT (MEDIUM CHAIN TRIGLYCERIDES) FAT SUPPLEMENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A dietary supplement containing medium-chain fatty acids that are directly absorbed into the portal vein and used for energy, useful in managing hypertriglyceridemia without compromising nutritional needs."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GEMFIBROZIL DRUG THERAPY&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An oral medication prescribed to reduce triglyceride levels by inhibiting lipoprotein synthesis and increasing HDL cholesterol levels, often used in combination with dietary fat restriction for patients with hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ORLISTAT DRUG THERAPY&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An oral medication used to inhibit pancreatic lipase, reducing the absorption of dietary fats and thus lowering triglyceride levels, often prescribed alongside dietary changes for patients with hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;INTRAMUSCULAR INTRODUCTION OF GAIN-OF-FUNCTION LPL VARIANT THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A therapeutic approach approved in Europe involving the introduction of a gain-of-function variant of the LPL gene through intramuscular injection, aimed at increasing lipase activity and lowering triglyceride levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DGAT1 INHIBITORS TREATMENT APPROACH&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"An investigational treatment targeting diacylglycerol O-acyltransferase 1 (DGAT1), an enzyme involved in lipid synthesis during fat absorption, aiming to lower triglyceride levels through oral administration."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;TRIGLYCERIDES (TG)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A type of lipid that is transported via lipoproteins in the bloodstream. Elevated levels can lead to various health issues such as pancreatitis and cardiovascular disease."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;VERY-LOW-DENSITY LIPOPROTEINS (VLDL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Particles synthesized by the liver containing triglycerides, cholesterol, and proteins. They are involved in transporting lipids from the liver to peripheral tissues where they can be broken down by LPL."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;P.Q240H MUTATION&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"The p.Q240H mutation alters the structure and function of the lipoprotein lipase protein, contributing to hypertriglyceridemia."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCT FAT SUPPLEMENT&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Medium-chain triglyceride supplements provide an alternative source of energy without increasing triglyceride levels in patients managing hypertriglyceridemia."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VLDL&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Elevated VLDL particles contribute significantly to hypertriglyceridemia due to insufficient breakdown by LPL in patients with LPL gene mutations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOPIRAMATE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Topiramate is a drug used to treat alcohol dependence, with efficacy and adverse event profiles varying by genotype."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs2832407 genotype moderates the effect of topiramate in European-American subgroups, influencing both treatment efficacy and adverse events."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;HDDS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Heavy drinking days (HDDs) are a measure used to assess alcohol dependence, with reduction indicating therapeutic efficacy."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ADVERSE EVENT SEVERITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The severity of adverse events experienced by patients treated with topiramate is influenced by both genotype and treatment group."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407*C-HOMOZYGOTES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2832407*C-homozygotes is a specific genotype associated with the rs2832407 genomic variant, showing significant differences in treatment response and adverse events when treated with topiramate."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A-allele carriers are individuals carrying the less responsive allele of rs2832407, showing minimal difference in treatment efficacy and adverse event severity compared to placebo."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ABCB1 RS1045642 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the ABCB1 gene at position rs1045642 has been associated with acute nausea severity."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CYP2D6 INTERMEDIATE OR EXTENSIVE METABOLIZER PHENOTYPE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The CYP2D6 intermediate or extensive metabolizer phenotype refers to the genetic variation influencing drug metabolism, particularly for anti-emetic medications."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS&quot;">
      <data key="d0">"THERAPEUTIC TREATMENT"</data>
      <data key="d1">"Chemotherapy regimens that are highly likely to cause severe nausea and vomiting in patients receiving cancer treatment."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Acute nausea reported by patients undergoing chemotherapy, with severity classified as CTCAE grade 2 or above."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DELAYED CINV (NAUSEA AND VOMITING)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by delayed onset of nausea and vomiting following the administration of anti-emetic medications post-chemotherapy treatment."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PALONOSETRON&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Prescribed anti-emetic medication used in the study to prevent chemotherapy-induced nausea and vomiting (CINV)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DEXAMETHASONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Anti-inflammatory steroid often prescribed alongside palonosetron for prophylaxis against CINV."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PROCHLORPERAZINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Additional anti-emetic medication commonly used in the treatment of acute and delayed nausea following chemotherapy."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ONDANSETRON&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Another common anti-nausea drug administered to patients undergoing chemotherapy."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;FOSAPREPITANT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A neurokinin-1 receptor antagonist used for the prevention of acute and delayed CINV."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HTR3B (RS45460698)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in the HTR3B gene, which was examined for its association with chemotherapy-induced nausea and vomiting."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HOURS OF SLEEP BEFORE CHEMOTHERAPY&quot;">
      <data key="d0">"PATIENT-REPORTED VARIABLE"</data>
      <data key="d1">"Amount of sleep reported by patients the night before undergoing chemotherapy treatment."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CYP2D6 ACTIVITY SCORE&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The CYP2D6 activity score reflects the functional activity of patients with intermediate or extensive metabolizer phenotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT-REPORTED SEVERITY OF ACUTE NAUSEA&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Less sleep before chemotherapy was associated with more severe acute nausea reported by patients."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HISTORY OF MORNING SICKNESS&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Patients with a history of morning sickness were more likely to report CTCAE grade 2 or above acute nausea."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The LCT transcript shows significant age-related reduction in lactase non-persistent individuals, but remains stable or slightly increases in persistent individuals."&lt;SEP&gt;"The steady-state level of LCT mRNA varies significantly across individuals and decreases with age, affecting lactase enzyme production."&lt;SEP&gt;"The transcript of the lactase gene (LCT) that is regulated by LOC100507600 lncRNA."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"Epigenetic modifications such as DNA methylation play a critical role in regulating the expression levels of the LCT gene over time and among individuals."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MCM6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MCM6 gene is involved in DNA replication and repair and has regulatory regions that are modified with age, influencing LCT activity."&lt;SEP&gt;"The MCM6 gene is located near the LCT gene and harbors variants that are associated with lactase persistence, influencing the DNA methylation patterns around the LCT gene."&lt;SEP&gt;"The MCM6 gene, located near the LCT gene, shows differential DNA modifications linked to lactose persistence or non-persistence."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;C/T-13910 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in MCM6 intron 13 at position -13910 that influences lactase persistence and non-persistence, affecting DNA modification density near the LCT gene."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTOSE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lactose is a sugar found primarily in milk and dairy products; its digestion depends on the activity of lactase produced by the LCT gene."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Dairy products are sources of dietary lactose, and their consumption is influenced by lactase persistence determined by genetic and epigenetic factors."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE/NON-PERSISTENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of lactase non-persistence involves a gradual decline in lactase production after infancy due to changes in DNA methylation patterns around the LCT gene."&lt;SEP&gt;"The physiological process where individuals may maintain (persistence) or lose (non-persistence) lactose digestion capability after weaning."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INTESTINAL EPITHELIAL CELLS (ENTEROCYTES)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Jejunum enterocytes are specialized intestinal cells that express the LCT gene and produce lactase to digest dietary lactose."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE ENZYME&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The enzyme responsible for breaking down lactose into glucose and galactose, synthesized from the LCT mRNA."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CHROMOSOME 2, 9, 19&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"These chromosomes contain genetic regions under investigation for their role in lactase persistence/non-persistence via DNA modification analysis."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CYTOSINES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The density of unmodified cytosine bases within specific genomic regions is inversely correlated with LCT mRNA levels, indicating a key molecular interaction in lactose digestion regulation."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MTAG-CLICK METHOD&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"A technique used to enrich the unmodified DNA fraction for chromosome-wide analysis of DNA modification patterns around genes such as LCT."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE GENE (LCT)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding lactase, essential for breaking down lactose in milk and dairy products, showing age-related decline in activity."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;POSTNATAL DAY 6 VS. 60&quot;">
      <data key="d0">"DEVELOPMENTAL STAGE"</data>
      <data key="d1">"Comparative stage used to study the decline of intestinal lactase activity from infancy to adulthood in mice models."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE/DISEASE NON-PERSISTENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A genetic condition characterized by varying levels of lactase expression in adulthood based on specific haplotypes at the LCT and MCM6 loci."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;CPG SITES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific DNA modification sites observed at 35 CpG locations within the LCT and MCM6 regions, indicating differential methylation patterns."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNA MODIFICATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Changes in DNA methylation levels that influence gene expression and cellular functions."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LCT EXON 1&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A region within the LCT gene that shows significant modification differences between white blood cells and intestinal tissues, indicating regulatory function."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;MCM6 INTRON 13-EXON 16 REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region in MCM6 where DNA modifications differ significantly based on genetic background, influencing lactase expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;HISTONE MARKS (H3K4ME1 AND H3K27AC)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Chromatin marks that indicate active enhancers or promoters in regions around LCT and MCM6 genes."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNA METHYLATION CHANGES WITH AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process where differential DNA methylation patterns develop over time, linked to lactase persistence or non-persistence."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LCT INTRON 5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region within intron 5 of LCT where significant DNA modification differences were observed."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LCT INTRON 3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region within intron 3 of LCT showing differential methylation patterns."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LCT INTRON 2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region within intron 2 of LCT with significant DNA modification differences."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LOC100507600 LNCRNA PROMOTER REGION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The promoter region for the long non-coding RNA LOC100507600 located in intron 5 of LCT."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;MCM6 EXON 17-3â² UTR&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A genomic region within exon 17 and 3â² untranslated region (3â²-UTR) of MCM6 with significant DNA modification differences linked to lactase expression regulation."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;WHITE BLOOD CELLS&quot;">
      <data key="d0">"TISSUE/SAMPLE TYPE"</data>
      <data key="d1">"Samples used for assessing the differential methylation patterns in LCT-MCM6 regions compared to intestinal tissues."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;ENTEROCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"The main cell type of interest for studying DNA modification profiles and their relation to lactase expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;ENTEROCYTE-DEFICIENT JEJUNUM&quot;">
      <data key="d0">"TISSUE/SAMPLE TYPE"</data>
      <data key="d1">"A tissue sample used in comparison with enterocytes to observe differential methylation patterns."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNA METHYLATION CHANGES ACROSS TISSUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differential DNA methylation observed across different tissues (white blood cells vs. intestinal tissues) linked to the regulation of LCT expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNASE I HYPERSENSITIVITY SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Sites within chromatin that are sensitive to DNase I, indicating active regulatory elements in LCT and MCM6 regions."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;H3K4ME1 AND H3K27AC ENHANCERS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Histone marks indicative of enhancer activity observed at specific genomic loci around LCT and MCM6 genes."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENCE (LNP)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by reduced lactase expression in adulthood, associated with certain genetic haplotypes at the LCT-MCM6 locus."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;C/T-13910 SNP RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific single nucleotide polymorphism within the MCM6 gene linked to lactase persistence or non-persistence conditions."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;G/A-22018 SNP RS182549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another single nucleotide polymorphism within the MCM6 gene that shows linkage with lactose persistence or non-persistence."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;INSERTION/DELETION IN LCT INTRON 1 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variation involving an insertion-deletion event located in intron 1 of the LCT gene, affecting mRNA levels."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;C-13910 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant (-13910) within the MCM6 gene associated with different DNA modification patterns across age groups and genotypes."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;HAPLOTYPES CONTAINING C-13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These haplotypes influence the level of DNA modifications and LCT activity across different age groups."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENCE (CC) INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Individuals with CC genotype at -13910 variant exhibit lactase non-persistence, characterized by a decrease in LCT mRNA levels with aging."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE (TT) INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Individuals with TT genotype at -13910 variant show persistence of lactase activity across age groups."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;AGE-RELATED DNA MODIFICATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which DNA modifications accumulate or decrease over time, influencing gene expression and enzyme activities such as LCT in enterocytes."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LCT INTRON 2 REGION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A highly conserved region within the LCT intron that is involved in regulatory functions across mammalian species."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LOC100507600 LNCRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"An antisense transcript of LOC100507600, which positively correlates with and modulates LCT mRNA levels."&lt;SEP&gt;"Long non-coding RNA that regulates LCT mRNA levels in Caco-2 cells."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;MCM6 EXON 16&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A part of the MCM6 transcript that shows significant differences in DNA modification between haplotypes containing C-13910 and T-13910."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LCT ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The enzymatic activity of lactase which is regulated by genetic and epigenetic factors, particularly showing differential patterns with aging in different genotypes."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;EPIGENETIC PROCESSES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Processes involving changes to DNA methylation or other modifications that do not alter the primary sequence but influence gene expression over time."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LCTâMCM6 REGULATORY ELEMENTS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Regulatory sequences within LCT and MCM6 genes involved in modulating lactase activity through epigenetic mechanisms, specifically DNA methylation patterns changing with age."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;EVOLUTIONARY CONSERVATION OF EPIGENETIC FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The extent to which the regulatory elements contributing to the downregulation of lactase expression are conserved across different mammalian species."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;CHROMATIN MARKS IN MICE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Specific chromatin marks (H3K27ac, H3K4me1) identified in adult mice that correlate with the regulation of Lct and Mcm6 genes."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LCT INTRON 8 REGION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A conserved region within LCT intron 8 showing significant age-related DNA modification changes, similar to those observed in human studies."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;INTRONIC CONSERVED ELEMENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Specific introns that are highly conserved across mammalian species and play a role in regulating lactase expression."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LNCRNA LOC100507600 REGULATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The regulation of LCT mRNA by the natural antisense lncRNA LOC100507600, which positively correlates with and modulates lactase enzyme expression."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;CACO-2 CELL LINE&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Human intestinal epithelial cell line Caco-2 used for studying lactase persistence and gene expression."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;SNP -13910 TT GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific single nucleotide polymorphism in the Caco-2 cell line, characterized by the presence of two thymine (T) alleles (-13910 position)."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;MCM6 MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the MCM6 gene, which remains unchanged upon silencing of LOC100507600 lncRNA in Caco-2 cells."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CTCF BINDING SITE&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"A protein binding site for CTCF (CCCTC-binding factor), a DNA-binding protein involved in chromosome architecture and regulation of gene expression."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;DNA METHYLATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"DNA methylation is an epigenetic modification that can influence the differential splicing and expression of genes such as CTLA4."&lt;SEP&gt;"The addition of methyl groups to DNA, which can affect the interaction between proteins like CTCF and their binding sites on DNA."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT PROMOTER ELEMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A regulatory sequence upstream of a gene that controls its transcription rate. In this case, it's part of an intron within the LCT gene in mice."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE&quot;">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"The genetic condition where individuals continue to express high levels of lactase into adulthood."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9 SYSTEM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A genome editing technology that uses a Cas9 protein guided by guide RNA to make precise edits in DNA sequences, used here to delete specific intronic regions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The product of LCT mRNA, which is the enzyme responsible for breaking down lactose into glucose and galactose."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;MCM6 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein encoded by the MCM6 gene, which influences the regulation of neighboring genes like LCT through its intronic regions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE GENE REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process governing the expression and activity levels of lactase enzymes throughout life, influenced by genetic variations and environmental factors."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ENHANCER ELEMENTS&quot;">
      <data key="d0">"GENETIC ELEMENT"</data>
      <data key="d1">"DNA sequences that increase the transcriptional activity of genes, often located in introns like those in LCT and MCM6."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTOSE DIGESTION CAPABILITY&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"Consumption patterns of dairy products can influence the digestive capability based on LCT gene expression levels and epigenetic modifications."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;LCT GENE REGULATION&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"Genomic regions within these chromosomes are critical for understanding the transcriptional regulation of the LCT gene across individuals with varying lactase persistence statuses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EPIGENETIC ANALYSIS&quot;">
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"This method enables comprehensive epigenetic analysis by enriching unmodified DNA fractions for detailed investigation of DNA modification changes around key genes like the LCT gene."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C/T-13910 SNP RS4988235 AND G/A-22018 SNP RS182549&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Genetic variations at these SNPs are strongly associated with lactase persistence or non-persistence conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at rs4988235 is associated with lactase persistence and influences milk consumption patterns."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE ALLELE (T)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The T allele of the rs4988235 variant is associated with lactase persistence in individuals, indicating an ability to digest lactose efficiently."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CC GENOTYPE AT RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the CC genotype at rs4988235 are less likely to consume milk due to lactase non-persistence, leading to difficulties in digesting milk products."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The pattern of milk consumption varies between individuals with different genotypes at the rs4988235 locus, particularly showing a lower rate among those with the CC genotype."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RENAL CELL CARCINOMA (RCC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Milk consumption is associated with an elevated risk of RCC compared to non-consumers, although the variant at rs4988235 does not influence this risk directly."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CZECH REPUBLIC&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The Czech Republic shows a notable association between milk consumption and an increased risk of renal cell carcinoma (RCC)."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;ROMANIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In Romania, there was no observed association between the genotype at rs4988235 and milk drinking habits."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;POLAND&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Minor allele frequency for rs4988235 in Poland is 0.40, showing a moderate influence on lactase persistence among the population."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RUSSIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In Russia, the minor allele frequency of rs4988235 is 0.35, reflecting intermediate frequencies within Eastern European populations."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;UK&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The UK shows a different pattern for the lactase persistence allele at rs4988235 compared to other regions, with the 'C' allele being more common (0.26 frequency)."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RCC&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"While individuals with the T allele of rs4988235 show normal milk consumption patterns, there was no observed direct influence on RCC risk compared to other factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BCL11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BCL11A gene is associated with baseline, MTD (Maximum Tolerated Dose), and delta HbF levels in patients treated with hydroxyurea."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS1427407&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1427407 is a SNP within the BCL11A gene that correlates with higher baseline, MTD, and delta HbF levels after hydroxyurea treatment."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS4671393&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4671393 is another SNP in the BCL11A gene that shows association with increased baseline, MTD, and delta HbF values following hydroxyurea treatment."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS11886868&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs11886868 is a SNP in the BCL11A gene that approaches statistical significance for an association with baseline HbF levels and is significantly associated with MTD and delta HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HMIP-2 (OR HBS1L-MYB) &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HMIP-2 gene harbors SNPs rs9399137 and rs9402686, which are associated with increased baseline and MTD HbF levels but not delta HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS9399137&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in HMIP-2 is associated with higher baseline and MTD HbF values, but loses significance when corrected for baseline HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS9402686 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant within HMIP-2 that also shows an association with increased baseline and MTD HbF levels after hydroxyurea treatment."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HYDROXYUREA (HU)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An antineoplastic drug used in the study for its hematological benefits, particularly increasing HbF levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HEMOGLOBIN F (HBF)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of elevated hemoglobin F levels as a response to hydroxyurea treatment, which has therapeutic implications."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;ANC (ABSOLUTE NEUTROPHIL COUNT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The absolute neutrophil count is a hematological parameter measured before and after hydroxyurea treatment to assess its impact on blood cell counts."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;SEX&quot;">
      <data key="d0">"PHYSIOLOGICAL FACTOR"</data>
      <data key="d1">"Gender, used as a covariate in the regression models for baseline HbF levels, MTD HbF, and delta HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;AGE AT START OF HU TREATMENT (AGE)&quot;">
      <data key="d0">"PHYSIOLOGICAL FACTOR"</data>
      <data key="d1">"The age of patients when they started hydroxyurea treatment, used as a covariate in regression models to correct for baseline and post-treatment HbF levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HAPLOTYPES &quot;">
      <data key="d0">"GENOMIC FEATURE"</data>
      <data key="d1">"Combinations of alleles at different loci that are inherited together on the same chromosome, analyzed for their association with HbF levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HMIP-2 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific single nucleotide polymorphism (SNP) in the HMIP-2 region."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;C-A HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A haplotype consisting of a C to A substitution, which was associated with MTD HbF levels before correction for baseline HbF."&lt;SEP&gt;"A rare haplotype combination in CD subjects, associated with MAPbacteremia presence but not as strongly linked compared to the C-G haplotype."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;MTD HBF&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"MTD HbF refers to the physiological process or level of fetal hemoglobin (HbF) in mature blood cells, often used as a measure in medical studies related to conditions like sickle cell disease."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;BASELINE HBF&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The baseline level of fetal hemoglobin (HbF), serving as a reference point for assessing changes or associations with other genomic variants or haplotypes."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;DELTA HBF&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Delta HbF refers to the change in levels of fetal hemoglobin (HbF) from baseline, used to measure responses or effects over time or due to genetic factors."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;RS11886868 &quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"The BCL11A gene includes rs11886868 SNP that shows association with MTD and delta HbF levels but not baseline."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HMIP-2 (OR HBS1L-MYB)&quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"The HMIP-2 gene contains rs9399137 SNP, which is linked to increased baseline and MTD HbF levels post-HU treatment."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9399137 &quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"The HMIP-2 gene contains rs9399137 SNP, which is linked to increased baseline and MTD HbF levels post-HU treatment."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGRESSION MODELS &quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"The age when patients begin hydroxyurea treatment is used as a covariate in regression models to correct for baseline and post-treatment hemoglobin F (HbF) levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEASURED PARAMETERS &quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"Absolute neutrophil count is one of the hematological parameters measured before or after hydroxyurea treatment to assess its impact on blood cell counts, though no correlations were found with these SNPs."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BCL11A &quot;">
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d1">"The BCL11A gene contains haplotypes that influence baseline and MTD HbF levels in patients treated with hydroxyurea, particularly the G-G-T reference haplotype vs. T-A-C variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCA GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FANCA gene is involved in the Fanconi anemia pathway, responsible for DNA repair and genomic stability."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;C.2574C&gt;G/P.SER858ARG MUTATION IN FANCA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific mutation in the FANCA gene that leads to a change from serine to arginine at position 858, previously identified in individuals with Fanconi anemia."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCD2 PROTEIN MONOUBIQUITINATION DEFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of monoubiquitination of FANCD2 protein is deficient in the subject's fibroblasts but normal in lymphoblastoid cells, indicating cellular heterogeneity."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCONI ANEMIA (FA) DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A rare genetic disorder characterized by bone marrow failure, genomic instability, and hypersensitivity to DNA crosslinking agents."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The UBE2T gene encodes for a protein that is essential in the Fanconi anemia pathway, particularly involved in ubiquitination of FANCD2."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS MUTATIONS IN UBE2T (G.202332626_202341295DEL AND G.202332626_202341295DUP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The subject has two mutations in the UBE2T gene: a paternal deletion resulting in loss of the start codon, and a maternal duplication causing a frameshift mutation."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A deficiency of the UBE2T protein is observed in fibroblast cells derived from the subject but not in lymphoblastoid cell lines, indicating somatic mosaicism."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;DNA CROSSLINKING AGENTS (DEB AND MMC)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Chemical agents that cause DNA crosslinks leading to chromosomal breakage; hypersensitivity of Fanconi anemia cells to these agents is a characteristic phenotype."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCI PROTEIN MONOUBIQUITINATION DEFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Similar to FANCD2, the monoubiquitination defect of FANCI protein in RA2627 fibroblasts indicates a disrupted Fanconi anemia pathway due to UBE2T deficiency."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;LYMPHOBLASTOID CELL LINE (LCL)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of cell line derived from lymphocytes, often used for genetic studies; in this case, it shows normal UBE2T levels and function compared to fibroblasts."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;RNA SEQUENCING (RNA-SEQ)&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"A high-throughput sequencing approach used to quantify gene expression profiles; RNA-seq was performed on RA2627 fibroblasts for transcriptome analysis."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;RT-QPCR ANALYSIS OF UBE2T TRANSCRIPT LEVELS&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Quantitative PCR method used to confirm the reduction in UBE2T transcript levels observed by RNA sequencing."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"UBE2T is a gene associated with Fanconi Anemia-T subtype."&lt;SEP&gt;"Ube2T is a protein that interacts specifically with the RING domain of human proteins, but not directly with URD according to experimental data."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;WILD TYPE UBE2T EXPRESSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Expression of wild type UBE2T in RA2627 fibroblasts rescued cellular hypersensitivity to crosslinking agents and restored monoubiquitination of FANCD2 and FANCI."&lt;SEP&gt;"Expression of wild type UBE2T in RA2627 fibroblasts rescued cellular hypersensitivity to crosslinking agents and restored physiological processes essential for DNA damage repair."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Monoubiquitination of FANCD2 is a physiological process essential for the repair of DNA crosslinking damage, which is restored by UBE2T expression in RA2627 cells."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCI MONOUBIQUITINATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Monoubiquitination of FANCI is a physiological process involved in the DNA repair mechanism, similar to that of FANCD2, and is also restored by UBE2T expression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCONI ANEMIA-T SUBTYPE (FA-T)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fanconi anemia subtype T results from deficiencies in the UBE2T gene, leading to defects in DNA repair processes."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;MMC (METHYL METHANESULFONATE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"MMC is a crosslinking agent that induces cellular hypersensitivity and triggers FANCD2 and FANCI monoubiquitination for DNA repair."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;DEB (DIEPOXYBUTANE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DEB is another crosslinking agent used in the study to induce cellular hypersensitivity, similar to MMC."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CISPLATIN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cisplatin is an environmental factor that causes DNA crosslinks and affects cell cycle distribution when introduced to cells with UBE2T deficiency."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RA2627 CELLS&quot;">
      <data key="d0">"PROTEIN (CELL LINE)"</data>
      <data key="d1">"RA2627 fibroblasts are a cellular model used in experiments to study the effects of wild type UBE2T expression on DNA repair processes."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;BJ CELLS&quot;">
      <data key="d0">"PROTEIN (CELL LINE)"</data>
      <data key="d1">"BJ cells serve as a control for normal cell lines, contrasting with RA2627 cells in experiments involving DNA repair and hypersensitivity to crosslinking agents."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS MUTATIONS IN UBE2T&quot;">
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d1">"The presence of compound heterozygous mutations leads to protein deficiency observed specifically in fibroblast cells, indicating tissue-specific expression or recombination."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR - DNA CROSSLINKING AGENTS (DEB AND MMC)&quot;">
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d1">"Individuals with Fanconi anemia are hypersensitive to DNA cross-linking agents like DEB and MMC, leading to chromosomal breakage."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UBE2T DEFICIENCY&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Deficiency of UBE2T leads to Fanconi anemia subtype T due to impaired DNA repair processes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION&quot;/&quot;FANCI MONOUBIQUITINATION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Overexpression of wild type UBE2T restores physiological processes essential for DNA damage repair."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MMC&quot;/&quot;DEB&quot;/&quot;CISPLATIN&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Crosslinking agents cause cellular hypersensitivity in RA2627 fibroblasts due to impaired DNA repair mechanisms when UBE2T is deficient."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RPS19 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPS19 is a gene associated with Diamond Blackfan Anemia (DBA) where mutations lead to defects in erythroid development."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MISSENSE MUTATION P.ARG62TRP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutation is one of the genetic variants affecting RPS19, leading to DBA symptoms."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MISSENSE MUTATION P.ARG101HIS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another missense mutation in the RPS19 gene that contributes to DBA pathology."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;FRAMESHIFT MUTATION C.58DELG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A frameshift mutation causing a loss of function effect and leading to reduced levels of the RPS19 protein due to NMD activation."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;SPLICE SITE MUTATION C.1-1G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutation affects the intron 1 acceptor splice site, resulting in exon 2 skipping and reducing functional transcripts."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS TRANSCRIPTOME&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcriptome of dermal fibroblasts isolated from DBA patients with RPS19 mutations is altered compared to healthy individuals."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DBA PATIENTS GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes that are differentially expressed in DBA patients, implicating pathways like aminoacyl-tRNA biosynthesis and glycine metabolism."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;INGENUITY PATHWAYS ANALYSIS (IPA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"IPA is used to analyze the dataset of genes differentially expressed in DBA patients relative to controls for pathway enrichment and biological function clustering."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AMINOACYL-TRNA BIOSYNTHESIS PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This metabolic pathway is significantly enriched among differentially expressed genes in DBA, involving enzymes like LARS, WARS, GARS, SARS, QARS, EPRS."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;GLYCINE SERINE AND THREONINE METABOLISM PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Genes involved in this pathway are differentially expressed in DBA patients indicating metabolic dysregulation."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DEATH RECEPTOR SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Enrichment of genes related to death receptor signaling suggests a role in cell death regulation in DBA pathology."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This pathway is enriched among differentially expressed genes, indicating potential immune dysregulation due to RPS19 mutations."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RAR ACTIVATION PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Enrichment of this pathway suggests roles in cellular signaling and transcriptional regulation affected by DBA-associated gene expression changes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PROTEIN SYNTHESIS GENES (RP GENES)&quot;">
      <data key="d0">"GENE CLUSTER"</data>
      <data key="d1">"RP genes are significantly enriched among differentially expressed genes, implicating a role in protein synthesis dysregulation in DBA."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;CELL DEATH REGULATION GENES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genes involved in cell death regulation are found to be altered in DBA patients according to IPA analysis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;LIPID METABOLISM GENES&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Enrichment of genes involved in lipid metabolism indicates dysregulation in this pathway among differentially expressed genes in DBA."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MOLECULAR TRANSPORT GENES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genes related to molecular transport are enriched, suggesting a role in cellular function alteration due to RPS19 mutations."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RP GENES CLUSTER (RPL22, RPL27A, RPL29, ETC.)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This cluster includes multiple ribosomal protein genes that are involved in various cellular processes such as lipid metabolism and molecular transport."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CELL DEATH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cell death refers to the process by which a cell ends its life cycle. It is regulated by specific biochemical pathways involving proteins and other molecules."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;LIPID METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This pathway involves the synthesis, breakdown, and transport of lipids in cells and tissues."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The movement of molecules across cellular membranes is essential for maintaining cell function."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;AMPD3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene encodes the adenosine monophosphate-activated phosphatase 3, involved in metabolic regulation and energy homeostasis."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CCND2 (CYCLIN D2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in cell cycle regulation, its overexpression is associated with cancer progression."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SOD2 (SUPEROXIDE DISMUTASE 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding a mitochondrial enzyme that dismutates superoxide radicals into hydrogen peroxide and molecular oxygen."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;TNFAIP3 (TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN 3)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene is involved in regulating the inflammatory response and plays a role in cancer and autoimmune diseases."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;COMP (CARTILAGE OLIGOMERIC MATRIX PROTEIN)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding a protein that is abundant in cartilage and bone tissues, playing a crucial role in tissue development and homeostasis."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;WARS (TRYPTOPHANYL-TRNA SYNTHETASE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Encodes an enzyme involved in protein synthesis by activating tryptophan for incorporation into proteins."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;ZIC1 (ZIC FAMILY MEMBER 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene coding for a zinc finger transcription factor that is important in embryonic development and neural tube formation."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CELLULAR DEVELOPMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This refers to the process by which cells develop into specialized cell types through differentiation."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;HAEMATOLOGICAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A category of diseases affecting blood, bone marrow, and lymph nodes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;IMMUNOLOGICAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Disorders related to the immune system's malfunction or abnormal response."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RENAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Conditions that affect kidney function."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A range of diseases affecting bones and joints."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;EMBRYONIC DEVELOPMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which an embryo forms during early development."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CONNECTIVE TISSUE FUNCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Processes involved in the formation, maintenance, and function of connective tissues such as bone and cartilage."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CELL CYCLE REGULATION&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"CCND2 is involved in cell cycle regulation, particularly in promoting progression from G1 to S phase."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"TNFAIP3 regulates inflammatory responses by controlling the NF-kappaB pathway."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTIOXIDANT DEFENSE&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"SOD2 plays a critical role in antioxidant defense mechanisms, protecting cells from oxidative damage."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN SYNTHESIS&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"WARS is involved in the process of protein synthesis by activating tryptophan for incorporation into proteins."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEURAL TUBE FORMATION&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"ZIC1 plays a critical role in neural tube formation during embryonic development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BDNF GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BDNF gene is associated with the polymorphisms rs6265 and rs2049046, influencing susceptibility to migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS6265 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant of the BDNF gene (G/A) that has been studied for its association with migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS2049046 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genetic variant of the BDNF gene (A/T) associated with migraine susceptibility."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;MIGRAINE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chronic neurological disease characterized by severe headaches, often accompanied by nausea and sensitivity to light/sound."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;CAUCASIAN POPULATION GROUPS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Five different Caucasian population groups were included in the studies, two of which came from Australian-based independent cohorts."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;BDNF RS6265 (G/A)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic polymorphism within the BDNF gene that was analyzed for its association with migraine susceptibility."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;BDNF RS2049046 (A/T)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genetic variant in the BDNF gene assessed for its link to migraines."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;NOS SCORE&quot;">
      <data key="d0">"QUALITY METRIC"</data>
      <data key="d1">"A scoring system used to evaluate the quality of studies included in a meta-analysis, with scores above 6 indicating good quality."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;STUDY QUALITY ASSESSMENT&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"The NOS score is used to evaluate the quality of studies included in the meta-analysis, ensuring high-quality results."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease condition characterized by psoriasiform reactions developing after treatment with adalimumab in patients suffering from severe hidradenitis suppurativa (HS)."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ADALIMUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An anti-TNF-Î± biological therapy used to treat chronic inflammatory conditions, such as HS. Paradoxical psoriasis can develop following treatment with adalimumab."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HIDRADENITIS SUPPURATIVA (HS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic skin disease characterized by inflammation and scarring within hair follicles and sweat glands."&lt;SEP&gt;"A severe disease characterized by painful nodules, abscesses, and tunnels in the armpits, groin, and buttocks. HS patients treated with anti-TNF-Î± drugs such as adalimumab may develop paradoxical psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PSORIASIFORM DERMATITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A dermatological condition that mimics psoriasis and can occur as a side effect of TNF inhibitors in patients with HS. It involves erythematous, pustular, and scaly lesions."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;IL-17A, IFN-Î, IL-22, IL-36Î&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Cytokines involved in the immune response and inflammation. They play significant roles in various inflammatory conditions including paradoxical psoriasis, where their expression levels differ from those seen in classical psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;BDCA2+ PDCS, CD15+ NEUTROPHILS, C-KIT/CD117+ MAST CELLS, CD68+ MACROPHAGES AND MONOCYTES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Immune cell populations that are significantly increased in paradoxical psoriasis compared to classical psoriasis, playing a crucial role in the inflammatory response."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;EPIDERMAL HYPERPLASIA WITH PARAKERATOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Histological changes observed in skin lesions of patients experiencing paradoxical psoriasis following anti-TNF-Î± treatment. This condition is characterized by thickened epidermis and retention of nuclei in the stratum corneum."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;INNATE IMMUNITY CELLS INFILTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process where innate immunity cells, including neutrophils, mast cells, macrophages, and monocytes, infiltrate paradoxical psoriasiform lesions to a greater extent than in classical psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PATIENT 1&quot;">
      <data key="d0">"DISEASE CASE STUDY"</data>
      <data key="d1">"A 48-year-old Caucasian woman with severe HS who developed psoriasiform eruptions after adalimumab treatment."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PSORIASIFORM REACTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A psoriasiform reaction is a skin condition resembling psoriasis, characterized by erythematous plaques covered with silvery scales."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ECZEMATOUS REACTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An eczematous reaction refers to atopic dermatitis or other forms of dermatitis causing inflammation and irritation of the skin."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CD3+ CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD3+ cells are T lymphocytes expressing CD3 antigen that plays an essential role in the activation of T cells."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;PSORIASIFORM LESIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Psoriasiform lesions refer to skin lesions resembling psoriasis, often seen in other inflammatory dermatoses or as a reaction pattern to drugs or irritants."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CLASSICAL PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic inflammatory skin condition characterized by red, scaly patches on the body and scalp."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;PBMCS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Peripheral blood mononuclear cells (PBMCs) are a mixture of white blood cells including lymphocytes, monocytes, and dendritic cells."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HS PATIENTS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"HS patients refer to individuals suffering from hidradenitis suppurativa, a chronic inflammatory skin disease."&lt;SEP&gt;"Patients suffering from HS disease where specific SNPs in genes like CCHCR1 and IL23R were detected."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IFN-Î (INTERFERON BETA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Type I interferon beta is a cytokine that plays an important role in antiviral defense and immune regulation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;KERATINOCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Keratinocytes are the predominant cell type in the epidermis, responsible for forming a protective barrier against environmental factors."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IFN-Î (INTERFERON KAPPA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Type I interferon kappa is another keratinocyte-derived cytokine involved in immune response and inflammation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LL-37&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LL-37, also known as cathelicidin antimicrobial peptide (CAMP), is an important component of innate immunity in epithelial cells."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LT-Î (LYMPHOTOXIN ALPHA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A cytokine member of the tumor necrosis factor family involved in immune responses and lymphoid tissue development."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LT-Î (LYMPHOTOXIN BETA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Another cytokine from the TNF family, LT-Î² plays a role in immune regulation through interactions with lymphotoxins."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ANTI-TNF-Î THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment for inflammatory conditions using agents that block or reduce tumor necrosis factor alpha (TNF-Î±)."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ERAP1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Endoplasmic Reticulum Aminopeptidase 1 is involved in the processing of peptides presented by MHC class I molecules, and polymorphisms are associated with diseases like psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HLA-C REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Human leukocyte antigen C (HLA-C) region contains genes encoding proteins critical for immune recognition and regulation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNF-Î (TUMOR NECROSIS FACTOR ALPHA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Cytokine involved in systemic inflammation, regulating cell survival, proliferation, differentiation, and apoptosis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-17F (INTERLEUKIN 17F)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A member of the IL-17 cytokine family, implicated in immune response to various stimuli and conditions such as psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-17RA (INTERLEUKIN 17 RECEPTOR A)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Cell surface receptor for interleukins involved in mediating responses against fungi and bacteria."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-23R (INTERLEUKIN 23 RECEPTOR)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Receptor for the cytokine IL-23, part of signaling pathways involved in immune regulation and inflammatory diseases such as psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-12B (INTERLEUKIN 12 SUBUNIT BETA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Subunit of interleukin-12, a cytokine important for innate and adaptive immunity responses."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;NFKBIZ GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Inhibitor of kappa B kinase epsilon (IÎºBÎ¶) gene involved in NF-ÎºB signaling pathway regulation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNFAIP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tumor necrosis factor alpha-induced protein, encoding A20, a negative regulator of inflammatory responses."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CDSN GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Corneodesmosin gene, involved in epidermal cell adhesion and integrity."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CCHCR1 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Cockayne syndrome C helicase and RNAse D homolog 1, associated with skin barrier function."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HLA-CW6 ALLELE&quot;">
      <data key="d0">"GENETIC MARKER"</data>
      <data key="d1">"Human leukocyte antigen Cw6 is an allele of HLA-C associated with increased susceptibility to autoimmune diseases like psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS30187/RS30186/RS26653 (ERAP1 SNPS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms in the ERAP1 gene, contributing to genetic variation and disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS9264942/RS10484554/RS2524095/RS28383849/RS9264944/RS147538049/RS9264946 (HLA-C SNPS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Various single nucleotide polymorphisms in the HLA-C region linked to increased risk for psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS11209026 (IL23R SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism in IL23R gene previously associated with paradoxical reactions to anti-TNF therapies."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;EPITHELIAL BARRIER INTEGRITY PROTECTIONS&quot;">
      <data key="d0">"BIOLOGICAL FUNCTION"</data>
      <data key="d1">"Functions of various proteins that help maintain the integrity and protective capabilities of epithelial layers against pathogens and inflammation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HLA-C GENOMIC REGION VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms within the HLA-C genomic region, linked to psoriasis susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;NFKBIZ GENE VARIANTS (RS3217713)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in NFKBIZ gene affecting IÎºBÎ¶ protein involved in NF-ÎºB signaling pathway regulation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNFAIP GENE VARIANTS (RS610604)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms in TNFAIP gene, associated with A20 protein that regulates inflammatory responses."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CDSN GENE VARIANTS (RS1062470/RS707913)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms in CDSN gene associated with psoriasis and skin barrier integrity."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CCHCR1 GENE VARIANTS (RS1576/RS130079/RS746647)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants of the CCHCR1 gene, possibly influencing skin barrier function and disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISM ANALYSIS OF HIDRADENITIS SUPPURATIVA PARADOXICAL REACTIONS&quot;">
      <data key="d0">"RESEARCH METHODOLOGY"</data>
      <data key="d1">"The investigation into genetic variations, such as SNPs and other genomic alterations, contributing to the development of paradoxical reactions in hidradenitis suppurativa patients treated with biologic agents."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS17192540 (HLA-CW6 SNP POSITION)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific position on chromosome associated with HLA-Cw6 allele, linked to increased susceptibility for autoimmune conditions."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;SECOND HLA-C VARIANTS REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Different genomic regions containing variants of HLA-C genes that could contribute to disease predisposition."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS707913 CCHCR1 SNP IN PATIENT 3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide variation observed within the CCHCR1 gene, potentially linked to skin barrier integrity and disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS280519 SHARED BETWEEN PATIENTS 1 AND 3 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Common genetic variant shared between two patients with paradoxical reactions after anti-TNF therapy."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS6869870 (CDSN SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the CDSN gene, associated with skin barrier function and psoriasis susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS20541 (IL23R SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism in interleukin 23 receptor gene linked to inflammatory diseases such as psoriasis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS6978583 (NFKBIZ SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the NFKBIZ gene, associated with NF-ÎºB signaling pathway regulation and disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS10484562 (HLA-C SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism in HLA-C region linked to psoriasis risk."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS2097370 (CCHCR1 SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the CCHCR1 gene, possibly influencing skin barrier function and disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS6865241 (TNFAIP SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism in TNFAIP gene associated with inflammatory responses regulation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS907717 (ERAP1 SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the ERAP1 gene, contributing to genetic variation and disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS6432587 (CDSN SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism in CDSN gene linked to skin barrier integrity and psoriasis risk."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS10924937 (IL23R SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the IL-23 receptor gene, associated with inflammatory disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS6871574 (TNFAIP SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism in TNFAIP gene affecting A20 protein regulation of inflammation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS10936144 (HLA-C SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the HLA-C region linked to psoriasis risk and disease progression."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;RS7528684 (NFKBIZ SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphism in NFKBIZ gene, associated with NF-ÎºB signaling pathway regulation and inflammatory response modulation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CCHCR1 (RS1576)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP variant in the CCHCR1 gene identified by rs1576."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;CCHCR1 (RS130079)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP variant in the CCHCR1 gene identified by rs130079."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;CCHCR1 (RS746647)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP variant in the CCHCR1 gene identified by rs746647."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R (RS11209026)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP variant in the IL23R gene previously associated with paradoxical psoriasiform reactions to antiâTNFs, but not found in HS patients."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R (RS72676067)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant detected in patient 2."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R (RS1004819)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant detected in patient 1."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIFORM REACTIONS TO ANTIâTNFS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by paradoxical psoriasiform reactions that may occur with anti-TNF treatments, previously associated with the IL23R (rs11209026) SNP."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS1576&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant within the CCHCR1 gene."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS130079&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant within the CCHCR1 gene."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS746647&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant within the CCHCR1 gene."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene where multiple SNPs have been identified and are associated with paradoxical psoriasiform reactions to anti-TNFs."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS11209026&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant in the IL23R gene previously associated with paradoxical psoriasiform reactions to anti-TNF treatments."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS72676067&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant detected in patient 2."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS1004819&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP variant detected in patient 1."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIFORM REACTIONS TO ANTIâTNFS &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by paradoxical psoriasiform reactions that may occur with anti-TNF treatments, previously associated with the IL23R (rs11209026) SNP."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;HS PATIENTS &quot;">
      <data key="d0">"PATIENT GROUP"</data>
      <data key="d1">"Patients suffering from HS disease where specific SNPs in genes like CCHCR1 and IL23R were detected."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;DISEASE, PARADOXICAL PSORIASIFORM REACTIONS TO ANTIâTNFS &quot;">
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d1">"The SNP IL23R (rs11209026) has been previously associated with paradoxical psoriasiform reactions to anti-TNF treatments."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FANCL gene encodes a protein that is involved in DNA repair pathways."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The human FANCL central domain, also known as the UBC-RWD domain or URD, has a unique structure compared to its Drosophila counterpart and contains an intermediary position between E2 fold with Î²-flap in the catalytic position and Î±-helix in non-catalytic RWD-like folds."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DRWD DOMAIN STRUCTURE (DMFANCL)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The DRWD domain structure of Drosophila melanogaster is a structural homologue to human FANCL central domain but with differences in secondary structures and conserved residues, particularly in the N-terminal lobe."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;E2 UBC ENZYME STRUCTURE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The E2 Ubiquitin-Conjugating Enzymes are structurally similar to both lobes of the human FANCL central domain but more so with the C-terminal lobe containing a significant RWD fold hit."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CYSTEINE IN URD N-TERMINAL LOBE (URD)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A cysteine residue located within the Î²-element of the human FANCL central domain's N-terminal lobe, although structurally positioned similarly to a catalytic cysteine of E2 enzymes like Ube2T, does not form thioester bonds with ubiquitin as observed in typical E2 enzymes."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;THIOESTER CHARGE ASSAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A biochemical test used to determine the ability of the URD cysteine residue to form a covalent bond via thioester linkage with activated C terminus of ubiquitin, showing that the URD is unable to do so."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HYDROPHOBIC CORE BETWEEN LOBES OF HUMAN FANCL CENTRAL DOMAIN AND DMDRWD DOMAINS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The hydrophobic core formed between the N-terminal and C-terminal lobes in human FANCL central domain, though not entirely conserved with residues in the same position for interaction being different between vertebrate and invertebrate FANCLs, maintains a highly conserved region contributing to structural stability."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The surface conservation between human URD and Drosophila DRWD is approximately 32%, with the C-terminal lobe being more conserved than the N-terminal lobe at 20% versus 12% respectively."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCHES ON HUMAN FANCL CENTRAL DOMAIN (URD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The human URD exhibits additional surface hydrophobic residues compared to DmDRWD, including a patch on the N-terminal lobe and another near Î±-helix 1, possibly contributing to differential interactions required in vertebrate systems."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;VERTEBRATE FANCLS FEATURE (ELEMENT SWAP)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A vertebrate-specific feature of FANCL proteins where an element swap occurs, placing the N-terminal lobe in a position intermediary between E2 fold with Î²-flap and Î±-helix in non-catalytic RWD-like folds."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;UBE2T CATALYTIC CYSTEINE RESIDUE (UBIQUITIN-CONJUGATING ENZYME)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The catalytic cysteine residue of Ube2T, an E2 ubiquitin-conjugating enzyme, which forms a thioester bond with ubiquitin."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CATALYTIC CYSTEINE IN URD N-TERMINAL LOBE (URD)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A cysteine residue within the Î²-element of human FANCL central domainâs N-terminal lobe, located structurally similar to Ube2T's catalytic cysteine but unable to form a thioester bond with ubiquitin."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;INTERACTION RESIDUES BETWEEN LOBES (HUMAN URD VS DMDRWD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific residues interacting between the N- and C-terminal lobes of human FANCL central domain (URD) compared to Drosophila DRWD, not entirely conserved but showing high conservation in hydrophobic core regions."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;SURFACE CONSERVATION COMPARISON DETAILS (URD VS DMDRWD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Detailed surface conservation analysis comparing human URD and Drosophila DRWD domains reveals differences in surface exposure and hydrophobic patches, indicative of potential differential interaction requirements in vertebrate systems."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HYDROPHOBIC EXPOSURE PATCHES (URD N-TERMINAL LOBE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Additional hydrophobic residues on the human URDâs N-terminal lobe compared to DmDRWD, suggesting possible unique surface features contributing to interaction specificity in vertebrates."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CONSERVATION OF FANCL PROTEINS (VERTEBRATE VS INVERTEBRATE)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Comparative conservation analysis showing vertebrate-specific elements and differences between vertebrate and invertebrate FANCL proteins, highlighting evolutionary adaptations."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;URD&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The URD is a protein domain involved in interactions with other proteins such as Ube2T and FANCI/FANCD2."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;RING DOMAIN&quot;">
      <data key="d0">"PROTEIN PART"</data>
      <data key="d1">"The RING domain binds Ube2T and plays a role in substrate binding via hydrophobic patches on its surface."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FANCI&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein involved in DNA repair and maintenance, specifically part of the Fanconi anemia pathway."&lt;SEP&gt;"FANCI is one of the substrates that interact with URD through specific hydrophobic patches."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCD2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein involved in DNA repair and maintenance, particularly in the Fanconi anemia pathway, which interacts with FANCI."&lt;SEP&gt;"FANCD2 is another substrate that interacts with URD via exposed hydrophobic patches on its surface."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCHES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"Hydrophobic patches on the URD are crucial for binding to FANCI and FANCD2, as observed in mutagenesis experiments."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;DMDRWD&quot;">
      <data key="d0">"PROTEIN PART"</data>
      <data key="d1">"The DmDRWD is a part of the protein FANCL in Drosophila, which has conserved regions similar to human URD."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;Î-HELIX 1 AND LARGE KINKED HELIX PATCH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"This patch lies between Î±-helix 1 and the N-terminal region of the large kinked helix, corresponding to residues Leu-121, Ala-140, Ile-184, Tyr-187, and Leu-191."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;Î-MEANDER PATCH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"A patch resides on the URD between the last Î²-strand of the four-stranded Î²-meander (Î²4) and the Î²-element corresponding to residues Leu-149, Tyr-165, Phe-166, and Val-167."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;HYDROPHOBIC GROOVE ON C-TERMINAL DOMAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"A hydrophobic groove exists between the last Î²-strand of the four-stranded Î²-meander and Î±-helix 3 that follows, corresponding to residues Ile-243, Met-246, Leu-248, Leu-264, Leu-268, and Trp-271."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;ELECTROSTATIC POTENTIAL OF SURFACE URD VS DMDRWD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The electrostatic potential surfaces differ between human URD and Drosophila DRWD, with a large positive patch on the latter that is absent in the former."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;L248A/F252A/L254A/I265A MUTANT URD&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutant variant of the URD protein shows reduced binding affinity with FANCI and FANCD2 compared to wild type."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;W212A/L214A MUTANT URD&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutant variant of the URD protein behaves similarly to wild type in substrate binding assays."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FGFR4 RS351855 (GLY388ARG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FGFR4 rs351855 variant is a functional genetic variant associated with differential treatment effects of colesevelam on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS4975017&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"KLB rs4975017 is a genomic variant that shows differential treatment effects associated with CT, specifically affecting GC24 value."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS17618244 (ARG728GLN)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The KLB rs17618244 variant is a functional genetic variant showing numerical but not statistically significant differential treatment effects of colesevelam on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;COLESEVELAM TREATMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Colesevelam treatment affects the CT, AC t1/2, and GC24 levels in patients with different genotypes."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;AC T1/2 (AREA UNDER CURVE TIME 1/2)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"AC t1/2 refers to the half-life of the area under the curve measurement for a substance, used here to assess the effect of treatment on drug metabolism and pharmacodynamics."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;GC24 (GLYCEMIC CONTROL 24 HOURS)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"GC24 is a measure reflecting glycemic control over 24 hours post-treatment with colesevelam, indicating the impact of treatment on blood glucose levels."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;CT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CT refers to changes in the transit time or clearance rate associated with drug effects and genetic variations."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 RS376618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in FGFR4 that did not show significant differential treatment effects but was part of the study's candidate SNPs."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;HEALTHY CONTROL PATIENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The control group used to assess Hardy-Weinberg equilibrium and differential treatment effects for various genotypes."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;HWE ASSESSMENT&quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"This genomic variant failed to satisfy Hardy-Weinberg equilibrium in the study."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBS-D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Irritable Bowel Syndrome with Diarrhea (IBS-D) is a disease characterized by chronic abdominal pain and loose, frequent stools."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;IBS-C&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Irritable Bowel Syndrome with Constipation (IBS-C) is a disease characterized by chronic abdominal pain and infrequent, hard stools."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;CHOLECYSTECTOMY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cholecystectomy is the surgical removal of the gallbladder, which can affect bile acid metabolism and digestion."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SERUM FGF19&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FGF19, or Fibroblast Growth Factor 19, is a physiological process involved in regulating bile acid synthesis and metabolism."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;STOOL BA (BILE ACIDS)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway of bile acids involves their production, secretion into the intestines, and reabsorption through enterohepatic circulation."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SERUM C4&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"C4 is a biomarker associated with cholestasis and liver dysfunction, indicating altered bile acid metabolism."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FGFR4 RS1966265&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the FGFR4 gene that has been marginally associated with stool BA levels."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;KLB RS17618244&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the KLB gene that was tested for association but did not show significant results with serum C4 or stool BA."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;BILE ACIDS (BA)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Bile acids are metabolic products of cholesterol that play a crucial role in fat digestion and absorption."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FASTING SERUM FGF19 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FGF19 levels measured after fasting, which are involved in bile acid synthesis regulation."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;48-HOUR STOOL WEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurement of stool weight over a 48-hour period, used to assess fat malabsorption and overall digestive health."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;48-HOUR STOOL FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurement of fat content in stool over a 48-hour period, an indicator of fat digestion efficiency."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FGFR4 RS351855, FGFR4 RS376618&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Genetic variants KLB rs17618244 and other FGFR4 SNPs were tested but showed no significant associations with serum C4 or stool BA."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI, STOOL BA (BILE ACIDS)&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Higher BMI is correlated with higher serum C4 levels and total stool bile acids, indicating a relationship between metabolic status and FGF19 regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGF19 LEVELS&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Higher BMI is correlated with higher serum C4 levels and total stool bile acids, indicating a relationship between metabolic status and FGF19 regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAAP20&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20 is a 20 kDa protein that binds to FANCA through its N-terminal region and contains a conserved UBZ domain in its C-terminal extremity."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FANCA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCA is a protein with which FAAP20 interacts, particularly through the binding of FAAP20's N-terminal region."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;K63-LINKED UB2 (K63-UB2)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A molecular interaction involving two ubiquitin molecules linked by K63 residue."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBZ DOMAIN (OF FAAP20-UBZ)&quot;">
      <data key="d0">"PROTEIN DOMAIN"</data>
      <data key="d1">"The UBZ domain is a conserved C-terminal region in the FAAP20 protein that specifically interacts with K63-linked Ub chains."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ÎÎÎ-FOLD &quot;">
      <data key="d0">"STRUCTURE TYPE"</data>
      <data key="d1">"A classical structure type for UBZ domains, though FAAP20-UBZ lacks the two short Î² strands found in this fold."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;CENTRAL Î-HELIX (RESIDUES 160â173)&quot;">
      <data key="d0">"PROTEIN STRUCTURE FEATURE"</data>
      <data key="d1">"The central part of the FAAP20 protein structure that interacts with one Ub moiety of K63-Ub2."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ZINC ION&quot;">
      <data key="d0">"METAL ION INTERACTION"</data>
      <data key="d1">"A zinc ion coordinated by conserved residues Cys147, Cys150, His166 and Cys170 to bridge the first loop and the Î±-helix of FAAP20-UBZ."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ILE44 PATCH (OF UB)&quot;">
      <data key="d0">"PROTEIN STRUCTURE FEATURE"</data>
      <data key="d1">"A specific region in ubiquitin involved in interactions with other proteins, particularly through hydrophobic patches including Ile44 residue."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;K63 OF DISTAL UB&quot;">
      <data key="d0">"MOLECULAR INTERACTION POSITION"</data>
      <data key="d1">"The Lys63 residue on the distal ubiquitin molecule that interacts specifically with FAAP20-UBZ via a canonical Ile44-centered hydrophobic patch."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FAAP20-UBZ (RESIDUES 143â180)&quot;">
      <data key="d0">"PROTEIN STRUCTURE FEATURE"</data>
      <data key="d1">"The specific region of the FAAP20 protein that binds K63-linked Ub2."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITIN (UB)&quot;">
      <data key="d0">"MOLECULAR INTERACTION "</data>
      <data key="d1">"A small regulatory protein, commonly attached to other proteins and involved in various cellular processes."&lt;SEP&gt;"Ubiquitin is a small protein modifier involved in various cellular processes such as ubiquitination and signal transduction. In this context, it interacts with FAAP20-UBZ through specific residues to facilitate the recruitment of FAAP20 to DNA damage sites."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;K48-LINKED UB2&quot;">
      <data key="d0">"MOLECULAR INTERACTION "</data>
      <data key="d1">"Two ubiquitins linked by a lysine 48 residue, involved in interactions with FAAP20."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;M1-LINKED UB2&quot;">
      <data key="d0">"MOLECULAR INTERACTION "</data>
      <data key="d1">"Direct linkage of two ubiquitin molecules at their N-terminal methionines."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;GST-PULLDOWN ASSAY&quot;">
      <data key="d0">"BIOLOGICAL ASSAY "</data>
      <data key="d1">"Technique used to study protein-protein interactions, involving glutathione S-transferase (GST) fusion proteins."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ISOTHERMAL TITRATION CALORIMETRY (ITC)&quot;">
      <data key="d0">"PHYSICAL METHOD "</data>
      <data key="d1">"A method for measuring heats associated with binding events and determining affinity constants."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;TWO SHORT Î STRANDS &quot;">
      <data key="d0">"STRUCTURE TYPE "</data>
      <data key="d1">"Structural elements typically present in the classical UBZ fold but absent in FAAP20-UBZ structure."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;LEU8, ILE44, VAL70, THR66, HIS68 (OF UB)&quot;">
      <data key="d0">"PROTEIN RESIDUES "</data>
      <data key="d1">"Specific residues and their aliphatic portions involved in hydrophobic interactions with FAAP20-UBZ."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FAAP20-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20-UBZ is a protein that interacts with Ubiquitin (Ub) through specific intermolecular interactions, contributing to the binding and recruitment of FAAP20 to DNA damage sites."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ICL SITES&quot;">
      <data key="d0">"DISEASE OR PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"ICL (Interstrand Crosslink) Sites are locations on DNA where interstrand crosslinks occur, which can lead to DNA damage and are recognized by proteins like FAAP20 for repair processes."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;WRNIP1-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"WRNIP1-UBZ is a protein that interacts with Ubiquitin (Ub) through specific residues in its Î²Î²Î± fold structure, contributing to the binding and recruitment of WRNIP1 to DNA damage sites."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;RAD18-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"RAD18-UBZ is a protein that interacts with Ubiquitin (Ub) through specific residues in its Î²Î²Î± fold structure, contributing to the binding and recruitment of RAD18 to DNA damage sites."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;POLÎ-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PolÎ·-UBZ is a protein that seems to interact differently with Ubiquitin (Ub) compared to other UBZ proteins like WRNIP1-CREB3L2 and RAD18, contributing uniquely to cellular processes."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;NEMO-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NEMO-UBZ is a protein that interacts with Ubiquitin (Ub) through specific residues in its structure, distinct from the canonical Î²Î²Î± fold seen in WRNIP1 and RAD18 UBZs."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20 C-TERMINAL LOOP AND Î-HELIX INTERACTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific molecular interactions between FAAP20's C-terminal loop and Î±-helix residues with Ubiquitin (Ub) are essential for the binding of FAAP20 to DNA damage sites."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;UB-INTERACTING RESIDUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Interactions between specific residues on proteins like FAAP20-UBZ, WRNIP1-UBZ, RAD18-UBZ, NEMO-UBZ, and PolÎ·-UBZ with Ubiquitin (Ub) are critical for protein binding and localization to DNA damage sites."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ILE44-CENTERED HYDROPHOBIC PATCH OF UB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION"</data>
      <data key="d1">"This patch, centered around Ile44 in ubiquitin (Ub), is a hydrophobic region that interacts with FAAP20-UBZ."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;LEU8, VAL70, THR66, HIS68 OF UB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION"</data>
      <data key="d1">"These residues contribute to the Ile44-centered hydrophobic patch in ubiquitin (Ub) that interacts with FAAP20-UBZ."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ASP37 IN WRNIP1 Î-HELIX AND ASP177 IN C-TERMINAL LOOP OF FAAP20&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION"</data>
      <data key="d1">"These residues interact with Arg42 in ubiquitin (Ub) to facilitate binding and localization of proteins like WRNIP1 and FAAP20."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;PRO21-VAL22 IN THE Î-LOOP OF WRNIP1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION"</data>
      <data key="d1">"These residues interact with Ile44 in ubiquitin (Ub) to facilitate binding and localization of WRNIP1 protein."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;PRO398-LYS399 IN NEMO-UBZ AND GLU636-LYS637 IN POLÎ-UBZ&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION"</data>
      <data key="d1">"These residues are involved in interactions with ubiquitin (Ub) that differ from canonical Î²Î²Î± fold structures seen in WRNIP1 and RAD18 UBZs."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;C-TERMINAL LOOP OF FAAP20-UBZ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The C-terminal loop interacts specifically with residues on ubiquitin (Ub) to facilitate binding and localization of FAAP20 protein."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;Î-LOOP OF WRNIP1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This loop contributes to the interaction between WRNIP1-UBZ and ubiquitin (Ub)."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;NEMO-UBZ (PDB CODE: 2JVX)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein with a unique binding mechanism for Ub compared to other proteins like WRNIP1-UBZ and RAD18-UBZ, characterized by distinct residues in the Î²-loop."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;POLÎ-UBZ (PDB CODE: 2I5O)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein that interacts with Ub similarly to FAAP20-UBZ but differently from NEMO-UBZ due to specific residue conservation and replacements."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;UB&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Ubiquitin, a small regulatory protein involved in various cellular processes including the modification of other proteins through ubiquitination."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;WRNIP1-UBZ (PDB CODE: 2JVX)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein that interacts with Ub through its Î²-loop and has residues that are differently conserved compared to NEMO-UBZ and PolÎ·-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;FAAP20-UBZ (PDB CODE: 2I5O)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein that interacts with Ub through specific residues in the Î±-helix, similar to Rabex5-MIU and different from NEMO-UBZ due to residue conservation."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;RAD18-UBZ (PDB CODE: 2JVX)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein that interacts with Ub through its Î²-loop in a manner distinct from FAAP20-UBZ and PolÎ·-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;VPS27-UIM (PDB CODE: 1Q0W)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A UBD involved in binding to ubiquitin, with similar critical residues for Ub binding compared to Rabex5-MIU and FAAP20-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;RABEX5-MIU (PDB CODE: 2C7M AND 2FIF)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A UBD that binds ubiquitin similarly to FAAP20-UBZ, with convergent evolution of critical Ub binding residues compared to Vps27-UIM."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;MIU (MOTIF INTERACTING WITH UBIQUITIN)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A motif interacting with ubiquitin that shares similarity in critical binding residues with FAAP20-UBZ and Rabex5-MIU, suggesting convergent evolution."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;UIM (UB-INTERACTING MOTIF)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An Ub-binding motif involved in interactions with ubiquitin, with polarity opposite to FAAP20-UBZ but similar critical residues for binding compared to Vps27-UIM and Rabex5-MIU."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;Î-LOOP (IN UBZ DOMAINS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A structural element of UBZ domains involved in the interaction with Ub, characterized by distinct residue patterns among different groups of proteins."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;Î-HELIX (IN UBZ/UIM/MIU STRUCTURES)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A structural element crucial for Ub binding in FAAP20-UBZ and Rabex5-MIU, showing convergent evolution with Vps27-UIM."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;K63 OF DISTAL UB &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"The central Î±-helix in FAAP20-UBZ interacts specifically with the K63 residue on the distal ubiquitin molecule."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;K48-LINKED UB2 &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP20 can bind to K48-linked diubiquitin chains, indicating non-specific binding preference."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;M1-LINKED UB2 &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP20 interacts with M1-linked diubiquitin chains, demonstrating non-specific binding capability."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCA INTERACTION STUDIES &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"GST-pulldown technique used to investigate binding interactions between FAAP20 and FANCA."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GST-PULLDOWN ASSAY &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"GST-pulldown technique used to investigate binding interactions between FAAP20 and FANCA."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BINDING AFFINITY MEASUREMENT &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"ITC measures equilibrium dissociation constants for protein-protein interactions, such as PolÎ· UBZ with ubiquitin."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLASSICAL UBZ FOLD &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"Typically present in classical UBZ folds but absent in FAAP20-UBZ structure."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYDROPHOBIC INTERACTIONS &quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"Residues and their aliphatic portions involved in hydrophobic interactions with FAAP20-UBZ."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA DAMAGE REPAIR PROCESS&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"The presence of ICL sites indicates a need for DNA repair processes, where proteins like FAAP20-UBZ play crucial roles in recruitment and repair."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ARG42 IN UBIQUITIN (UB)&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"These residues interact with Arg42 on ubiquitin to facilitate binding and localization."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2395182&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at position rs2395182, where the minor 'G' allele is more prevalent in healthy controls than in CD patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7775228&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at position rs7775228, where the minor 'C' allele has a higher frequency among healthy controls compared to CD patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS2187668&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at position rs2187668 with the minor 'T' allele more frequently present in CD patients than in controls."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ2.5 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The homozygous HLA-DQ2.5 haplotype is significantly higher among CD patients compared to healthy controls and is considered a risk factor for the disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ8 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Heterozygous DQ8 (in combination with DQ2.2) haplotypes were highly frequent among CD patients, suggesting its role as an additional risk factor."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract."&lt;SEP&gt;"Crohnâs disease is a chronic inflammatory bowel disorder that affects the digestive tract and shows genetic predisposition based on HLA-DQ haplotypes."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;HEALTHY CONTROLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Individuals without Crohn's Disease used as a control group in genetic studies."&lt;SEP&gt;"Individuals without asthma used as a comparison group for studying asthmatic patients."&lt;SEP&gt;"The healthy control group includes individuals without Crohn's disease, used for comparison with CD patients in genetic studies."&lt;SEP&gt;"The group serving as a control in genetic studies to compare against HIV-infected individuals."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A common autoimmune manifestation seen in the patient group of CD patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An autoimmune condition observed in a small subset (8%) of CD patients."&lt;SEP&gt;"Anti-thyroglobulin and anti-thyroid peroxidase antibodies indicate the presence of autoimmune thyroiditis in STAT5B deficient siblings."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A rare autoimmune disease manifestation found in 3% of the CD patient group."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;OSTEOMALACIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Non-autoimmune disease manifestations observed in a small percentage (5%) of CD patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;SEIZURE DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurological disorder seen in 4% of the patient group with Crohn's disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DOWN SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Found in 4% of the study participants diagnosed with CD, indicating an associated genetic condition."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7454108&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at position rs7454108 with no significant difference in minor allele frequency between CD patients and controls."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HOMOZYGOUS HLA-DQ2.2 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Predicted to be more frequent among control groups than CD patient group, suggesting its potential protective effect against Crohn's disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DQ8/DQX HAPLOTYPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Heterozygous DQ8 in combination with DQX haplotype is significantly more frequent among CD patients compared to healthy controls, indicating a risk factor for the disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;CHRONIC DIARRHEA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A common clinical symptom seen in CD patients, characterized by prolonged diarrhea lasting more than 4 weeks."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ABDOMINAL PAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Another common symptom observed in Crohnâs disease patients, typically localized to the lower abdomen."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ANOREXIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition of loss of appetite or disinterest in food commonly seen in CD patients due to gastrointestinal inflammation."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ABDOMINAL DISTENSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Symptom characterized by the swelling of the abdomen, often associated with bowel obstruction or gas accumulation in Crohnâs disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;REAL-TIME PCR GENOTYPING&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"Validation method used to confirm the accuracy of HLA-DQ haplotypes determined by Real-time PCR genotyping, showing 100% concordance in randomly selected individuals from both study groups."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1128503 (ABCB1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs1128503 in the ABCB1 gene is associated with grade 3â4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS12762549 (ABCC2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs12762549 in the ABCC2 gene is associated with grade 3â4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS363717 (ABCA1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs363717 in the ABCA1 gene is associated with grade 3â4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS11615 (ERCC1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs11615 in the ERCC1 gene is associated with grade 3â4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS4986910 (CYP3A4)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs4986910 in the CYP3A4 gene is associated with thrombocytopenia grade 3â4."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS2074087 (ABCC1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs2074087 in the ABCC1 gene is significantly correlated with use of erythropoietin-stimulating agents (ESAs)."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS2073337 (ABCC2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs2073337 in the ABCC2 gene is significantly correlated with use of colony-stimulating factors (CSFs)."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1695 (GSTP1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs1695 in the GSTP1 gene is significantly correlated with use of CSFs."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1799793 (ERCC2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs1799793 in the ERCC2 gene is significantly associated with progression-free interval (PFI)."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS3814879 (TGFBR2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs3814879 in the TGFBR2 gene is associated with an increased risk for severe radiation pneumonitis."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS7156029 (HLA-DQB1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs7156029 in the HLA-DQB1 gene is correlated with response to immunotherapy."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS113498797 (MYH6)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant rs113498797 in the MYH6 gene is associated with increased risk of atrial fibrillation."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1799793 (ERCC2 Gâ&gt;âA)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in ERCC2 gene, specifically the G&gt;A substitution at position rs1799793, is significantly correlated with platinum-free interval (PFI) survival."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RS12762549 (ABCC2 Aâ&gt;âG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in ABCC2 gene, specifically the A&gt;G substitution at position rs12762549, was significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors but not significant after adjusting only for age."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RS6104 (SERPINB2 Câ&gt;âG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in SERPINB2 gene, specifically the C&gt;G substitution at position rs6104, was significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors but not significant after adjusting only for age."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ERCC2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ERCC2 gene is involved in nucleotide excision repair and its variant rs1799793 correlates with platinum-free interval (PFI) survival."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ABCC2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ABCC2 gene, also known as MRP2, plays a role in drug transport and its variant rs12762549 is associated with platinum-free interval (PFI) survival."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;SERPINB2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SERPINB2 gene encodes a serine protease inhibitor that is involved in inflammation regulation, and its variant rs6104 shows an association with platinum-free interval (PFI) survival."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ERCC2 Gâ&gt;âA VARIANT CARRIERS (GG)&quot;">
      <data key="d0">"GENOMIC VARIANT CARRIER GROUP"</data>
      <data key="d1">"Individuals carrying the GG genotype of rs1799793 in ERCC2 gene show a significant advantage in platinum-free interval compared to AA or GA carriers."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ERCC2 Gâ&gt;âA VARIANT CARRIERS (AA/GA)&quot;">
      <data key="d0">"GENOMIC VARIANT CARRIER GROUP"</data>
      <data key="d1">"Individuals carrying the AA or GA genotype of rs1799793 in ERCC2 gene show a significant disadvantage in platinum-free interval compared to GG carriers."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Platinum-free interval is a measure of the time between the end of primary chemotherapy and the start of subsequent therapy or disease progression, indicating survival duration."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;AGE AT DIAGNOSIS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/LIFESTYLE FACTOR"</data>
      <data key="d1">"Age at diagnosis is an environmental factor that influences patient prognosis in medical studies."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;FIGO STAGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/PATHOLOGICAL CONDITION"</data>
      <data key="d1">"The FIGO stage indicates the extent of ovarian cancer progression and affects survival outcomes."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;TUMOR GRADE&quot;">
      <data key="d0">"DISEASE SEVERITY INDICATOR"</data>
      <data key="d1">"Tumor grade is a measure used to classify tumor aggressiveness and impact prognosis."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RESIDUAL DISEASE AFTER DEBULKING SURGERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/PATHOLOGICAL CONDITION"</data>
      <data key="d1">"The amount of residual disease after debulking surgery influences patient outcomes following treatment."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;GRADE 3â4 ANEMIA&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs1128503 variant in ABCB1 is significantly associated with grade 3-4 anemia."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIA GRADE 3â4&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs4986910 variant in CYP3A4 is significantly associated with thrombocytopenia grade 3-4."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ERYTHROPOIETIN-STIMULATING AGENTS (ESAS)&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs2074087 variant in ABCC1 is significantly associated with the use of ESAs."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLONY-STIMULATING FACTORS (CSFS)&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs2073337 variant in ABCC2 is significantly associated with the use of CSFs."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROGRESSION-FREE INTERVAL (PFI)&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs1799793 variant in ERCC2 is significantly associated with PFI."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RADIATION PNEUMONITIS&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs3814879 variant in TGFBR2 is associated with an increased risk for severe radiation pneumonitis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESPONSE TO IMMUNOTHERAPY&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs7156029 variant in HLA-DQB1 is correlated with the response to immunotherapy."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ATRIAL FIBRILLATION&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs113498797 variant in MYH6 increases the risk of atrial fibrillation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLATINUM-FREE INTERVAL&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The genomic variant rs1799793 in ERCC2 gene is significantly correlated with platinum-free interval (PFI) survival."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UMPS GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"UMPS is a gene identified as containing genetic alterations that may contribute to certain phenotypes."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;DE NOVO DELETION ON CHROMOSOME 3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A de novo 6.4 Mb deletion on chromosome 3, chr3:121233326â127618464, contains the UMPS gene and may contribute to a patientâs phenotype."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.302DELA IN I4&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous alteration (c.302delA) found in individual I4 leading to premature stop and loss of protein function."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.385G&gt;T IN I7 AND S7&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Maternally inherited variant (c.385G&gt;T) found in individuals I7, their healthy brother S7, and possibly others leading to premature stop codon."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.889G&gt;T IN I10 AND I11&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Maternally inherited variant (c.889G&gt;T) found in individuals I10 and I11 causing protein truncation leading to loss of normal function."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.224C&gt;A IN PEDIGREE 2 FAMILY MEMBERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous missense alteration (c.224C&gt;A) found in multiple members of pedigree 2, potentially derived from either parent or unknown origin."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.286A&gt;G AND C.1285G&gt;C IN I3 AND M3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Two heterozygous missense alterations (c.286A&gt;G and c.1285G&gt;C) found in individuals I3 and his healthy mother M3, possibly on the same allele."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.310G&gt;A IN I5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous missense alteration (c.310G&gt;A) detected in individual I5 leading to a change from Gly104 to Arg, potentially pathogenic."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.689G&gt;A AND C.688C&gt;T IN I6 AND I7&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Maternally inherited missense alterations (c.689G&gt;A and c.688C&gt;T) found in individuals I6 and I7 leading to Arg230His and Arg230Cys changes, respectively."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.857T&gt;A IN I9&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous missense alteration (c.857T&gt;A) detected in individual I9 leading to a change from Ile286 to Asn, potentially pathogenic."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.451G&gt;A IN I11&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous missense alteration (c.451G&gt;A) found in individual I11 leading to a change from Val151 to Met, potentially pathogenic."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.360A&gt;G IN I6&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Maternally inherited synonymous variant (c.360A&gt;G) found in individual I6 leading to no change in protein sequence but still considered relevant for further study."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;PROTEIN TRUNCATION OR NONSENSE-MEDIATED MRNA DECAY (NMD)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process that leads to loss of normal protein function due to premature stop codons in mRNAs."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;HETEROZYGOUS MISSENSE ALTERATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Different heterozygous missense alterations were found across individuals, potentially leading to changes in UMPS protein functionality."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.286A&gt;G AND C.1285G&gt;C VARIANTS IN I3 AND M3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Two different variants (c.286A&gt;G and c.1285G&gt;C) found within the UMPS gene of individual I3 and his mother M3."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PROGRAMS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Software programs used to predict the pathogenicity of genetic variants detected in individuals."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;HIGH-DENSITY GENE-CENTRIC ARRAY CGH TESTING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A testing method used to identify gene-specific deletions or duplications, particularly for UMPS gene."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;TGF-SS1 (RS1800469 C/T)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TGF-Ã1 (rs1800469 C/T) SNP is a genetic variant in the promoter region of the TGF-Ã1 gene, showing significant association with colorectal cancer risk."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-8 (RS4073 T/A)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The IL-8 (rs4073 T/A) polymorphism is a genetic variant in the promoter region of the interleukin-8 gene, not significantly associated with CRC risk."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-10 (RS1800896 A/G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The IL-10 (rs1800896 A/G) polymorphism is a genetic variant in the promoter region of the interleukin-10 gene, showing significant association with reduced CRC risk."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-22 (RS1179251 C/G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The IL-22 (rs1179251 C/G) polymorphism is a genetic variant in the promoter region of the interleukin-22 gene, showing an association with CRC risk."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-22 (RS2227485 C/T)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The IL-22 (rs2227485 C/T) polymorphism is a genetic variant in the promoter region of the interleukin-22 gene, not significantly associated with CRC risk."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-27 (RS17855750 T/G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The IL-27 (rs17855750 T/G) polymorphism is a genetic variant in the promoter region of the interleukin-27 gene, showing an association with reduced CRC risk."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colorectal cancer is a disease where several genes' variants have been studied for their association with increased or decreased risk."&lt;SEP&gt;"Colorectal cancer is a type of cancer that starts in the colon or rectum."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27&lt;SEP&gt;chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-8 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-8 gene encodes the protein interleukin-8, which is involved in immune and inflammatory responses."&lt;SEP&gt;"The IL-8 gene is involved in immune response regulation and has a polymorphism (rs4073 T/A) studied for its association with colorectal cancer risk."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-27 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-27 gene has a promoter SNP (rs17855750 T/G) showing an association with reduced risk of CRC, although not highly significant."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;TGF-SS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TGF-Ã1 gene is involved in various cellular processes and contains the rs1800469 C/T polymorphism which significantly correlates with colorectal cancer development."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;CRC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colorectal Cancer (CRC) is a disease characterized by the uncontrolled growth of cells in the colon or rectum."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;T ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The T allele is another genetic variant that has been observed in relation to colorectal cancer, though its association did not reach statistical significance."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;IL-22 GENE (RS1179251 C/G)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The rs1179251 C/G polymorphism in IL-22 gene is associated with a decreased risk of developing CRC but lacks strong statistical significance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 GENE (RS17855750 T/G)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The G allele in IL-27 gene shows protective effects against colorectal cancer development, though the association is weak."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 GENE (RS1800896 A/G)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The genetic variants of IL-8 and IL-10 both contribute to immune system modulation, with IL-10 showing a more pronounced effect on CRC risk reduction."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 GENE (RS4073 T/A)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The genetic variants of IL-8 and IL-10 both contribute to immune system modulation, with IL-10 showing a more pronounced effect on CRC risk reduction."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TGF-SS1 GENE (RS1800469 C/T)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Both TGF-Ã1 and IL-10 genes have polymorphisms studied for CRC risk, with contrasting outcomes: increased risk in TGF-Ã1, reduced risk in IL-10."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTROL GROUP VS CRC PATIENTS&quot;">
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d1">"A lower frequency of the T allele was observed in CRC patients compared to the control group but did not reach statistical significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T ALLELE FREQUENCY&quot;">
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d1">"A lower frequency of the T allele was observed in CRC patients compared to the control group but did not reach statistical significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TSLP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TSLP gene is implicated in asthma susceptibility as evidenced by the association of specific SNPs with asthma risk."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;RS1898671&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in the TSLP gene, rs1898671, has been associated with increased risk for asthma in certain populations."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;SNP (RS1898671)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This specific variant shows different effects on asthma susceptibility depending on smoking history."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;EX-SMOKERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"The subgroup of ex-smokers has a higher risk associated with the TSLP SNP rs1898671 compared to never-smokers."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NEVER-SMOKERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"In contrast, individuals who have never smoked did not show significant association between SNP rs1898671 and asthma risk."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA SUSCEPTIBILITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The genetic variant in the TSLP gene influences susceptibility to asthma depending on lifestyle factors such as smoking history."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TSLP HAPLOTYPE (GAGGGCAAAG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This specific haplotype shows a significant increased risk of asthma after adjusting for age, BMI and population stratification."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMATIC PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This entity refers to individuals diagnosed with asthma included in the study."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NYUBAR POPULATION&quot;">
      <data key="d0">"STUDY POPULATION"</data>
      <data key="d1">"A specific population of 387 unrelated asthmatic patients and 212 unrelated healthy controls included in the analysis."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;SELF-REPORTED RACE/ETHNICITY INFORMATION&quot;">
      <data key="d0">"DEMOGRAPHIC CHARACTERISTIC"</data>
      <data key="d1">"Information provided by participants regarding their racial and ethnic background used to adjust for population stratification in genetic studies."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;LUNG FUNCTION TESTS (FEV1, FVC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurements assessing lung function that were significantly different between asthmatic patients and healthy controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TOTAL IGE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Blood levels of immunoglobulin E which were higher in asthma cases compared to controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ATOPIC STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL CONDITION"</data>
      <data key="d1">"The presence of atopy, characterized by elevated total IgE and sensitization to common allergens, was more prevalent among asthmatic patients."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;POPULATION STRATIFICATION ADJUSTMENT&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Race/ethnicity information is used to adjust for potential biases in genetic association studies."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PTPN2 gene is associated with CD through a significant SNP, rs478582."&lt;SEP&gt;"The PTPN2 gene is associated with autoimmune diseases such as celiac disease, inflammatory bowel disease, rheumatoid arthritis and type 1 diabetes."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN22 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PTPN22 gene is studied for its potential role in CD and inflammatory autoimmune diseases due to the SNP rs2476601."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the PTPN2 gene is significant in Crohn's Disease (CD) compared to healthy controls, showing an increased frequency of heterozygous and minor alleles in CD subjects."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific SNP in the PTPN22 gene associated with various inflammatory autoimmune diseases but not significant in CD compared to healthy controls, except for haplotype analysis."&lt;SEP&gt;"The rs2476601 variant of the PTPN22 gene is a risk allele associated with certain autoimmune diseases. It influences the expression and function of LYP protein variants, impacting Treg-mediated suppression."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;PTPN2 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the PTPN2 gene shows significantly lower relative expression levels in CD subjects than in healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"No direct effect on protein level described, but changes at genetic and transcript levels suggest potential influence on protein function or stability."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;IFN-Î EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Expression of IFN-gamma is evaluated in relation to the SNPs rs478582 and rs2476601, but specific effects are not detailed in this text."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;CD (CROHN'S DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by lower expression of PTPN2/PTPN22 genes compared to healthy controls, influenced by certain SNPs."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;HAPLOTYPE COMBINATION T-G&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This haplotype combination between PTPN2:rs478582 and PTPN22:rs2476601 was found more frequently in healthy controls than CD subjects."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;HAPLOTYPE COMBINATION C-G&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The haplotype combination of heterozygous/major alleles for rs478582 and rs2476601 is significantly higher in CD compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;HAPLOTYPE COMBINATION T-A&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A haplotype with a minor allele for PTPN2:rs478582 combined with the heterozygous or minor allele for PTPN22:rs2476601."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;HAPLOTYPE COMBINATION C-A&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The haplotype combination of heterozygous/major alleles for rs478582 and the minor/heterozygous or minor allele for rs2476601 is significantly higher in CD compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PREDISPOSITION TO CD&quot;">
      <data key="d0">"DISEASE SUSCEPTIBILITY"</data>
      <data key="d1">"Certain genetic variants like rs478582 and rs2476601 influence predisposition to Crohn's Disease."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2:RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the PTPN2 gene associated with increased susceptibility to MAPbacteremia in Crohn's disease (CD) subjects."&lt;SEP&gt;"A genomic variant in the PTPN2 gene associated with changes in relative gene expression and susceptibility to Mycobacterium avium subsp. Paratuberculosis (MAP) infection."&lt;SEP&gt;"A genomic variant located on the PTPN2 gene, specifically rs478582."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD AVERAGE RELATIVE GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The average relative gene expression of CD subjects was lower when comparing heterozygous or minor alleles in PTPN2:rs478582 and PTPN22:rs2476601 compared to healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;IFN-Î GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The expression of IFN-Î³ increases when there is a combined presence of MAPbacteremia and specific genetic variants (SNPs) related to PTPN2 or PTPN22 genes."&lt;SEP&gt;"The gene expression of IFN-Î³ was higher in CD subjects with heterozygous or minor alleles in PTPN2:rs478582, but not affected by similar alleles in PTPN22:rs2476601."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS (MAP)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental factor that shows increased detection and susceptibility in CD subjects with specific genetic variants compared to healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;PTPN22:RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the PTPN22 gene associated with increased susceptibility to MAPbacteremia in CD subjects."&lt;SEP&gt;"A genomic variant in the PTPN22 gene not changing the expression of its protein but affecting susceptibility when combined with MAP infection."&lt;SEP&gt;"Another genomic variant located on the PTPN22 gene, specifically rs2476601."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN2 GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Expression of the PTPN2 gene is reduced in CD subjects relative to healthy controls regardless of MAPbacteremia status."&lt;SEP&gt;"Gene expression analysis of PTPN2 gene shows significant changes in CD subjects with heterozygous or minor alleles compared to healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN22 GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gene expression analysis of the PTPN22 gene does not show significant differences between carriers and non-carriers of minor alleles but shows a lower expression in CD subjects overall."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;TC ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous or minor alleles in PTPN2:rs478582, specifically the TC and CC genotypes."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;CC ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor allele (CC) of PTPN2:rs478582 associated with increased susceptibility to MAPbacteremia in CD subjects."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;MAPBACTEREMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease condition characterized by the presence of Mycobacterium avium subspecies paratuberculosis (MAP) bacteria in blood, often linked to inflammatory bowel diseases like Crohn's disease."&lt;SEP&gt;"Presence of Mycobacterium avium complex (MAC) bacteria within the bloodstream, often associated with immunocompromised states."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;GA ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous alleles (GA) of PTPN22:rs2476601 associated with increased MAPbacteremia presence compared to healthy controls."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;AA ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor allele (AA) in PTPN22:rs2476601, rare and not strongly linked to MAPbacteremia in CD subjects."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;C-G HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A haplotype combination of C-G alleles in PTPN2:rs478582 and PTPN22:rs2476601, significantly associated with MAPbacteremia presence in CD subjects."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;T-A HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A haplotype combination of T-A alleles in PTPN2:rs478582 and PTPN22:rs2476601, associated with MAPbacteremia presence but less common than C-G haplotype."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;T-CELL PROLIFERATION RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which T-cells multiply and increase in number."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;T-CELL FUNCTIONALITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The functional capabilities and responsiveness of T-cells to various stimuli in the immune system."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PHA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Phytohemagglutinin (PHA), a lectin used as a mitogen to stimulate cell proliferation in vitro."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAP PPD-LIKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A substance similar to purified protein derivative of Mycobacterium avium complex (MAC) used for antigenic stimulation in immune responses."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;IFNG&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding interferon-gamma (IFN-Î³), which plays a critical role in immune response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in regulation of T-cell activation and cytokine production."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with autoimmune diseases, including Crohn's Disease (CD)."&lt;SEP&gt;"PTPN22 is a gene associated with autoimmune disorders, particularly through its risk variant rs2476601. It influences Treg-mediated suppression and is expressed more highly in regulatory T cells (Tregs) compared to conventional T cells."&lt;SEP&gt;"PTPN22 is a gene that encodes the protein tyrosine phosphatase non-receptor type 22 (LYP), which plays an important role in immune cell function."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;MAP INFECTION SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d1">"The susceptibility to MAP infection is increased among CD subjects with heterozygous or minor alleles in PTPN22:rs2476601 compared to healthy controls."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD SUBJECTS WITH MINOR ALLELES&quot;">
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d1">"CD subjects carrying heterozygous or minor alleles in PTPN2:rs478582 have significantly lower gene expression compared to healthy controls."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MAPBACTEREMIA PRESENCE&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"CD subjects with MAPbacteremia have significantly lower relative gene expression levels of PTPN2 compared to healthy controls, irrespective of MAP presence status."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN2:RS478582 AND PTPN22:RS2476601 SNPS&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"The presence of specific genetic variants (SNPs in PTPN2 or PTPN22) combined with MAPbacteremia leads to increased IFN-Î³ expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYMPHOCYTE SUBSET&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The differentiation and activation of lymphocytes into distinct subsets such as naÃ¯ve, memory, and regulatory T cells is a physiological process regulated by various genes including PTPN22."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;T1D NON-RISK ALLELE (LYP-620R)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The LYP-620R variant of the PTPN22 gene encodes a non-risk allele associated with lower risk for Type 1 Diabetes (T1D)."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;RISK ALLELE (LYP-620W)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The LYP-620W variant of the PTPN22 gene is considered a risk allele and is associated with higher susceptibility to T1D."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;PTPN22 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The expression of PTPN22 is a molecular interaction involving transcriptional regulation and post-transcriptional modifications in various cell states."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TCR SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"T-cell receptor (TCR) signaling pathway is the process by which T cells recognize antigens and initiate immune responses, involving multiple downstream pathways such as calcium signaling and MAPK/ERK activation."&lt;SEP&gt;"The process by which T cell receptor engagement initiates a series of signaling events leading to cellular activation and differentiation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CA2+ FLUX&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Calcium flux is a molecular interaction that occurs during TCR signaling, affecting cell functions like gene expression and proliferation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;PERK SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Phosphorylation of extracellular signal-regulated kinase (pERK) is part of the MAPK/ERK pathway activated in response to TCR ligation, influencing cell survival and differentiation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;ACTIVATION MARKERS ON T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Surface expression of activation markers such as CD69, ICOS, CD25, and CTLA-4 on T cells is a molecular interaction indicative of immune cell activation and response to stimuli."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TRANSCRIPT OF PTPN22&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the PTPN22 gene is quantified in different T cell subsets to assess expression levels under various conditions."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;NAÃVE CD4+ TCONV&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"NaÃ¯ve CD4+ Tconv cells are an initial stage of differentiation for T helper cells before encountering antigens."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MEMORY TCONV CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Memory Tconv cells represent a subset of T cells that have previously encountered and responded to an antigen, remaining in circulation to provide rapid response upon re-exposure."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TREGS (REGULATORY T CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulatory T cells (Tregs) are a specialized population of T cells responsible for maintaining self-tolerance and suppressing immune responses to prevent autoimmunity."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;POLYCLONAL ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which resting T cells are activated by exposure to multiple antigens, leading to increased expression of activation markers."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;BICISTRONIC CONSTRUCTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Bicistronic constructs express two proteins from a single mRNA transcript, commonly used in gene therapy for simultaneous delivery and regulation of two genes or their products."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;LENTIVIRUS TRANSDUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which lentiviruses are used to introduce genetic material into cells, often utilized in research and therapeutic applications for modifying cellular function."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;EGFP (ENHANCED GREEN FLUORESCENT PROTEIN)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A protein commonly used as a reporter gene to track the expression of other genes or proteins within living cells due to its fluorescence under UV light."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD69&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein marker expressed following Tconv activation and involved in immune cell signaling."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;ICOS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Inducible Co-Stimulator, a protein that is dynamically expressed during T-cell activation indicating an active state of the cell."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD25&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The high-affinity component of IL-2 receptor, upregulated in activated T-cells, contributing to IL-2 signaling."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD226&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein involved in cell adhesion and signaling during T-cell activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PD-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Programmed Cell Death Protein 1, a marker of T cell exhaustion or activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CTLA-4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Cytotoxic T-Lymphocyte Antigen 4, involved in the regulation of immune responses by binding to CD80 and CD86."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PTPN22 R620W VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant form of PTPN22 that confers altered function on the LYP protein involved in T-cell activation and proliferation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP-620R&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LYP-620R is a variant of the LYP protein that significantly represses T helper responder cell (Tresp) proliferation."&lt;SEP&gt;"Variant of LYP associated with reduced impact on T cell activation compared to LYP-620W, affecting signaling pathways."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;LYP-620W&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A variant of the LYP protein that exhibits less ability to downregulate activation markers in Tconv cells compared to LYP-620R."&lt;SEP&gt;"LYP-620W is a variant of the LYP protein with reduced suppression compared to LYP-620R in T helper responder cells (Tresps)."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;T CONVOLUTIONAL CELLS (TCONV)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"T-helper cells that contribute to the adaptive immune response through cytokine production."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IL-2&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"A cytokine produced by activated T-cells that stimulates proliferation and survival of immune cells."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TH1 SIGNATURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Th1 signature refers to the immune response mediated predominantly by Th1-type CD4+ helper T cells. It has been implicated in several autoimmune disorders associated with genetic risk factors such as rs2476601 variant of PTPN22."&lt;SEP&gt;"The process by which certain autoimmune disorders are associated with a Th1-type response characterized by IFNÎ³ secretion."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which cells increase in number through repeated cell divisions."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;ANTI-CD3 AND ANTI-CD28 STIMULATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A method used to activate T-cells, involving antibodies against CD3 and CD28 receptors."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PMA AND IONOMYCIN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Mitogens used for inducing cell proliferation in vitro."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;K562 AAPCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of artificial antigen-presenting cells (aAPC) used to stimulate T-cell responses in experiments."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IL-4, IL-5, IL-9, IL-10, AND IL-13&quot;">
      <data key="d0">"CYTOKINE PANEL"</data>
      <data key="d1">"A set of cytokines secreted by CD4+ effector T cells that play roles in Th2-type immune responses."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IFNÎ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Interferon gamma (IFNÎ³) is a signaling molecule produced by T cells that plays a significant role in cellular immune responses and inflammation."&lt;SEP&gt;"Interferon gamma, a cytokine important for Th1-mediated immunity and plays a role in promoting cell-mediated immune response."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;LYP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LYP is a protein that has variants such as LYP-620R and LYP-620W which influence the effector cytokine secretion in T cells."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Treg stands for regulatory T cells, which play a crucial role in maintaining immunological tolerance by suppressing immune responses through various mechanisms including cytokine secretion."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Autoimmune disorders are diseases where the body's immune system attacks healthy tissues. The PTPN22 gene variant rs2476601 is associated with an increased risk of these conditions."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TCONV&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Tconv stands for conventional T cells, which are distinct from regulatory T cells (Tregs) and play roles in immune responses. Overexpressed LYP variants can alter their susceptibility to regulation by Treg."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TRESP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Tresps refer to activated T helper cells or effector T cells that respond to antigen stimulation, their proliferation is regulated by molecules like LYP variants and influenced by Treg suppression."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;EGFP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Enhanced green fluorescent protein (eGFP) is used to mark and track cells in experiments, allowing for the assessment of cellular functions like proliferation and suppression by Tregs or LYP variants."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;CYTOKINE PANEL&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"These cytokines together form a panel of markers used to assess Th2-mediated immune responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2476601 RISK VARIANT&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The rs2476601 risk variant influences PTPN22 gene expression, altering the function of LYP protein variants and contributing to disease risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP-620W VARIANT&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Overexpressed LYP-620W in Tregs slightly increased their suppressive capacity compared to controls, indicating an intrinsic impact on regulatory function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP VARIANTS&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The secretion of IFNÎ³ was not altered by the overexpression of LYP variants, suggesting that its production may be independent of PTPN22 gene regulation in this context."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRESP PROLIFERATION&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Overexpression of LYP-620R significantly represses the proliferation of T helper responder cells (Tresps)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG SUPPRESSION CAPACITY&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The overexpression of LYP-620W variant slightly increased the suppressive capacity of regulatory T cells compared to controls."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22 RISK VARIANT&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The PTPN22 risk variant may alter Treg-mediated suppression capacity, influencing disease risk in autoimmune disorders."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG-MEDIATED SUPPRESSION CAPACITY&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The PTPN22 risk variant may alter Treg-mediated suppression capacity, influencing disease risk in autoimmune disorders."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL TRACKING&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Enhanced green fluorescent protein (eGFP) is used to track and differentiate cells such as transduced Tregs from untransduced cells for studying their functions like proliferation and suppression capacity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAG72&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TAG72 is a gene expressed on the surface of ovarian cancer cells and used as a target for CAR T cell therapy."&lt;SEP&gt;"TAG72 is a gene that codes for a transmembrane glycoprotein commonly expressed in ovarian and breast cancers, serving as an antigen target for CAR T cell therapy."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The 4-1BB intracellular co-stimulatory domain enhances the anti-tumor activity of CAR T cells by providing additional signaling pathways."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CC49 HUMANIZED SCFV&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A humanized single-chain variable fragment derived from CC49 antibody, used as a targeting moiety in CAR constructs to bind TAG72 antigen on tumor cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD3Î CYTOLYTIC DOMAIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The CD3Î¶ cytoplasmic domain is part of the T-cell receptor complex and mediates downstream signaling involved in cell activation, proliferation, and cytotoxicity."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CAR T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Chimeric Antigen Receptor (CAR) T cells are engineered immune cells designed to express a synthetic receptor that recognizes specific antigens on cancer cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVARIAN CANCER CELL LINES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A collection of cell lines derived from ovarian tumors used in laboratory research for understanding tumor biology and testing therapeutic agents."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72-BBÎ CAR T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CAR T cells engineered to express a chimeric receptor targeting TAG72 with co-stimulation provided by 4-1BB signaling domain, used in the treatment of ovarian cancer."&lt;SEP&gt;"CAR T cells targeting the TAG72 antigen, which are used to treat ovarian cancer."&lt;SEP&gt;"CAR T cells that target the TAG72 antigen for cancer therapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;SOLUBLE TAG72 ANTIGEN SHEDDING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process where the TAG72 antigen is shed from tumor cells into a soluble form in the extracellular environment."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;IFNÎ RELEASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Interferon-gamma (IFN-Î³) release is a measure of T cell activity and its ability to recognize and respond to specific antigens expressed on cancer cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TUMOR KILLING ABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The capability of CAR T cells to specifically target, bind, and kill tumor cells expressing the antigen TAG72."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72-BBÎ CAR CONSTRUCT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A second-generation chimeric antigen receptor (CAR) construct targeting TAG72 with components including CC49 scFv, ÎCH2 Fc spacer, CD4 transmembrane domain, 4-1BB co-stimulatory domain, and CD3Î¶ signaling domain."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;DPBMCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Peripheral blood mononuclear cells (PBMC) that have been depleted of CD14+ and CD25+ cells, used as a source for CAR T cell generation."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD19T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A truncated version of the CD19 protein used for tracking CAR T cells during manufacturing and expansion."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;SKOV3 CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Human ovarian cancer cell line, SKOV3, which does not express surface TAG72 antigen."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVCAR8 CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A cell line derived from ovarian cancer cells that expresses low levels of MUC1 but lacks TAG72 and MUC16 expression."&lt;SEP&gt;"Human ovarian cancer cell line, OVCAR8, which does not express surface TAG72 antigen."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;COV362.4 CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Human ovarian cancer cell line with low expression of surface TAG72 antigen."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVCAR3 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A human epithelial ovarian carcinoma cell line used to establish tumors in immune-compromised mice for evaluating the efficacy of TAG72-BBÎ¶ CAR T cells."&lt;SEP&gt;"Human ovarian cancer cell line expressing high levels of surface TAG72 antigen, approximately 42% by flow cytometry."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OV90 CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Human ovarian cancer cell line with very high expression of surface TAG72 antigen, approximately 90% by flow cytometry."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;LS174T COLON CANCER LINE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colon cancer cell line expressing the TAG72 antigen, used as a positive control in experiments targeting ovarian cancer cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72 EXPRESSION LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The quantitative measurement of TAG72 protein expression on tumor cell surfaces or in ascites samples from patients with ovarian cancer."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TUMOR KILLING POTENTIAL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The ability of CAR T cells to recognize, bind, and kill tumor cells based on the presence of specific antigens like TAG72."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OAS3, OAS4, AND OAS7&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Ascites from three patients with ovarian cancer expressing different levels of the TAG72 protein."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;NSG MICE&quot;">
      <data key="d0">"ANIMAL MODEL"</data>
      <data key="d1">"NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice are an immune-deficient mouse strain used for xenograft studies of human cancer models."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;INTRAPERITONEAL DELIVERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of administering drugs or cells directly into the peritoneal cavity to target abdominal cancers, enhancing local drug concentration and efficacy."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;SYSTEMIC INTRAVENOUS DELIVERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A method for delivering therapeutic agents throughout the body via intravenous injection, with systemic distribution."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;TUMOR GROWTH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The uncontrolled growth of abnormal cells to form a mass or lump in the body, often associated with cancer development and progression."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;ANTI-TUMOR ACTIVITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An interaction that describes the effectiveness of treatments aimed at inhibiting tumor growth or killing cancerous cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;REPEAT DOSING&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A therapeutic approach involving multiple administrations of a drug or treatment to enhance efficacy and prolong response duration."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;HUCD45+CD19T+&quot;">
      <data key="d0">"CELL MARKER"</data>
      <data key="d1">"CAR T cells can be identified in the blood of treated mice using this marker, indicating their presence and circulation following intraperitoneal administration."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;RELATIVE TUMOR GROWTH KINETICS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure used to track the progression or regression of tumor growth over time relative to untreated controls or baseline measures."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVARIAN CANCER XENOGRAFT MODELS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Experimental models of ovarian cancer used for testing therapeutic interventions like CAR T cell therapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TAG72 ANTIGEN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding an antigen expressed on the surface of some ovarian cancer cells, targeted by CAR T cells in this study."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR RECURRENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process where tumors regrow after initial treatment response."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC1 ANTIGEN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding another cell surface antigen expressed on some ovarian cancer cells, involved in tumor heterogeneity and escape mechanisms."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC16 ANTIGEN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene coding for an antigen found on the surface of certain ovarian cancer cells, related to therapeutic targeting strategies."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;CAR T CELL THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A form of immunotherapy where T cells are engineered to express a chimeric antigen receptor (CAR) that targets specific antigens expressed by tumor cells."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR HETEROGENEITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The presence of genetic and phenotypic diversity within tumors, contributing to resistance against targeted therapies."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OVCAR3 TUMORS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Experimental tumors derived from OVCAR3 cells, used to study the efficacy of CAR T cell therapy in ovarian cancer models."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OV90 TUMOR MODEL&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A model system using OV90 cells to evaluate the impact of CAR T cell therapy on tumor growth and recurrence."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at the THSD4-UACA-TLE3 locus on chromosome 15q23 was found to be significantly associated with FEV1/FVC in Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;RS12441227&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP is the most significant variant at the THSD4-UACA-TLE3 locus, explaining 2.9% of residual variance in FEV1/FVC among Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;C10ORF11 GENE ON CHROMOSOME 10Q22.3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene is associated with FEV1/FVC and has shown genome-wide significance when analyzed excluding asthmatics."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;CCL23-CCL18 LOCUS ON CHROMOSOME 17Q12&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at this locus, near the CCL23-CCL18 genes, is associated with FEV1/FVC in Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;PITPNC1 LOCUS ON CHROMOSOME 17Q24.2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The PITPNC1 gene region has been found to be associated with FEV1/FVC among Hutterite subjects."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;CHAF1B LOCUS ON CHROMOSOME 21Q22.13&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant near the CHAF1B gene is significantly associated with FEV1/FVC, particularly in non-asthmatic samples."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;IL37 GENE ON CHROMOSOME 2Q13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene has been identified as being associated with FEV1 among Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;ASXL3 LOCUS ON CHROMOSOME 18Q12.1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic SNP in the ASXL3 gene is associated with FVC among Hutterite subjects."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FEV1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Forced expiratory volume in one second, a physiological process measure of lung function."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FVC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Forced vital capacity, another measure used to assess lung health and function."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FEV1/FVC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FEV1/FVC is a physiological process representing forced expiratory volume in one second as a proportion of forced vital capacity, often used to assess lung function."&lt;SEP&gt;"The ratio of FEV1 to FVC is a critical physiological process indicator for assessing respiratory health."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;HERITABILITY (H2/H2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Broad and narrow sense heritabilities measuring the proportion of phenotypic variance attributable to genetic variation in lung function measures among Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;LOW FEV1/FVC ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Allelic variants associated with lower FEV1/FVC values, indicating genetic influences on lung function."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;Î-DEFENSIN GENES CLUSTER 1-3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Clusters of Î²-defensin genes identified in the GRAIL analysis as being significantly related to the predictive SNPs for FEV1/FVC."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CCL18 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A chemokine gene (CC motif ligand 18) identified in the GRAIL analysis and functionally connected to Î²-defensin genes and CXCL12/TNFRSF13B."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CXCL12 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A chemokine gene (C-X-C motif ligand 12) found to be significantly related in the GRAIL analysis, connected to CCL18 and TNFRSF13B genes."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;TNFRSF13B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tumor necrosis factor receptor superfamily member 13B gene identified as functionally significant in the GRAIL analysis for FEV1/FVC variance explanation."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3 LOCUS SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genetic variants at this locus did not show functional connections to other genes defined by 80 SNPs, but are replicated loci in the GWAS study."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;C10ORF11 LOCUS SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs at this locus were not functionally connected to any other genes defined by the 80 SNPs identified in the study."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CCL23-CCL18 LOCUS SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A significant genomic variant located between CCL23 and CCL18, showing functional connections with Î²-defensin gene clusters, CXCL12, and TNFRSF13B."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;THSD4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located within the THSD4-UACA-TLE3 locus, identified in the GWAS study."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;UACA GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located within the THSD4-UACA-TLE3 locus, identified in the GWAS study."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;TLE3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located within the THSD4-UACA-TLE3 locus, identified in the GWAS study."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;C10ORF11 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene at the C10orf11 locus, which did not show functional connections to other genes defined by 80 SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;GWAS STUDY&quot;">
      <data key="d0">"RESEARCH METHOD"</data>
      <data key="d1">"A type of research study that searches the entire genome to find genetic variations associated with particular diseases, traits, or states."&lt;SEP&gt;"Genome-wide association study (GWAS) aimed at identifying genetic variants associated with FEV1/FVC in the Hutterite population."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;GRAIL ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"A computational method used to identify functional connections between genes near GWAS predictive SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CTLA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CTLA4 is a gene that plays a role in immune regulation and its expression levels can be influenced by epigenetic DNA methylation."&lt;SEP&gt;"CTLA4 is a gene that plays a role in the immune system regulation."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RS231775&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs231775 is a genomic variant of CTLA4 associated with primary biliary cholangitis (PBC) susceptibility."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS231725&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs231725 is another genomic variant of CTLA4 linked to PBC susceptibility."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS3087243&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs3087243 is a genomic variant of CTLA4, but it does not show an association with PBC susceptibility."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS5742909&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs5742909 is another genomic variant of CTLA4 that was investigated for its association with PBC susceptibility and found to be non-significant."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PRIMARY BILIARY CHOLANGITIS (PBC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"PBC is a chronic liver disease characterized by the progressive destruction of bile ducts, often associated with specific genetic polymorphisms such as those in CTLA4."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS3087243 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism of rs3087243 within the CTLA4 gene that does not show a significant association with PBC susceptibility."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS5742909 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism in CTLA4, rs5742909, is also found to be non-significantly associated with primary biliary cholangitis (PBC) risk."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;FIXED-EFFECTS MODEL&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"In meta-analysis, this model assumes that there is a single true effect size across all included studies."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RANDOM-EFFECTS MODEL&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"Used in meta-analysis when it's assumed that the true effect sizes differ between studies due to variability (heterogeneity)."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PRIMARY BILIARY CHOLANGITIS SUSCEPTIBILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Refers to the likelihood or predisposition for individuals to develop primary biliary cholangitis, influenced by genetic factors such as CTLA4 variants."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSES&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"Evaluates the robustness of meta-analysis results to individual studies or assumptions about study effects."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PUBLICATION BIAS EVALUATION&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Assesses whether smaller, less significant studies are underrepresented in published research findings."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PBC&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The genetic variant rs231775 increases susceptibility to primary biliary cholangitis (PBC)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PBC SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The polymorphism rs3087243 within CTLA4 does not influence the risk of primary biliary cholangitis (PBC)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTLA4 POLYMORPHISMS&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The meta-analysis focuses on the association between CTLA4 polymorphisms and primary biliary cholangitis (PBC) susceptibility."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HETEROGENEOUS STUDIES&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"Preferred for meta-analysis when there is significant variability among study results."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTLA4 VARIANTS&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The susceptibility to PBC varies based on specific genetic variants within the CTLA4 gene, affecting immune system regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"Assesses whether certain polymorphisms are inherited together more frequently than expected by chance, providing insights into their co-occurrence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;META-ANALYSIS STABILITY&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"Conducted to ensure the stability of meta-analysis results when individual studies or assumptions about study effects are omitted."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESEARCH INTEGRITY&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"Ensures that the conclusions drawn from the meta-analysis are not skewed by publication bias, maintaining research integrity and validity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IKBKE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IKBKE gene, located upstream of the long coding RNA RP11â534L20.5, plays a role in regulating inflammatory responses to viral infections."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;STAT6 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"STAT6 is a transcriptional activator involved in T cell differentiation and has genetic regulatory effects within CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;STX2 GENE (SYNTAXIN 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The STX2 gene, involved in intracellular vesicle transport, shows evidence of genetic regulation by cis-eQTLs in both CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CIS-REGULATORY SNP (EQTL) FOR IKBKE GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A cis-regulatory SNP that influences gene expression near the IKBKE gene, regulating inflammatory responses to viral infections through genetic control of long coding RNA RP11â534L20.5."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CIS-REGULATORY SNP (EQTL) FOR STAT6 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A cis-regulatory SNP that influences the expression of STAT6, a transcriptional activator involved in T cell differentiation."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CIS-REGULATORY SNP (EQTL) FOR STX2 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A cis-regulatory SNP affecting gene expression levels of syntaxin 2, which is involved in intracellular vesicle transport in CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;BAYESIAN HIERARCHICAL MODELLING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A statistical method used to assess the specificity and proportion of shared eQTLs between different cell types by combining information across genes within one framework."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;EFFECT SIZE (EQTL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The measure of how much gene expression levels change due to genetic variants, which influences the statistical power in detecting significant eQTL effects."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CTLA4 GENE EXPRESSION REGULATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genetic control over CTLA4 gene expression and alternative splicing patterns specific to CD4+ T cells, with differential methylation affecting mRNA levels between CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;DNA METHYLATION OF CTLA4 GENE LOCUS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Differential DNA methylation at a CpG site near the second exon of CTLA4 inversely correlates with gene expression levels, indicating cell type-specific regulation."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CTLA4 POLYMORPHISM CT60A/G (RS3087243)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant in strong linkage disequilibrium with the MH30C/G polymorphism is associated with lower CTLA4 mRNA expression and increased risk of autoimmune diseases."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;T1D AND RA-ASSOCIATED VARIANTS (E.G., RS231775, RS3087243)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific SNPs associated with Type 1 Diabetes (T1D) and Rheumatoid Arthritis (RA), influencing CTLA4 gene expression levels in CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;(AT)N REPEAT POLYMORPHISM IN THE 3âUTR OF CTLA4&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Length variation in this repeat region is associated with differential mRNA expression levels of CTLA4, contributing to disease risk in autoimmune conditions."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;ALTERNATIVE SPLICING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process where a single gene can produce multiple transcripts and proteins due to different ways in which the exons are spliced together."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CG26091609&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A CpG site (cg26091609) associated with CTLA4 gene expression."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;EQTL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Expression Quantitative Trait Loci (eQTLs) are genomic variants that influence the expression levels of genes, particularly in specific cell types like CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;T1D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 1 Diabetes (T1D) is a disease influenced by genetic variants and associated with specific gene functions in CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;MTOR SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The mTOR signaling pathway plays a role in the regulation of cellular processes such as growth, metabolism, and autophagy. It is influenced by genetic variants associated with T1D."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RS1131017&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP (rs1131017) located in the 5'UTR of RPS26 gene, linked to eQTL effects and several GWAS SNPs associated with autoimmune diseases."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RPS26&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ribosomal small subunit protein RPS26 gene is affected by trans-acting regulatory locus in T cells. Its expression level can be regulated by genetic variants such as rs1131017."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;TRANS-EQTL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Trans-Expression Quantitative Trait Loci (trans-eQTL) refers to the effect of a SNP on gene expression located far (&gt;5 Mb) from the locus. It can have significant effects in specific cell types like CD4+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL27 GENE REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region close to IL27 associated with trans-eQTLs and genetic variants linked to lower expression of IRF1, STAT1, and reduced risk for Type 1 Diabetes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RS4788084[T]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP is located near the IL27 gene and is associated with a decreased expression level of STAT1 in CD4+ T cells, contributing to lower T1D risk."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;MISSENSE SNP RS181206[G]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense variant within the IL27 gene that changes an amino acid (Leu119Pro) and influences expression levels of IRF1, STAT1, and REC8. It is associated with T1D susceptibility."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;STAT1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Signal transducer and activator of transcription 1 (STAT1) gene, whose expression level can be influenced by genetic variants associated with T1D risk."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;BAYESIAN TEST FOR COLOCALISATION&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A method used to determine whether a variant in the genome is causally related to both a disease and changes of expression in genes, suggesting shared causal variants."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;5'UTR&quot;">
      <data key="d0">"GENE REGION"</data>
      <data key="d1">"The 5' untranslated region (5' UTR) is the section at the beginning of an mRNA molecule that precedes the start codon and does not code for any protein but can affect gene expression."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;GWAS SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms (SNPs) identified through Genome-Wide Association Studies (GWAS) as being associated with particular traits or diseases."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;AUTOPHAGY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which a cell digests parts of itself or damaged organelles. It is regulated by signaling pathways such as mTOR."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;INFECTIOUS DISEASES&quot;">
      <data key="d0">"DISEASE CATEGORY"</data>
      <data key="d1">"A category of diseases caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IMMUNE RESPONSE REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process through which the immune system responds to pathogens or other triggers, often influenced by genetic factors like CTLA4 expression."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL27RA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by IL27RA functions as part of a receptor complex for the cytokine interleukin-27 (IL-27), which activates signaling pathways involved in immune regulation."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;GP130&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Gp130, also known as IL6ST, is a transmembrane protein that functions as an accessory subunit for various cytokine receptors including those for IL-27 and IL-12."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IRF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interferon regulatory factor 1 (IRF1) is a transcription factor involved in the regulation of interferon-responsive genes and plays a role in immune responses against viral infections."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;STAT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Signal transducer and activator of transcription 1 (STAT1) is a protein that functions as an intracellular signal transducer for cytokines like IL-27, involved in the regulation of gene expression in response to immune stimuli."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL6ST (GP130)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"GP130 acts as an accessory subunit for receptors of several interleukins including IL-27 and IL-12. It is critical for signaling pathways that regulate inflammatory responses."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27RA, GP130 (RECEPTOR COMPLEX)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This receptor complex forms when IL27 binds to its corresponding receptors, initiating intracellular signal transduction pathways involved in immune regulation."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;EBI3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Epstein-Barr virus-induced gene 3 (EBI3) is a subunit of the interleukin-35 and interleukin-27 cytokines that plays a role in modulating the immune response."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin-27 (IL-27) is a cytokine involved in immune regulation, particularly in inducing interferon-stimulated genes such as IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;SNP RS181206[G]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant (Single Nucleotide Polymorphism) located in the IL-27 gene region that is associated with changes in expression levels of IRF1 and STAT1 genes."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INTERFERON-STIMULATED RESPONSE ELEMENTS (ISRE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Binding sites for transcription factors like STAT1 and IRF1, involved in the regulation of interferon-responsive gene expression."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES (T1D)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic autoimmune condition characterized by destruction of insulin-producing beta cells in the pancreas leading to high blood sugar levels."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;TRANSCRIPT LEVELS OF IRF1, STAT1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The measurement and regulation of transcript levels for genes IRF1 and STAT1 are critical processes in understanding gene expression changes due to genetic variants."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL-27 CYTOKINE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin-27 (IL-27) is a cytokine involved in immune responses, produced by innate immune cells and binding to its receptor complex to activate signaling pathways."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HEK293 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Human embryonic kidney 293 cells are commonly used for transient expression studies of proteins and for the production of recombinant proteins."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"PBMCs are isolated from blood, consisting mainly of lymphocytes including T-cells and B-cells, and monocytes used in immunological studies."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INNATE IMMUNE CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Immune cells such as macrophages and dendritic cells that provide an immediate defense against pathogens by recognizing them and initiating immune responses."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;GP130 (IL6ST)&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Together, IL27RA and gp130 form a receptor complex necessary for the signal transduction pathway activated by IL-27 binding."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STAT1/STAT3 PATHWAY&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Binding of STAT1 or STAT3 dimers to ISREs initiates transcriptional regulation of interferon-responsive genes such as IRF1 and STAT1."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL27 SNP RS181206[G]&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The genetic variant IL27 SNP rs181206[G] is associated with decreased expression of IRF1 and STAT1 genes in CD4+ T cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IRF1, STAT1 EXPRESSION LEVELS&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The genetic variant IL27 SNP rs181206[G] is associated with decreased expression of IRF1 and STAT1 genes in CD4+ T cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 SIGNALING&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Innate immune cells produce IL-27 which interacts with its receptor complex on T cells, leading to activation of the STAT1/STAT3 pathway."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 TRANSFECTION EXPERIMENT&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Human embryonic kidney 293 cells are used to produce and study IL-27 protein variants (Leu119 and Pro119) in the context of their effects on IRF1 and STAT1 expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 EFFECTS STUDY&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Human peripheral blood mononuclear cells are used to assess how different IL-27 variants affect IRF1 and STAT1 transcript levels, providing insight into gene regulation mechanisms."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4073 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism located at rs4073 within the IL-8 gene that affects asthma risk."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS2227306 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism at rs2227306 within the IL-8 gene associated with increased susceptibility to asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by the IL-8 gene, involved in immune and inflammatory responses."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 MRNA TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the IL-8 gene that is expressed at higher levels in asthma patients compared to controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic disease affecting the airways, associated with genetic and environmental factors."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;PBMC COMPOSITION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The composition of peripheral blood mononuclear cells, which did not differ significantly between asthma patients and healthy controls in this study."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;MODERATE-SEVERE ASTHMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A more severe form of asthma characterized by higher IL-8 serum concentrations compared to mild asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;MILD ASTHMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A less severe form of asthma with lower levels of IL-8 mRNA and protein compared to moderate-severe asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 SERUM LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The level of IL-8 protein measured in serum, which is significantly higher in asthma patients compared to controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA RISK&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d1">"Carrying the homozygous TT genotype at rs4073 increases asthma susceptibility, indicating a strong genetic link to disease risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASAH1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ASAH1 gene is located on chromosome 8p22-p21.3 and contains 86 HapMap SNPs and 14 typed SNPs."&lt;SEP&gt;"The ASAH1 gene is under study in genetic analyses involving different kernels and tests for detecting gene effects."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a&lt;SEP&gt;chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A kernel machine SNP-set test was used for the ASAH1 gene with a linear kernel, showing higher power than the min test when causal SNPs have moderate LD with typed SNPs."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;MIN TEST&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The min test, when applied to imputed data and gene effects, typically has lower empirical power compared to other tests like IBS kernel or linear kernel."&lt;SEP&gt;"The single SNP-based min test is used as a benchmark and gives correct size but lower power compared to the kernel machine method for ASAH1 and NAT2 genes under certain conditions."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a&lt;SEP&gt;chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;NAT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located on 8p22, NAT2 has 22 HapMap SNPs and 4 typed SNPs. The power of the min test is higher in specific scenarios where a single causal SNP is highly correlated with one typed SNP."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;FGFR2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene used for illustrating the performance of kernel machine method compared to the min test, showing superiority in regions with high LD and comparable power in regions with weak LD."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HLA-B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Part of the human leukocyte antigen (HLA) complex on chromosome 6p21.3, HLA-B has only 6 HapMap SNPs and 2 typed SNPs, demonstrating how rare alleles can be upweighted by using MAF as weights."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;GENETIC VARIANTS (SNPS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variants or single nucleotide polymorphisms (SNPs) are used in the SNP-set test to determine genetic associations and predict disease susceptibility."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS2523608)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP, rs2523608, has a higher MAF and acts as a causal variant in some studies."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;IBS KERNEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The IBS kernel is used to test for gene effects and shows high power when the model is correctly specified."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;LINEAR KERNEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A linear kernel used in genetic studies often suffers from substantial power loss due to mis-specification of the model."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;EMPIRICAL TYPE 1 ERROR RATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In genetic studies, the empirical type 1 error rate is an important measure of test reliability, with rates for linear kernel and min test being reported as 0.0566 and 0.0404 respectively at Î±=0.05."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;EMPIRICAL POWER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Empirical power measures the ability of a statistical test to detect an effect when there is one, with IBS kernel showing higher empirical power compared to linear kernel and min test in some cases."&lt;SEP&gt;"Measures the actual ability of tests to detect gene effects under study conditions."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;LD (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Good linkage disequilibrium structure between causal SNPs and typed SNPs can impact the performance of gene set tests, like in the case of ASAH1 where good LD leads to better test performance."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The weighted IBS kernel incorporates information on rare variants' importance into its function."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;MAF (MINOR ALLELE FREQUENCY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"MAF is used to describe the frequency of less common alleles in a population, impacting gene effect studies."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;CAUSAL SNP (RS2523608)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP acts as a causal variant influencing the power of different kernel functions."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;EPISTASIS (INTERACTIONS BETWEEN GENES)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Epistatic interactions influence gene effect studies and model specification."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;LD STRUCTURE (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The LD structure between SNPs is crucial for the performance of SNP-set tests, especially in the context of ASAH1 gene effects."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;MAF&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"The minor allele frequency of rs2523608 influences its role as a causal variant in genetic studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1893217&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (SNP) mapped to the PTPN2 gene that influences response rates for anti-CTLA-4 treatment in metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;IL2, ADAD1 AND IL21 LOCUS&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"The genomic region containing IL2, ADAD1 and IL21 is associated with allergy, colitis and type 1 diabetes."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;RS17388568&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A significant SNP mapped to the IL2-IL21 locus that influences response rates for anti-PD-1 treatment in metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-CTLA-4 TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A type of immunotherapy used to treat metastatic melanoma by targeting CTLA-4."&lt;SEP&gt;"Anti-CTLA-4 treatment is one of the treatments considered in the pooled association analysis."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;ANTI-PD-1 TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A type of immunotherapy used to treat metastatic melanoma by targeting PD-1."&lt;SEP&gt;"Anti-PD-1 treatment is another therapy included in the pooled association analysis across different treatments."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;COMBINATION THERAPY (ANTI-CTLA-4 AND ANTI-PD-1)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A combination therapy involving both anti-CTLA-4 and anti-PD-1 treatments for treating metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;METASTATIC MELANOMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An advanced stage of melanoma cancer that has spread from its original site to other parts of the body."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;NIVOLUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A type of PD-1 inhibitor used in immunotherapy for treating metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;PEMBROLIZUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Another type of PD-1 inhibitor used in immunotherapy for treating metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;IPILIMUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A CTLA-4 inhibitor used in immunotherapy for treating metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;TREMELIMUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Another CTLA-4 inhibitor used in immunotherapy for treating metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ICIS (IMMUNE CHECKPOINT INHIBITORS)&quot;">
      <data key="d0">"THERAPY CLASS"</data>
      <data key="d1">"Class of drugs including anti-PD-1 and anti-CTLA-4 treatments that boost the immune system's ability to fight cancer."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;PTPN2 GENE REGION&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"The genomic region containing PTPN2, linked to autoimmune diseases and response to immunotherapy in metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;IL2-IL21 GENOMIC LOCUS&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"A genetic locus containing IL2, ADAD1, and IL21, associated with allergy, colitis, type 1 diabetes, and response to immunotherapy in metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;COMBINATION THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Combination therapy, involving a combination of anti-CTLA-4 and anti-PD-1 treatments, was studied for its effect on patient response."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;TREATMENT RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The treatment response is the physiological process being analyzed in patients treated with different therapies."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;BONFERRONI METHOD&quot;">
      <data key="d0">"METHODOLOGICAL PROCEDURE"</data>
      <data key="d1">"A method used to adjust for multiple testing, which was applied in the study but did not yield significant associations."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;HOLM-BONFERRONI METHOD&quot;">
      <data key="d0">"METHODOLOGICAL PROCEDURE"</data>
      <data key="d1">"Another method used to adjust for multiple testing alongside the Bonferroni method."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;SAMPLE SIZE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The sample size of 43 patients is too small, leading to limited power in detecting significant associations between SNPs and treatment response."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;CONFIDENCE INTERVAL&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Wide confidence intervals indicate the limitations due to a smaller sample size, affecting the study's ability to detect meaningful differences."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;IL2-IL21 LOCUS&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The IL2-IL21 locus contains rs17388568, a significant SNP linked to increased efficacy of anti-PD-1 therapy in metastatic melanoma."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-CTLA-4 TREATMENT RESPONSE RATE&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The presence of the minor allele G in rs1893217 is associated with a reduced likelihood of response to anti-CTLA-4 treatment."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-PD-1 TREATMENT RESPONSE RATE&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The presence of the minor allele GA or AA in rs17388568 is associated with a higher likelihood of response to anti-PD-1 treatment."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLERGY, COLITIS, TYPE 1 DIABETES&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The SNP rs17388568 is associated with increased risk for conditions like allergy, colitis and type 1 diabetes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IPILIMUMAB, TREMELIMUMAB&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"Ipilimumab and tremelimumab are drugs used in anti-CTLA-4 treatment for metastatic melanoma."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NIVOLUMAB, PEMBROLIZUMAB&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"Nivolumab and pembrolizumab are drugs used in anti-PD-1 treatment for metastatic melanoma."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METASTATIC MELANOMA PATIENTS&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The presence of rs1893217 influences the efficacy of anti-CTLA-4 treatment in metastatic melanoma patients."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"EBNA2 is a protein that binds chromatin at multiple sclerosis (MS) risk loci dependent on the MS risk allele."&lt;SEP&gt;"EBNA2 is a protein that interacts with MS risk loci and alters gene expression, potentially affecting immune evasion."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;MS RISK SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Multiple genomic variants have been identified as eQTLs in lymphoblastoid cell lines (LCLs), with evidence suggesting their binding sites are occupied by EBNA2."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TRAF3/RCOR1 SNP (RS1258869)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant located at the TRAF3/RCOR1 locus has been shown to affect chromatin binding of EBNA2 and is associated with MS risk."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;CD40 SNP (RS1883832)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant, rs1883832, at the CD40 locus shows preferential EBNA2 binding to its risk allele, impacting gene expression and MS risk."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFAIP8 SNP (RS32658)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs32658 at the TNFAIP8 locus demonstrates a protective effect with EBNA2 binding to its non-risk allele, altering gene expression in LCLs."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFRSF1A SNP (RS180069)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs180069 at the TNFRSF1A locus is preferentially bound by EBNA2 to its protective allele, affecting gene expression and MS risk."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TBX6 SNP (RS3809627)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs3809627 at the TBX6 locus is associated with a protective effect when EBNA2 binds to its non-risk allele, influencing MS risk."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBNA2-TAT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A modified form of EBNA2 that inhibits its transcriptional function by disrupting the interaction with RBP-JÎº. It affects LCL proliferation and alters expression of several MS risk genes."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LMP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Expression of LMP1, an Epstein-Barr virus (EBV) gene regulated by EBNA2, is significantly reduced in response to EBNA2-TAT treatment."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TRAF3 GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alteration in TRAF3 gene expression due to inhibition of EBNA2 function suggests its role in MS risk regulation."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;CD40 GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in CD40 gene expression as a result of inhibiting EBNA2 function imply an involvement in MS pathogenesis through altered transcriptional activity."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;CLECL1 GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Significant reduction in CLECL1 gene expression following inhibition of EBNA2 indicates its role influenced by this protein's regulation."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFAIP8 GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Modulation of TNFAIP8 gene expression through interaction with EBNA2 suggests a link between this process and MS risk factors."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFRSF1A GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in TNFRSF1A gene expression due to inhibition of EBNA2 function may contribute to changes in MS susceptibility."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBV DNA COPY NUMBER&quot;">
      <data key="d0">"METABOLIC PATHWAY/MOLECULAR INTERACTION"</data>
      <data key="d1">"The copy number variation of EBV DNA within LCLs is a stable phenotype, influenced by both genetic factors and transcriptional regulators like EBNA2."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;MULTIPLE SCLEROSIS (MS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease involving the immune system attacking the central nervous system, with several genomic risk variants identified in association studies."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;MS RISK LOCI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"MS risk loci are genomic variants associated with multiple sclerosis (MS) that interact with EBNA2 to alter gene expression and influence immune evasion."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TRAF3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TRAF3 is a gene at an MS risk locus where EBNA2 binds preferentially to the risk allele, leading to lower expression of TRAF3."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;CD40&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CD40 is a gene at an MS risk locus where EBNA2 binds preferentially to the protective allele, resulting in relatively lower expression compared to B cells."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TNFAIP8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFAIP8 is a gene at an MS risk locus that exhibits altered allelic association with expression upon EBNA2 binding and treatment with EBNA2-TAT."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TNFRSF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFRSF1A is a gene at an MS risk locus where EBNA2 preferentially binds to the protective allele, leading to lower expression compared to B cells."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TBX6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TBX6 is a gene at an MS risk locus that exhibits altered allelic association with expression upon EBNA2 binding and treatment with EBNA2-TAT."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;RCOR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RCOR1 is a gene at an MS risk locus where the effect of EBNA2 on expression alters relative allelic expression compared to B cells."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;CLECL1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CLECL1 is a gene at an MS risk locus that exhibits altered allelic association with expression upon EBNA2 binding and treatment with EBNA2-TAT, but no significant effect of genotype on expression."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBV LATENCY III PROGRAM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The EBV latency III program is a physiological process involving the Epstein-Barr virus (EBV) where EBNA2 interacts with MS risk genes to influence gene expression and immune evasion."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LMP1 AND LMP2 SIGNALLING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"LMP1 and LMP2 signalling refers to molecular interactions involved in the latency III program of Epstein-Barr virus (EBV) infection, which are influenced by EBNA2 interaction with MS risk genes."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;HOST IMMUNE EVASION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Host immune evasion is a physiological process where pathogens or viruses alter host gene expression to evade the immune system's detection and response."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBNA2-TAT TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"EBNA2-TAT treatment is used in experiments to inhibit EBNA2 function, thereby altering gene expression at MS risk loci and influencing immune evasion."&lt;SEP&gt;"Treatment with EBNA2-TAT inhibits the function of EBNA2, leading to alterations in gene expression at MS risk loci."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;GENOTYPE EFFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The genotype effect refers to differences in gene expression or phenotype due to genetic variation at MS risk loci."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;ALLELIC ASSOCIATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Allelic association refers to the relationship between specific alleles and their influence on gene expression or phenotype, particularly relevant for MS risk genes."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBNA2/RISK GENE INTERACTION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The effect of EBNA2 on expression at risk loci is postulated to increase host immune evasion through regulation of these risk genes in the latency III program.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COX-2 GENE POLYMORPHISM (RS20417)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in the COX-2 gene, rs20417, has been associated with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ITGA2 GENE POLYMORPHISM (RS1126643)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in the ITGA2 gene, rs1126643, is significantly linked to increased risk of aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;COX-1 GENE POLYMORPHISM (RS3842787)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No significant association found between the COX-1 gene polymorphism rs3842787 and aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ITGA2B GENE POLYMORPHISM (RS20118426)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ITGA2B gene polymorphism rs20118426 shows no significant association with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition where aspirin does not effectively prevent blood clots, associated with specific genetic variants."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CAUCASIAN PATIENTS AND CONTROLS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Study participants of Caucasian ethnicity involved in the research on aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CHINESE PATIENTS AND CONTROLS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Study participants of Chinese ethnicity involved in the research on aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CAD (CORONARY ARTERY DISEASE)&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"A condition where coronary arteries are narrowed or blocked, significantly contributing to heterogeneity in studies involving genetic polymorphisms and aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20417&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with differences in percentage of CAD between patients and controls."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;RS1126643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant for which averaged platelet number was a significant source of heterogeneity."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;AVERAGED PLATELET NUMBER&quot;">
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d1">"Averaged platelet number was found to be a significant source of heterogeneity for rs1126643, indicating an interaction between averaged platelet count and the genomic variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLATELETS&quot;">
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d1">"CAD is associated with various physiological processes including platelet function and number."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STAT5B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A homozygous nonsense mutation (c.1892G&gt;A) was identified in the STAT5B gene leading to a truncated protein."&lt;SEP&gt;"The STAT5B gene is associated with a loss-of-function variant that affects CD8+ T cell activation and homeostasis."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5&lt;SEP&gt;chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;HOMOZYGOUS NONSENSE MUTATION C.1892G&gt;A, P.W631*&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A homozygous nonsense mutation (c.1892G&gt;A) in STAT5B that converts a tryptophan at position 631 to a stop codon."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;WILD-TYPE FLAG-STAT5B (F-STAT5B WT)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A wild-type protein of the STAT5B gene used for comparison in functional analyses."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GROWTH HORMONE (GH)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GH is a physiological process that stimulates phosphorylation and nuclear localization of STAT5B, critical for its function."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A recombinant protein used to treat growth hormone insensitivity syndrome in the three siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SEVERE SHORT STATURE, HEIGHT SDS â6.5, â5.06, AND â4.7 &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological condition characterized by significantly below-normal height for age among the siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by inflammation of the thyroid gland with an autoimmune response in two of the siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SEVERE POST-NATAL GROWTH FAILURE &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The severe failure to grow and develop normally after birth, evident in all three siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;IN-VITRO FERTILIZATION (IVF) &quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"A medical procedure used for conception of patient 1."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;B CELL HYPERACTIVITY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An immune response observed in STAT5B deficient patients characterized by sustained B cell hyperactivity leading to atopy and autoimmunity."&lt;SEP&gt;"Sustained B cell hyperactivity is observed in STAT5B deficient siblings leading to atopy and autoimmunity."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;TRANSCRIPT OF STAT5B GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the STAT5B gene is affected by the homozygous nonsense mutation c.1892G&gt;A."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SRC HOMOLOGY 2 (SH2) DOMAIN AND TRANSACTIVATION DOMAIN (TAD)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These domains are critical for STAT5B activation, homodimer formation, and transcriptional activity."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GH RECEPTOR (GHRS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The GH receptor is used in HEK cells to evaluate the functional capacity of STAT5B p.W631* protein."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;NUCLEAR LOCALIZATION &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Following GH treatment, nuclear localization of wild-type STAT5B protein occurs but not in mutant form."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;NK CELLS &quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Cells that are reduced in number and impaired function due to deficiency in STAT5B."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;REACTIVE AIRWAY DISEASE &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by airway inflammation and constriction, developed similarly across the siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ATOPIC ECZEMA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An allergic skin condition observed in two of the siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;FETAL ALCOHOL SYNDROME LIKE FEATURES &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A set of features that resemble fetal alcohol syndrome observed due to the mutation's effects."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;STAT5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"STAT5B is a gene that plays a critical role in immune function, including the maintenance of T cell levels and regulation of B cells."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;LOF STAT5B VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A loss-of-function variant of STAT5B leads to reduced expression and impaired function of STAT5B protein."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;GH STIMULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GH stimulation is a physiological process that typically induces phosphorylation and nuclear translocation of the STAT5B protein, but is affected in patients with the LOF variant."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;NK CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NK cells are immune cells whose number and function are impaired in STAT5B deficient individuals due to reduced STAT5B activity."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;B CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"B cells are immune cells that exhibit increased immunoglobulin production in STAT5B deficient patients, often leading to elevated serum levels of IgE and associated atopic symptoms."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IGG, IGA, IGM, IGE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"IgG, IgA, IgM, and IgE are immunoglobulins that show normal or increased levels in STAT5B deficient patients, with elevated IgE being associated with atopic conditions."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;CHRONIC ECZEMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chronic eczema is a disease condition often found in children with STAT5B deficiency due to high levels of IgE."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;REACTIVE AIRWAY DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Reactive airway disease, commonly seen in atopic individuals, can be linked to increased IgE levels in STAT5B deficient patients."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;THYMIC T CELL PRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of thymic T cell production may be impaired in STAT5B deficient individuals, leading to reduced numbers of mature T cells."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;PERIPHERAL DESTRUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Peripheral destruction is a possible mechanism for the reduction of T cells in STAT5B deficient patients."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;RECENT THYMIC EMIGRANTS (RTE)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"RTEs are young T cells that have recently emigrated from the thymus, with their levels being assessed to evaluate thymic output in STAT5B deficient individuals."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IL-2 SIGNALING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"IL-2 signaling pathway involves STAT5B in inducing FOXP3 expression and maintaining self-tolerance."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;MEMORY CD8+ T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Memory CD8+ T cells exhibit pronounced dysregulation in young STAT5B deficient siblings, with reduced naÃ¯ve subsets and elevated memory/activation phenotypes."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IMMUNE DYSREGULATION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"The impaired regulation of immune responses in individuals with STAT5B deficiency, leading to various clinical manifestations such as increased IgE levels and autoimmune conditions."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;ANTI-THYROGLOBULIN ANTIBODIES&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Antibodies against thyroglobulin are elevated in patients with autoimmune thyroiditis associated with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;ANTI-THYROID PEROXIDASE (TPO) ANTIBODIES&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Antibodies targeting TPO are found to be increased in individuals suffering from autoimmune thyroiditis linked to STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;SELF-TOLERANCE&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"The ability of the immune system to distinguish self-cells from foreign cells, which is compromised by defects in IL-2 signaling due to reduced STAT5B activity."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;THYMIC FUNCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The development and maturation process occurring within the thymus for T lymphocytes, potentially impaired in individuals with defective STAT5B function."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IMMATURE T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"T cells that have not yet matured fully are affected by reduced STAT5B activity, leading to an accumulation of immature T cells or their accelerated destruction."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;THYROIDITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammation of the thyroid gland, commonly associated with autoimmune conditions in STAT5B deficient individuals."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;ALLERGIC SYMPTOMS&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Symptoms arising from allergic reactions due to elevated IgE levels observed in STAT5B deficiency patients."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IMMUNE RESPONSE DYSREGULATION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"An altered immune response causing overproduction of certain immunoglobulins and increased susceptibility to autoimmune conditions, characteristic of individuals with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;STAT5B VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A loss-of-function (LOF) STAT5B genomic variant is associated with dysregulation of CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ TEM CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The proportion of CD4+ TEM cells remained within normal ranges, indicating no significant alterations in this cell subset."&lt;SEP&gt;"The proportion of CD4+ TEM cells remained within normal ranges, suggesting no significant impact from the genomic variant on this cell subset."&lt;SEP&gt;"The proportion of CD4+ TEM cells remained within normal ranges, unaffected by the STAT5B variant."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEM CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Increases in CD8+ TEM cell proportions became significant with age, indicating a critical role for STAT5B variant in their regulation."&lt;SEP&gt;"Increases in the percentage of CD8+ TEM cells became clinically significant with age, suggesting a critical role for STAT5B variant in their activation and homeostasis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEMRA CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Elevations in CD8+ TEMRA cell proportions during infancy suggest a critical period influenced by STAT5B deficiency."&lt;SEP&gt;"Elevations in the percentage of CD8+ TEMRA cells detected during infancy normalized around age 4, indicating a developmental trajectory influenced by STAT5B deficiency."&lt;SEP&gt;"Elevations of CD8+ TEMRA cells during infancy suggest an early impact of STAT5B deficiency on T cell development."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;STAT5B DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients with STAT5B deficiency exhibit elevated CD8+ memory T cells from birth, indicating a fundamental role in T cell regulation."&lt;SEP&gt;"Patients with STAT5B deficiency exhibit elevated proportions of CD8+ memory T cells beginning in infancy, suggesting a critical role for this genomic variant in immune cell regulation."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ MEMORY T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No alterations were identified in the proportion of CD4+ memory T cells, indicating normal regulation despite STAT5B deficiency."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;LOF MUTATION IN STAT5B&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A loss-of-function mutation in the STAT5B gene leads to abnormal regulation of CD8+ T cells."&lt;SEP&gt;"A specific genomic mutation in the STAT5B gene causes dysregulation of CD8+ T cells and memory T cell proportions."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;PHOSPHORYLATION/NUCLEAR TRANSLOCATION&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"GH stimulation typically results in phosphorylation and nuclear translocation of STAT5B, but this process is impaired by the LOF variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STAT5B GENE EXPRESSION&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"Impaired expression or function of STAT5B leads to reduced numbers and function of NK cells in deficient individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IGE LEVELS&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"Increased immunoglobulin production by B cells, particularly IgE, is associated with elevated serum levels leading to allergic conditions such as chronic eczema and reactive airway disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOXP3 EXPRESSION&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"Maintenance of T cell levels is influenced by the expression level of FOXP3, which is affected in patients with defective STAT5B function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG FUNCTION&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"Evaluation of RTEs helps assess the function and maintenance of regulatory T cells in STAT5B deficient patients over time.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-2 SIGNALING PATHWAY&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"The IL-2 signaling pathway is crucial for Treg differentiation and function, mediated by STAT5B's role in FOXP3 induction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NAIVE T CELLS&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"Young STAT5B deficient siblings exhibit dysregulated memory CD8+ T cells with reduced naÃ¯ve subsets and elevated memory/activation phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD8+ MEMORY T CELLS&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Patients with STAT5B deficiency have elevated proportions of CD8+ memory T cells from infancy onwards, indicating a critical role for the STAT5B variant in CD8+ T cell homeostasis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DRB1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-DRB1 gene is involved in immune responses and has specific alleles such as HLA-DRB1*07:01."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SNP RS28383172&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs28383172 is a Single Nucleotide Polymorphism (SNP) associated with HLA-DRB1*07:01 carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype is a genetic variant associated with E. coli ASP hypersensitivity."&lt;SEP&gt;"This specific haplotype is associated with certain immune responses and genetic predispositions to diseases."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62&lt;SEP&gt;chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SNP RS2395182&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2395182 is a SNP involved in predicting the HLA-DRB1*07:01âDQA1*02:01âDQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SNP RS4713586&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4713586 is a SNP used in predicting the HLA-DRB1*07:01âDQA1*02:01âDQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SNP RS7775228&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs7775228 is a SNP involved in predicting the HLA-DRB1*07:01âDQA1*02:01âDQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM (LD)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Linkage disequilibrium refers to the non-random association of alleles at different loci in a genome, which is important for genetic studies and predicting disease susceptibility."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DQA1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-DQA1 gene is part of the human leukocyte antigen complex and forms haplotypes with other genes like HLA-DRB1 and HLA-DQB1."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;ALLELE CARRIER STATUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Refers to the presence or absence of specific alleles in an individual's genome, important for predicting disease susceptibility and immune responses."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HAPLOTYPE TAGGING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of using a set of genetic markers (SNPs) to predict haplotype carrier status, crucial for genotyping large populations efficiently."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SENSITIVITY&quot;">
      <data key="d0">"MEASUREMENT METRIC"</data>
      <data key="d1">"A measure indicating the proportion of actual positives that are correctly identified as such."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SPECIFICITY&quot;">
      <data key="d0">"MEASUREMENT METRIC"</data>
      <data key="d1">"A measure indicating the proportion of actual negatives that are correctly identified as such."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;POSITIVE PREDICTIVE VALUE (PPV)&quot;">
      <data key="d0">"MEASUREMENT METRIC"</data>
      <data key="d1">"The probability that subjects with a positive test truly have the condition."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;NEGATIVE PREDICTIVE VALUE (NPV)&quot;">
      <data key="d0">"MEASUREMENT METRIC"</data>
      <data key="d1">"The probability that subjects with a negative test truly do not have the condition."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"E. coli ASP hypersensitivity is an allergic condition caused by the dietary protein alpha-lactalbumin from E. coli."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;TLR7 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TLR7 gene is involved in the immune response to HIV infection, with specific polymorphisms (rs179008 and rs179009) being studied for their association with disease progression."&lt;SEP&gt;"The TLR7 gene is studied for its polymorphisms (rs179008 and rs179009) in relation to HIV disease progression."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;POLYMORPHISM RS179008 AND RS179009&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These genomic variants in the TLR7 gene are associated with altered risk of HIV infection, as indicated by reduced occurrence in infected individuals compared to healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;HIV DISEASE STAGES&quot;">
      <data key="d0">"DISEASE STAGE"</data>
      <data key="d1">"The progression of HIV disease is linked to genetic factors such as the presence or absence of certain TLR7 polymorphisms."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TOBACCO AND ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Consumption of tobacco and alcohol in individuals with HIV infection shows a non-significant impact on the distribution of TLR7 gene variants."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;DEMOGRAPHIC PROFILE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The demographic profile includes age and sex distributions that influence genetic associations in HIV-infected individuals versus healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 HAPLOTYPES (RS179008 AND RS179009)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific haplotypes of the TLR7 gene polymorphisms are analyzed for association with HIV infection, particularly focusing on AG and other combinations."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;BASELINE CD4 COUNTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline CD4 counts represent the initial level of CD4 cells in patients before considering any changes due to treatment or disease progression."&lt;SEP&gt;"CD4 counts at the baseline are used to assess immune system health and its correlation with TLR7 gene polymorphisms."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;TLR7 (RS179008)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TLR7 (rs179008) is a specific polymorphism of the TLR7 gene that has been studied for its correlation with HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TLR7 (RS179009)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TLR7 (rs179009) is another polymorphism of the TLR7 gene examined in relation to HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;AGE AND SEX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Age and sex are physiological processes or attributes that were correlated with HIV disease progression through multivariate logistic regression analysis."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TOBACCO USAGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The use of tobacco is an environmental factor considered in the correlation study for HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;ALCOHOL USAGE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Alcohol usage is a lifestyle factor that was analyzed along with other factors in relation to its effect on HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;CD4 COUNTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline CD4 counts, an indicator of immune system status, were correlated with HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HIV disease progression is the condition that was examined for factors influencing its course and severity through statistical analysis."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Multivariate logistic regression analysis was used to correlate age, sex, tobacco use, alcohol usage, baseline CD4 counts, and TLR7 polymorphisms with HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TOBACCO AND ALCOHOL USAGE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Both tobacco and alcohol usage are lifestyle factors that were analyzed for their impact on HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TLR7 GENE POLYMORPHISM RS179008 AND RS179009&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Consumption of tobacco or alcohol does not significantly alter the distribution patterns of TLR7 gene polymorphisms in HIV-infected individuals."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;ALK R1275Q&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ALK R1275Q is a genomic variant known as a hotspot mutation in neuroblastoma (NBL) tumors."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NRAS Q61K&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"NRAS Q61K is an activating mutation commonly found in melanoma, thyroid, and colorectal cancers."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-B*15:01&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Another allele of the HLA class I protein involved in presenting peptides to T cells for immune recognition."&lt;SEP&gt;"HLA-B*15:01 is a protein that functions as an MHC molecule involved in presenting peptides to TCRs."&lt;SEP&gt;"HLA-B*15:01 is a protein that interacts with neoepitopes derived from ALK R1275Q to form p/MHC complexes in vitro."&lt;SEP&gt;"HLA-B*15:01 is another allele of the HLA class I protein that also presents peptides to T cells for immune recognition."&lt;SEP&gt;"The HLA-B*15:01 protein binds peptide antigens for presentation to T cells."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-52a8c1d4352526a90e26deb6f06682d2&lt;SEP&gt;chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;MAQDIYRASY AND AQDIYRASYY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These are two predicted HLA-B*15:01-restricted decamer neoepitopes arising from ALK R1275Q mutation."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;AQDIYRASY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This is a nonamer neoepitope derived from ALK R1275Q that binds to HLA-B*15:01 with better binding affinity compared to its parental self-antigen."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-A*02:01&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HLA-A*02:01 is a protein that interacts with ALK R1275Q-derived nonamer (GMAQDIYRA) to form p/MHC complexes."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-A*01:01&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An allele of the HLA class I protein that presents peptides to T cells for immune recognition."&lt;SEP&gt;"HLA-A*01:01 binds the NRAS-derived neoepitope ILDTAGKEEY arising from Q61K mutation."&lt;SEP&gt;"HLA-A*01:01 is an allele of the HLA class I protein, involved in presenting peptides to T cells for immune recognition."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NEUROBLASTOMA (NBL)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Neuroblastoma is a disease where ALK R1275Q and other recurrent mutations play significant roles."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;PEPTIDE/MHC COMPLEXES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Formation of stable p/MHC complexes from neoepitopes with HLA proteins in vitro provides insights for therapeutic interventions."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;PROTECT SOFTWARE&quot;">
      <data key="d0">"SOFTWARE TOOL"</data>
      <data key="d1">"ProTECT software is used to identify neoepitope-generating mutations and their corresponding HLA binding affinities."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NRAS Q61K NEOEPITOPE ILDTAGKEEY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"ILDTAGKEEY is a neoepitope arising from the NRAS Q61K mutation, which binds to HLA-A*01:01."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ZNF717 Q716 MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A ZNF717 mutation (Q716) present in three samples of the NBL cohort."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;F1174L/I/C MUTATIONS IN ALK &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Three different mutations (F1174L, F1174I, and F1174C) found in ALK among samples of the NBL cohort."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-B*15:03&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Close relative of HLA-B*15:01 that binds to ARDIYRASYY with a score of 2.2% and ARDIYRASY with a score of 4.7%."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;GMAQDIYRA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A nonamer derived from ALK R1275Q that binds to HLA-A*02:01."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;P/MHC COMPLEX STABILITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Formation of stable peptide/MHC complexes is crucial for the interaction between neoepitopes and HLAs."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ALK NEOEPITOPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"ALK neoepitopes are specific sequences from ALK proteins recognized by the immune system, shown to bind with HLA-B*15:01."&lt;SEP&gt;"ALK-derived neoepitopes are peptide sequences presented by MHC molecules in cancer patients, potentially leading to an immune response."&lt;SEP&gt;"Peptide sequences derived from ALK mutations that can be presented by MHC molecules and recognized by CD8+ T cells, potentially leading to an immune response."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE AQDIYRASY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A nonamer peptide (AQDIYRASY) binds specifically to HLA-B*15:01 and forms an extended conformation within the binding groove."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE AQDIYRASYY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A specific decamer peptide sequence that binds HLA-A*01:01 and is structurally characterized by X-ray crystallography."&lt;SEP&gt;"The decamer peptide (AQDIYRASYY) also binds specifically to HLA-B*15:01, adopting a more compact 310 helical conformation within the groove."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DIFFERENTIAL SCANNING FLUORIMETRY (DSF)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A technique used to assess the kinetic stability of p/MHC complexes based on melting temperature measurements."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;EPSTEINâBARR VIRUS&quot;">
      <data key="d0">"PATHOGEN"</data>
      <data key="d1">"Epstein-Barr virus is a pathogen from which HLA-B*15:01-restricted antigens are derived and studied for their structural properties."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 (UBE2M)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein UBE2M is another source of peptides that bind to HLA-B*15:01, used in comparative studies with ALK-derived neoepitopes."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;SARS CORONAVIRUS&quot;">
      <data key="d0">"PATHOGEN"</data>
      <data key="d1">"A pathogen from which the peptide VQQESSFVM is derived and studied for its structural binding characteristics with HLA-B*15:01."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;TCRS (T-CELL RECEPTORS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"T-cell receptors are molecules that recognize specific peptides presented by MHC complexes, such as those bound to ALK neoepitopes and HLA-B*15:01."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;NEOEPITOPES&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Neoepitopes are specific peptide sequences derived from tumor antigens or mutated proteins, recognized by T-cells via MHC complexes."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;ALK R1275Q NEOEPITOPE&quot;">
      <data key="d0">"GENOMIC VARIANT, PROTEIN"</data>
      <data key="d1">"The ALK R1275Q mutation produces neoepitopes that can be recognized by the immune system as altered peptides."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ALK (ANAPLASTIC LYMPHOMA KINASE)&quot;">
      <data key="d0">"GENE, GENOMIC VARIANT"</data>
      <data key="d1">"ALK is a gene involved in cancer development and can harbor mutations such as R1275Q that produce neoepitopes recognized by the immune system."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A peptide derived from ALK sequence without the C-terminal Tyr, which forms less stable complexes with HLA-B*15:01 compared to its decamer counterpart."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A peptide derived from ALK sequence with an additional C-terminal Tyr that forms more stable complexes with HLA-B*15:01, enhancing immune recognition."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SELF-PEPTIDE (ARDIYRASY)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The self-peptide ARDIYRASY is derived from normal ALK sequence and its binding to HLA-B*15:01 implies tolerance rather than immunity, suggesting it is excluded due to steric hindrance."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TCRS (T CELL RECEPTORS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TCRs are proteins that recognize peptide antigens presented by MHC molecules and initiate an immune response against foreign or altered cells."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ALK R1275Q NEOEPITOPES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Neoepitopes derived from ALK gene mutation at position R1275Q, which are targeted in cancer immunotherapies."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA ALLELES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HLA alleles, such as HLA-A, B, and C types, play a role in presenting neoepitopes to T cells for immune response."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PEPTIDES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Peptides derived from ALK R1275Q mutation are evaluated for their interaction with various HLAs."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15:01 STRUCTURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"X-ray structure of HLA-B*15:01 used as a template to model peptide/HLA interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;ROSETTA COMPARATIVE MODELING CALCULATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Comparative modeling approach to predict peptide/HLA binding, using fixed-peptide backbone threading and energy minimization."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HIGH-THROUGHPUT APPROACH FOR PEPTIDE/HLA INTERACTIONS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Developed method that combines structural templates with computational predictions to assess peptide/HLA interactions across a wide range of HLA alleles."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NONAMER AND DECAMER ALK PEPTIDES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Peptides derived from ALK mutation, evaluated for their binding affinity with various HLAs in the study."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;BINDING ENERGY PREDICTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Predicted energy values indicating the strength of interaction between peptides and HLA alleles."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15:84 ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HLA allele that shows lowest binding energy for decamer peptide, suggesting strong binding affinity."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15:107 ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HLA allele demonstrating the lowest binding energy for nonamer peptide, indicating high affinity binding."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;KULLBACKâLEIBLER SEQUENCE LOGO&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Sequence logo revealing preferred residues in HLA peptide-binding groove that facilitate strong peptide/MHC interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;THERMAL STABILITY OF DECAMER COMPLEX WITH HLA-A*01:01&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Refolding experiment confirming the thermal stability and structural integrity of decamer peptide complexed with HLA-A*01:01."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-A*01:01 STRUCTURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"X-ray structure of HLA-A*01:01 used for refolding experiments to validate peptide/HLA interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;MOCK POLYALA HLA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An artificial HLA allele in which all residues are mutated to Ala, serving as a negative control for binding energy predictions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;IN VITRO REFOLDING EXPERIMENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Refolding experiments performed in vitro to validate the structural stability of peptide/HLA complexes."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;POLAR CONTACTS IN MHC BINDING GROOVE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific polar interactions observed between residues in HLA and peptides, such as Thr, Lys, Trp, and Tyr residues."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;STABLE RECOMBINANT P/MHC COMPLEXES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Recombinant complexes formed by refolding experiments, showing thermal stability and structural integrity."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE AQDIYRASYY (PDB ID 6AT9)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A decamer peptide that binds HLA-A*01:01 and is structurally characterized by X-ray crystallography."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;TCRS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"T-cell receptors (TCRs) are responsible for recognizing MHC-bound peptides, initiating an immune response."&lt;SEP&gt;"T-cell receptors responsible for recognizing MHC-bound peptides, initiating an immune response."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;SARS CORONAVIRUS-DERIVED EPITOPE (VQQESSFVM)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An immunodominant epitope derived from SARS-CoV that is recognized by CD8+ T cells."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;PURIFIED COMPLEX WITH HLA-A*01:01&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A purified complex formed between the peptide and HLA-A*01:01, characterized by X-ray crystallography."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;POLAR CONTACTS WITHIN MHC GROOVE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific hydrogen bonding interactions between the peptide and residues in the MHC groove, contributing to stability of the p/MHC complex."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;PPARÎ GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PPARÎ³ gene plays a crucial role in adipocyte differentiation and insulin sensitivity, influencing metabolic processes such as lipid metabolism and inflammation."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;PPARÎ PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein product of PPARÎ³ interacts with RXRÎ± to regulate gene expression involved in lipid metabolism and inflammation."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;RXRÎ PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"RXRÎ± is a partner protein for PPARÎ³, involved in the regulation of genes important for lipid metabolism and inflammation."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;ARDIYRASYY AND ARDIYRASY&quot;">
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d1">"HLA-B*15:03 binds to both ARDIYRASYY and ARDIYRASY with scores of 2.2% and 4.7%, respectively, indicating its role in immune recognition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTECT SOFTWARE ANALYSIS&quot;">
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d1">"In vitro analysis of p/MHC complexes stability provides insights into therapeutic target validation for neuroblastoma mutations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B*15:01 BINDING COMPLEXES&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"DSF is used to measure the kinetic stability of p/MHC complexes formed by HLA-B*15:01 and neoepitopes, indicating thermal stabilities."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B*15:01 BINDING MOTIF&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"Peptides derived from EpsteinâBarr virus follow established binding motifs for HLA-B*15:01, similar to those of ALK neoepitopes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK NEOEPITOPES BOUND TO HLA-B*15:01&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The interaction between TCRs and the p/MHC complexes formed by ALK-derived peptides bound to HLA-B*15:01 mediates immune recognition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Î2M (BETA-2-MICROGLOBULIN)&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The binding of neoepitopes to Î²2m is crucial for the formation of stable MHC class I complexes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK R1275Q NEOEPITOPE (DECAMER)&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"The HLA-B*15:01 protein binds the ALK R1275Q decamer peptide, facilitating immune recognition and response."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B*15:01/DECAMER PEPTIDE COMPLEX&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"TCRs recognize the HLA-B*15:01 complexed with ALK R1275Q decamer peptide, initiating an immune response against cancer cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS74420772&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism located in 3p14.1, achieving genome-wide significance in TwinGene study."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS35923643-G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The leading SNP identified in the discovery GWAS meta-analysis for IgM anti-PC measurement with an effect size of 0.19 (rank order normalized SD)."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GRAMD1B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located within a linkage disequilibrium block that includes six SNPs achieving genome-wide significance in the discovery GWAS meta-analysis."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS735665-A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A proxy SNP for rs35923643-G, associated with IgM levels and CLL risk."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGM ANTI-PC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"IgM antibodies directed against polyreactive antigens, often associated with immune responses or autoimmunity."&lt;SEP&gt;"Measurement of IgM antibodies against phosphatidylcholine, an important marker in autoimmune and inflammatory conditions."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a&lt;SEP&gt;chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of cancer affecting B lymphocytes that have accumulated in the bone marrow and blood."&lt;SEP&gt;"A type of cancer characterized by the presence of too many lymphocytes in the blood, bone marrow, and lymph nodes."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a&lt;SEP&gt;chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;SNPS IN 1P31.3 AND 11Q24.1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific single nucleotide polymorphisms identified as significant in GWAS studies for IgM anti-PC levels."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GENERAL IMMUNOGLOBULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of immunoglobulins (IgG, IgA, IgM) measured in the blood, which are indicators of immune system activity and health."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS35923643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located in the LD block at locus 11q24.1, associated with IgM anti-PC and CLL."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;H3K4ME1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Monomethylated histone H3 lysine 4 (H3K4Me1) is a chromatin mark indicative of regulatory elements such as enhancers or promoters."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;DNASEI HYPERSENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"DNase I hypersensitive sites are regions in the genome that are more accessible to DNase I, indicating active transcriptional regulatory regions."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These binding sites are where specific proteins (transcription factors) attach to DNA to control gene expression."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RUNX3 BINDING MOTIF&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Runt-related transcription factor 3 (RUNX3) is a protein that binds to DNA at specific sequences, influencing the regulation of genes involved in various biological processes including cell proliferation and differentiation."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;IGM ANTI-PC AND CLL PHENOTYPIC ASSOCIATION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This refers to the association between IgM anti-polyclonal antibodies (anti-PC) and Chronic Lymphocytic Leukemia (CLL), a disease characterized by an accumulation of B lymphocytes in the bone marrow, blood, and lymph nodes."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;STRATIFIED COX PROPORTIONAL HAZARDS MODEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A statistical method used to analyze survival data and estimate hazard ratios for different groups or strata while adjusting for potential confounders."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;LOCUS 11Q24.1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific region of chromosome 11, q-arm at position 24.1, shared between IgM anti-PC and CLL."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;SNP RS35923643 BINDING IMPACT ON RUNX3&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"The SNP rs35923643 alters the predicted affinity of RUNX3 to bind DNA, potentially affecting gene regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLL&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"There is an association between Chronic Lymphocytic Leukemia (CLL) and IgM anti-PC levels, indicating potential biological relevance to disease progression or diagnosis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <edge source="&quot;OBESITY&quot;" target="&quot;SKELETAL MUSCLE MASS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Skeletal muscle mass is often inversely related to body fat content in obese individuals."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;HS-CRP CONCENTRATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased hs-CRP concentrations are often associated with obesity and systemic inflammation."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;EGFR&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Renal function can be impaired in obese individuals due to increased metabolic and vascular pressures."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;KOREAN BALANCED DIET INTAKE&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Intake of a Korean balanced diet can influence obesity risk through its nutritional profile."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;AGE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The prevalence of obesity tends to increase with age due to changes in metabolism and lifestyle."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;PHYSICAL ACTIVITY LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher physical activity levels are associated with lower obesity risk through increased energy expenditure."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC SYNDROME&quot;" target="&quot;PPARÎ GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants in the PPARÎ³ gene are associated with an increased risk of developing metabolic syndrome, which includes conditions like obesity and type 2 diabetes.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAIST CIRCUMFERENCE&quot;" target="&quot;FAT MASS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A higher waist circumference generally correlates with greater abdominal fat mass, a component of obesity risk."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAIST CIRCUMFERENCE&quot;" target="&quot;BLOOD PRESSURE (SBP/DBP)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Higher waist circumference is commonly linked to higher blood pressure, indicating cardiovascular risks."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAIST CIRCUMFERENCE&quot;" target="&quot;(CA)16 ALLELE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of (CA)16 allele is associated with increased waist circumference in individuals moving from normal glucose levels to impaired fasting glucose, impaired glucose tolerance, and Type 2 Diabetes Mellitus."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM TOTAL CHOLESTEROL&quot;" target="&quot;LDL CONCENTRATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Total cholesterol levels are influenced by LDL concentration, with higher levels contributing to cardiovascular risks."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM TRIGLYCERIDE&quot;" target="&quot;ALCOHOL INTAKE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Consumption of alcohol can lead to elevated serum triglycerides due to its metabolic effects."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM HDL CONCENTRATION&quot;" target="&quot;REGULAR EXERCISE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Engaging in regular exercise tends to increase HDL levels, promoting cardiovascular health."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;KIDNEY FUNCTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Low eGFR indicates reduced kidney function, often seen in hypertensive patients."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;PRKAG2 GENE VARIANTS (RS7463059)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The PRKAG2 gene variant is associated with changes in eGFR, particularly in individuals with diabetes, highlighting its role in kidney function regulation."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALT CONCENTRATION&quot;" target="&quot;AST CONCENTRATION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"High ALT concentrations often indicate liver damage or disease, which can also affect AST levels."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DII (DIETARY INFLAMMATORY INDEX)&quot;" target="&quot;SUGAR-CONTAINING FOODS INTAKE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Higher dietary inflammatory index scores are associated with higher intake of sugar-containing foods."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRIED FOOD INTAKE&quot;" target="&quot;WESTERN-STYLE DIET INTAKE&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"A Western-style dietary pattern often includes high intake of fried foods, contributing to health risks."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;" target="&quot;REGULAR EXERCISE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Following a plant-based diet combined with regular exercise can reduce obesity risk through multiple pathways."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;" target="&quot;BMI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A high intake of plant-based foods can mitigate genetic impact on BMI, suggesting a protective role against obesity risk when combined with low PRS.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A high intake of plant-based diet can reduce the genetic impact (high PRS) on obesity risk, highlighting the protective role of dietary patterns against genetic predisposition.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Participant's age was positively correlated with higher scores of social disinhibition, indicating a significant environmental influence."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Younger age was associated with a higher risk of reporting CTCAE grade 2 or above acute nausea."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER&quot;" target="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Average BMI differs between genders, often reflecting differences in body composition and fat distribution."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FAMILY HISTORY OF OBESITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A family history of obesity can lead to higher BMI and related health risks due to shared genetics and environment."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of the FTO SNP is associated with increased BMI in individuals without university studies but not in those with higher education."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A measure used to categorize the severity of obesity, studied in association with genetic risk alleles."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;BASELINE COLONIC ARACHIDONIC ACID (AA) MEASUREMENT IN PARTICIPANTS WITH OR WITHOUT MINOR ALLELES IN THE FADS GENE CLUSTER&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Participants with minor alleles in the FADS gene cluster had a lower BMI at baseline."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SEX (MALE/FEMALE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both males and females experience a positive correlation between BMI and increased snoring, though mechanisms may vary by sex."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SODIUM IN URINE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher sodium levels in urine are often associated with higher BMI values due to dietary habits and salt intake.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FTO GENE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FTO gene is associated with obesity risk, indicating a potential causal relationship between the genetic variation in this region and BMI values.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;MACF1 GENE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The MACF1 gene's association with musculoskeletal traits also includes an influence on BMI values, linking physical structure to obesity risk.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SEX-STRATIFIED GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Separate analyses conducted on males and females revealed distinct genetic factors contributing to variations in BMI, influencing snoring predisposition differently between sexes.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;PGS (POLYGENIC SCORE)&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Adjusting for BMI in the GWAS reduces SNP heritability but does not eliminate genetic predisposition to snoring as indicated by PGS."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;AGE DISTRIBUTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Older age associated with the GA genotype group may influence BMI, particularly in men where variations are more pronounced."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;NYUBAR POPULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The BMI of asthmatic cases was significantly higher than that of the control group within the NYUBAR population."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNAJC27_RS713586&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The DNAJC27 variant influences the process of regulating energy intake or expenditure via interaction with transcription factors involved in obesity development."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1_RS9356744&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The CDKAL1 variant affects energy intake/expenditure through its influence on the regulation of transcription factors, impacting obesity risk."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TFAP2B_RS2206277&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A genetic variation in TFAP2B influences the development of obesity by modulating energy intake/expenditure pathways through interaction with transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF_RS6265&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The BDNF variant impacts energy intake or expenditure, contributing to the risk of developing obesity via its role in modulating transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MYL2_RS3782889&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Although MYL2 SNP does not meet statistical significance, it is implicated in obesity risk through regulation of energy intake/expenditure pathways."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OLFM4_RS9568856&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"The OLFM4 variant influences the process of regulating energy intake or expenditure, playing a role in obesity development through its interaction with transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO_RS1421085&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A genetic variant in FTO affects the regulation of energy intake/expenditure, thereby influencing the obesity risk by acting as a hub gene."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MC4R_RS6567160&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.5</data>
      <data key="d5">"The MC4R variant acts as a hub gene in regulating energy intake/expenditure pathways, contributing significantly to obesity risk through its modulation of transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GIPR_RS1444988703&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A genetic variant in GIPR impacts energy intake/expenditure via regulation of transcription factors, thereby influencing the risk of obesity."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BODY MASS INDEX (BMI)&quot;" target="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Adherence to the Mediterranean diet contributes to a reduction in body mass index among individuals."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High fried-food consumption mitigates the genetic impact from high PRS on BMI, showing that diet plays a crucial role in modifying obesity risk.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;EDUCATION LEVEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Educational level interacts with the FTO SNP to determine obesity risk, showing an inverse relationship between higher education and obesity prevalence."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Adjusting for physical activity does not change the significant association between the FTO SNP and obesity risk in most populations but modifies this effect when education is considered as an environmental factor.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS&quot;" target="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High fried-food consumption offsets the genetic impact from PRS in terms of increasing BMI; thus, diet can modify obesity risk independent of genetic predisposition.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;IFG/IGT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher BMI levels are positively associated with IFG/IGT status at baseline in comparison to normal glucose tolerance subjects (NGT).")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;MEDIATOR OF PLEIOTROPIC EFFECTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Body Mass Index is a key mediator in the pleiotropy observed between certain SNPs and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;GRK5 (CA)N REPEATS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Polymorphisms within GRK5's CA repeat sequences are linked with higher BMI in individuals progressing from normal glucose levels to prediabetes and T2DM, indicating a genetic influence on obesity."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher BMI was observed alongside less physical activity among the colorectal cancer cases compared to controls.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Body Mass Index (BMI) was multiadjusted and associated with T2D-related quantitative traits, though no significant associations were found."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;HYPERURICAEMIA (HUA)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher body mass index (BMI) significantly increases HUA risk in both male and female carriers of the ABCG2 rs2231142 T allele."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;IBS-D&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Patients with IBS-D have a higher BMI compared to IBS-C and HV, indicating potential metabolic differences."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SERUM FGF19&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher BMI is correlated with higher serum C4 and total stool BA, which are also related to lower fasting serum FGF19 levels."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FTO rs1558902 genotype interacts with high-protein diets to influence weight loss and body composition changes, particularly in terms of fat-free mass and total fat."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;WEIGHT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals carrying the FTO risk allele (A) experience greater weight loss on a high-protein diet compared to those without this genotype."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;FAT DISTRIBUTION CHANGES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A high-protein diet leads to changes in fat distribution, including reductions in visceral and subcutaneous adipose tissue, which is modulated by the FTO rs1558902 genotype."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;A ALLELE (RISK ALLELE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals carrying the A allele show greater weight loss and changes in body composition when consuming a high-protein diet compared to non-carriers."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;FAT DISTRIBUTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The high-protein diet significantly influenced fat distribution changes in individuals with the AA genotype, leading to more substantial decreases in body fat."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;TOTAL FAT CHANGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Particularly in individuals with specific genotypes, high-protein diets can lead to significant reductions in total body fat."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT DISTRIBUTION CHANGES&quot;" target="&quot;LOW-FAT DIET&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genotype-time interactions on changes in fat distribution are observed under low-fat dietary conditions."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT DISTRIBUTION CHANGES&quot;" target="&quot;GENOTYPE-TIME INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The interaction between genotype and dietary intake over time significantly impacts changes in fat distribution."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINEAR MIXED MODELS ANALYSIS&quot;" target="&quot;TOTAL FAT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The analysis using linear mixed models reveals that individuals with the AA genotype on a high-protein diet show greater total fat loss over time compared to those without this genotype."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL FAT LOSS&quot;" target="&quot;FAT-FREE MASS LOSS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Changes in total fat are often accompanied by corresponding losses or gains in fat-free mass, indicating an overall shift in body composition."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL FAT LOSS&quot;" target="&quot;TRUNK FAT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Loss in trunk fat is a component of total fat loss, reflecting changes in central adiposity due to dietary and genetic influences."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;BASELINE BMI&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The baseline BMI provides a reference for measuring the impact of genetic variants such as those in the FTO gene on body mass over time."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;ANTHROPOMETRIC MEASUREMENTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FTO gene variant (rs9939609) has a significant association with various anthropometric measurements, indicating its role in obesity risk."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO gene contains a specific single nucleotide polymorphism (SNP) that influences obesity risk.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;RS1558902 SNP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This specific SNP within FTO influences CRP levels, highlighting gene-specific impacts on systemic inflammation markers.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE BMI&quot;" target="&quot;FM%&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The initial FM% provides context for how genetic factors and dietary interventions can influence the percentage of body fat over time."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FM% (FAT MASS PERCENTAGE)&quot;" target="&quot;TRUNK FAT CHANGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Alterations in trunk fat, as measured by FM%, can be influenced by genotype-time interactions and specific diets like the high-protein diet."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VISCERAL ADIPOSE TISSUE (VAT) CHANGES&quot;" target="&quot;GENE-DIET INTERACTION ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Analysis reveals that gene-diet interactions significantly impact changes in visceral adipose tissue, particularly in response to high-protein diets."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Those carrying the AA genotype had less loss of TAT and SAT during the low-protein dietary intervention relative to non-carriers."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;GG GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals carrying the GG genotype have lower TAG concentrations compared to those with AA genotypes for GCKR rs780094 SNP, indicating a genetic influence on lipid levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;BREAST CANCER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The AA genotype of rs1695 polymorphism does not show a significant association with breast cancer, according to our findings."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;TAT (TOTAL ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In response to a low-protein diet, participants carrying the AA genotype exhibited less reduction of total abdominal adipose tissue compared to others."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;SAT (SUBCUTANEOUS ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The AA genotype carriers showed smaller decreases in subcutaneous abdominal adipose tissue during low-protein diet interventions."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;ANTHROPOMETRIC VARIABLES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO rs9939609 polymorphism is associated with anthropometric measurements, including weight, BMI and waist circumference."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION LEVEL&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Educational level interacts significantly with the FTO rs9939609 polymorphism to determine BMI and obesity risk, highlighting environmental-genetic interactions."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;UNIVERSITY STUDIES EDUCATION LEVEL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Individuals with higher education do not exhibit a significant association between the FTO rs9939609 polymorphism and anthropometric measures, suggesting mitigating factors in these groups."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The level of physical activity interacts with the presence of the FTO SNP to influence BMI, especially among certain educational groups."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The effect of the FTO SNP on obesity risk varies depending on educational attainment, indicating a gene-environment interaction.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRIMARY STUDIES EDUCATION LEVEL&quot;" target="&quot;SECONDARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both primary and secondary education levels show similar patterns of increased obesity risk associated with the FTO SNP compared to university studies."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;INTENSIVE LIFESTYLE INTERVENTION GROUP&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Increased physical activity as part of an intervention group helps in reducing weight and lowering type 2 diabetes risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION&quot;" target="&quot;UNIVERSITY STUDIES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals who undertake university studies are part of the broader category of education level, which can influence health outcomes related to genetic factors such as the FTO SNP.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;DIETARY PATTERN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TCF7L2 gene interacts with various dietary patterns in the context of type 2 diabetes risk assessment."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;RS7903146&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The rs7903146 variant within the TCF7L2 gene modifies the association between other genetic factors and Type 2 diabetes risk."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The TCF7L2 gene contains SNPs that are significantly associated with BMI at baseline, indicating its role in obesity predisposition.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;SNPS IN FTO, TAL1, AND TCF7L2 GENES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The TCF7L2 gene contains the SNP rs7903146, a significant obesity predisposing SNP associated with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT&quot;" target="&quot;TYPE 2 DIABETES (T2D)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Genetic variants interact with environmental factors to modify the susceptibility or resistance to developing type 2 diabetes."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of specific genetic variants, including CC genotype and T allele, influences the risk or occurrence of colorectal cancer.")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;NURSES' HEALTH STUDY (NHS)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Longitudinal studies like the NHS help to understand how dietary patterns influence long-term health outcomes such as type 2 diabetes risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Dietary patterns interact with genotypes to modify physiological processes such as lipid metabolism.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both dietary patterns and physical activity are lifestyle factors that influence glucose tolerance and diabetes risk.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;IL-22 PROTEIN&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"IL-22 protein levels may be influenced by dietary patterns, though this specific link was not detailed in the text.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"The text does not directly link nutrients to dietary patterns affecting pharmacogenomics algorithms.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;CYP24A1 TRANSCRIPT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Unspecified dietary patterns may influence the expression and activity of CYP24A1."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;LACTOSE DIGESTION CAPABILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Consumption patterns of dairy products can influence the digestive capability based on LCT gene expression levels and epigenetic modifications."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTENSIVE LIFESTYLE INTERVENTION GROUP&quot;" target="&quot;FINISH DIABETES PREVENTION STUDY (DPS)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The DPS uses an intensive lifestyle intervention group to assess the impact of lifestyle changes on reducing type 2 diabetes risk compared to usual care."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET GROUPS&quot;" target="&quot;WHOLE GRAIN INTAKE AND FIBER CONSUMPTION&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The Mediterranean diet groups focus on extra-virgin olive oil or mixed nuts, which are associated with whole grain intake and fiber consumption."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;PREVENCIÃN CON DIETA MEDITERRÃNEA (PREDIMED)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The PREDIMED study assesses how a Mediterranean diet affects cardiovascular disease and type 2 diabetes risk factors in at-risk populations."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Interventions aimed at promoting weight loss can reduce the incidence of T2D among individuals carrying certain genetic variants."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;GENETIC VARIANTS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Multiple genetic variants are associated with an increased risk of Type 2 Diabetes, highlighting the polygenic nature of the disease."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;CUMULATIVE RISK SCORE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The cumulative risk score, derived from multiple genetic variants, significantly differentiates between individuals with T2D and those without, indicating its utility as a predictive tool."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;BCL2L11 GENE CPG SITE (CG07547695)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Methylation at this site is associated with a higher risk of Type 2 Diabetes, suggesting its role in the disease's pathogenesis."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;CEP55 GENE CPG SITE (CG24371383)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Methylation at this site is associated with a higher risk of Type 2 Diabetes, suggesting its role in the disease's pathogenesis."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;CPB1 GENE CPG SITE (CG04072156)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Methylation at this site is associated with a higher risk of Type 2 Diabetes, suggesting its role in the disease's pathogenesis."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;HISTONE CLUSTER 1 H4D (HIST1H4D) CPG SITE (CG08170869)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Decreased methylation at this site is associated with an increased risk of Type 2 Diabetes, indicating a role in disease progression."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;DISHEVELLED-1 (DVL1) CPG SITE (CG03465880)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Decreased methylation at this site is associated with an increased risk of Type 2 Diabetes, indicating a role in disease progression."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMERICAN DIABETES PREVENTION PROJECT (DPP)&quot;" target="&quot;GLYCEMIC INDEX AND GLYCEMIC LOAD&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Studies like DPP evaluate how glycemic index and load affect type 2 diabetes risk when combined with lifestyle interventions."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;RS7903146 RISK T-ALLELE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs7903146 variant in the TCF7L2 gene shows interaction with fiber and whole-grain intake among individuals carrying a specific allele, increasing T2D incidence."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;RS4506565&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs4506565 variant within the TCF7L2 gene interacts with dietary fiber and whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;RS12255372&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs12255372 variant within the TCF7L2 gene shows interaction with dietary fiber but not carbohydrates, affecting type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;ADH1C *1/*2 VARIANT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ADH1C genotype modifies the association between alcohol intake and T2D risk among women carrying a specific allele of TCF7L2 gene."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBER INTAKE&quot;" target="&quot;TCF7L2 RS12255372 CARRIERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Carriers of the TCF7L2 variant rs12255372 show interaction with dietary fiber to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS11196208 A-ALLELE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A-allele carriers of TCF7L2 variant rs11196208 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS7903146 AA-GENOTYPE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"AA-genotype carriers of TCF7L2 variant rs7903146 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS7903146 AC-GENOTYPE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"AC-genotype carriers of TCF7L2 variant rs7903146 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS4506565 CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Carriers of the TCF7L2 variant rs4506565 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10923931 NOTCH2 GENE&quot;" target="&quot;NOTCH2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A genetic variant in the NOTCH2 gene interacts with fiber intake, influencing type 2 diabetes risk among individuals carrying a specific allele of this gene."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZBED3 GENE&quot;" target="&quot;NOTCH2 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ZBED3 gene shows interaction with dietary fiber intake and modifies T2D risk similar to NOTCH2 gene interactions, both involved in WNT signaling pathway."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRS1 RS2943641&quot;" target="&quot;GIPR RS10423928&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both genetic variants (IRS1 and GIPR) interact with carbohydrate intake to modify type 2 diabetes risk, but findings are not consistent across studies."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAV2 VARIANT RS2270188&quot;" target="&quot;HECTD4 VARIANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both CAV2 variant and HECTD4 variants show interaction with dietary fat to modify T2D risk, though findings vary between studies."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 POLYMORPHISMS &quot;" target="&quot;DIETARY FACTORS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Polymorphisms in TCF7L2 interact with various dietary factors, including fiber and whole grains, to influence type 2 diabetes incidence."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WESTERN DIETARY PATTERN &quot;" target="&quot;T2D-GRS &quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The effect of a Western dietary pattern on T2D risk is amplified in individuals with high genetic susceptibility (high T2D-GRS)."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RS12255372&quot;" target="&quot;T2D&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This genetic variant of TCF7L2 is significantly associated with a reduced incidence of type 2 diabetes in intervention studies compared to control groups."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146 RISK TâALLELE&quot;" target="&quot;T2D&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of the rs7903146 T allele is linked to an increased risk of developing type 2 diabetes but showed lower incidence in intervention groups."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENPP1 RS1044498 DIABETOGENIC VARIANT&quot;" target="&quot;T2D&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This variant of ENPP1 is associated with a higher risk for type 2 diabetes but weight loss interventions seem to mitigate this risk."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MC4R RS17066829&quot;" target="&quot;WEIGHT LOSS INTERVENTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"While there's a trend towards interaction, the MC4R variant does not show significant interactions with weight loss interventions for reducing T2D incidence."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPARÎ RS1152003 CCâGENOTYPE&quot;" target="&quot;T2D&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The PPARÎ³ gene variant is associated with a reduced risk of type 2 diabetes under intervention conditions compared to controls."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFÎ RS1800629 GGâGENOTYPE&quot;" target="&quot;T2D&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This genetic variant shows lower T2D incidence among individuals who undergo weight loss interventions."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADRA2B GLU9-ALLELE&quot;" target="&quot;WEIGHT LOSS INTERVENTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The ADRA2B gene's Glu9 allele is associated with a reduced risk of type 2 diabetes upon undergoing weight loss interventions."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPC RS2070895 AâALLELE&quot;" target="&quot;T2D&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This genetic variant in LIPC shows a lower incidence of T2D under intervention conditions compared to non-intervention groups."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;TYPE 1 DIABETES (T2D)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Certain genetic variations increase susceptibility to developing type 2 diabetes, and their interaction with lifestyle factors can modify disease risk."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;MICROBIAL TAXA VARIABILITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variants have a limited impact on variability in microbial taxa composition in the gut, highlighting the need for caution when interpreting results from MR analyses.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT LOSS INTERVENTIONS&quot;" target="&quot;RCT STUDY POPULATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Randomized controlled trials investigating the effects of weight loss interventions on populations carrying different genetic variants for T2D."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FFAR4 VARIANT&quot;" target="&quot;PPARÎ VARIANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variants in PPARÎ³ show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;IFG/IGT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Individuals with IFG/IGT have an increased risk of developing T2D compared to those with NGT, as indicated by baseline clinical characteristics and longitudinal data from the EpiDREAM cohort study.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WFS1 GENE&quot;" target="&quot;RS10010131 GENOMIC VARIANT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A specific variant in the WFS1 gene (rs10010131) is associated with Type 2 Diabetes risk."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1 GENE&quot;" target="&quot;RS10946398 GENOMIC VARIANT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"An association between a CDKAL1 variant and T2D was observed for a specific variant (rs10946398), indicating its role in disease susceptibility."&lt;SEP&gt;"An association between a CDKAL1 variant and T2D was observed in the study sample, indicating its role in disease susceptibility."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;JAZF1 GENE&quot;" target="&quot;RS864745 GENOMIC VARIANT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A genomic variant (rs864745) within JAZF1 is associated with an increased risk of Type 2 Diabetes, showing the gene's importance in disease pathogenesis."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9 GENE&quot;" target="&quot;RS4607103 GENOMIC VARIANT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"An association between ADAMTS9 and T2D was noted for a specific variant (rs4607103), with differing effects observed in different populations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CUMULATIVE RISK SCORE&quot;" target="&quot;LOGISTIC REGRESSION MODEL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"A logistic regression model was applied to assess the relationship between cumulative risk scores and disease status in T2D patients compared to controls, showing significant associations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;TYPE 7 DIABETES RISK ANALYSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic analysis shows that adjusting for the genomic variant rs7903146 in TCF7L2 gene removes significant associations with Type 2 diabetes, suggesting its importance."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;TCF7L2 RISK VARIANT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;TCF7LL2 RISK VARIANT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;RISK ALLELES COUNT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The count of risk alleles is a factor influencing the association with Type 2 diabetes, particularly when considering variants like rs7903146 in TCF7L2."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;INSULIN SENSITIVITY (ISI)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Decreased insulin sensitivity is a significant risk factor for developing type 2 diabetes, as shown by associations with KB levels in the METSIM study.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Environmental factors such as diet, smoking, and BMI play significant roles in the development of type 2 diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genetic variations such as SNPs associated with type 2 diabetes influence the levels of ketone bodies in individuals."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;SNP RS79105258&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"The minor allele of SNP rs79105258 is inversely associated with the risk of developing Type 2 diabetes among black coffee consumers."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;BLACK COFFEE INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Regular black coffee intake was associated with a reduced risk of developing type 2 diabetes compared to non-consumers."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;SNP&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The minor allele of each SNP has an inverse association with the risk of developing type 2 diabetes, suggesting protective effects."&lt;SEP&gt;"The minor allele of each SNP has an inverse relationship with type 2 diabetes, indicating that the presence of this variant may reduce the risk of developing the disease."</data>
      <data key="d6">chunk-b803830d07bff8ae14550f6458048707</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"GWAS studies identify genetic variants, such as SNPs, that are associated with increased risk or protective effects against type 2 diabetes."</data>
      <data key="d6">chunk-b803830d07bff8ae14550f6458048707</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;AGE FACTOR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There was no evidence for interaction between age and Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;SEX FACTOR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No significant interaction with sex was found in the analysis of Type 2 diabetes risk associated with the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;BMI FACTOR&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Body Mass Index (BMI) did not significantly interact with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;DEGREE OF AFRICAN ANCESTRY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The degree of African ancestry had no significant interaction with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;NGT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The transition from NGT to IFG/IGT is significantly correlated with higher baseline BMI levels and a positive increase in BMI change over time compared to stable NGT status.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;GENOMIC VARIANT (SNPS)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Specific genomic variants or SNPs influence susceptibility to IFG/IGT, affecting baseline BMI levels and the progression from NGT to IFG/IGT over time.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;NATIVE NORTH AMERICAN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Native North Americans showed lower prevalence of IFG/IGT, suggesting potential protective genetic or environmental factors unique to this ethnic group.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;" target="&quot;IMPAIRED FASTING GLYCAEMIA (IFG)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"FPG levels above normal but below diabetic thresholds indicate IFG, a condition associated with an increased risk of developing type 2 diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EAST ASIAN&quot;" target="&quot;FPG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In East Asian populations, Fasting Plasma Glucose levels might be influenced by genetic factors contributing to lower prevalence of T2D compared to other ethnic groups.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AFRICAN&quot;" target="&quot;2HPG&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher rates of Two-hour Plasma Glucose indicate that African ancestry may be associated with increased risk due to higher 2hPG levels leading to greater BMI changes over time.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAL1 GENE&quot;" target="&quot;SNPS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TAL1 gene has SNPs that are significantly associated with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAL1 GENE&quot;" target="&quot;SNPS IN FTO, TAL1, AND TCF7L2 GENES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The TAL1 gene contains the SNP rs2984618, another obesity predisposing SNP associated with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEPR GENE&quot;" target="&quot;GRS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"While the LEPR gene alone does not show a significant main effect on BMI, it interacts with GRS in relation to glycemic status traits like FPG.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEPR GENE&quot;" target="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"FPG interacts with the rs1011527 SNP in LEPR on baseline BMI, suggesting a role of glycemic status traits in modulating genetic effects on obesity.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;BMI BASELINE AND CHANGE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNPs are significantly associated with baseline BMI but not with changes in BMI over time.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;BMI BASELINE AND CHANGE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The GRS is a significant predictor of increased BMI at baseline, indicating the cumulative genetic risk for obesity.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTA&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"The Genetic Risk Score (GRS) is associated with performance on Trail Making Test Part A (TMTA), a measure of visual search speed and processing speed.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTB&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Survivors with higher GRS scores performed significantly worse on Trail Making Test Part B (TMTB) than those with lower GRS scores, indicating an association between genetic risk and cognitive flexibility.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;PEGDH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant association was found between the Genetic Risk Score (GRS) and performance on Paired Associate Learning Digit Span High Load (PEGDH).")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;PEGNDH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Similarly, no significant association was observed between GRS and the performance of patients in Paired Associate Learning Number Digit High Load (PEGNDH).")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;DIG&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Genetic Risk Score (GRS) did not show any association with impairment on the Digit Span Test (DIG), assessing working memory and attention.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;CFL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant correlation was found between GRS and impaired performance in Coding Figure Learning (CFL).")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;POLYMORPHISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Genetic Risk Score (GRS) is computed based on the presence and frequency of polymorphisms across six genomic loci."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;CUMULATIVE IV MTX EXPOSURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The cumulative intravenous exposure to methotrexate influences the Genetic Risk Score, affecting cognitive outcomes."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;DIVERGT BATTERY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant association was found between GRS and impairment on DIVERGT battery performance scores, suggesting variability in how genetic risk impacts different aspects of cognition."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;" target="&quot;RS1011527 SNP IN LEPR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This SNP interacts with FPG on baseline BMI but does not show a significant main effect on BMI without considering the interaction term.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS (GENOTYPE RISK SCORE)&quot;" target="&quot;BMI BASELINE AND CHANGE ASSOCIATIONS AND INTERACTIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The GRS is significantly associated with increased BMI at baseline, indicating cumulative genetic risk in the context of obesity."</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2HPG&quot;" target="&quot;FPG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FPG&quot;" target="&quot;GRK5 (CA)N REPEATS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Polymorphisms within GRK5's CA repeat sequences are associated with increased fasting plasma glucose in individuals transitioning from normal glucose levels to IFG and T2DM, indicating a genetic predisposition towards hyperglycemia."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 1298A&gt;C&quot;" target="&quot;NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Carriers of the MTHFR 1298AC/CC genotypes are at a higher risk for neurocognitive deficits compared to those with AA genotype."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 1298A&gt;C&quot;" target="&quot;TMTB PERFORMANCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Survivors with MTHFR 1298AC/CC genotypes scored significantly lower on TMTB compared to those with AA genotype."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS 2756A&gt;G&quot;" target="&quot;PEGNDH SCORE DIFFERENCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Survivors with MS 2756AA genotype scored lower on the PEGNDH test compared to those with AG/GG genotypes."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS 2756A&gt;G&quot;" target="&quot;TMTA PERFORMANCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Survivors carrying MS 2756AA genotype performed worse on TMTA than survivors with AG/GG genotypes."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTRR 66A&gt;G&quot;" target="&quot;CFL PERFORMANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Individuals carrying MTRR 66AA genotype showed significantly worse performance in executive function tests (CFL)."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSER POLYMORPHISMS&quot;" target="&quot;TMTB PERFORMANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Individuals with TSER 2R/3R and 3R/3R genotypes scored lower on TMTB compared to those with 2R/2R genotype."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTX-RELATED NEUROTOXICITY&quot;" target="&quot;LONG-TERM NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Early MTX-induced neurotoxic symptoms were predictive of long-term cognitive deficits, despite no significant effect on all test measures."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMTB&quot;" target="&quot;INTRATHECAL MTX EXPOSURE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Intrathecal methotrexate administration affects cognitive performance as measured by Trail Making Test Part B (TMTB)."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FINE MOTOR SKILLS&quot;" target="&quot;PEGDH TEST&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTRR 66A&gt;G GENOTYPES&quot;" target="&quot;PEGNDH TEST&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIG TEST&quot;" target="&quot;WORKING MEMORY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant at SLC30A8 is associated with higher baseline fasting proinsulin levels and this association remains significant even after adjusting for various factors.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;DPP COHORT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant SLC30A8 rs13266634 shows significant association with higher fasting proinsulin levels in the DPP cohort at baseline.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;FASTING INSULIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Adjustment for fasting insulin is necessary to accurately determine the relationship between SLC30A8 risk alleles and proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;TROGLITAZONE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The use of troglitazone as an intervention led to a decrease in fasting proinsulin levels, similar to metformin but less effective than lifestyle changes.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;C RISK ALLELE AT SLC30A8 RS13266634&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Higher proinsulin levels are associated with the presence of the C risk allele at SLC30A8, but this association becomes non-significant after one year of DPP intervention.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;AGE, SEX, ETHNICITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These demographic factors were accounted for when assessing the impact of interventions on fasting proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE INTERVENTION GROUP&quot;" target="&quot;METFORMIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both lifestyle changes and metformin interventions reduce proinsulin levels, but the decrease in the lifestyle group is significantly larger than that of the metformin group (p&lt;0.001).")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METFORMIN&quot;" target="&quot;TROGLITAZONE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Both metformin and troglitazone showed similar effects on reducing fasting proinsulin levels compared to each other, but both were less effective than the lifestyle intervention group.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;SREBP1C&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Expression levels of PNPLA3 are positively correlated with SREBP1c, indicating they are part of the same regulatory pathway for lipid metabolism."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;ACC-1&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Accumulation of hepatic triacylglycerol is associated with elevated PNPLA3 and ACC-1 expression levels, suggesting a coordinated regulation in lipogenesis."&lt;SEP&gt;"The expression of ACC-1 parallels that of PNPLA3 in response to different stimuli such as citrate or glucose conditions."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;GLUCOSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression level of PNPLA3 gene is regulated by glucose concentration, as shown by depletion-refeeding conditions experiments."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;CITRATE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Citrate increases PNPLA3 protein levels but its isomer, isocitrate, does not have this effect."&lt;SEP&gt;"Incubation with citrate increases PNPLA3 expression, suggesting a role for this Krebs cycle intermediate in lipid synthesis regulation."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;PYRUVATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Pyruvate has no impact on the expression of PNPLA3 in cells compared to citrate or acetate."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;FAS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Expression patterns of FAS and PNPLA3 are similar under various metabolic conditions, including high glucose levels."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;OLEIC ACID (OA)&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Oleic acid decreases PNPLA3 gene expression without affecting lipid accumulation when PNPLA3 is knocked down."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;Î-LINOLENIC ACID (ALA)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Unlike other unsaturated fatty acids like OA or LA, ALA does not suppress PNPLA3 expression."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH CARBOHYDRATE DIET (HC)&quot;" target="&quot;LIPID EMULSION (LE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Inclusion of lipid emulsion with a high carbohydrate diet attenuates PNPLA3 expression dose-dependently."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-FAT DIET (HF)&quot;" target="&quot;EXERCISE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Voluntary exercise suppresses the elevation of PNPLA3 mRNA induced by high-fat diet in mice."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCOSE&quot;" target="&quot;CHREBP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression patterns of ChREBP are similarly modulated to those of PNPLA3 in response to changes in glucose availability."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FATTY ACID SYNTHASE (FAS)&quot;" target="&quot;PNPLA3 KNOCKDOWN&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"PNPLA3 knockdown results in increased mRNA levels of FAS, a key lipogenic enzyme."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2-DEOXY-D-GLUCOSE&quot;" target="&quot;HIGH GLUCOSE LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Treatment with 2-deoxy-D-glucose inhibits the induction of SREBP1c and PNPLA3 by high glucose levels, indicating it disrupts metabolic pathways dependent on glucose metabolism."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;FAS&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"While insulin increases FAS expression, it does not affect the hepatic PNPLA3 levels in HepG2 cells."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Prophylactic insulin administration can delay but does not prevent diabetes in NOD mice by potentially inducing a state of 'Î²-cell rest' that reduces metabolic stress and immune-mediated destruction."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;Î-CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Insulin is produced and secreted by Î²-cells. Its deficiency or dysfunction leads to diabetes."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCAGON&quot;" target="&quot;PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Treatment with glucagon stimulates PC expression while having no effect on PNPLA3 mRNA levels, indicating specificity of hormonal effects."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINOLEIC ACID (LA)&quot;" target="&quot;SREBP1C, FAS, PNPLA3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"La and oleic acid reduce the mRNA levels of SREBP1c, FAS, and PNPLA3 under both low and high glucose conditions."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EICOSAPENTAENOIC ACID (EPA)&quot;" target="&quot;SREBP1C, FAS, PNPLA3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both EPA and DHA decrease the gene expressions of SREBP1c, FAS, and PNPLA3 under various glucose conditions."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;" target="&quot;FATTY ACIDS RATIO MIX&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The combination of OA:LA:ALA suppresses the gene expressions of SREBP1c, FAS, and PNPLA3 to a greater extent than individual fatty acids."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OIL RED O STAINING&quot;" target="&quot;LIPID ACCUMULATION&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Used for assessing lipid accumulation in HepG2 cells following metabolic perturbations like varying glucose conditions or exogenous fatty acid treatments."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW GLUCOSE CONDITION&quot;" target="&quot;GLUCAGON, PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Under low glucose conditions, glucagon stimulation increases the expression of PC but does not affect PNPLA3 mRNA levels."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIPPOCAMPAL TRANSCRIPTOME CHANGES&quot;" target="&quot;MIRNOME CHANGES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Changes in miRNA levels correlate with alterations observed in the hippocampal transcriptome due to PNS exposure."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEURODEVELOPMENT PATHWAYS&quot;" target="&quot;INFLAMMATION PATHWAYS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both neurodevelopment and inflammation pathways are affected by PNS exposure, highlighting a broad impact on biological processes."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOOD MRNA TRANSCRIPTOMICS CHANGES&quot;" target="&quot;EARLY LIFE TRAUMA EXPOSURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Exposure to early life trauma leads to significant changes in blood mRNA transcriptomics, similar to those seen following PNS exposure."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE-PATHWAY INTERACTION&quot;" target="&quot;COMMON GENE OVERLAP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The interaction between genes and pathways modulated by environmental factors (PNS or early life trauma) results in a subset of overlapping genes with altered expression patterns."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGF-Î1&quot;" target="&quot;FOXO1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The IPA Software analysis identified FoxO1 and TGF-Î²1 as interacting within the same cluster, forming part of signaling pathways related to cytokines, glucocorticoid receptors, and TGF-Î²1."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A2M&quot;" target="&quot;CHILDHOOD SEXUAL ABUSE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic variations within A2M show significant GxE interactions when exposed to sexual abuse during early life, predicting adult depressive symptoms."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;ENVIRONMENTAL FACTOR (EMOTIONAL STRESS IN CHILDHOOD)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The interaction between FoxO1 gene variants and early emotional stress predicts depressive symptoms in adulthood, as observed in two independent clinical cohorts."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;AS1842856&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"AS1842856 inhibits FoxO1, countering the cortisol-induced upregulation of FoxO1 and reduction in neuronal proliferation.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SGK-1 is a downstream target gene regulated by FoxO1, involved in mediating some glucocorticoid effects on brain function.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;HIPPOCAMPUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FoxO1 is up-regulated in the hippocampus following exposure to stress or trauma.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;CHILDHOOD TRAUMA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Exposure to childhood trauma leads to upregulation of FoxO1 in blood samples, indicating a link between environmental factors and gene expression.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPRESSION&quot;" target="&quot;BDI SCORES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"BDI scores are a measure of the severity of depression and its symptomatology."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPRESSION&quot;" target="&quot;BCL2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Gene BCL2 is involved in cellular processes that may contribute to the development or progression of depressive symptoms through its interaction with environmental factors."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPRESSION&quot;" target="&quot;BCL9&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Gene BCL9, associated with Wnt signaling pathways, interacts with environmental stressors during childhood, contributing to depression in adulthood."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPRESSION&quot;" target="&quot;EYEBLINK CONDITIONING (EBC)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The impact of maternal depression on neurodevelopmental outcomes in infants needs further investigation.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;FADS1/FADS2 HAPLOTYPE GENES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FADS1/2 genes are studied through specific SNPs for their influence on fatty acid metabolism."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;MR EGGER ANALYSIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variants or SNPs were analyzed using MR Egger to detect potential biases in causal inference studies."</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Minor alleles for certain SNPs are associated with an increased risk of social disinhibition, while others have a protective effect against it."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL&quot;" target="&quot;NEUROGENESIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Cortisol negatively affects neurogenesis through the activation of FoxO1 signaling pathway.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;" target="&quot;STRESSED RATS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Elevated SGK-1 levels are observed in stressed rats, indicating a link with glucocorticoid effects on brain function.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;" target="&quot;DEPRESSED PATIENTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Blood samples from depressed patients show elevated SGK-1 levels, linking stress and brain function alterations to disease states.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)&quot;" target="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This cell line is used to study the effects of cortisol on neuronal proliferation mediated by FoxO1.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROGENITOR STEM CELLS&quot;" target="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These cells play a role in neuronal proliferation which is negatively affected by cortisol through the FoxO1 pathway.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;LONG-TERM WEIGHT LOSS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genomic variant rs4771122 is nominally significantly associated with long-term weight loss after bariatric surgery, indicating its influence on this outcome."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;PRE-SURGICAL BMI&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The association of the minor allele (G) in rs4771122 with pre-surgical weight and BMI suggests a genetic predisposition to higher pre-operative obesity levels."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;TRAJECTORY GROUP MEMBERSHIP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs4771122 variant is associated with trajectory group membership, indicating its role in determining different post-surgical weight management outcomes."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG-TERM WEIGHT LOSS&quot;" target="&quot;WEIGHT OBSERVATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Measurements of body weight over time post-surgery are crucial for assessing the long-term effectiveness of bariatric surgery in achieving sustained weight loss."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG-TERM WEIGHT LOSS&quot;" target="&quot;NADIR WEIGHT LOSS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Achieving significant nadir weight loss early on can predict a more favorable long-term weight maintenance outcome after bariatric surgery."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG-TERM WEIGHT LOSS&quot;" target="&quot;TWO YEAR PERCENT WEIGHT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The level of two-year percent weight loss is an initial indicator of the likelihood and extent of sustained long-term weight loss post-surgery."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK GENE&quot;" target="&quot;GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mutations within the GCK gene are the cause of genetic disorders such as GCK-MODY, with these specific variants being critical for diagnosis and understanding disease mechanism."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)&quot;" target="&quot;ACMG GUIDELINES FOR GENOMIC VARIANT INTERPRETATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The ACMG guidelines are used to classify the pathogenicity of GCK gene mutations, impacting clinical management and genetic counseling for patients with GCK-MODY."&lt;SEP&gt;"The ACMG guidelines provide a framework for interpreting the pathogenicity of identified genomic variants in the context of GCK-MODY."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEQUENCING ANALYSIS OF GENETIC VARIANTS &quot;" target="&quot;CO-SEGREGATION WITH DIABETES PHENOTYPE TESTING &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"After identifying potential disease-causing variants through sequencing analysis, co-segregation testing is used to confirm their clinical significance in familial contexts."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARENTAL/EXTENDED FAMILY DNA TESTING &quot;" target="&quot;GCK VARIANTS (VUS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Testing family members for VUS helps confirm co-segregation with disease phenotype, aiding in variant classification."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING HYPERGLYCEMIA LEVELS &quot;" target="&quot;HBA1C TESTING &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both tests assess blood sugar control but HbA1c provides a broader time frame assessment."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;TAG CONCENTRATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Adherence to the Mediterranean diet is inversely associated with triglyceride concentrations."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;HDL-C CONCENTRATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is directly associated with higher HDL cholesterol levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Adherence to the Mediterranean diet lowers the apolipoprotein B to apolipoprotein A-I ratio, indicating reduced cardiovascular risk."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is inversely associated with hypertriacylglycerolaemia risk."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals who are physically active tend to have higher adherence to the Mediterranean diet."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;SYSTOLIC BLOOD PRESSURE (SBP)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Adherence to the Mediterranean diet correlates with reduced systolic blood pressure levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;DIASTOLIC BLOOD PRESSURE (DBP)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is associated with lower diastolic blood pressure levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;INSULIN RESISTANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is associated with improved insulin sensitivity and reduced insulin resistance."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG CONCENTRATION&quot;" target="&quot;GCKR RS780094 SNP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The GCKR rs780094 single nucleotide polymorphism is positively associated with TAG levels in individuals carrying the AA genotype compared to GG genotypes."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG CONCENTRATION&quot;" target="&quot;RS1260326 SNP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs1260326 single nucleotide polymorphism similarly affects TAG concentrations as the GCKR rs780094 SNP, indicating a genetic impact on lipid metabolism."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HBA1C CONCENTRATION&quot;" target="&quot;MEDITERRADIAN DIET ADHERENCE (MD)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is associated with lower HbA1c concentrations."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;" target="&quot;GCKR RS780094 SNP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The GCKR rs780094 single nucleotide polymorphism is associated with an increased risk of hypertriacylglycerolaemia."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GG GENOTYPE&quot;" target="&quot;BREAST CANCER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GG genotype is associated with a higher risk of developing breast cancer compared to other genotypes, according to our study."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LDL-C CONCENTRATION&quot;" target="&quot;GCKR RS780094 SNP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GCKR rs780094 single nucleotide polymorphism affects LDL cholesterol concentrations, similar to its impact on triglycerides and other lipid markers."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN RESISTANCE&quot;" target="&quot;HFD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High-fat diets exacerbate insulin resistance in both control and SENP1-aP2KO mice, with more severe effects observed in the latter.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;ALCOHOL SELF-ADMINISTRATION BEHAVIOR&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The smoking status of individuals influences their behavior in alcohol self-administration, with trends suggesting a marginally shorter latency to drink for smokers."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both physical activity and smoking status are lifestyle factors that do not significantly alter the relationship between alcohol consumption and cortisol levels when adjusted for."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG LEVELS&quot;" target="&quot;GENOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genotype of an individual influences TAG levels in blood, indicating a genetic effect on lipid metabolism.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;DIETARY FIBER INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Lower dietary fiber intake and less physical activity were observed in cases compared to controls for colorectal cancer risk.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE-DIET INTERACTION&quot;" target="&quot;GENOMIC VARIANT RS4988235&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Interactions between dietary factors and specific genomic variants (such as rs4988235) modulate gut microbial abundance."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCC8 MUTATIONS&quot;" target="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in ABCC8 gene are associated with CHI symptoms and patient classification into diazoxide-responsive or unresponsive groups."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUD1 MUTATIONS&quot;" target="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mutations in GLUD1 contribute to the pathogenesis of CHI among patients with hypoglycemia and hyperinsulinemia."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;" target="&quot;18F-DOPA PET/CT SCAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This scan is used for diagnosing and understanding the focal lesions causing CHI, particularly when surgery confirms diffuse pancreatic disease."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPOGLYCEMIA&quot;" target="&quot;INSULIN HORMONE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Abnormally high levels of insulin hormone can lead to hypoglycemia in CHI patients."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPOGLYCEMIA&quot;" target="&quot;LOW-PROTEIN DIET (1.5 G/KG/DAY)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This dietary pattern aims to manage hypoglycaemia by restricting protein intake and was successful in three patients without recurrence of symptoms."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE THERAPY&quot;" target="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Effective treatment strategy for many CHI patients, reducing the frequency of hypoglycemic episodes and improving overall health outcomes."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KATP CHANNEL GENE MUTATIONS&quot;" target="&quot;GLUD1 GENE MUTATIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mutations in both KATP channel genes (ABCC8 and KCNJ11) and GLUD1 gene are identified among CHI patients, indicating diverse genetic factors contributing to the disease."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE-UNRESPONSIVE GROUP&quot;" target="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Patients who do not respond to diazoxide treatment often show diffuse rather than focal pancreatic lesions upon surgical examination."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPILEPSY&quot;" target="&quot;HYPOGLYCEMIC BRAIN INJURY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Persistent hypoglycemia due to CHI can lead to epilepsy and brain injury, particularly in patients who do not receive timely therapeutic intervention."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FREQUENT FEEDINGS AND DIETARY MANAGEMENT&quot;" target="&quot;NEONATAL PERIOD AND INFANCY PERIOD (1-12 MONTHS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Frequent feeding is often initiated early after birth or during infancy to manage blood glucose levels in CHI patients, especially for those with hypoglycemia detected shortly after birth."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;HYPERTRICHOSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Diazoxide treatment for hypoglycemia can lead to hypertrichosis, a side effect observed in 55% of treated patients."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;MALABSORPTION SYMPTOMS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A few cases experienced malabsorption symptoms after stopping diazoxide therapy, affecting their ability to maintain stable blood glucose levels post-treatment."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;NAUSEA AND VOMITING&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Patients treated with diazoxide often experience nausea and vomiting as side effects, impacting their quality of life."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;SEVERE GASTROINTESTINAL UPSET&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A more severe form of gastrointestinal disturbance that can be caused by diazoxide treatment and necessitates nasogastric feeding."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"One patient had to stop diazoxide due to thrombocytopenic purpura, a side effect which is serious and required discontinuation of the treatment."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATECTOMY&quot;" target="&quot;DIABETES MELLITUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Following pancreatectomy surgery for managing hypoglycaemia, some patients developed diabetes mellitus requiring insulin treatment."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS&quot;" target="&quot;SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Pancreatic surgery can lead to diabetes mellitus in patients, requiring them to use insulin therapy post-surgery."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS&quot;" target="&quot;SERUM URIC ACID LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Patients with diabetes mellitus may exhibit higher serum uric acid levels due to altered metabolism and medication effects."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC AND BHB LEVELS&quot;" target="&quot;INSULIN SECRETION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Higher insulin secretion is associated with lower AcAc and BHB levels, suggesting a role of insulin in regulating ketone body metabolism.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC AND BHB LEVELS&quot;" target="&quot;RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Certain genetic variants are linked to elevated KB levels, indicating a potential molecular basis for their role in diabetes risk.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TWO-HOUR POST-PRANDIAL GLUCOSE (2HPG)&quot;" target="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Elevated 2hPG levels indicate IGT, a condition linked to an increased risk of developing type 2 diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;" target="&quot;T2D QUANTITATIVE TRAITS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Impaired glucose tolerance is a physiological process that shows borderline protective association with IGT for rs12123883."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METSIM STUDY&quot;" target="&quot;HYPERGLYCEMIA AND INCIDENT DIABETES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The METSIM study tracks participants over time to identify factors that increase the risk of hyperglycemia and incident diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERGLYCEMIA&quot;" target="&quot;SENP1-AP2KO&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In SENP1-aP2KO mice, hyperglycemia is observed earlier under HFD conditions than in normal diet scenarios, accelerating the onset of diabetic phenotypes.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Folate metabolism is part of broader nutrient-related physiological processes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;MTHFR C677T&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MTHFR C677T variant affects folate metabolism efficiency and thus impacts cardiovascular health outcomes."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;MTHFR A1298C&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Like MTHFR C677T, the A1298C variant also influences the metabolic pathways involving folate and its derivatives."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Disruptions in folate metabolism, influenced by MTHFR A1298C variant, can exacerbate cardiovascular risk factors in patients with Leiomyoma Venosa."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;S-FOL (SERUM FOLATE)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The serum folate measurement reflects the current status of folic acid metabolism within an individual's body."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;WB-FOL (WHOLE BLOOD FOLATE)&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Whole blood folate measurement provides a more comprehensive view of intracellular and circulating folate levels, impacting metabolic pathway assessment."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic background and environmental factors like ancestral admixture affect disease management through pharmacogenomics algorithms.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The FADS1 gene shows associations with AcAc or BHB levels, indicating an influence on ketone body metabolism."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2&quot;" target="&quot;HEIGHT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High Mobility Group AT-Hook 2 is a key gene for height variation in individuals."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FFAS (FREE FATTY ACIDS)&quot;" target="&quot;CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression of CPT1A gene correlates positively with fasting FFAs and negatively with insulin sensitivity, linking fatty acid oxidation to metabolic health."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;" target="&quot;FATTY ACIDS OXIDATION (FFA OXIDATION)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The CPT1A gene regulates the entry of long-chain acyl-CoAs into mitochondria for fatty acid oxidation."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The HMGCS2 gene plays a role in ketogenesis by catalyzing the production of 3-hydroxy-3-methylglutaryl-CoA from acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)&quot;" target="&quot;KETOGENESIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HMGCS2 gene plays a critical role in ketogenesis by catalyzing the formation of 3-hydroxy-3-methylglutaryl-CoA from acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"ACAT1 is involved in the breakdown of ketone bodies, specifically converting acetoacetyl-CoA into two molecules of acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)&quot;" target="&quot;KETOLYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ACAT1 gene encodes an enzyme that catalyzes the final step in ketone body breakdown, converting acetoacetyl-CoA into two molecules of acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDH1 (BHB DEHYDROGENASE, TYPE 1)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The BDH1 gene is involved in BHB metabolism and regulates its levels through enzymatic activity."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXCT1 (3-OXOACID COA TRANSFERASE 1)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"OXCT1 catalyzes the conversion of acetoacetyl-CoA to acetyl-CoA, an essential step in ketolysis and regulation of BHB levels."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACSS2 (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ACSS2 gene product activates fatty acids, influencing beta-oxidation and metabolic processes like insulin sensitivity."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS (KETONE BODIES)&quot;" target="&quot;KETOGENESIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The synthesis of ketone bodies from acetyl-CoA during periods of fasting or low carbohydrate intake is a central component of ketogenesis."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS (KETONE BODIES)&quot;" target="&quot;KETOLYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Ketolysis involves the breakdown of ketone bodies back into acetyl-CoA and other metabolites, regulating their levels in the body."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1 GENE VARIANT&quot;" target="&quot;CHOLESTEROL METABOLISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The APOC1 locus variant influences cholesterol metabolism by affecting serum CRP and lipid profiles.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A GENE VARIANT&quot;" target="&quot;GLYCEMIC PHENOTYPES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNPs in the HNF1A gene affect fasting glucose levels, illustrating genetic influence on metabolic conditions such as diabetes.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6R GENE VARIANT&quot;" target="&quot;INFLAMMATION REGULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants near IL6R are linked to inflammatory responses measured by CRP and may modulate cardiovascular risks.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;MC4R GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants near MC4R contribute to CRP variability, underscoring the genetic underpinnings of inflammation in cardiometabolic disorders.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;IL6R&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Effects on CRP levels remain significant after adjustments for BMI, cholesterol, or HbA1C.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;MC4R&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs near MC4R do not significantly affect CRP levels in the WGHS study.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;PLTP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNPs near PLTP are not associated with CRP levels after correction for multiple testing.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;LXR/RXR ACTIVATION PATHWAY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Significantly enriched pathway involved in the influence of genetic loci on CRP and cardiometabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;DIABETES DIAGNOSIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Elevated CRP levels in the blood serve as a clinical parameter aiding in the diagnosis of diabetes, particularly T1DM.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2867125 SNP&quot;" target="&quot;TMEM18 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Significant association of this SNP near TMEM18 suggests a role for this genomic region in CRP regulation and cardiometabolic conditions.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLTP GENE&quot;" target="&quot;LDL-CHOLESTEROL METABOLISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variations around PLTP affect LDL-cholesterol levels, highlighting complex interactions between genes and lipid metabolism.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1F10&quot;" target="&quot;GWAS NOT REPORTED&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IL1F10 was not previously reported in GWAS for the specific phenotype, indicating novel associations.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPP1R3B&quot;" target="&quot;CRP AND METABOLIC PHENOTYPES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"PPP1R3B gene shows pleiotropic effects on CRP levels and multiple cardiometabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF4A&quot;" target="&quot;T2D RISK&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"HNF4A influences risk of T2D and CRP levels, showing biological pleiotropy.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PABPC4&quot;" target="&quot;CRP&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic locus near PABPC4 is associated with changes in CRP levels, influenced by lipid mediators.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B&quot;" target="&quot;HDL CHOLESTEROL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Association between BCL7B and HDL cholesterol decreases considerably after adjustment for CRP.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A&quot;" target="&quot;CAD RISK&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"SNPs in HNF1A are associated with an increased risk of coronary artery disease (CAD).")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1&quot;" target="&quot;T2D RISK&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Genetic variants near APOC1 influence the risk of type 2 diabetes and serum CRP levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No consistent associations were found between variants of CRP gene and ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;RS20417&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant rs20417 is associated with differences in the percentage of CAD between patients and controls."</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;PLATELETS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CAD is associated with various physiological processes including platelet function and number."</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLESTEROL LEVELS&quot;" target="&quot;CRP ASSOCIATIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Levels of cholesterol influence genetic associations with CRP and cardiometabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HBA1C&quot;" target="&quot;CRP ASSOCIATIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Adjustment for HbA1C decreases the association between certain SNPs and metabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FXR/RXR ACTIVATION PATHWAY&quot;" target="&quot;GENETIC PLEIOTROPY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Pathway enriched by genes showing pleiotropic effects on CRP levels and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP ASSOCIATIONS&quot;" target="&quot;HEPATIC CHOLESTASIS PATHWAY&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Pathway significantly enriched by genetic loci influencing CRP and cardiometabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC EFFECTS&quot;" target="&quot;MODY SIGNALING&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACUTE PHASE RESPONSE SIGNALING PATHWAY&quot;" target="&quot;GENETIC INFLUENCES&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CC genotype of miR-34b/c rs4938723 was associated with a decreased risk of intracranial aneurysm compared to the TT genotype."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genotype frequencies of miR-34b/c rs4938723 in the control group meet Hardy-Weinberg equilibrium requirements."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">-2.0</data>
      <data key="d5">"No association between TP53 Arg72Pro and IA risk was observed in genotypic or allelic analysis."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;GENOTYPE FREQUENCY DISTRIBUTION&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"The TP53 Arg72Pro genotypes show a distribution pattern that aligns with genetic expectations for this polymorphism."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;" target="&quot;PCR (POLYMERASE CHAIN REACTION)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"PCR is commonly utilized to detect SNP variations in genetic studies."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;" target="&quot;HIND III RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"RFLP analysis can be used to identify specific SNPs within a gene or genomic region."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;" target="&quot;SEQUENCING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High-resolution sequencing technologies enable the precise identification of SNP variants in individual genomes."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;GENOTYPE DISTRIBUTION OF SNPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Used to verify random mating and genetic equilibrium in SNP distribution among participants."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;GENOTYPE DISTRIBUTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genotype distribution of controls matches Hardy-Weinberg equilibrium in most studies, indicating no significant deviation from expected genetic frequencies."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OR (ODDS RATIO)&quot;" target="&quot;95% CI (CONFIDENCE INTERVAL)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Odds Ratio is reported alongside the 95% confidence interval to provide an estimate of the precision of the association between genotypes and IA risk."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COL4A1&quot;" target="&quot;WEIGHT Z-SCORE CHANGE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"An intronic variant in COL4A1 on chromosome 13 is associated with changes in weight z-score."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSEN34&quot;" target="&quot;LINEAR GROWTH (HEIGHT CHANGE)&quot;">
      <data key="d4">7.2</data>
      <data key="d5">"A gene on chromosome 19 where a variant in the 5â²UTR region significantly influences linear growth, measured as height change."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTNR1B&quot;" target="&quot;FASTING GLUCOSE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"An intronic SNP in MTNR1B on chromosome 11 is strongly linked to fasting glucose levels."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOA5-ZNF259 REGION&quot;" target="&quot;TRIGLYCERIDES&quot;">
      <data key="d4">6.7</data>
      <data key="d5">"Variants within this genomic area significantly affect triglyceride levels."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCSK2&quot;" target="&quot;TOTAL ANTIOXIDANTS&quot;">
      <data key="d4">8.3</data>
      <data key="d5">"An intronic SNP in PCSK2 on chromosome 20 is associated with total antioxidants in the body."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCH1&quot;" target="&quot;24-H URINARY DOPAMINE:CREATININE RATIO&quot;">
      <data key="d4">6.3</data>
      <data key="d5">"An intronic SNP in GCH1 on chromosome 14 influences the ratio of 24-hour urinary dopamine to creatinine."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;XPA/FOXE1 (TTF-2)&quot;" target="&quot;SERUM TSH&quot;">
      <data key="d4">8.6</data>
      <data key="d5">"A group of SNPs in the flanking region of XPA/FOXE1 on chromosome 9 are highly associated with serum thyroid-stimulating hormone levels."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARHGAP11A INTRONIC VARIANT&quot;" target="&quot;SLEEP DURATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This variant is associated with sleep duration, indicating a genetic influence on this physiological process."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C21ORF34 SNP&quot;" target="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP in C21orf34 was detected for respiratory quotient during sleep, suggesting an impact on metabolic efficiency during rest."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPL7P3 VARIANT&quot;" target="&quot;LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This variant is associated with accelerometer-measured light activity, implying a genetic effect on physical behavior patterns."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCFL VARIANT&quot;" target="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The variant in the 3â²UTR of CTCFL is linked to sedentary-light activity during sleep, indicating an influence on daily movement patterns through genetic variation."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATK GENE &quot;" target="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Highly significant variants for total energy expenditure were identified in the MATK gene, suggesting a strong genetic association with overall metabolic rate."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATK GENE &quot;" target="&quot;TOTAL ENERGY EXPENDITURE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variants in MATK are significantly associated with total energy expenditure, highlighting its role in overall metabolic pathways."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHRNA3 GENE &quot;" target="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic associations detected for CHRNA3 linked to sleeping energy expenditure, indicating this gene's role in basal metabolism during sleep."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHRNA3 GENE &quot;" target="&quot;SLEEPING ENERGY EXPENDITURE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CHRNA3 gene is linked to sleeping energy expenditure, indicating a genetic impact on basal metabolism during sleep."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP DURATION &quot;" target="&quot;ARHGAP11A INTRONIC VARIANT &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The intronic variant in ARHGAP11A is associated with sleep duration, indicating a direct genetic influence on this physiological process."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPIRATORY QUOTIENT (RQ)&quot;" target="&quot;C21ORF34 SNP &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP in C21orf34 influences the respiratory quotient during sleep, suggesting a significant impact of genetic variation on metabolic efficiency."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIGHT ACTIVITY &quot;" target="&quot;RPL7P3 VARIANT &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variation in RPL7P3 is associated with accelerometer-measured light activity, indicating its role in physical behavior patterns."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEDENTARY-LIGHT ACTIVITY &quot;" target="&quot;CTCFL VARIANT &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CTCFL variant affects sedentary-light activity during sleep, reflecting the genetic influence on low-intensity movements."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RNASE1, ASS1P11&quot;" target="&quot;URINARY NITROGEN EXCRETION, CREATININE EXCRETION&quot;">
      <data key="d4">7.5</data>
      <data key="d5">"Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLKB1, MPRIP&quot;" target="&quot;SERUM FREE IGF-1, SERUM IGFBP-3&quot;">
      <data key="d4">7.9</data>
      <data key="d5">"Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DARC, GREB1, DFNB31, CCR3, RASGEF1A, ABO&quot;" target="&quot;MCP-1, IL-6&quot;">
      <data key="d4">9.8</data>
      <data key="d5">"Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP&quot;" target="&quot;TMEM229B, ARHGAP11A, C21ORF34&quot;">
      <data key="d4">7.8</data>
      <data key="d5">"An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS3833080: P.GLY369_ASP370DEL9&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant rs3833080 affects the amino acid sequence of the APOBR protein."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS180743: P.PRO428ALA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A non-synonymous SNP in APOBR that alters an amino acid, potentially affecting protein function."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The study population of extremely obese children and adolescents were screened for variants in the APOBR gene."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;GENETIC VARIANT RISK ALLELES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Risk alleles within APOBR are associated with increased odds for obesity in individuals."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS151233, RS149271, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These are additional variants in APOBR that do not affect amino acid sequences but may influence gene expression or regulation."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS180743 G-ALLELE AND RS3833080 DELETION ALLELE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These genetic variants were associated with obesity in case-control studies of extremely obese children and adolescents."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, ENSEMBL, PROVEAN&quot;" target="&quot;GENOMIC VARIANT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These bioinformatics tools predict functional effects of genetic variations identified in the study."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1036_1062DEL27&quot;" target="&quot;APOBR TRANSCRIPT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A common deletion variant affecting a transcript, with no predicted function on protein structure."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;SULT1A1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SULT1A1 gene contains the genomic variant rs142786317, which affects transcription factor binding sites and splicing enhancer/silencer elements."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A1&quot;" target="&quot;MET1VAL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This non-synonymous variant in SULT1A1 was not reproducibly identified across multiple samples, suggesting it may be a false positive or an artifact of sequencing."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A1&quot;" target="&quot;P.PRO200 = (RS3176926)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This synonymous variant in SULT1A1 is predicted to alter the binding domains for splicing regulators and transcription factor AML-1, potentially impacting gene expression."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.PRO19LEU (RS10797300)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Detected in SULT1A2, this variant shows potential functional modification based on prediction tools, indicating a possible impact on protein function."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.SER44ASN (RS145008170)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This conservative amino acid change in SULT1A2 near the binding pocket of xenobiotics is predicted to have a 'non-neutral' or 'deleterious' impact on function."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.TYR62PHE (RS4987024)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This non-conservative missense variant in SULT1A2 is predicted by various tools to have a higher probability of functional changes, though results are mixed."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.ALA164VAL (RS142241142)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The non-conservative exchange in SULT1A2 away from the binding pocket is predicted to have less significant functional impact compared to other variants."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.ASN235THR (RS1059491)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This conservative SNP in SULT1A2 is predicted by PolyPhen2, SNAP and SIFT as likely to be functionally relevant, indicating probable alterations to the protein."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM&quot;" target="&quot;C.3536C&gt;G &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Detected in TUFM's 3' untranslated region, this variant is predicted to alter splicing regulator or transcription factor binding sites, impacting gene regulation."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM&quot;" target="&quot;RS7187776: C.-55T&gt;C, RS4788099: C.500â19T/C, RS8061877: C.248â18G&gt;A, AND RS61737565: C.922+29C&gt;G&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A series of intronic variants in TUFM are predicted to lead to changes in transcription factor binding sites or splicing regulatory elements, potentially affecting gene expression."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM&quot;" target="&quot;TRANSCRIPTION FACTOR BINDING SITE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Disruption of transcription factor binding sites in TUFM may alter gene expression regulation."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS61737565: C.922+29C&gt;G&quot;" target="&quot;SRY, HFH 2, HMG-IY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs61737565 variant affects the binding sites for transcription factors such as SRY, HFH 2, and HMG-IY."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SRY, HFH 2, HMG-IY&quot;" target="&quot;RS8061877&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Disruption of transcription factor binding sites by rs8061877 affects the interaction with proteins like SRY, HFH 2, and HMG-IY."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICE SITES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The g.28854194C/G variant affects splice enhancer and silencer sites impacting mRNA processing."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICE ENHANCER BINDING SITE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The g.28854194C/G variant alters splice enhancer binding sites affecting splicing patterns."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICING SILENCER SITE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The g.28854194C/G variant changes splicing silencer sites impacting mRNA stability and translation."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;EPA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No significant genotype-by-diet interactions were found for EPA, indicating that EPA levels are less influenced by genetic variants in the FADS1/2 gene cluster."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;LPL GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in the LPL gene are causative of LPL deficiency and contribute to hypertriglyceridemia symptoms."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;MCM6 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant C/T-13910 SNP in MCM6 influences DNA modification density around the LCT gene, affecting lactase persistence."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;IL1B&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genomic variant in the IL1B gene is suggested to be associated with increased risk of ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;PTGS1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genomic variants in the PTGS1 gene are also suggested to influence ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;TAQI GENE (RS731236)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The TaqI gene variant rs731236 has been evaluated for its association with an increased risk of ovarian cancer, and while it shows no significant association in all populations, a slight increase is observed specifically in Caucasians."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;GG GENOTYPE (CDX-2)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GG genotype serves as a reference group in studies evaluating the association between other genotypes like AA or GA and ovarian cancer risk, showing no significant increase over this baseline."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B RS7596684&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This genomic variant is suggested to have an association with the risk of developing ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1 RS2282169&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This genomic variant is suggested to be associated with the risk of developing ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;ALOX15&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No consistent associations were observed between variants of ALOX15 gene and the risk of developing ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;CCL2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Variants in the CCL2 gene showed no significant association with ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;IL18&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Results for the IL18 gene did not show significant associations with ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;IL6&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No strong association was observed between variants in IL6 gene and ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;APAI (RS7975232)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant association was found between the ApaI variant and ovarian cancer risk as determined by fixed-effect model analysis."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;BSMI (RS1544410)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The BsmI variant does not show a significant association with increased ovarian cancer risk according to the fixed-effect model, although heterogeneity exists across studies due to deviation from Hardy-Weinberg equilibrium in some cases."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;FOKI (RS2228570 OR RS10735810)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FokI variant has a significant association with an increased risk of ovarian cancer, particularly in TT and CT carriers compared to CC carriers."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTOLOGICAL SUBTYPE OF OVARIAN CANCER&quot;" target="&quot;IL1B, PTGS1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 RS1051266&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is less evidence for an association between SLC19A1 SNP and childhood ALL risk compared to NOS3 rs3918186."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 GENE&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The NOS3 gene is part of the folate metabolic pathway, and genetic variations within this gene are associated with childhood ALL risk."&lt;SEP&gt;"The NOS3 gene, as part of the folate metabolic pathway, is associated with increased risk for childhood ALL through SNP rs3918186."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 GENE&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variations in the NOS3 gene significantly increase the risk of developing childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 GENE&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SLC19A1 gene, part of the folate metabolic pathway, shows less evidence in data for association with childhood ALL risk compared to NOS3 rs3918186."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 GENE&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While associated with increased risk, evidence for SLC19A1 in contributing to childhood ALL is less compelling compared to NOS3."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC PATHWAY&quot;" target="&quot;MTHFD2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MTHFD2 gene is part of the folate metabolic pathway and has SNPs associated with childhood ALL risk in initial screening."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC PATHWAY&quot;" target="&quot;BHMT2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Like MTHFD2, BHMT2 is a gene within the folate metabolic pathway showing SNP associations but not proceeding to final analysis due to lower posterior probability."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC PATHWAY&quot;" target="&quot;POSTERIOR PROBABILITY OF INCLUSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The posterior probability measure helps determine which SNPs from the folate metabolic pathway genes should proceed for further analysis based on initial screening data."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 RS3918186 RISK FACTOR&quot;" target="&quot;BAYES FACTORS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The Bayes factor of 7.38 for NOS3 rs3918186 indicates strong evidence that this SNP is associated with childhood ALL risk."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 RS1051266 RISK FACTOR&quot;" target="&quot;BAYES FACTORS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Bayes factor of SLC19A1 rs1051266 indicates less evidence compared to NOS3 rs3918186, showing a weaker association with childhood ALL risk."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY EATING DIET GROUP AND MEDITERRANEAN DIET GROUP DIETARY PATTERNS&quot;" target="&quot;LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Dietary patterns significantly influenced long chain n-3 fatty acid concentrations in serum after dietary interventions."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION&quot;" target="&quot;LINEAR REGRESSION ANALYSIS FOR FATTY ACID INTAKE AND BASELINE SERUM AA CONCENTRATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Fatty acid intake was a significant predictor of baseline serum long chain n-3 fatty acid concentration."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARACHIDONIC ACID (AA)&quot;" target="&quot;BASELINE SERUM AA CONCENTRATION MEASUREMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The baseline measurement of arachidonic acid concentration is critical for understanding its influence on health outcomes."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE DISTRIBUTION OF SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;BMI DIFFERENCE BETWEEN MINOR ALLELE CARRIERS AND NON-CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Significant BMI difference correlates with the presence of minor alleles in genotypes."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE AA CONCENTRATION MEASUREMENT IN SERUM AND COLON&quot;" target="&quot;FATTY ACID METABOLISM PATHWAY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Baseline arachidonic acid levels serve as an important marker for metabolic pathways."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY INTAKE OF LONG CHAIN N-3 FATTY ACIDS AND BASELINE CONCENTRATION PREDICTION&quot;" target="&quot;LONG CHAIN N-3 PUFA DIETARY INTAKE INCREASE IN HEALTHY EATING GROUP&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Predictive analysis aligns with observed dietary intervention outcomes for long chain omega-3 intake."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AS A COVARIATE IN GENOTYPE ANALYSIS&quot;" target="&quot;SERUM AND COLON FATTY ACID CONCENTRÃÃES BY GENOTYPE GROUP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age retained as covariate for more accurate fatty acid concentration analysis based on genotype."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYUNSATURATED FAT: SATURATED FAT RATIO&quot;" target="&quot;MEDITERRANEAN DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Mediterranean group had a slight increase in the polyunsaturated fat:saturated fat ratio, but this change was not statistically significant."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON AA CONCENTRATIONS&quot;" target="&quot;HEALTHY EATING DIET&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"For individuals without minor alleles in FADS1/2 gene cluster, colon AA concentrations increased significantly under the Healthy Eating diet compared to the Mediterranean diet."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;MUFA&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The Mediterranean diet significantly increased MUFA levels, indicating its impact on fatty acid metabolism."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;N-3 PUFA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both long-chain n-3 PUFA and MUFA significantly increased in the Mediterranean arm only, showing a dietary pattern's effect on omega-3 polyunsaturated fatty acids."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;SERUM 18:2 N-6&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The Mediterranean dietary pattern significantly decreased serum levels of 18:2 n-6."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;PULSE RATE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"An increase in pulse rate is observed to be causally influenced by snoring according to the generalized summary-data-based MR (GSMR) analysis.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP APNOEA&quot;" target="&quot;EXCESSIVE DAYTIME SLEEPINESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals suffering from sleep apnea commonly experience excessive daytime sleepiness as a result of poor quality nighttime sleep.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;" target="&quot;GENOMIC VARIANTS &quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These variants were identified through GWAS as having a significant impact on the genetic predisposition to snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS &quot;" target="&quot;SNP HERITABILITY (H2SNP)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The heritability measure captures variance explained by genomic risk loci associated with snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS &quot;" target="&quot;TOP 15 RISK LOCI &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Specific genomic variants within these top risk loci are significant in influencing the genetic predisposition to snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;SCHIZOPHRENIA &quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The negative genetic correlation indicates distinct underlying genetic factors between schizophrenia and the tendency to snore."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;AVERAGE SPO2 &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Despite being a measure of oxygen saturation, average SpO2 does not show a significant genetic correlation with habitual snoring compared to minimum SpO2 and Perc90."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;PERC90 (PERCENT OF SLEEP WITH OXYHEMOGLOBIN SATURATION UNDER 90%) &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"This measure is significantly genetically correlated with habitual snoring, especially after adjusting for BMI."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;CORONARY ARTERY DISEASE &quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A disease that shows a moderate genetic correlation with habitual snoring, indicating overlapping risk factors."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;FLUID INTELLIGENCE SCORE &quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A negative genetic correlation suggests that the genetic factors influencing fluid intelligence and habitual snoring are distinct."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-REPORTED SLEEP APNOEA &quot;" target="&quot;OXYGEN HEMOGLOBIN SATURATION (SPO2)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"These measures, particularly minimum and percent under 90% SpO2, correlate genetically with sleep apnea and thereby with habitual snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEART ATTACK &quot;" target="&quot;BMI ADJUSTMENT ANALYSIS &quot;">
      <data key="d4">8.0</data>
      <data key="d5">"After controlling for BMI in the GWAS analysis, heart attack is no longer genetically associated with snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION &quot;" target="&quot;BMI ADJUSTMENT ANALYSIS &quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Similar to heart attack, hypertension shows a loss of genetic correlation with habitual snoring upon adjustment for BMI."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATIONAL ATTAINMENT&quot;" target="&quot;SMOKING&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"Both educational attainment and smoking show nominal associations with milk consumption, suggesting they could be confounding factors in the relationship between dietary patterns and health outcomes."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOCTURNAL HYPOXIA MEASURES (MINIMUM SPO2, AVERAGE SPO2 AND PERC90)&quot;" target="&quot;GENETIC CORRELATION WITH SNORING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These measures correlate genetically with snoring after adjustment for BMI, indicating a strong genetic influence on the relationship between nocturnal hypoxia and snoring.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DLEU7 GENE ON CHROMOSOME 13&quot;" target="&quot;MSRB3 GENE ON CHROMOSOME 12&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both genes are identified in association studies for snoring, highlighting their potential role in the genetic architecture of this condition.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL11B GENE&quot;" target="&quot;ROBO2 GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These two genes share some associations with snoring and musculoskeletal traits, suggesting common underlying biological pathways or mechanisms.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMG6 GENE&quot;" target="&quot;ANAPC4 GENE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"These genes are both linked to musculoskeletal traits such as height and heel bone mineral density, suggesting interconnected pathways related to body morphology and snoring.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LMO4 GENE&quot;" target="&quot;RNA5SP471 GENE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Both genes have been associated with sleep disorders like insomnia and narcolepsy, indicating a shared role in the regulation of sleep patterns.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAJOR CORONARY HEART DISEASE&quot;" target="&quot;HEART ATTACK&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The risk of heart attack is strongly linked with coronary heart disease, which can result from atherosclerosis in the coronary arteries.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS200391180&quot;" target="&quot;RECENT SNORING&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"This genomic variant identified in females significantly influences the likelihood of recent snoring."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX-STRATIFIED GWAS ANALYSIS&quot;" target="&quot;PGS (POLYGENIC SCORE)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The polygenic score derived from GWAS results can predict recent snoring based on genetic risk factors."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PGS (POLYGENIC SCORE)&quot;" target="&quot;TOP HITS IN GWAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The top hits from GWAS analyses contribute significantly to the polygenic score which predicts recent snoring risk."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;PROBABLE OSA&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Severe cases of recent snoring may indicate probable obstructive sleep apnea, a serious health condition requiring medical attention."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;SNORING SEVERITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The severity of snoring increases with the frequency and intensity of recent snoring episodes."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;CROSS-SEX GENETIC CORRELATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"High genetic correlation between sexes indicates similar genetic predispositions towards snoring in both males and females."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP APNOEA &quot;" target="&quot;SNORING &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CONSUMPTION FREQUENCY &quot;" target="&quot;SMOKING FREQUENCY &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D STATUS&quot;" target="&quot;BMI PRE-PREGNANCY (KG/M2)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Pre-pregnancy BMI can influence maternal vitamin D status due to lifestyle factors including diet and exercise."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDBP POLYMORPHISMS&quot;" target="&quot;NEONATAL VITAMIN D STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variants in VDBP can influence neonatal vitamin D status at birth."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI PRE-PREGNANCY (KG/M2)&quot;" target="&quot;UVB EXPOSURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Pre-pregnancy BMI and UVB exposure both influence maternal vitamin D status during pregnancy."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UVB EXPOSURE&quot;" target="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Exposure to UVB light is a critical environmental factor affecting the production of vitamin D in pregnant women."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GESTATION PERIOD (WEEKS)&quot;" target="&quot;MATERNAL HEIGHT (CM)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Maternal height may interact with the duration of gestation affecting prenatal care and neonatal outcomes."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE (RS2298850)&quot;" target="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CC genotype at rs2298850 is associated with higher maternal 25(OH)D concentrations, indicating a positive impact on vitamin D status."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE (RS4588)&quot;" target="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CC genotype at rs4588 also shows association with elevated maternal 25(OH)D during delivery, impacting neonatal health."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH BIOCHEMICAL DATA&quot;" target="&quot;MATERNAL HEIGHT (CM)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Maternal height may correlate with biochemical data taken at birth, impacting prenatal care and neonatal health outcomes."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;VEGF SERUM LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs3025020 genotype is positively correlated with higher serum VEGF levels, indicating its role in angiogenesis and possibly exacerbating PCOS-related metabolic disturbances."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;INSULIN RESISTANCE INDEX HOMA-IR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs3025020 genotype is positively correlated with increased insulin resistance, suggesting its role in the pathogenesis of metabolic disturbances associated with PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele carrier of rs3025020 SNP is associated with higher levels of hs-CRP, indicating a pro-inflammatory effect."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;BIOACTIVE TESTOSTERONE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs3025020 genotype is positively correlated with increased bioactive testosterone levels, contributing to hyperandrogenism in PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;VEGF SERUM LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs2010963 genotype is inversely correlated with serum VEGF levels, indicating a protective role against PCOS metabolic disturbances."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;FREE TESTOSTERONE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs2010963 genotype is inversely correlated with free testosterone levels, indicating a protective role against hyperandrogenism characteristic of PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;ERYTHROCYTE SEDIMENTATION RATE (ESR)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele carrier of rs2010963 SNP is associated with lower levels of ESR, indicating an anti-inflammatory effect."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;BIOACTIVE TESTOSTERONE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs2010963 genotype is inversely correlated with bioactive testosterone levels, suggesting a protective effect against hyperandrogenism."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL TESTOSTERONE LEVELS&quot;" target="&quot;PCOS&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"While total testosterone levels are comparable between women with PCOS and controls, the bioactive forms of these hormones show differences that correlate with disease pathology."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;LH/FSH RATIO&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The ratio of LH to FSH is elevated in women with PCOS compared to control subjects, indicating a key hormonal imbalance characteristic of this condition."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;SHBG LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Significantly lower SHBG levels are observed in women with PCOS compared to controls, contributing to increased free androgens."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;TSH LEVELS&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"While TSH levels are higher but within normal range in women with PCOS compared to controls, this may reflect a subtle thyroid dysfunction or metabolic alteration."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HS-CRP LEVELS&quot;" target="&quot;INFLAMMATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATION&quot;" target="&quot;PHOSPHORYLATION OF IKK, IÎBÎ AND NF-ÎB P65/RELA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased phosphorylation events are associated with enhanced inflammation in adipose tissues of SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATION&quot;" target="&quot;IKK, IÎBÎ AND NF-ÎB P65/RELA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Phosphorylation of these proteins leads to NF-ÎºB activation contributing to the inflammatory response in adipose tissues.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-INFLAMMATORY EFFECT&quot;" target="&quot;ESR LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 LEVELS&quot;" target="&quot;VEGFA SNPS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VEGFA SNPS&quot;" target="&quot;IL-6 LEVELS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No correlation between IL-6 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VEGFA SNPS&quot;" target="&quot;TNFÎ LEVELS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No correlation between TNFÎ± levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VAL CARRIER GENOTYPE&quot;" target="&quot;RESPONSE BIAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Individuals carrying the val variant showed higher response bias compared to iso homozygotes, indicating a genetic influence on behavioral responses."&lt;SEP&gt;"Individuals carrying the val variant showed higher response bias compared to iso homozygotes, indicating a relationship between this genotype and behavior."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISO HOMOZYGOTE GENOTYPE&quot;" target="&quot;RESPONSE BIAS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with the iso homozygote genotype exhibited lower response bias as compared to val carriers, suggesting a genetic influence on behavioral responses."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISO HOMOZYGOTE GENOTYPE&quot;" target="&quot;SHOCK INTENSITY SELECTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with the iso homozygote genotype selected lower levels of shock intensity than val carriers, indicating differential stress sensitivity."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;ISO HOMOZYGOTES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals homozygous for the iso allele show less pronounced changes in response bias under stress conditions compared to val carriers, suggesting differential susceptibility to environmental stressors.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;CONDITION (STRESS VS NO-STRESS)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The manipulation of stress condition significantly affects response bias, with reduced bias towards rewarded stimuli observed under stress compared to no-stress conditions.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;SKIN CONDUCTANCE RESPONSES (SCR)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Changes in skin conductance responses are associated with variations in response bias during stress conditions; elevated SCRs correlate with altered cognitive biases under stress, yet do not fully explain genotype effects on response bias.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;CRHR1 SNPS (RS12938031, RS10445364, RS4076452)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of CRHR1 SNPs does not significantly alter the effect of MR genotype on stress-induced response bias reductions but slightly modifies variance explanation.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;MR GENOTYPE (COMT GENE VARIANTS)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Differences in MR genotype, particularly the val allele compared to iso homozygotes, uniquely explain changes in response bias during stress conditions after controlling for other influencing factors like discriminability and SCR.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAI SCORES&quot;" target="&quot;TIME Ã CONDITION Ã GENOTYPE INTERACTION&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"There was a trend showing that STAI scores increased over time and condition differently across genotypes, suggesting genetic modulation of stress response."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISCRIMINABILITY&quot;" target="&quot;SHOCK INTENSITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Although there were significant main effects for discriminability and block number, no differences emerged between genotype groups in any block regarding the impact of shock intensity on discriminability.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRHR1 GENE&quot;" target="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Polymorphisms in the CRHR1 gene are linked to variations in reward learning deficits induced by stress, indicating a genetic basis for differential susceptibility to stress effects on cognitive processes.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION Ã TIME Ã GENOTYPE TREND&quot;" target="&quot;PANAS NA&quot;">
      <data key="d4">0.6</data>
      <data key="d5">"The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SC RESPONSES&quot;" target="&quot;TIME Ã GENOTYPE INTERACTION&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;ALLELE FREQUENCY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The frequency of specific alleles in a population affects the prevalence and severity of genetic diseases like type 2 diabetes."</data>
      <data key="d6">chunk-b803830d07bff8ae14550f6458048707</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;TREATMENT RESPONSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"None of the SNPs tested showed significant association with treatment response after multiple testing adjustments.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMP4 GENE&quot;" target="&quot;NUMBER OF TEETH TRAIT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in BMP4 play a role in the number of permanent teeth, though less pronounced than with 'age at first tooth' trait."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACNB2 GENE&quot;" target="&quot;DENTAL DEVELOPMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in CACNB2 are found to be linked to variations in age at first tooth, suggesting a role in the timing of tooth development."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDON GENE&quot;" target="&quot;TOOTH MORPHOGENESIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNP rs4937076 near CDON gene is associated with phenotypes related to dental morphogenesis."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AJUBA/C14ORF93 GENE&quot;" target="&quot;DENTAL PHENOTYPES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP rs997154 near AJUBA gene is associated with phenotypic variation in dental development traits."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TEX14/RAD51C GENE&quot;" target="&quot;TOOTH COUNT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The SNP rs412000 near TEX14/RAD51C is associated with variation in the count of teeth at one year."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAM155EâEDA&quot;" target="&quot;CRANIOFACIAL DEVELOPMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant FAM155E-EDA is involved in craniofacial development measures."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMP4&quot;" target="&quot;TOOTH ERUPTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Bone Morphogenetic Protein 4 (BMP4) influences the timing of tooth eruption and number of primary teeth."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGF2BP1&quot;" target="&quot;TOOTH ERUPTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1) influences tooth eruption timing."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MSRB3&quot;" target="&quot;DENTAL PHENOTYPE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Methionine Sulfoxide Reductase B3 (MSRB3) contributes significantly to dental phenotype development."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADK&quot;" target="&quot;NOSE WIDTH&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Adenosine Kinase (ADK) variants are associated with measures of nose width in craniofacial studies."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AJUBA&quot;" target="&quot;HEIGHT AND CRANIOFACIAL PHENOTYPES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"LIM Domain Containing 7 Protein (AJUBA) is involved in mid-brow height increase, possibly linked to height."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEIGHT&quot;" target="&quot;GENOMIC VARIANT (RS35866622)&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"This genetic variant is associated with increased height in individuals, reflecting its impact on physical traits."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 GENE&quot;" target="&quot;PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The pathway analysis for 'age at first tooth' highlights pathways that include genes like HMGA2 and BMP4 as being significant, indicating their importance in dental health."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 GENE&quot;" target="&quot;AGE AT FIRST TOOTH TRAIT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variants in HMGA2 significantly influence when an individual develops their first tooth."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH SCORE (PMETA = 0.0012)&quot;" target="&quot;HEIGHT TRAIT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic variants associated with age at first tooth show a moderate association with height, suggesting an underlying biological link between these traits."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR NUMBER OF TEETH SCORE (PMETA = 9.8 Ã 10â4)&quot;" target="&quot;HEIGHT TRAIT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic variants associated with the number of teeth also show a moderate association with height, similarly suggesting an underlying biological link between these traits."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)&quot;" target="&quot;ALLIGATOR SOFTWARE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ALLIGATOR software is used to conduct pathway analysis for 'age at first tooth', revealing significant biological pathways involved."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALU/OPN1SW GENE&quot;" target="&quot;ORAL HEALTH&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variation in this region affects oral health parameters like age of first tooth and number of teeth."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENTAL PHENOTYPES&quot;" target="&quot;MSRB3 GENE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The SNP rs1956529 in MSRB3 region is associated with phenotypic variation related to dental traits."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADK GENE&quot;" target="&quot;ORAL DEVELOPMENT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENTAL TRAITS&quot;" target="&quot;DLEU7 GENE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KCNJ2 GENE&quot;" target="&quot;TOOTH DEVELOPMENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGF2BP1 GENE&quot;" target="&quot;ORAL DEVELOPMENT TRAITS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ORAL DEVELOPMENT TRAITS&quot;" target="&quot;LINC01278 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants around LINC01278 gene are linked to oral developmental traits such as the timing of first tooth eruption."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENTAL MORPHOGENESIS&quot;" target="&quot;EDA GENE&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"SNPs in EDA region are associated with phenotypic variations in dental morphology and development."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 REGION&quot;" target="&quot;TOOTH COUNT VARIABILITY&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AT FIRST TOOTH TRAIT&quot;" target="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GWAS investigates genetic variants associated with when an individual first develops teeth."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;" target="&quot;NUMBER OF TEETH TRAIT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The GWAS also explores genetic factors influencing the number of permanent teeth in adults, though less significant pathways were found compared to 'age at first tooth'."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELL TRANSFER-COLITIS MODEL&quot;" target="&quot;IL-10 SIGNALING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The T cell transfer model is used to evaluate how IL-10 signaling affects disease progression and severity in a T cell-dependent manner.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 SIGNALING&quot;" target="&quot;MACROPHAGES (MÎ¦)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-10 signaling into macrophages is shown to be critical in mitigating the severity of colitis, indicating a protective role for these cells in disease progression.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 SIGNALING&quot;" target="&quot;IL-1Î PRODUCTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Signaling through IL-10 receptor negatively regulates pro-IL-1Î² production and maturation by macrophages, inhibiting inflammation."</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DSS COLITIS MODEL&quot;" target="&quot;MACROPHAGES (MÎ¦)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IL-10 signaling into macrophages plays an important role in reducing inflammation in the DSS colitis model, independent of T cells.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎTDEL MICE&quot;" target="&quot;DISEASE DEVELOPMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Selective deletion of IL-10RÎ± specifically in T cells does not significantly influence disease development or severity in a T cell transfer-mediated colitis model.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎDCDEL AND IL-10RÎMDEL MICE&quot;" target="&quot;COLITIS SEVERITY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Deletion of the IL-10 receptor alpha specifically in macrophages intensifies disease severity, suggesting a protective role for IL-10 signaling within this cell type.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;LAMINA PROPRIA MACROPHAGES (LPMÎ¦S)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased activation and numbers of lamina propria macrophages correlate with exacerbated colitis in IL-10RÎ±MdelRag1â/â mice, highlighting their role in disease pathogenesis."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-6RÎâ/â T CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Absence of IL-6 receptor alpha in T cells results in a decreased ability to induce colitis, indicating its role in disease pathogenesis."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-6&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Interleukin-6 signaling supports T cell expansion and contributes to severe clinical disease during colitis, especially in Rag1â/â mice."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-1Î&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Elevated expression of IL-1Î² contributes to the pathogenesis of colitis in mice lacking functional IL-10RÎ±MdelRag1, suggesting its role as a pro-inflammatory mediator."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;FOXP3+ CD4+ T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The absolute numbers of Foxp3+ CD4+ T cells are diminished in the absence of disease development in Rag1â/â mice, indicating their role in maintaining immune tolerance during colitis."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-1Râ/â T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Absence of IL-1 receptor signaling reduces the severity of colitis in both IL-10RÎ±MdelRag1â/â and Rag1â/â recipients, indicating a role for IL-1 in disease pathogenesis."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Interleukin-1 signaling is essential for the development of colitis, particularly when other inflammatory mediators like IL-6 are not required due to genetic mutations such as those found in IL-10RÎ±MdelRag1â/â mice."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL1B GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Il1b gene is involved in inflammatory responses that occur during DSS-induced colitis.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;CASPASE 3&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased cleaved caspase 3 levels indicate higher apoptosis in mice lacking CARD9 during colitis.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;GUT MICROBIOTA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Abnormalities in the gut microbiota, particularly under conditions of CARD9 deficiency, contribute to the development or exacerbation of colitis symptoms."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;INTERLEUKIN-10 (IL-10)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"IL-10 plays a role in regulating inflammation but no differences were noted between CARD9 deficient and normal mouse models in this context."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CX3CR1-DRIVEN CRE TRANSGENE&quot;" target="&quot;SPONTANEOUS COLITIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CX3CR1-driven Cre transgene leads to spontaneous colitis when used to delete IL-10RÎ± in a subset of immune cells.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYS-M-CRE TRANSGENE&quot;" target="&quot;NEUTROPHIL ROLE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Deletion of IL-10RÎ± using Lys-M-Cre transgene in neutrophils and macrophages shows a complex effect on colitis severity, indicating the need for further studies.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 GENE&quot;" target="&quot;COLITIS SEVERITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The IL-10 gene's product (IL-10) plays a protective role in reducing colitis severity through immune regulation.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎFL/FL MICE&quot;" target="&quot;DISEASE MODELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Mice with floxed IL-10 receptor alpha gene are used in various models to understand the cell-specific effects of IL-10 signaling on colitis.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUTROPHILS&quot;" target="&quot;IL-10RÎMDELRAG1â/â&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Depletion studies indicate that neutrophil depletion does not significantly impact the disease state in IL-10RÎ±MdelRag1â/â mice, suggesting a minimal role for neutrophils in exacerbating the condition."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUTROPHILS&quot;" target="&quot;LY6G&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Antibodies against Ly6G are used to selectively deplete neutrophils for experimental purposes in models like IL-10RÎ±MdelRag1â/â, highlighting the importance of specific cell types in disease pathogenesis."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECTAL PROLAPSE&quot;" target="&quot;DISEASE OUTCOME&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Rectal prolapse is a severe symptom observed in mice with high disease severity, indicating advanced stages of colitis.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎMDELRAG1â/â&quot;" target="&quot;LAMINA PROPRIA MACROPHAGES (LPMÎ¦S)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genetic modification affects the function and activation state of lamina propria macrophages, increasing their numbers and enhancing their activity levels."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎMDELRAG1â/â&quot;" target="&quot;RAG1â/â&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IL-10RÎ±Mdel mutation is studied in a Rag1-deficient background, which lacks mature T cells and B cells, to assess the impact of specific immune cell types on disease severity."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎMDELRAG1â/â&quot;" target="&quot;DENDRITIC CELLS (DCS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The role and function of dendritic cells in the disease exacerbation are explored but not significantly altered in IL-10RÎ±MdelRag1â/â mice, indicating their minimal impact on disease progression."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LAMINA PROPRIA MACROPHAGES (LPMÎ¦S)&quot;" target="&quot;IL-10&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The lack of IL-10 signaling into lamina propria macrophages leads to heightened activation and proliferation rates, contributing to increased disease severity in IL-10RÎ±MdelRag1â/â mice."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;T REGULATORY CELLS (TREGS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The function of regulatory T cells is not overtly impacted by the absence of IL-10 signaling in macrophages, indicating alternative mechanisms for Treg suppressive activity are employed."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;TH17 CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The production of IL-10 does not significantly affect Th17 cell numbers or functions in colitis models."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T REGULATORY CELLS (TREGS)&quot;" target="&quot;CD4 T CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A subset of CD4+ T cells can differentiate into regulatory T cells upon activation, playing a critical role in maintaining tolerance and preventing autoimmunity. In the context of IL-10RÎ±MdelRag1â/â mice, this process remains intact."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T REGULATORY CELLS (TREGS)&quot;" target="&quot;FOXP3&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The upregulation of Foxp3 is critical for the differentiation and function of regulatory T cells, playing a key role in immune regulation. Its expression remains intact in IL-10RÎ±MdelRag1â/â mice."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T REGULATORY CELLS (TREGS)&quot;" target="&quot;MESENTERIC LYMPH NODES (MLNS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Regulatory T cells can be found in high numbers within mesenteric lymph nodes, which are crucial sites for regulating intestinal immunity and preventing excessive inflammation."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T REGULATORY CELLS (TREGS)&quot;" target="&quot;LYP-620W&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The LYP-620W variant can block Treg proliferation similar to the LYP-620R variant, indicating differential impact on Tconv and Treg."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAG1â/â&quot;" target="&quot;CASPASE-1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In Rag1 deficient cells (Rag1â/â), caspase-1 activity is suppressed by autocrine IL-10, which can be blocked with anti-IL-10R antibody."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎâ/âRAG2â/â&quot;" target="&quot;ITREG&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic deletion of IL-10 receptor beta subunit and Rag2 results in impaired induction and function of induced regulatory T cells (iTregs), highlighting the importance of these components for proper immune regulation."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎMDELRAG1â/â MICE&quot;" target="&quot;T CELLS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"T cell transfer experiments show that T cells do not significantly influence disease magnitude in IL-10RÎ±MdelRag1â/â mice, indicating the immune response is primarily driven by other mechanisms such as MÏ."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎMDELRAG1â/â MICE&quot;" target="&quot;TH17 CELLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The Th17 cell response is increased and critical for the development of colitis in IL-10RÎ±MdelRag1â/â mice."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELLS&quot;" target="&quot;IL-27 SIGNALING&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Innate immune cells produce IL-27 which interacts with its receptor complex on T cells, leading to activation of the STAT1/STAT3 pathway."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELLS&quot;" target="&quot;IL-27 CYTOKINE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-27 produced by innate immune cells interacts with T cells via its receptor complex, initiating pathways that regulate immune responses."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELLS&quot;" target="&quot;FOXP3 EXPRESSION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Maintenance of T cell levels is influenced by the expression level of FOXP3, which is affected in patients with defective STAT5B function.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MÎ¦ IL-10 RESPONSE&quot;" target="&quot;PRO-INFLAMMATORY CYTOKINE PRODUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An attenuated MÏ IL-10 response leads to increased pro-inflammatory cytokine production and heightened disease severity."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎMDEL LPMÎ¦S&quot;" target="&quot;TH17 CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"LPMÏs from IL-10RÎ±Mdel mice produce elevated levels of Th17-promoting cytokines, contributing to increased colitis severity."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-6&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Interleukin-6 is essential for the development and maintenance of Th17 cell populations during inflammation."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;RORÎT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The transcription factor RORÎ³T is required for the differentiation of naive T cells into Th17 cells."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;RAG1â/â MICE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The number of Th17 cells is significantly decreased in Rag1â/â recipients compared to IL-10RÎ±MdelRag1â/â, indicating a role for adaptive immunity in Th17 cell regulation."</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-1R&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The IL-1 response modulates Th17 cell populations at the site of inflammation, supporting their role in promoting colonic inflammation."</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;INTERLEUKIN-17A (IL-17A)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"TH17 cells produce IL-17A, but in this context, there were no observed differences in IL-17 production between Card9â/ââGF mice and WT controls."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;TNF-Î&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both IL-6 and TNF-Î± are involved in the inflammatory response in colitis and their production is upregulated in IL-10RÎ±Mdel mice."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-Î&quot;" target="&quot;HIDRADENITIS SUPPURATIVA (HS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Anti-TNF-Î± drugs, like adalimumab, are used to treat HS by inhibiting TNF-Î±, a cytokine involved in inflammation.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-Î&quot;" target="&quot;PSORIASIFORM DERMATITIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The condition of psoriasiform dermatitis can develop paradoxically after anti-TNF-Î± therapy such as adalimumab treatment.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Î&quot;" target="&quot;MAPBACTEREMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of MAPbacteremia is associated with higher expression levels of IFN-Î³ in CD patients."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Î&quot;" target="&quot;IFNG&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The IFN-Î³ protein is encoded by the IFNG gene."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Î&quot;" target="&quot;INOS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Increased iNOS expression correlates with elevated IL-1Î² production, indicating enhanced pro-inflammatory activity of MÏs in IL-10RÎ±Mdel mice."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+IL-17A+ T CELLS&quot;" target="&quot;RORÎT-GFP REPORTER T CELLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These CD4+ IL-17A+ T cells can be identified using RORÎ³T-GFP reporter T cells, highlighting the role of Th17 cells in colitis."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARGINASE EXPRESSION&quot;" target="&quot;INOS EXPRESSION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased iNOS activity correlates with a decrease in Arginase expression indicating an enhanced pro-inflammatory phenotype for MÏs."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6RÎâ/â T CELLS&quot;" target="&quot;COLONIC INFLAMMATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"T cells lacking IL-6 receptor alpha subunit exhibit reduced inflammation compared to WT controls in colitis models."</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RÎMDEL&quot;" target="&quot;IL-1Î PRODUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic modification affecting IL-10 signaling leads to increased pro-IL-1Î² expression and maturation in macrophages, contributing to disease progression."</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLONIC INFLAMMATION&quot;" target="&quot;LPMÎ¦S (LINâCD11B+ CD11Câ/LO F4/80HI LY6Gâ SIGLECFâ)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Macrophages in the lamina propria are a primary source of IL-1Î², contributing to inflammatory responses in colitis."</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Î PRODUCTION&quot;" target="&quot;CASPASE-1 CLEAVAGE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Cleavage of pro-IL-1Î² by caspase-1 is essential for the production and release of active IL-1Î² during inflammation."</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Î PRODUCTION&quot;" target="&quot;INFLAMMASOME STIMULATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Activation of inflammasomes triggers the caspase-1 pathway, leading to cleavage and activation of pro-IL-1Î²."</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRO-IL-Î&quot;" target="&quot;CASPASE-1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Pro-IL-1Î² requires cleavage and activation by caspase-1 to become mature IL-1Î², a process inhibited by IL-10 signaling."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MÎ¦S&quot;" target="&quot;TH17 CELL MATURATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Macrophages (MÏs) can influence Th17 cell differentiation through the secretion of cytokines like IL-1 and IL-6, which are regulated by factors such as IL-10."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;IL-1RÎMDEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In cells with altered IL-1 receptor alpha chain (IL-1RÎ±Mdel), caspase-1 activation is not properly regulated, leading to increased pro-inflammatory cytokine production."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;LPS AND ATP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Stimulation with LPS and ATP activates caspase-1, leading to the cleavage and maturation of pro-inflammatory cytokines like IL-1Î²."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL MATURATION&quot;" target="&quot;LPMÎ¦S&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Liver-derived macrophages (LPMÏs) can directly influence Th17 cell maturation through the secretion of IL-1 and IL-6, processes regulated by factors like IL-10."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL MATURATION&quot;" target="&quot;TGFÎ&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Transforming growth factor beta (TGFÎ²), when combined with other signals such as IL-6, promotes the differentiation of naive T cells into Th17 helper T cells."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;16S RRNA GENE V4 REGION&quot;" target="&quot;DNA EXTRACTION METHOD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The DNA extraction method significantly affects the observed variability in the 16S rRNA gene V4 region."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BACTEROIDES GENUS&quot;" target="&quot;HERITABILITY ESTIMATION OF GUT MICROBIOME COMPOSITION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Estimations for heritability show significant evidence that the Bacteroides genus is influenced by genetic factors."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA EXTRACTION METHOD&quot;" target="&quot;16S RRNA GENE VARIABLE REGIONS V4-V5&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The DNA extraction method influences the variability observed in sequencing regions of 16S rRNA gene V4-V5."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TWINSUK COHORT TWIN PAIRS&quot;" target="&quot;NETHERLANDS TWIN REGISTRY (NTR) COHORT TWIN PAIRS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These twin cohorts are used to replicate and validate intraclass correlation coefficients for heritability studies of gut microbiome composition."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIDDLE-EASTERN COHORT&quot;" target="&quot;EAST ASIAN COHORT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both cohorts represent different ethnic backgrounds contributing to genetic and environmental diversity."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY ESTIMATION OF GUT MICROBIOTA ALPHA DIVERSITY METRICS (SHANNON, SIMPSON, INVERSE SIMPSON)&quot;" target="&quot;HERITABILITY ESTIMATION OF 159 BACTERIAL TAXA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"While no heritability was found for alpha diversity metrics, certain bacterial taxa were identified as heritable."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY ESTIMATION OF 159 BACTERIAL TAXA&quot;" target="&quot;RUMINICLOSTRIDIUM GENUS AND PEPTOSTREPTOCOCCAEAE FAMILY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These two microbial groups were among the 159 bacterial taxa that showed evidence for heritability in genetic studies."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT GENE&quot;" target="&quot;COPSAC2010 COHORT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The COPSAC2010 cohort contributed significantly to heterogeneity seen in LCT gene associations with Bifidobacterium abundance."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT GENE&quot;" target="&quot;CPG SITES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The LCT gene exhibits significant modification differences at CpG sites in enterocytes compared to other tissues, indicating regulatory roles of these genomic variants."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT GENE&quot;" target="&quot;MCM6 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both genes are involved in the regulation of lactase expression, with MCM6 acting as a modulator for LCT activity through regulatory elements."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT2 GENE&quot;" target="&quot;GENOMIC VARIANT RS182549&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Functionally relevant variants, such as those in FUT2, are also found among loci influencing gut microbial composition."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT2 GENE&quot;" target="&quot;COBALAMIN ABSORPTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic variations in the FUT2 gene impact cobalamin metabolism and absorption, influencing gut microbiota composition."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM&quot;" target="&quot;MILK PRODUCTS INTAKE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Consumption of milk products positively correlates with Bifidobacterium abundance in individuals with specific LCT genotypes."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM&quot;" target="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased presence of Bifidobacterium in gut microbiota correlates with reduced risk or impact of ulcerative colitis according to MR analyses.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT RS182549&quot;" target="&quot;AGE AND ETHNICITY HETEROGENEITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The effect of the genomic variant (rs182549) on Bifidobacterium abundance varies significantly across different ethnicities and age groups."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AND ETHNICITY HETEROGENEITY&quot;" target="&quot;GEM_V12 AND GEM_ICHIP SUBCOHORTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These subcohorts demonstrated significant SNP-age interactions affecting Bifidobacterium abundance, highlighting the importance of age and ethnicity."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT RS4988235&quot;" target="&quot;GEM_V12 AND GEM_ICHIP SUBCOHORTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This variant showed differential effects on Bifidobacterium abundance in different age groups within these subcohorts."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SIMPSON, INVERSE SIMPSON, AND SHANNON DIVERSITY INDICES&quot;" target="&quot;TWINSUK COHORT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These diversity indices were used to evaluate heritability in the TwinsUK cohort but did not show significant genetic hits."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT2-FUT1 LOCUS&quot;" target="&quot;R. TORQUES GROUP&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FUT2-FUT1 locus influences Ruminococcus torques genus group abundance through genetic variation affecting mucus glycans levels."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;R. TORQUES GROUP&quot;" target="&quot;FRUIT INTAKE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Intake of fruit correlates with reduced abundance of Ruminococcus torques group due to genetic variation at the FUT2 locus."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLISONELLA ABUNDANCE&quot;" target="&quot;PEPTOSTREPTOCOCCACEAE ABUNDANCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both Allisonella and Peptostreptococcaceae abundances are affected by genetic variants related to vitamin B2 (riboflavin) and B12 metabolism."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COBALAMIN ABSORPTION&quot;" target="&quot;B12-DEFICIENT ANEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Impaired cobalamin absorption, due to CUBN gene mutations, leads to increased risk of vitamin B12 deficiency anemia."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS7574352&quot;" target="&quot;PEPTOCOCCACEAE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of this SNP is negatively correlated with the abundance of Peptococcaceae, a family of bacteria linked to gut health conditions like ulcerative colitis."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHROMOGRANIN A&quot;" target="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High levels of chromogranin A are associated with increased risk of ulcerative colitis and negatively correlated with the presence of Peptococcaceae bacteria."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ULCERATIVE COLITIS&quot;" target="&quot;ACTINOBACTERIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher abundance of Actinobacteria suggests a potential protective effect on the occurrence or severity of ulcerative colitis, based on MR analysis results.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1 GENE&quot;" target="&quot;MISSENSE SNP RS181206[G]&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The missense variant rs181206[G] influences the expression levels of IRF1 gene, which is associated with T1D susceptibility and colocalized variants."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT GENE (RS182549)&quot;" target="&quot;TYPE 2 DIABETES MELLITUS (T2DM)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Polymorphisms in the LCT gene are associated with increased risk for Type 2 Diabetes Mellitus, particularly in individuals predisposed to lactose intolerance."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT1/FUT2 LOCUS (RS35866622)&quot;" target="&quot;FISH INTAKE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FUT1/FUT2 locus is positively associated with the dietary pattern of fish intake and negatively linked to certain diseases like cholelithiasis."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FISH INTAKE&quot;" target="&quot;GENOMIC VARIANT (RS35866622)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This genetic variant is positively associated with dietary patterns such as fish intake, influencing various health outcomes."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;" target="&quot;RAW VEGETABLE INTAKE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Intake of raw vegetables shows a nominal correlation with abundance of Bifidobacteria, but this relationship needs further validation due to multiple testing issues."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES MELLITUS (T2DM)&quot;" target="&quot;(CA)16 ALLELE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of the (CA)16 allele is significantly associated with increased risk for T2DM compared to other alleles, indicating a genetic predisposition."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT (RS182549)&quot;" target="&quot;TYPE 2 DIABETES MELLITUS FAMILY HISTORY (PATERNAL)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of this variant increases the risk for Type 2 Diabetes Mellitus in individuals with a paternal history of T2DM."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT (RS182549)&quot;" target="&quot;TYPE 2 DIABETES MELLITUS FAMILY HISTORY (MATERNAL)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This genetic variant also increases the risk for Type 2 Diabetes Mellitus in individuals with a maternal history of T2DM."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT (RS182549)&quot;" target="&quot;SIBLINGS' TYPE 2 DIABETES MELLITUS RISK&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs182549 variant increases the risk for siblings developing Type 2 Diabetes Mellitus based on familial genetic factors."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT (RS35866622)&quot;" target="&quot;HIGH CHOLESTEROL LEVELS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The rs35866622 variant near the FUT1/FUT2 locus positively influences high cholesterol levels and metabolic conditions."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT1/FUT2 LOCUS GENETIC VARIANTS&quot;" target="&quot;OILY FISH INTAKE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic variations at this locus are linked to the consumption of oily fish and influence metabolic traits."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT1/FUT2 LOCUS GENETIC VARIANTS&quot;" target="&quot;MEAN PLATELET VOLUME&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"These genetic variants impact blood markers such as mean platelet volume, which is associated with immune functions."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXALOBACTERACEAE&quot;" target="&quot;RHEUMATOID ARTHRITIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Higher abundance of Oxalobacteraceae family members has a negative correlation with rheumatoid arthritis, suggesting protective effects against the disease.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIAL TAXA VARIABILITY&quot;" target="&quot;AUTOIMMUNE DISEASES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The relationship between genetic factors, microbial taxa variability, and autoimmune diseases is being investigated to understand causality better.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIAL TAXA VARIABILITY&quot;" target="&quot;CARDIOVASCULAR DISEASES&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Causal links between cardiovascular health and the composition of gut microbiota are being explored using MR analysis for a comprehensive understanding.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIAL TAXA VARIABILITY&quot;" target="&quot;METABOLIC DISEASES&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"MR analysis aims to uncover potential causal relationships between metabolic conditions and microbial taxa variability in the gut.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIAL TAXA VARIABILITY&quot;" target="&quot;PSYCHIATRIC DISORDERS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Investigations into how microbial taxa variability might influence psychiatric disorders are part of ongoing MR analysis studies.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PREFERENCES&quot;" target="&quot;MR ANALYSIS (MENDELIAN RANDOMIZATION)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No evidence of causal relationships between dietary preferences and gut microbial taxa abundance was identified using strict criteria in MR analysis.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;RS1893217&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genomic variant rs1893217, mapped to the PTPN2 gene, is associated with increased risk for autoimmune diseases such as celiac disease and type 1 diabetes."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235 T/T GENOTYPE&quot;" target="&quot;MILK INTAKE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The rs4988235 T/T genotype is associated with a higher intake of milk, indicating genetic influence on dietary patterns."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LP (T) ALLELES&quot;" target="&quot;PLASMA C15:0 LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals carrying the LP (T) alleles exhibit increased plasma C15:0 levels due to higher dairy consumption."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES RISK FACTORS&quot;" target="&quot;HDL CHOLESTEROL LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased number of LP (T) alleles is associated with modestly lower HDL cholesterol, influencing diabetes risk factors."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAIRY PRODUCTS INTAKE&quot;" target="&quot;POTATOES INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The intake of dairy products is positively correlated with potatoes but negatively correlated with fruits and vegetables."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WINE CONSUMPTION&quot;" target="&quot;MULTIVARIABLE ADJUSTMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"After multivariable adjustment, wine consumption decreases as LP (T) allele count increases."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK OF DEVELOPING DIABETES&quot;" target="&quot;BASELINE HBA1C LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Despite variations in baseline HbA1c levels and dietary patterns, there is no significant association with the risk of developing diabetes for individuals carrying the rs4988235 genotype."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235 GENOTYPE&quot;" target="&quot;GENETIC DEVIATION FROM HWE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The rs4988235 genotype shows deviation from Hardy-Weinberg equilibrium in several European populations, indicating population-specific genetic influences."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOMOZYGOUS LP (T/T)&quot;" target="&quot;MILK CONSUMPTION VARIABILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals homozygous for the T/T allele exhibit variability in milk consumption across different countries, suggesting environmental influences on dietary patterns."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY INTAKE OF DAIRY PRODUCTS&quot;" target="&quot;INTAKE OF NON-DAIRY FOODS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"While there is an association with dairy product intake, the rs4988235 genotype also alters intakes of non-dairy foods such as potatoes and cereal products."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLASMA C17:0 LEVELS&quot;" target="&quot;HDL CHOLESTEROL VARIABILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Similar to plasma C15:0 levels, variations in C17:0 are observed but do not reach statistical significance, linking them to the LP genotype and HDL cholesterol variability."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE&quot;" target="&quot;FASD&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Maternal dietary intake of choline during pregnancy may influence FASD outcomes in infants, although more research is needed to fully understand this relationship."</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CONSUMPTION&quot;" target="&quot;SOMATIC GROWTH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Heavy alcohol consumption during pregnancy can lead to poor somatic growth in infants.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CONSUMPTION&quot;" target="&quot;CT GENOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Individuals with the CT genotype exhibit a greater reward response when consuming alcoholic beverages compared to those without this genotype."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING&quot;" target="&quot;FETAL ALCOHOL SPECTRUM DISORDERS (FASD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Maternal smoking, along with heavy drinking, can exacerbate the risks and symptoms of FASD.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILLICIT DRUGS (METHAMPHETAMINE)&quot;" target="&quot;EYEBLINK CONDITIONING (EBC)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The use of illicit drugs during pregnancy may influence neurodevelopmental processes such as eyeblink conditioning in infants.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FETAL ALCOHOL SPECTRUM DISORDERS (FASD)&quot;" target="&quot;EYEBLINK CONDITIONING (EBC)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Infants with FASD may show poorer performance in eyeblink conditioning compared to healthy infants.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FETAL ALCOHOL SPECTRUM DISORDERS (FASD)&quot;" target="&quot;INFANT AGE AT ASSESSMENT&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Age of assessment is crucial for detecting early signs of FASD in infants.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EYEBLINK CONDITIONING (EBC)&quot;" target="&quot;DURATION OF CHOLINE SUPPLEMENTATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Longer duration of choline supplementation correlates with improved neurodevelopmental outcomes in EBC tests.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GESTATIONAL AGE (GA)&quot;" target="&quot;SOMATIC GROWTH&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Proper somatic growth is contingent upon adequate gestational age and the absence of harmful environmental factors.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOMATIC GROWTH&quot;" target="&quot;CIGARETTES PER DAY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Maternal smoking can negatively affect fetal somatic growth and development.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALORIC INTAKE&quot;" target="&quot;CHOLINE STATUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Proper caloric intake is necessary to support adequate choline status during pregnancy.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GESTATIONAL AGE AT BOOKING, SCREENING, OR RANDOMIZATION&quot;" target="&quot;PROTOCOL ADHERENCE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Timing of initial assessments influences the feasibility and adherence to treatment protocols.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEEKS GESTATION AT RANDOMIZATION&quot;" target="&quot;CHOLINE SUPPLEMENTATION EFFECTIVENESS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The effectiveness of choline supplementation may vary based on gestational age at initiation.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX OF INFANT&quot;" target="&quot;GESTATIONAL AGE AND SOMATIC GROWTH&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The sex of the infant can influence growth patterns observed during gestation and after birth.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTOCOL ADHERENCE AND PERCENT CRS&quot;" target="&quot;CATCH-UP GROWTH&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Higher adherence to choline supplementation protocols correlates with better neurodevelopmental outcomes, including catch-up growth patterns.")</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12325817&quot;" target="&quot;PEMT GENE EXPRESSION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs12325817 variant of the PEMT gene affects choline synthesis capacity and may alter maternal dietary requirements for adequate nutrition during pregnancy."</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12325817&quot;" target="&quot;CHOLINE INTAKE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Mothers carrying the rs12325817 variant of PEMT gene have reduced endogenous choline synthesis capacity, potentially impacting dietary choline requirements during pregnancy."</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P=0.393&quot;" target="&quot;Î§Â²(1)=0.73&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ÏÂ² test result and the p-value indicate no statistically significant differences between the choline-treated group and placebo group regarding FAS/PFAS diagnosis."</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE INTAKE&quot;" target="&quot;MATERNAL DIETARY STATUS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Mothers' dietary choline intake status is an environmental factor that can significantly impact infant health outcomes, especially in relation to FASD risk."</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAS/PFAS DIAGNOSIS&quot;" target="&quot;MATERNAL DIETARY CHOLINE STATUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The study's findings suggest that maternal dietary choline status does not significantly impact the diagnosis of FAS or PFAS in infants."</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10886471 SNP&quot;" target="&quot;GRK5 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant at rs10886471 is located within the GRK5 gene, influencing its expression through intronic CA repeat sequences."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRK5 GENE&quot;" target="&quot;IMPAIRED FASTING GLUCOSE (IFG)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variations within GRK5, specifically the CA repeat polymorphisms, influence the risk of developing IFG and subsequently T2DM."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRK5 GENE&quot;" target="&quot;(CA)17 ALLELE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The (CA)17 allele is more prevalent in individuals without abnormal blood glucose levels compared to those with prediabetes or T2DM, suggesting a protective genetic factor."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;(CA)16 ALLELE&quot;" target="(&quot;CA)N ALLELES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The (CA)15, (CA)17, (CA)18, and (CA)19 alleles are classified together as a multiple allele in contrast to the reference (CA)16 allele."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPAIRED FASTING GLUCOSE (IFG)&quot;" target="&quot;T2D QUANTITATIVE TRAITS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Impaired fasting glucose is one of the physiological processes measured as part of T2D quantitative traits."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRK5 (CA)N REPEATS&quot;" target="&quot;2H PG&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Polymorphisms within GRK5's CA repeat sequences are linked with higher postprandial glucose levels in individuals moving from normal glucose tolerance to IGT and T2DM, suggesting a genetic component in impaired glucose metabolism."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;(CA)N ALLELES&quot;" target="&quot;IFG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The multiple alleles (excluding (CA)16) show a significant negative correlation with IFG, indicating a protective effect against this condition."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;(CA)N ALLELES&quot;" target="&quot;IGT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is a significant negative association between the studied alleles and IGT, suggesting these variants reduce the risk of impaired glucose tolerance."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFG GROUP&quot;" target="&quot;IFG, IGT, T2DM GROUPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The NFG group serves as the control for comparing against groups with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and Type 2 Diabetes Mellitus (T2DM)."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;(CA)N ALLELES, T2DM&quot;" target="&quot;OR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The odds ratio is used to measure the association between specific alleles (such as (CA)n variants) and the risk of developing conditions like Type 2 Diabetes Mellitus."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX4 GENE&quot;" target="&quot;RS8178974&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A single SNP (rs8178974) in the GPX4 gene was found to be significantly associated with increased risk for colorectal cancer.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALCIUM INTAKE&quot;" target="&quot;SELENIUM INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both selenium and calcium intakes were noted to differ between cases of colorectal cancer and controls, indicating possible nutritional influences on disease susceptibility.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALCIUM INTAKE&quot;" target="&quot;DIETARY FIBER INTAKE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both dietary fiber and calcium intakes were found to be lower in cases with colorectal cancer than in healthy controls.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;META-ANALYSIS RESULTS&quot;" target="&quot;FIXED-EFFECTS MODEL&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Used when studies show low heterogeneity, indicating a common effect size across different populations."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM CONCENTRATION&quot;" target="&quot;COLORECTAL ADENOMA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The meta-analysis indicated a stronger inverse association between selenium levels and the risk of developing adenomas compared to cancers.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9 GENE&quot;" target="&quot;NOD2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CARD9 gene, along with NOD2 mutations, contributes to increased susceptibility to Crohnâs disease by influencing immune responses and gut microbiota interactions."</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WT MICE TRANSCRIPTOME&quot;" target="&quot;REG3G GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The transcriptome of WT mice during colitis shows increased expression of Reg3g gene, indicative of an immune response.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REG3B GENE&quot;" target="&quot;IL-22 PROTEIN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Expression of the Reg3b gene is regulated by IL-22 protein to induce REGIII-Î² during colitis recovery.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 PROTEIN&quot;" target="&quot;NKP46+ CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-22 protein influences the proportion and activity of NKp46+ cells during DSS-induced colitis.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 PROTEIN&quot;" target="&quot;AHR (ARYL HYDROCARBON RECEPTOR)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Interleukin-22 interacts with AHR activation, promoting local IL-22 production in the gut to regulate inflammation."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUNGAL MICROBIOTA&quot;" target="&quot;BACTERIAL MICROBIOTA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The fungal and bacterial microbiotas are both altered but differently between WT and Card9â/â mice during DSS-induced colitis, with increased instability in Card9â/â mice.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GUT MICROBIOTA&quot;" target="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The gut microbiota influences tryptophan metabolism, producing AHR ligands like indole derivatives that activate AHR."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENE&quot;" target="&quot;CARD9â/ââGF MICE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In mice lacking CARD9 (Card9â/ââGF), there is a significant downregulation of IL-22, which affects the immune response and mucosal repair during colitis recovery."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRAEPITHELIAL ÎÎ T CELLS&quot;" target="&quot;IL-22 PRODUCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Î³Î´ T cells contribute to IL-22 production, which is involved in immune regulation and protection against intestinal inflammation."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH22 CELLS&quot;" target="&quot;INTERLEUKIN-22 (IL-22)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"TH22 cells are a primary source of IL-22, which is crucial for mucosal healing. The study indicates that CARD9 deficiency leads to decreased IL-22 production by TH22 cells."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NATURAL KILLER (NK) CELLS&quot;" target="&quot;INTERLEUKIN-22 (IL-22)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"While NK cells contribute to innate immune responses, no difference was observed in IL-22 production by NKp46+ ILCs between Card9â/ââGF mice and WT controls."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REG3G AND REG3B GENES&quot;" target="&quot;INTERLEUKIN-22 (IL-22)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression of REG proteins, encoded by Reg3g and Reg3b genes, is influenced by IL-22 signaling. Their reduced expression in Card9â/ââGF mice suggests impaired IL-22 signaling."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRYPTOPHAN METABOLISM&quot;" target="&quot;IDO1 GENE/PROTEIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IDO1 mediates tryptophan metabolism into kynurenine, which is involved in immune regulation and can influence AHR activation."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRYPTOPHAN METABOLISM&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Impaired tryptophan metabolism leads to defective activation of the Aryl Hydrocarbon Receptor (AHR), contributing to increased susceptibility to colitis in both mouse models and human IBD."</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR (ARYL HYDROCARBON RECEPTOR)&quot;" target="&quot;INDOLE DERIVATIVES (IAA)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"AHR interacts with indole derivatives like IAA to promote local IL-22 production, essential for gut health."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KYNURENINE (KYN)&quot;" target="&quot;IDO1 GENE/PROTEIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Production of Kynurenine is regulated by the activity of IDO1, impacting immune responses and inflammation."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTOBACILLUS STRAINS&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Supplementation with Lactobacillus strains rescues AHR activation in Card9â/â mice, suggesting their importance for gut health."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTESTINAL DENDRITIC CELLS/MACROPHAGES&quot;" target="&quot;IL-23 PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Dendritic cells/macrophages produce IL-23 to stimulate the production of IL-22 by T cells and ILCs."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FECZ (6-FORMYLINDOLO(3,2-B)CARBAZOLE)&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Fecz activates the Aryl Hydrocarbon Receptor (AHR), which can reduce colitis severity by promoting IL-22 production."</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATORY BOWEL DISEASE (IBD)&quot;" target="&quot;ATG16L1 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mutations in the ATG16L1 gene are linked with an increased risk of developing inflammatory bowel diseases, including Crohnâs disease."</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FECAL SAMPLES&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Analysis of fecal samples from IBD patients revealed decreased AHR activation compared to healthy subjects, indicating impaired gut microbiota activity in producing AHR ligands."</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION&quot;" target="&quot;CARD9 GENOMIC VARIANT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The risk allele within CARD9 is associated with reduced ability of fecal microbiota to activate AHR in vitro assays from patients with IBD."</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDO1 ENZYME ACTIVITY&quot;" target="&quot;KYNURENINE LEVELS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Increased IDO1 activity promotes the production of Kynurenine from tryptophan, indicating defective AHR activation in inflammatory bowel disease (IBD)."</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Î2M&quot;" target="&quot;SH2B3 EXPRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Decreased SH2B3 expression leads to higher Î²2M levels, which is causally related to hypertension."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Î2M&quot;" target="&quot;SH2B3 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Reduced function of the SH2B3 protein leads to higher Î²2M levels, contributing to hypertension risk."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;ANGIOTENSIN II&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Angiotensin II administration in mice induces hypertensive responses and increases Î²2M expression."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;SH2B3â/â MOUSE MODEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Sh2b3 knockout mouse model shows enhanced hypertensive responses and end-organ damage due to elevated Î²2M expression."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;ALBUMINURIA&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"The presence of albumin in urine is an indicator of kidney damage associated with hypertension."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SH2B3 EXPRESSION&quot;" target="&quot;CIS GENETIC VARIATION WITHIN SH2B3&quot;">
      <data key="d4">1.8</data>
      <data key="d5">"A cis genetic variation affects the expression of SH2B3, influencing its function and Î²2M levels."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL MODEL&quot;" target="&quot;NEW-ONSET HYPERTENSION PREDICTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The clinical model improves the prediction of new-onset hypertension when combined with Î²2M levels."</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KIDNEY FUNCTION&quot;" target="&quot;ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"RPTECs are critical for understanding how genomic variants influence kidney function through their regulatory chromatin state."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1 SNP RS2236224&quot;" target="&quot;FOLATE INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased risk observed for infants with CT genotype in MTHFD1 SNP rs2236224 when compared to CC genotype with higher folate intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1 SNP RS2236225&quot;" target="&quot;FOLATE INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased risk observed for infants with CT genotype in MTHFD1 SNP rs2236225 when compared to CC genotype with higher folate intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1 SNP RS11627387 AG GENOTYPE&quot;" target="&quot;FOLATE INTAKE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Infants carrying the AG genotype in MTHFD1 SNP rs11627387 show a four-fold increase in risk of NTD when compared to those with GG genotype and high maternal folate intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;MTHFR SNP RS1476413&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"Heterozygous mothers carrying MTHFR SNP rs1476413 show a decreased risk of NTD-affected pregnancies with low folate intake compared to common homozygous mothers."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;MTHFR SNP RS1801131&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"Heterozygous mothers carrying MTHFR SNP rs1801131 show a decreased risk of NTD-affected pregnancies with low folate intake compared to common homozygous mothers."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;MTHFR SNP RS1801133&quot;">
      <data key="d4">0.69</data>
      <data key="d5">"Heterozygous mothers carrying MTHFR SNP rs1801133 show a decreased risk of NTD-affected pregnancies with low folate intake compared to common homozygous mothers."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;SHMT1 SNP RS669340 CG&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"Maternal heterozygous genotype at SHMT1 SNP rs669340 leads to a reduced risk of NTD-affected pregnancies with low folate intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;SHMT1 SNP RS12939757 AG&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Infants carrying the SHMT1 SNP rs12939757 AG genotype show an increased risk of NTDs with low maternal folate intake compared to AA genotype with high intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;TYMS SNP RS502396&quot;">
      <data key="d4">0.91</data>
      <data key="d5">"Mothers carrying the TYMS SNP rs502396 heterozygous genotype show a reduced risk of NTDs in low folate intake group compared to homozygous in high intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;TYMS SNP RS699517&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"Mothers carrying the TYMS SNP rs699517 heterozygous genotype show a reduced risk of NTDs in low folate intake group compared to homozygous in high intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;TYMS SNP RS2847153 AG GENOTYPE&quot;">
      <data key="d4">0.73</data>
      <data key="d5">"Infants carrying the AG genotype at TYMS SNP rs2847153 show a reduced risk of NTDs in low maternal folate intake compared to GG with high intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;MTHFR SNP RS1801131 TT GENOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Infants carrying the MTHFR SNP rs1801131 TT genotype show a higher risk of NTDs with high maternal folate intake compared to CT or CC genotypes."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;SHMT1 SNP RS4997765 AA GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Infants carrying the SHMT1 SNP rs4997765 AA genotype show a higher risk of NTDs with high maternal folate intake compared to GG genotype."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;TYMS SNP RS2847153 CG GENOTYPE&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"Infants carrying the TYMS SNP rs2847153 CG genotype show a reduced risk of NTDs with high maternal folate intake compared to GG genotype."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;MTHFD1 SNP RS6966057 AG GENOTYPE&quot;">
      <data key="d4">3.2</data>
      <data key="d5">"Infants carrying the MTHFD1 SNP rs6966057 AG genotype show a higher risk of NTDs with high maternal folate intake compared to GG genotype."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE&quot;" target="&quot;SHMT1 SNP RS3787486 AA GENOTYPE&quot;">
      <data key="d4">2.9</data>
      <data key="d5">"Infants carrying the SHMT1 SNP rs3787486 AA genotype show a higher risk of NTDs with high maternal folate intake compared to GG genotype."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10399931&quot;" target="&quot;CHI3LI GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genomic variant rs10399931 is located within the CHI3LI gene and was studied for its association with T2D."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10399931&quot;" target="&quot;SERUM C-PEPTIDE CONCENTRATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genomic variant rs10399931 shows a significant association with the serum C-peptide concentration after 2 hours, indicating its role in T2D quantitative traits."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI3LI GENE&quot;" target="&quot;T2D QUANTITATIVE TRAITS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The CHI3LI gene is associated with several quantitative traits of Type 2 Diabetes (T2D), though the associations are not significant after adjustments for various factors."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI3LI GENE&quot;" target="&quot;TGSNPS OF CHI3LI&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Tag single nucleotide polymorphisms (tag SNPs) associated with the CHI3LI gene were studied for their potential associations with Type 2 Diabetes (T2D)."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI3LI GENE&quot;" target="&quot;HAPLOTYPE BLOCKS OF CHI3LI&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Two identified haplotype blocks within the CHI3LI gene did not show any association with Type 2 Diabetes (T2D)."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D QUANTITATIVE TRAITS&quot;" target="&quot;SERUM C-PEPTIDE CONCENTRATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Quantitative traits in T2D include physiological processes such as serum C-peptide concentration, which showed a borderline significant association with rs10399931."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;BASELINE CD4 COUNTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Baseline CD4 counts are a physiological process measure used in the study of HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CFH Y402H RISK ALLELE&quot;" target="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;">
      <data key="d4">4.6</data>
      <data key="d5">"The interaction between CFH genotype and HLS significantly increases the odds for AMD."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A69S RISK ALLELE (ARMS2)&quot;" target="&quot;AMD&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"The A69S risk allele in ARMS2 gene increases odds for AMD when combined with poor lifestyle scores."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A69S RISK ALLELE (ARMS2)&quot;" target="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;">
      <data key="d4">1.75</data>
      <data key="d5">"Poor lifestyle score combined with ARMS2 genetic risk shows a sub-additive effect on AMD risk."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;AMD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A higher HLS score is associated with a lower likelihood of developing AMD, especially in women with stable diets."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;OMEGA-3 FATTY ACIDS INTAKE&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Intake of omega-3 fatty acids does not influence the interaction terms explaining HLS and AMD risk."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;LUTEIN/ZEAXANTHIN INTAKE LEVELS&quot;">
      <data key="d4">1.2</data>
      <data key="d5">"Higher dietary intake levels of lutein and zeaxanthin can partially explain some associations between HLS and AMD risk in high genetic risk individuals."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;ARMS2 GENOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The interaction between healthy lifestyle score and ARMS2 genotype does not show strong deviations from additive or multiplicative effects on AMD risk."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;" target="&quot;ARMS2 GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in the ARMS2 gene are associated with an increased risk for age-related macular degeneration."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;" target="&quot;COMPLEMENT PATHWAY GENES (CFB/C2, C3, AND CFI)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variations in complement pathway genes are associated with the risk of age-related macular degeneration."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;" target="&quot;SYNERGY INDEX (SI)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The Synergy Index assesses whether the interaction between genetic risk factors and healthy lifestyles has a more than additive effect on AMD risk."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;" target="&quot;ODDS RATIO (OR)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The odds ratio measures the increased likelihood of developing age-related macular degeneration among individuals with specific genetic and lifestyle factors compared to those without these factors."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;" target="&quot;COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants in the complement pathway genes are associated with the risk of AMD through their role in immune response and inflammation."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OMEGA-3 FATTY ACIDS&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Incorporating omega-3 fatty acids into a fat-restricted diet helps to lower triglyceride levels and manage hypertriglyceridemia in patients with LPL deficiency."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OMEGA-3 FATTY ACIDS&quot;" target="&quot;PPARÎ PROTEIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Dietary intake of omega-3 fatty acids influences the activity of PPARÎ³, reducing inflammatory responses through molecular interactions.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW/LOW LZ (LUTEIN/ZEAXANTHIN)&quot;" target="&quot;AMD RISK IN HIGH GENETIC RISK WOMEN&quot;">
      <data key="d4">1.34</data>
      <data key="d5">"Adjusting for low dietary intake of lutein and zeaxanthin attenuates the association between HLS and AMD risk in women with high genetic risk."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARMS2 GENE&quot;" target="&quot;A69S ALLELE&quot;">
      <data key="d4">1.8</data>
      <data key="d5">"The ARMS2 gene harbors an A69S allele that increases AMD risk when combined with poor lifestyle scores."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C3 (COMPLEMENT COMPONENT 3)&quot;" target="&quot;CFH AND ARMS2 GENES&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"While C3 does not show a main effect, it's considered in the context of other genetic factors influencing AMD risk."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CFI GENE&quot;" target="&quot;Y402H VARIANT IN CFH GENE&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"CFI gene status does not interact significantly with Y402H variant in CFH to influence AMD risk as much as other factors like HLS."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP C3 RS2230199&quot;" target="&quot;COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"rs2230199 is a specific genetic variant within the complement pathway gene C3 that may influence AMD risk."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP CFI RS10033900&quot;" target="&quot;COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"rs10033900 is a specific genetic variant within the complement pathway gene CFI that may influence AMD risk."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAD10 GENE&quot;" target="&quot;SNP RS11066015&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The ACAD10 gene is located at SNP rs11066015, which was selected as a significant variant for coffee-related genetic risk scores."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MYL2 GENE&quot;" target="&quot;SNP RS12229654&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The MYL2 gene is situated at SNP rs12229654, one of the genotyped SNPs selected for genetic risk score calculations."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CUX2 GENE&quot;" target="&quot;SNP RS79105258&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CUX2 gene is located near SNP rs79105258, an imputed variant chosen due to its strong association with habitual coffee consumption."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS11065828&quot;" target="&quot;GENETIC RISK SCORES&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Imputed SNP rs11065828 was used for calculating genetic risk scores influencing the risk of prediabetes and type 2 diabetes."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREDIABETES&quot;" target="&quot;BLACK COFFEE INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Consumption of â¥2 cups/day of black coffee was linked to a significantly lower risk of prediabetes, compared to non-consumers."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREDIABETES&quot;" target="&quot;SUGARED COFFEE CONSUMPTION&quot;">
      <data key="d4">0.95</data>
      <data key="d5">"Consumption of sugared coffee was also linked to lower risks of prediabetes in the study participants."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COFFEE CONSUMPTION&quot;" target="&quot;GENETIC RISK SCORES&quot;">
      <data key="d4">0.95</data>
      <data key="d5">"The association between habitual coffee consumption and the risk of prediabetes/type 2 diabetes varies by genetic risk scores calculated from significant SNPs."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQB1 GENE&quot;" target="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HLA-DQB1 gene contributes to the formation of this specific haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQB1 GENE&quot;" target="&quot;SENSITIVITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Evaluating sensitivity helps in understanding the effectiveness of HLA-DQB1 gene markers in predicting specific haplotype carrier statuses."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1&quot;" target="&quot;SUMOYLATION OF IKK SUBUNIT NEMO AND NF-ÎB P65/RELA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SENP1 regulates SUMOylation events on both NEMO and p65/RelA, influencing their activity."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1 PROTEIN&quot;" target="&quot;INSULIN LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Reduced SENP1 protein expression correlates with declining insulin secretion in SENP1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1 PROTEIN&quot;" target="&quot;INSULIN TOLERANCE TEST (ITT)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"ITT shows that despite reduced insulin secretion, insulin responsiveness is preserved in SENP1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1 PROTEIN&quot;" target="&quot;ADIPONECTIN, PDGFRÎ, AP2/FABP4 GENE PROMOTER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Specific promoters are used to drive adipocyte-specific deletion of the SENP1 gene leading to reduced protein expression.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS, TYPE 1 (T1DM)&quot;" target="&quot;GLUCOSE LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High glucose levels are an indicator of diabetes mellitus type 1 in SENP1-deficient mice.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS, TYPE 1 (T1DM)&quot;" target="&quot;GLUCOSE TOLERANCE TEST (GTT)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"GTT demonstrates impaired glucose tolerance in SENP1-deficient mice consistent with a type-1-like diabetic phenotype.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS, TYPE 1 (T1DM)&quot;" target="&quot;SENP1-PDGFRÎKO&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mice with adipocyte-specific deletion of the SENP1 gene driven by PdgfRÎ±-Cre exhibit a type-1-like diabetic phenotype.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS, TYPE 1 (T1DM)&quot;" target="&quot;SENP1-AP2KO&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mice with adipocyte-specific deletion of the SENP1 gene driven by aP2/Fabp4-Cre exhibit a type-1-like diabetic phenotype.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCOSE LEVELS&quot;" target="&quot;INTERSCAPULAR BROWN ADIPOSE TISSUE (IBAT)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Diminished SENP1 in iBAT correlates with increased glucose levels and development of diabetes.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN LEVELS&quot;" target="&quot;SENP1-SMKO AND SENP1-ECKO&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mice with smooth muscle cells/pericytes or vascular endothelial cells-specific deletion of the SENP1 gene do not develop high glucose levels despite similar Cre-mediated expression.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL-MEDIATED DESTRUCTION&quot;" target="&quot;Î-CELLS AND ISLETS DESTRUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Activated T-cells mediate destruction of Î² cells and islets leading to a loss of insulin-producing capacity, characteristic of type 1 diabetes mellitus (T1DM).")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO&quot;" target="&quot;IL-6, TNF-Î, IL-1Î&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High levels of these proinflammatory cytokines are expressed in PATs from SENP1-aP2KO mice even before the onset of diabetes, indicating their role in islet disruption and insulin resistance.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO&quot;" target="&quot;ADIPOGENESIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"HFD stimulates adipogenesis in peri-inguinal adipose tissues (PATs) of SENP1-aP2KO mice, increasing cell numbers at the expense of cell size compared to control mice.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO&quot;" target="&quot;T1DM AND T2DM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In the genetic context of SENP1-aP2KO mice, both Type 1 and Type 2 Diabetes Mellitus are augmented by high-fat dietary patterns leading to metabolic phenotypes.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO&quot;" target="&quot;CELL NUMBER INCREASE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An increase in cell numbers within adipose tissues (especially in PATs) is observed more prominently in the genetic model of SENP1-aP2KO compared to control conditions under HFD.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO&quot;" target="&quot;HYPERGLYCEMIA ONSET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In SENP1-aP2KO mice, hyperglycemia onset is accelerated (8 weeks under HFD vs. 12 weeks under chow), contributing to earlier development of diabetic phenotypes.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO&quot;" target="&quot;BASAL AND GLUCOSE-STIMULATED INSULIN LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Significantly reduced insulin levels observed in both basal and glucose-stimulated conditions in SENP1-aP2KO mice, further exacerbated by HFD.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOANTIBODIES, INSULIN AUTOANTIBODY (IAA)&quot;" target="&quot;PRE-DIABETIC PHASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"During the pre-diabetic phase preceding T1DM, autoantibodies such as IAA are directed against Î² cells indicating an autoimmune response.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BETA-HYDROXYBUTYRATE LEVELS&quot;" target="&quot;GLUCOSE METABOLISM DYSFUNCTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased beta-hydroxybutyrate levels indicate impaired glucose metabolism and can be used to diagnose diabetes, reflecting a loss in the body's ability to absorb glucose properly.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ T CELLS&quot;" target="&quot;Î-CELLS DESTRUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Activated CD8+ T cells infiltrate pancreatic islets destroying insulin-producing Î²-cells in individuals with Type 1 Diabetes Mellitus (T1DM).")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ T CELLS&quot;" target="&quot;SARS CORONAVIRUS-DERIVED EPITOPE (VQQESSFVM)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CD8+ T cells can recognize the SARS-CoV epitope presented by HLA-B*15:01, similar to how they recognize ALK neoepitopes."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ T CELLS&quot;" target="&quot;AUTOIMMUNE RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Helper T cells such as Th1 and Th17 promote inflammation and contribute to the autoimmune destruction of pancreatic islet Î² cells in type 1 diabetes mellitus.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ T CELLS&quot;" target="&quot;PTPN22 EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression of PTPN22 in CD4+ T cells varies across different subsets and activation states, influencing immune function."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ T CELLS&quot;" target="&quot;DNA METHYLATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Differential DNA methylation patterns in CD4+ T cells influence the differential splicing and expression of genes like CTLA4."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULATORY T CELLS (TREGS)&quot;" target="&quot;IMMUNE TOLERANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Reduction in regulatory T cells leads to a loss of immune tolerance, exacerbating autoimmune responses and contributing to the destruction of pancreatic islet Î²-cells.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULATORY T CELLS (TREGS)&quot;" target="&quot;IL-2 SIGNALING PATHWAY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The IL-2 signaling pathway is crucial for Treg differentiation and function, mediated by STAT5B's role in FOXP3 induction.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTIVATED DENDRITIC CELLS&quot;" target="&quot;AUTOIMMUNE RESPONSE INITIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Activated dendritic cells present antigens to T-cells initiating an immune response, leading to autoimmunity in Type 1 Diabetes Mellitus (T1DM).")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NRP-V7 POSITIVE CD8+ T CELLS&quot;" target="&quot;IGP1 PROTEIN&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Autoantigen NRP-V7 positive CD8+ T cells target IGP1 protein in pancreatic lymph nodes and spleen, indicating an autoimmune response targeting this protein.")&lt;SEP&gt;"These cells target IGP1 protein, indicating a direct role in the autoimmune response against pancreatic Î²-cells.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;" target="&quot;NOD MOUSE MODEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The NOD mouse model exhibits late-onset spontaneous diabetes, which is used to study the development of T1DM."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;" target="&quot;NF-ÎB ACTIVATION INHIBITOR JSH-23&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"JSH-23 treatment in SENP1-aP2KO mice ameliorates diabetes phenotypes, suggesting a critical role of NF-ÎºB-dependent inflammation in T1DM."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;" target="&quot;ISLET CELLS (ISLETS OF LANGERHANS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Disruption of islet cells, including beta cell apoptosis and immune infiltration, characterizes the progression of type 1 diabetes."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROINFLAMMATORY CYTOKINES IL-6, TNF-Î AND IL-1Î&quot;" target="&quot;T1DM&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Elevation of these cytokines is associated with an increased risk of developing T1DM through their inflammatory roles.")&lt;SEP&gt;"High levels of these cytokines are associated with the onset of T1DM through mechanisms involving immune cell expansion and inflammation.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROINFLAMMATORY CYTOKINES IL-6, TNF-Î AND IL-1Î&quot;" target="&quot;PATS (PERI-PANCREATIC ADIPOSE TISSUES)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"High levels of these cytokines produced by PATs contribute to local pancreatic inflammation and the development of diabetic phenotypes.")&lt;SEP&gt;"PATs express high levels of proinflammatory cytokines that induce local pancreatic inflammatory responses contributing to the development of diabetic phenotypes.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATIC MACROPHAGES&quot;" target="&quot;TISSUE DAMAGE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Infiltration and expression of high levels of proinflammatory cytokines by macrophages cause damage to pancreatic tissues at later stages.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMMUNE CELL RECRUITMENT&quot;" target="&quot;CCL5 (RANTES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Upregulation of CCL5 in islets recruits immune cells into pancreas, damaging Î²-cells and progressing T1DM.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6, TNF OR IL-1Î&quot;" target="&quot;CCL5 EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Proinflammatory cytokines from adipocytes induce CCL5 expression in islets, leading to immune cell recruitment and Î²-cell damage.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE SECRETION&quot;" target="&quot;MACROPHAGE INFILTRATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High levels of cytokines secreted from peri-pancreatic adipocytes lead to macrophage infiltration and subsequent damage to pancreatic islets.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE SECRETION&quot;" target="&quot;SENP1 KNOCKDOWN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Reduction of SENP1 leads to increased cytokine production by adipocytes, affecting local inflammation and immune regulation.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5 EXPRESSION&quot;" target="&quot;NF-ÎB PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Elevated CCL5 expression in pancreatic islets correlates with NF-ÎºB pathway activation, suggesting a link between inflammation and diabetes development."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ÎB DEPENDENT INFLAMMATION&quot;" target="&quot;ADIPOCYTE DIFFERENTIATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Activation of NF-ÎºB contributes to a reduced state of adipocyte differentiation with enhanced proinflammatory phenotype.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ÎB DEPENDENT INFLAMMATION&quot;" target="&quot;FABP4&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"FABP4-positive staining indicates enhanced NF-ÎºB activity specifically within adipocytes of SENP1-deficient mice.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ÎB DEPENDENT INFLAMMATION&quot;" target="&quot;IL-6, IL-1Î AND TNF-Î PROMOTERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased binding to these promoter regions by NF-ÎºB p65/RelA suggests enhanced inflammatory gene expression in SENP1-aP2KO adipocytes.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPARÎ SUMOYLATION&quot;" target="&quot;ADIPOCYTE DIFFERENTIATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SUMOylation of PPARÎ³ does not contribute significantly to the reduced adipocyte differentiation observed in SENP1-deficient mice.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IÎBÎ&quot;" target="&quot;NF-ÎB P65/RELA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IÎºBÎ± inhibits NF-ÎºB p65/RelA activity by binding it and preventing nuclear translocation."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ÎB P65/RELA&quot;" target="&quot;IL-6, TNF-Î, IL-1Î&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The activation of NF-ÎºB p65/RelA leads to the expression of these pro-inflammatory cytokines."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUMOYLATION OF IKK SUBUNIT NEMO AND NF-ÎB P65/RELA&quot;" target="&quot;SUMO1â3&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These SUMO proteins are involved in the SUMOylation process on NEMO and RelA proteins, affecting their activity."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO SUMOYLATION&quot;" target="&quot;NF-ÎB-DEPENDENT CYTOKINE EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SUMOylation of NEMO enhances NF-ÎºB signaling, leading to increased pro-inflammatory cytokine production."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO SUMOYLATION&quot;" target="&quot;SENP1-AP2KO MICE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In these mice, deletion of SENP1 results in increased NEMO SUMOylation in adipocytes."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ÎB-DEPENDENT CYTOKINE EXPRESSION&quot;" target="&quot;SENP1 GENE KNOCKOUT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Knockout of the Senp1 gene enhances NF-ÎºB signaling and pro-inflammatory cytokine production."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO MICE&quot;" target="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Elevated pro-inflammatory cytokine levels are observed in SENP1-aP2KO mice, indicating an inflammation-related mechanism involving SENP1."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO MICE&quot;" target="&quot;IFN-Î (INTERFERON GAMMA)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IFN-Î³ plays a role in inducing insulitis and leukocyte infiltration in the pancreatic islets of NOD mice, associated with T1DM progression."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO MICE&quot;" target="&quot;HIGH-FAT DIET (HFD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"HFD exacerbates the diabetic phenotype and adipocyte inflammation in SENP1-deficient mice, indicating a link between diet and disease progression."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATIC ADIPOCYTES (PATS)&quot;" target="&quot;SENP1 REGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SENP1 plays a crucial role in regulating inflammatory responses within pancreatic adipocytes."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP3 AND SENP5&quot;" target="&quot;SUMO2/3 DESUMOYLATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SENP3 and SENP5 contribute to the removal of SUMO2/3 from target proteins."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ETOPOSIDE VP16&quot;" target="&quot;NF-ÎB ACTIVATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Stress induction by Etoposide VP16 leads to enhanced NF-ÎºB activity in adipocytes."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOD MICE&quot;" target="&quot;T1DM DEVELOPMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The NOD mouse model is utilized to study the pathogenesis and progression of T1DM."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ÎB PATHWAY&quot;" target="&quot;HFD (HIGH-FAT DIET)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The NF-ÎºB pathway is involved in mediating the effects of high-fat diet on adipocyte inflammation and diabetes progression."</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;CELL SIZE REDUCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Under both normal chow and HFD conditions, HFD causes a reduction in the size of adipocytes within PATs from SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;ISLET STRUCTURE DISRUPTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High-fat diet significantly disrupts islet structures in the pancreas of SENP1-aP2KO mice, contributing to diabetes development and metabolic phenotypes.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;INSULIN RESPONSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Under high-fat diet conditions, insulin response is significantly induced to become more resistant in both control and SENP1-deficient mice, with a more severe phenotype observed in the latter.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIVER INSULIN RESISTANCE&quot;" target="&quot;SENP1-KO&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The loss of SENP1 gene function leads to liver insulin resistance under basal conditions, which is exacerbated under high-fat diet (HFD) conditions.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOSE DEPOT&quot;" target="&quot;FAT WEIGHT INCREASE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The increase in fat weight within adipose depots, including PATs of SENP1-aP2KO mice, is significantly influenced by HFD conditions.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5 (RANTES)&quot;" target="&quot;IMMUNE CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Upregulation of CCL5 in islets recruits immune cells into pancreas, causing damages to Î²-cells and contributing to T1DM progression.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOKI (RS2228570 OR RS10735810)&quot;" target="&quot;META-ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Meta-analysis combining results from various studies confirms a significant association between FokI variant and ovarian cancer risk."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APAI (RS7975232)&quot;" target="&quot;FIXED-EFFECT MODEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Using the fixed-effect model, no significant association was found between ApaI variant and ovarian cancer risk across multiple studies."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;OVARIAN CANCER RISK STUDIES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genotype distribution of controls in several subgroup studies for ApaI and BsmI variants deviated from Hardy-Weinberg equilibrium, affecting the validity of these genetic associations."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;CDX-2 GENE (RS11568820)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Departures from Hardy-Weinberg equilibrium for the Cdx-2 gene variant suggest potential biases or confounding factors in the study populations."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;TAQI GENE (RS731236)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Departures from Hardy-Weinberg equilibrium for the TaqI gene variant also suggest potential biases or confounding factors in the study populations."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;RS6265 POLYMORPHISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs6265 polymorphism is found to be in Hardy-Weinberg equilibrium, indicating no significant deviation from expected allele frequencies."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;RS2049046 POLYMORPHISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs2049046 polymorphism also maintains Hardy-Weinberg equilibrium, confirming the genetic data's reliability."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;META-ANALYSIS&quot;" target="&quot;CDX-2 GENE (RS11568820)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The meta-analysis of studies involving Cdx-2 gene variant rs11568820 provides a comprehensive estimate of its association with ovarian cancer risk."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;META-ANALYSIS&quot;" target="&quot;TAQI GENE (RS731236)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The meta-analysis of studies involving TaqI gene variant rs731236 provides a comprehensive estimate of its association with ovarian cancer risk."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;META-ANALYSIS&quot;" target="&quot;CTLA4 POLYMORPHISMS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The meta-analysis focuses on the association between CTLA4 polymorphisms and primary biliary cholangitis (PBC) susceptibility."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOMINANT GENETIC MODEL&quot;" target="&quot;RECESSIVE GENETIC MODEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both models were used to analyze genetic associations with ovarian cancer risk but provided different insights depending on the genotype distribution."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2 GENE (RS11568820)&quot;" target="&quot;JAPANESE SUBGROUP (LURIE ET AL.)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This subgroup within the population studies showed a departure from Hardy-Weinberg equilibrium, indicating potential genetic or environmental factors affecting the Cdx-2 gene variant's impact on ovarian cancer risk."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2 GENE (RS11568820)&quot;" target="&quot;NECC SUBGROUP (TWOROGER ET AL.)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This subgroup within the population studies showed a departure from Hardy-Weinberg equilibrium, indicating potential genetic or environmental factors affecting the Cdx-2 gene variant's impact on ovarian cancer risk."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2 GENE (RS11568820)&quot;" target="&quot;PUBLICATION BIAS TEST (EGGER'S TEST)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Eggerâs test was used to detect potential publication bias in the meta-analysis evaluating the association between Cdx-2 gene variant rs11568820 and ovarian cancer risk."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAQI GENE (RS731236)&quot;" target="&quot;NORTHERN SWEDEN SUBGROUP (CLENDENEN ET AL.)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This subgroup within the population studies showed a departure from Hardy-Weinberg equilibrium, indicating potential genetic or environmental factors affecting the TaqI gene variant's impact on ovarian cancer risk."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAQI GENE (RS731236)&quot;" target="&quot;PUBLICATION BIAS TEST (EGGER'S TEST)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Eggerâs test was used to detect potential publication bias in the meta-analysis evaluating the association between TaqI gene variant rs731236 and ovarian cancer risk."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY TEST&quot;" target="&quot;META-ANALYSIS (CDX-2 GENE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Sensitivity tests were conducted on the meta-analysis of Cdx-2 gene to assess its robustness against individual studies' influence, confirming the overall findings are not significantly influenced by any single study."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY TEST&quot;" target="&quot;META-ANALYSIS (TAQI GENE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Sensitivity tests were conducted on the meta-analysis of TaqI gene to assess its robustness against individual studies' influence, confirming the overall findings are not significantly influenced by any single study."</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS731236, RS7975232, RS1544410 GENOMIC VARIANTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The VDR gene contains these three genomic variants that were analyzed for their influence on susceptibility to T. cruzi infection and CCC development."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS2228570 GENOMIC VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A specific SNP in the VDR gene (rs2228570) was associated with a reduced risk of developing CCC and a trend towards protective effect against T. cruzi infection."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study investigates whether polymorphisms in the VDR gene are associated with susceptibility to T. cruzi infection."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS731236 GENOMIC VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This SNP is one of the genomic variants analyzed within the VDR gene for its influence on disease susceptibility."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS7975232 GENOMIC VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This SNP is one of the genomic variants analyzed within the VDR gene for its influence on disease susceptibility."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS1544410 GENOMIC VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This SNP is one of the genomic variants analyzed within the VDR gene for its influence on disease susceptibility."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS731236, RS7975232, RS1544410 GENOMIC VARIANTS&quot;" target="&quot;INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"These three SNPs in the VDR gene were analyzed for their influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228570 GENOMIC VARIANT&quot;" target="&quot;INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The minor allele of rs2228570*A showed a trend towards protective effect against T. cruzi infection but did not reach significance after correction for multiple testing."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228570 GENOMIC VARIANT&quot;" target="&quot;CHRONIC CHAGAS CARDIOMYOPATHY (CCC)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The minor allele of rs2228570*A was significantly associated with a reduced risk of developing CCC after correction for multiple testing."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1A -889C&gt;T&quot;" target="&quot;HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The IL-1A -889C&gt;T variant was studied for its association with the risk of developing HNP, but no significant associations were found."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1A -889C&gt;T&quot;" target="&quot;IL-1A (RS1800587)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The IL-1A gene variant rs1800587 corresponds to the genomic variant IL-1A -889C&gt;T."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-A 238G&gt;A&quot;" target="&quot;HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TNF-A 238G&gt;A variant was studied for its association with the risk of developing HNP, but no significant associations were found."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-A 238G&gt;A&quot;" target="&quot;TNF-A (RS361525)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The TNF-A gene variant rs361525 corresponds to the genomic variant TNF-A 238G&gt;A."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR TAQI RS731236&quot;" target="&quot;HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The VDR TaqI variant was studied for its association with the risk of developing HNP, but no significant associations were found."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR TAQI RS731236&quot;" target="&quot;VDR (RS731236)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The VDR gene variant rs731236 corresponds to the genomic variant VDR TaqI rs731236."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;B12&quot;" target="&quot;MATERNAL SERUM B12 LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Serum B12 levels are influenced by genetic variants and dietary intake, impacting maternal health."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;MATERNAL FOLATE LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Folate levels in pregnant women play a crucial role in fetal development."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;THCY (TOTAL HOMOCYSTEINE)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Higher tHcy concentrations are associated with lower folate levels, indicating a role for folate in the metabolism of homocysteine.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;INFERTILE MEN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Men with lower serum folate concentrations are more likely to be infertile, as indicated by the logistic regression analysis.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;CDC HPLC-MS/MS METHOD&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CDC HPLC-MS/MS method provides highly accurate measurements for the assessment of serum folate concentrations.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL SERUM B12 LEVELS&quot;" target="&quot;GWAS VARIANTS FOR B12 LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variants explain variance in maternal serum B12 concentrations."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL SERUM B12 LEVELS&quot;" target="&quot;FUT2 GENE (RS602662)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variation in FUT2 is associated with changes in maternal serum B12 concentrations."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL FOLATE LEVELS&quot;" target="&quot;GWAS VARIANTS FOR FOLATE LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These genetic variants contribute to the variation of folate levels in pregnant women."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL FOLATE LEVELS&quot;" target="&quot;MTHFR GENE (RS1801133)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MTHFR gene variant significantly influences the relationship between maternal folate levels and birthweight."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTHWEIGHT&quot;" target="&quot;MMACHC GENE (RS12272669)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The MMACHC variant has a lesser impact on birthweight compared to other genetic factors."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FETAL B12 LEVELS&quot;" target="&quot;GESTATIONAL DURATION&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"No significant causal relationship was identified between fetal B12 levels and gestational duration."</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL B12 LEVELS&quot;" target="&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"No evidence was found for a causal effect of maternal B12 levels on offspring birthweight."</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GESTATIONAL DURATION&quot;" target="&quot;DANISH COHORTS&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"The Danish cohorts were used to study the impact of maternal and fetal nutrient levels (B12 and folate) on gestational duration without significant findings."</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IVW ANALYSIS (INVERSE VARIANCE WEIGHTED)&quot;" target="&quot;FOLATE LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An IVW analysis detected a small but significant effect of folate levels on B12 levels within the Danish cohorts, indicating a molecular interaction between these nutrients."</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MTHFR C677T variant is significantly associated with an increased risk of Leiomyoma Venosa, especially in Asian populations."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR A1298C&quot;" target="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The MTHFR A1298C variant is less commonly tested but still relevant in the context of Leiomyoma Venosa, affecting folate metabolism and potentially contributing to cardiovascular risk."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;THROMBOSIS RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The PAIâ1 â675 4G/5G variant is directly linked to increased thrombotic tendencies and cardiovascular disease risk."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The PAI-1 -675 4G/5G variant is highly prevalent among patients with Leiomyoma Venosa, particularly in European and Asian populations."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 A844G&quot;" target="&quot;PLATELET AGGREGATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This genetic variant within PAI-1 affects platelet function and can lead to abnormal clot formation patterns."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 A844G&quot;" target="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The PAI-1 A844G variant may contribute to the risk of Leiomyoma Venosa, though less studied compared to other variants."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;THROMBOSIS RISK&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This prothrombin variant increases the risk of thrombotic events due to elevated levels of prothrombin in circulation."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The Prothrombin G20210A variant is associated with Leiomyoma Venosa, contributing to hypercoagulability which can lead to thrombotic events in these patients."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;BLOOD COAGULATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The factor V variant impacts coagulation factors, contributing to altered clotting efficiency and increased thrombosis risk."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;LEIOMYOMA VENOSA (LV)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The Factor V G1691A variant is linked with an increased risk of Leiomyoma Venosa, due to resistance to activated protein C leading to thrombotic complications."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEIOMYOMA VENOSA (LV)&quot;" target="&quot;METHIONINE METABOLISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Changes in methionine metabolism due to MTHFR C677T and A1298C variants may increase the risk of Leiomyoma Venosa by elevating homocysteine levels."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN B12 (COBALAMIN)&quot;" target="&quot;INFERTILE MEN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"B12 levels were found to be lower in infertile men compared to fertile controls but did not reach statistical significance.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RCF (REDUCED CYSTATHIONINE/FOLATE RATIO)&quot;" target="&quot;INFERTILE MEN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"In infertile men, RCF was lower compared to fertile controls before adjusting for education but lost significance after adding it to the model.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE (PEMT) M175V GENE VARIANT&quot;" target="&quot;MALE INFERTILITY&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The PEMT gene variant is positively associated with male infertility when homozygous for the minor V allele.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCOBALAMIN RECEPTOR GENE TCBLR (CD320) RS173665 VARIANT&quot;" target="&quot;MALE INFERTILITY&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The TCblR gene variant is negatively associated with male infertility in heterozygous subjects.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 1298A&gt;C MINOR C ALLELE&quot;" target="&quot;INFERTILE MEN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Homozygosity for the MTHFR 1298A&gt;C minor C allele was associated with infertility status but did not meet statistical significance after Bonferroni correction.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLIC ACID-CONTAINING VITAMIN SUPPLEMENTS&quot;" target="&quot;FOLATE AND B12 LEVELS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Subjects who reported taking vitamin supplements had higher folate and B12 concentrations compared to non-users, suggesting a role in maintaining optimal nutrient levels.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 677C&gt;T GENE VARIANT&quot;" target="&quot;INFERTILE MEN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This gene variant was not found to be significantly associated with male infertility in this study population, even when analyzing those with lower folate levels.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHMT1&quot;" target="&quot;RS638416&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Another polymorphism (rs638416) in the SHMT1 gene is also associated with a higher risk for TMD patients compared to healthy controls."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHMT1&quot;" target="&quot;PYRIMIDINE SYNTHESIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SHMT1 gene product plays a role in pyrimidine synthesis by transferring methyl groups to tetrahydrofolate derivatives."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1&quot;" target="&quot;RS2236225&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The MTHFD1 gene contains a polymorphism (rs2236225) linked to an increased susceptibility to neural tube defects, sensitive to folates."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1&quot;" target="&quot;NEURAL TUBE DEFECTS (NTDS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Polymorphisms within the MTHFD1 gene are associated with an increased risk of neural tube defects, especially in contexts where folates can protect against them."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTM1-NULL POLYMORPHISM&quot;" target="&quot;CARCINOGENS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The GSTM1-null polymorphism increases the risk of cancer and male infertility possibly due to greater sensitivity to environmental carcinogens and toxins."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTRR&quot;" target="&quot;RS1801394&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A substitution in MTRR (rs1801394) alters enzyme efficiency, reducing the affinity for substrate."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRD4-48BPTR&quot;" target="&quot;S-DRD4&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The DRD4 gene's 48-bp VNTR polymorphism can be characterized as S-DRD4 based on repeat length and is statistically significant in genotype frequencies."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;5,10-METHYLENETETRAHYDROFOLATE (5,10-CH2-THF)&quot;" target="&quot;THF&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Tetrahydrofolate undergoes methylation to produce 5,10-methylenetetrahydrofolate which is essential in many metabolic pathways."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLIC ACID&quot;" target="&quot;NUTRIENT METABOLISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Folic acid undergoes metabolism within the body involving various physiological processes such as DNA synthesis and amino acid metabolism."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC REAGENTS&quot;" target="&quot;LABORATORY CALIBRATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"CDC reagents are used to calibrate laboratory instruments, ensuring accurate measurements of analytes like folate levels across different testing conditions."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IH REAGENTS&quot;" target="&quot;LABORATORY CALIBRATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IH reagents serve as alternative standards for calibration in laboratories when not using CDC reagents."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROORGANISM CALIBRATOR (CDC-MO)&quot;" target="&quot;CALIBRATION ACCURACY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The microorganism calibrator provided by the CDC ensures accurate calibration of laboratory instruments, contributing to precise measurements across different conditions."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALIBRATOR (CDC-CAL)&quot;" target="&quot;LABORATORY STANDARDS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The CDC-provided calibrators are critical for maintaining consistent standards in folate testing among various laboratories."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WB-FOL &amp; S-FOL TESTING CONDITIONS&quot;" target="&quot;FOLIC ACID MEASUREMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These conditions are essential for the accurate measurement of whole blood and serum folate levels, influencing health assessments related to folic acid intake and metabolism."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LABORATORY TEST HARMONIZATION CONDITION&quot;" target="&quot;INTER-LABORATORY COMPARABILITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Harmonizing laboratory test conditions improves comparability and consistency in the measurements of folate levels across different laboratories."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC MBA TARGET VALUE&quot;" target="&quot;LABORATORY CALIBRATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This target value serves as a standard reference for laboratories to adjust their measurement protocols and ensure accuracy in folate analysis."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;S-FOL (SERUM FOLATE)&quot;" target="&quot;FOLIC ACID CALIBRATOR&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The folic acid calibrator ensures accurate measurements of serum folate levels across different laboratory settings."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC ROUND-ROBIN KIT (CDC-MO &amp; CDC-CAL)&quot;" target="&quot;LABORATORY STANDARDIZATION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"This kit ensures uniform calibration across different laboratories, enhancing comparability in folic acid measurement protocols."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LABORATORY #6 AND LABORATORY #9 RESULTS ANOMALIES&quot;" target="&quot;CALIBRATION ISSUES&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The inconsistencies observed in these laboratories suggest potential problems with their calibration processes or adherence to standard protocols."</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;S-FOL&quot;" target="&quot;WB-FOL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both measurements reflect the metabolic pathways of folate in serum and whole blood respectively, influencing nutritional assessment."</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1695 POLYMORPHISM&quot;" target="&quot;BREAST CANCER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs1695 polymorphism is associated with an increased risk of breast cancer."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BREAST CANCER&quot;" target="&quot;AG GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The AG genotype also lacks strong evidence for an association with increased risk of breast cancer based on our statistical analysis."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BREAST CANCER&quot;" target="&quot;CT GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The heterozygous CT genotype did not show a significant link to the development of breast cancer according to our statistical tests."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTP1 PROTEIN&quot;" target="&quot;ILE105VAL POLYMORPHISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Ile105Val SNP in GSTP1 protein decreases its amyloid-forming propensity, influencing the function and stability of the enzyme."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTP1 PROTEIN&quot;" target="&quot;ILE105VAL SNP ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Analysis indicates that the Ile105Val polymorphism modifies amyloid-forming properties of GSTP1 without altering its overall stability or function."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CT GENOTYPE&quot;" target="&quot;REWARD&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Individuals with the CT genotype report significantly greater reward from drinking alcoholic beverages compared to other genotypes."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TT GENOTYPE&quot;" target="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Participants with the TT genotype reported fewer drinks per drinking day in placebo vs olanzapine conditions compared to those with the CT genotype."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TT GENOTYPE&quot;" target="&quot;PLACEBO TREATMENT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Participants with the TT genotype showed less susceptibility to increased craving and drinking behavior in placebo conditions compared to those under active medication such as olanzapine or cyproheptadine."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;VARIANT A1 (10-7-7)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This specific variant within the p.R778L group accounts for the largest proportion in haplogroup A.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;HAPLOGROUPS B AND C&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These less common haplogroups are associated with a lower frequency compared to haplogroup A within p.R778L's genetic spectrum.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;CONTROL ONES (CHROMOSOMES)&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Chromosomes from control subjects show a much lower association with p.R778L compared to WD chromosomes.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;WD PATIENTS GROUP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The p.P992L variant also contributes significantly to the incidence of Wilson's disease in affected individuals."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;HAPLOGROUP E (10-9-5)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The genomic variant p.P992L is characterized by a more complex haplotype with haplogroup E being the most common.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;VARIANT E1 (10-9-5)&quot;">
      <data key="d4">24.0</data>
      <data key="d5">"This specific variant within haplogroup E makes up 69% of the genetic information related to p.P992L on WD chromosomes.")&lt;SEP&gt;"This specific variant within haplogroup E represents a significant portion of the genetic information related to p.P992L.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;HAPLOGROUP D (9-7-5)&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"A rare but distinct haplogroup associated with the genomic variant p.P992L on WD chromosomes.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;HAPLOGROUPS F, G, H AND I&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"These rare haplogroups are sporadically represented among WD chromosomes associated with p.P992L.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;FUJIAN PROVINCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The p.T935M variant shows particularly high prevalence in patients from Fujian province compared to other regions."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;HAPLOGROUP J (VARIANTS J1 AND J2)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The genomic variant p.T935M is uniquely associated with haplogroup J, representing a significant difference in genetic information on WD chromosomes.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WD PATIENTS GROUP&quot;" target="&quot;GEOGRAPHICAL REGIONS (SOUTHEASTERN CHINA)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Patients with WD have a distinct geographical distribution, with most cases found in southeastern Chinese regions like Fujian and Zhejiang."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINKAGE DISEQUILIBRIUM ANALYSIS&quot;" target="&quot;GENOMIC VARIANT (P.R778L)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This analysis reveals significant linkage disequilibrium between the p.R778L variant and specific microsatellite markers."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINKAGE DISEQUILIBRIUM ANALYSIS&quot;" target="&quot;HAPLOTYPE ASSOCIATION STUDY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The haplotype association study builds upon linkage disequilibrium data to further understand genetic associations in WD patients."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINKAGE DISEQUILIBRIUM ANALYSIS&quot;" target="&quot;GENETIC POLYMORPHISMS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Assesses whether certain polymorphisms are inherited together more frequently than expected by chance, providing insights into their co-occurrence."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOGROUP A&quot;" target="&quot;WD CHROMOSOMES&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Haplogroup A is overwhelmingly common on WD chromosomes associated with the p.R778L variant.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOGROUP A&quot;" target="&quot;VARIANT A1 (10-7-7)&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"This variant makes up a large proportion of haplogroup A among WD chromosomes related to p.R778L.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WD CHROMOSOMES&quot;" target="&quot;HAPLOGROUPS B AND C&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"These haplogroups are less common on WD chromosomes compared to haplogroup A in the context of p.R778L.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOGROUP E (10-9-5)&quot;" target="&quot;VARIANT E2 (10-9-6)&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"This variant within haplogroup E is much less common than variant E1 in relation to p.P992L.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VARIANT J1 (12-4-8)&quot;" target="&quot;HAPLOGROUP J (VARIANTS J1 AND J2)&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"This specific variant within haplogroup J is more frequently observed on WD chromosomes related to p.T935M.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2C9*2&quot;" target="&quot;WARFARIN DOSE PREDICTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CYP2C9*2 variant influences the predicted dose of warfarin based on its effect on drug metabolism."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1799853&quot;" target="&quot;WARFARIN DOSE PREDICTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs1799853 SNP, as part of a group affecting CYP2C9 activity, influences warfarin dose prediction."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS28371686&quot;" target="&quot;WARFARIN DOSE PREDICTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This SNP affecting CYP2C9 activity contributes to predicting appropriate warfarin dosages."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7900194&quot;" target="&quot;WARFARIN DOSE PREDICTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The rs7900194 variant impacting CYP2C9 activity influences the prediction of warfarin doses."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DVT/PE&quot;" target="&quot;WARFARIN TREATMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Patients with DVT or PE are commonly treated with warfarin to prevent blood clots."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HWE (HARDY-WEINBERG EQUILIBRIUM)&quot;" target="&quot;GENOMIC VARIANT ANALYSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Used to evaluate deviations in SNP frequencies for genomic studies and drug response predictions."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2C9 STAR VARIANT GROUP&quot;" target="&quot;WARFARIN DOSAGE PREDICTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The combination of CYP2C9 variants affects the prediction models for warfarin dosages based on genetic factors."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IWPC CLINICAL ALGORITHM&quot;" target="&quot;NOVEL AA ALGORITHM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The novel AA algorithm outperforms the IWPC clinical algorithm in detecting high-dose patients and predicting doses closer to observed values.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM&quot;" target="&quot;WAA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Our novel AA algorithm did not show association with WAA because population-specific variables are incorporated, accounting for admixture effects.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression levels or mutations in transcripts might affect protein function, influencing pharmacogenomics outcomes.")&lt;SEP&gt;"The transcript of the LPL gene is translated into lipoprotein lipase, which plays a critical role in lipid metabolism."</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Drug metabolism pathways involve molecular interactions that influence the efficacy of pharmacogenomics predictions.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;CYP24A1 GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CYP24A1 is involved in metabolic pathways that process vitamin D and maintain calcium homeostasis."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAA&quot;" target="&quot;AIMS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Ancestry Informative Markers (AIMs) enable accurate measurement of ancestral admixture among African Americans, influencing the efficacy of pharmacogenomics algorithms.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1&quot;" target="&quot;VITAMIN D METABOLISM&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The metabolic pathway of vitamin D metabolism involves the action of enzymes encoded by CYP24A1, impacting health outcomes like adenoma recurrence."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1&quot;" target="&quot;VILLOUS ADENOMA RECURRENCE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The CYP24A1 gene influences the recurrence of adenomas with villous histology."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1&quot;" target="&quot;RS927650&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs927650 variant within CYP24A1 is associated with changes in vitamin D levels and increased risk for colorectal adenomas."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1&quot;" target="&quot;C.1186Câ&gt;âT VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The c.1186Câ&gt;âT variant is a genomic alteration within the CYP24A1 gene that affects its function."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS927650&quot;" target="&quot;SNP GENOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP genotype of rs927650 is associated with changes in vitamin D levels and colorectal adenoma risk."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35051736&quot;" target="&quot;COLORECTAL ADENOMA RECURRENCE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genetic variants such as rs35051736 in the CYP24A1 gene are linked to a higher risk of advanced colorectal adenomas."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2296241&quot;" target="&quot;VITAMIN D CONCENTRATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genetic variant rs2296241 modulates the effect of vitamin D concentrations on the recurrence of colorectal adenomas."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D METABOLISM&quot;" target="&quot;1,25(OH)2D&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"This nutrient is produced through the metabolic pathway of vitamin D metabolism and impacts various physiological processes."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D CONCENTRATION&quot;" target="&quot;25(OH)D&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The concentration of 25(OH)D is a measure of vitamin D levels in the body, impacting health outcomes."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVANCED LESION RECURRENCE&quot;" target="&quot;CYP24A1 SNP GENOTYPE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genetic variants within the CYP24A1 gene are linked to a higher risk of advanced lesion recurrence."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.428_430DELAAG VARIANT&quot;" target="&quot;RS777676129 AMPLICON&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs777676129 amplicon includes the c.428_430delAAG variant and is used for genotyping."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186Câ&gt;âT VARIANT&quot;" target="&quot;RS114368325 AMPLICON&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs114368325 amplicon includes the c.1186Câ&gt;âT variant and is used for genotyping."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186Câ&gt;âT VARIANT&quot;" target="&quot;CYP24A1 TRANSCRIPT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The c.1186Câ&gt;âT variant alters the transcript of CYP24A1, affecting its function."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SANGER SEQUENCING&quot;" target="&quot;HRMA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Sanger sequencing confirms HRMA results by providing direct DNA sequence data."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SANGER SEQUENCING&quot;" target="&quot;REAL-TIME PCR GENOTYPING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Validation method used to confirm the accuracy of HLA-DQ haplotypes determined by Real-time PCR genotyping, showing 100% concordance in randomly selected individuals from both study groups."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COPPER DEPENDENCY&quot;" target="&quot;DOPAMINE-B-HYDROXYLASE ACTIVITY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Activity levels reflect copper-dependent physiological processes affecting neurodevelopmental outcomes."&lt;SEP&gt;"Deficient dopamine-b-hydroxylase activity, which is copper-dependent, indicates a physiological process inconsistent with Menkes disease in the proband."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MENKES DISEASE&quot;" target="&quot;CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The cerebrospinal fluid (CSF) copper and catecholamine ratios fall within ranges established for classical Menkes disease, providing diagnostic criteria."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENVER DEVELOPMENTAL SCREENING TEST II&quot;" target="&quot;DEVELOPMENTAL SKILLS ASSESSMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This test measures developmental skills levels which are significantly delayed compared to age-appropriate milestones in the patient."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BRAIN MRI&quot;" target="&quot;NEURODEVELOPMENTAL ISSUES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"MRI findings of atrophy and delayed myelination indicate neurodevelopmental issues in the patient."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;" target="&quot;PERIPHERAL NERVOUS SYSTEM FUNCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Clinical studies measured motor action potentials to assess peripheral nervous system function, which were within normal ranges for infants aged 1-2 years."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;" target="&quot;NEUROPHYSIOLOGICAL ASSESSMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Velocity measurement is a part of neurophysiological assessment, indicating the patient's conduction velocity was within normal range for age."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;" target="&quot;PERIPHERAL SENSORY FUNCTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Sensory action potentials were measured to assess peripheral sensory function in the patient, showing results above the lower limit of normal."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACO-2 CELLS&quot;" target="&quot;IDI-T AND IDI-C TRANSCRIPTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Transfection of Caco-2 cells with rat IDI coding sequences produces IDI-T (T variant) and IDI-C (C variant) transcripts."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACO-2 CELLS&quot;" target="&quot;TERT-BUTYLHYDROPEROXIDE (T-BHP)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Cells grown in normal medium show resistance to tert-butylhydroperoxide; lower concentrations are used when cells are Se-depleted."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACO-2 CELLS&quot;" target="&quot;C VARIANT (IDI-C)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Cells transfected with the C variant show lower cell viability and increased ROS levels in response to oxidative challenges."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAT IDI CODING SEQUENCES&quot;" target="&quot;GPX4 3â²UTR&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Rat IDI coding sequences are linked to the GPX4 3â²UTR for transfecting Caco-2 cells."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDI-T AND IDI-C TRANSCRIPTS&quot;" target="&quot;GAPDH TRANSCRIPT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Relative transcript levels of IDI-T and IDI-C are measured against GAPDH for normalization purposes."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDI-T AND IDI-C TRANSCRIPTS&quot;" target="&quot;ROS LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Levels of reactive oxygen species are higher in cells expressing the IDI-C transcript compared to those expressing IDI-T."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX ACTIVITY&quot;" target="&quot;SELENIUM (SE)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The activity of glutathione peroxidase, an antioxidant enzyme, varies significantly with selenium supply levels in Caco-2 cells."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX ACTIVITY&quot;" target="&quot;SE-SUPPLEMENTED MEDIUM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In Se-supplemented conditions, IDI-C cells show higher GPx activity compared to IDI-T cells, suggesting an impact on antioxidant defense mechanisms."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENOPROTEIN H MRNA LEVELS&quot;" target="&quot;SE-DEPLETED MEDIUM&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"In both Se-depleted and supplemented conditions, selenoprotein H mRNA levels are lower in IDI-C cells than in IDI-T cells."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T VARIANT (IDI-T)&quot;" target="&quot;RS713041&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The T variant is associated with different transcript expression patterns compared to the C variant when assessed via real-time PCR."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX4 MRNA LEVELS&quot;" target="&quot;SE-SUPPLY CONDITIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Levels of GPX4 mRNA do not differ significantly between IDI-T and IDI-C cells under both depleted and supplemented selenium conditions."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TR1 PROTEIN LEVELS&quot;" target="&quot;SE-DEPLETED MEDIUM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In Se-depleted medium, TR1 protein levels are similar in IDI-T and IDI-C cells, indicating no significant impact of the variants on this protein under these conditions."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENOPROTEIN H MRNA&quot;" target="&quot;SE SUPPLY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The expression of selenoprotein H mRNA is significantly lower in IDI-C cells compared to IDI-T cells under both Se-depleted and supplemented conditions, indicating a differential response to selenium levels."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TERT-BUTYLHYDROPEROXIDE (TBHP)&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Tert-butylhydroperoxide induces oxidative stress in cells, affecting their viability and selenoprotein expression."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDI-C CELLS&quot;" target="&quot;IDI-T CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IDI-C cells exhibit greater sensitivity to oxidative stress than IDI-T cells under low selenium conditions but show higher viability with increased selenium concentrations."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM-FREE CONDITIONS&quot;" target="&quot;SELENIUM DEPLETION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Cells grown under serum-free conditions experience selenium depletion, affecting their response to oxidative challenges and selenoprotein expression."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAT&quot;" target="&quot;P.VAL136MET&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CHAT gene mutation p.Val136Met affects expression levels and is observed in three patients, indicating its impact on protein function.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAT&quot;" target="&quot;P.ALA557THR&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CHAT gene mutation p.Ala557Thr impacts expression levels significantly and was detected in five patients, with one patient homozygous for this variant.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.ALA557THR&quot;" target="&quot;PATIENT 10&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Carries both p.Ala557Thr and a nonsense mutation affecting expression levels and phenotype.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.ALA557THR&quot;" target="&quot;THERMAL STABILITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This mutation compromises the thermal stability of ChAT protein, affecting its functionality.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAT TRANSCRIPT&quot;" target="&quot;WILD-TYPE CHAT PROTEIN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The ChAT transcript translates into two protein isoforms of 70 kDa and 74 kDa from alternative start sites in the spinal cord (S-type).")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MISSENSE MUTANTS CHAT PROTEINS&quot;" target="&quot;KINETIC PROPERTIES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Missense mutants alter kinetic parameters of wild-type CHAT proteins, affecting their activation rate constants.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MISSENSE MUTANTS CHAT PROTEINS&quot;" target="&quot;THERMAL STABILITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Some missense mutations in the CHAT gene compromise the thermal stability of mutant proteins.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTIDINE-TAGGED CHAT CDNAS&quot;" target="&quot;NI-NTA COLUMN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"His-tagged constructs are purified from E. coli using Ni-NTA columns for further kinetic analysis.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION PATTERNS&quot;" target="&quot;LCT MRNA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Steady-state levels of LCT mRNA correlate inversely with DNA methylation densities at specific CpG sites near the LCT and MCM6 genes."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION PATTERNS&quot;" target="&quot;MCM6 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MCM6 gene harbors SNPs that influence DNA methylation near the LCT gene, modulating lactase enzyme production."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION PATTERNS&quot;" target="&quot;CYTOSINES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Unmodified cytosine densities serve as a marker for DNA methylation patterns, influencing LCT mRNA levels and enzyme activity over time."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION PATTERNS&quot;" target="&quot;LACTASE GENE (LCT)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Epigenetic modifications, particularly DNA methylation patterns near this gene, are crucial in determining lactose digestion capability and enzyme production levels over time."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXIDATIVE STRESS MARKERS&quot;" target="&quot;CPG ISLAND SHORES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Phenotype-associated CpGs are enriched in CpG island shores compared to all CpGs on the array, indicating a functional role for these regions in oxidative stress regulation.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROMOTERS&quot;" target="&quot;GENE EXPRESSION REGULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Phenotype-associated CpGs located near promoters suggest their potential regulatory influence over gene expression through transcriptional control mechanisms.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TF BINDING SITES (JASPAR DATABASE)&quot;" target="&quot;REGULATORY ELEMENT FUNCTIONALITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Identified TF binding sites provide evidence for the functionality of specific regulatory elements in influencing gene expression patterns.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHOSPHORYLATION AND PHOSPHATE/PHOSPHOROUS METABOLIC PROCESSES&quot;" target="&quot;FUNCTIONAL ANNOTATION CLUSTERING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These processes cluster into functional annotations based on their enrichment scores, implying a biological significance related to oxidative stress markers.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEQTLS (METHYLATION QUANTITATIVE TRAIT LOCI)&quot;" target="&quot;GENETIC VARIATION AND DNA METHYLATION REGULATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The presence of meQTLs suggests that genetic variation can significantly impact DNA methylation levels, a key epigenetic modification involved in gene regulation.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CIS-MEQTL SNPS&quot;" target="&quot;CHD RISK GENES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Specific SNPs associated with cis-meQTL show modest associations with CHD risk genes identified through GWAS data.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHD (CORONARY HEART DISEASE)&quot;" target="&quot;T2D (TYPE 2 DIABETES)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Both diseases share some genetic and epigenetic influences, indicating possible common pathways or mechanisms of disease development.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOGRAM CONSORTIUM&quot;" target="&quot;GWAS DATA ANALYSIS FOR CHD&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"This consortium contributes to the analysis of GWAS data aimed at identifying genetic risk factors specific to coronary heart disease (CHD).")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAGRAM CONSORTIUM&quot;" target="&quot;T2D GENETIC RISK FACTORS IDENTIFICATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The DIAGRAM consortium facilitates research into understanding genetic risk factors contributing to type 2 diabetes (T2D), enhancing our knowledge of the condition's heritability and biological basis.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZNF341 CPG SITE (CG11842944)&quot;" target="&quot;HEART FAILURE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Methylation levels at this site are associated with heart failure, suggesting its importance in the development of cardiovascular diseases."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ATP6 GENE&quot;" target="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The MT-ATP6 gene harbors a de novo mutation that results in an amino acid change from Leucine to Arginine at position 156."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ATP6 GENE&quot;" target="&quot;COMPLEX V (ATP SYNTHASE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MT-ATP6 gene encodes a subunit necessary for the function of complex V, which synthesizes ATP from ADP and Pi."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;" target="&quot;LEIGH SYNDROME&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The mutation in MT-ATP6 gene is responsible for about 10â20% of Leigh syndrome cases due to its effect on ATP synthase activity."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;" target="&quot;EXOME SEQUENCING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The technique used to detect the presence of this genomic variant within mitochondrial DNA."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;" target="&quot;GSNAP ALIGNMENT TOOL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Used for aligning reads from next-generation sequencing data to identify the genomic variant in mitochondrial DNA."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;" target="&quot;HETEROPLASMIC VARIANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This mutation might be present as heteroplasmy where it is not detected in all mitochondrial copies due to low levels."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;" target="&quot;RFLP ASSAY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A method used alongside capillary sequencing for validation of the presence of this mutation in patient DNA."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;" target="&quot;COMPLEX V DEFICIENCY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The mutation leads to deficient activity of ATP synthase (complex V), contributing to the pathogenesis of Leigh syndrome."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTDNA 8993T&gt;G (C.467T&gt;G, P.LEU156ARG)&quot;" target="&quot;ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The mutation affects complex V within this pathway, reducing ATP production through the electron transport chain."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFV1 GENE&quot;" target="&quot;C.736G&gt;A, P.GLU246LYS VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A missense variant in NDUFV1 that affects the FMN binding site of the protein subunit involved in complex I."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFV1 GENE&quot;" target="&quot;COMPLEX I (NADH DEHYDROGENASE)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The NDUFV1 gene encodes a subunit required for complex I activity, which is part of the electron transport chain."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.437G&gt;A (SER146ASN)&quot;" target="&quot;COQ2 PROTEIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This genomic variant changes an amino acid residue critical for the function of the COQ2 protein."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COQ2 PROTEIN&quot;" target="&quot;FMN BINDING SITE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Mutations at the FMN binding site may affect the COQ2 protein's ability to function properly in coenzyme Q10 biosynthesis."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ND1 GENE (MITOCHONDRIAL)&quot;" target="&quot;SUBUNIT 1 (MT-ND1)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MT-ND1 gene encodes subunit 1, which is a part of complex I in the electron transport chain."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ND1 GENE (MITOCHONDRIAL)&quot;" target="&quot;3754C&gt;A VARIANT IN MT-ND1 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The variant within the MT-ND1 gene disrupts normal mitochondrial function, contributing to various disorders such as Leber optic atrophy."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;3754C&gt;A MUTATION&quot;" target="&quot;LEBER OPTIC ATROPHY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This mutation can cause Leber optic atrophy by disrupting mitochondrial function."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUBUNIT 1 (MT-ND1)&quot;" target="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mutations in subunit 1 can lead to deficiencies in complex I, causing mitochondrial dysfunction."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEBER OPTIC ATROPHY&quot;" target="&quot;MELAS SYNDROME&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both diseases are caused by mutations in mtDNA and affect the function of mitochondria."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERIPHERAL BLOOD CELLS DNA EXTRACTION AND SEQUENCING PROCESS&quot;" target="&quot;MTDNA COVERAGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The process of extracting and sequencing peripheral blood cells' DNA includes coverage analysis for both nuclear exome and mtDNA."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VARIANT CLASSIFICATION (RUNES)&quot;" target="&quot;CATEGORY 1-3 VARIANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Runes classifies variants into categories based on their potential impact, with category 1-3 indicating high significance."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COENZYME Q2 HOMOLOG, PRENYLTRANSFERASE (COQ2)&quot;" target="&quot;C.437G&gt;A VARIANT AND C.1159C&gt;T VARIANT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mutations in the COQ2 gene can result in coenzyme Q10 deficiency and are associated with specific genetic variants."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OPRM1&quot;" target="&quot;ADH1B (RS1229984)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Like ALDH2, ADH1B genotype is also controlled for in the analyses of OPRM1's effects."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NALTREXONE&quot;" target="&quot;PLACEBO&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The comparison between naltrexone and placebo is central to assessing the pharmacogenetic effects on alcohol craving and side effects."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NALTREXONE&quot;" target="&quot;ALCOHOL CRAVING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The analysis focuses on whether naltrexone affects alcohol craving based on OPRM1 genotype groupings."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DROWSINESS&quot;" target="&quot;RINGING IN THE EARS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both drowsiness and ringing in ears are significant side effects observed more frequently with naltrexone than placebo, indicating an interaction between medication and participant experience."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CRAVING&quot;" target="&quot;CURRENT CIGARETTE SMOKING STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The status was examined as a potential moderator of alcohol craving effects related to OPRM1 genotype and medication, but found not significant."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUBJECTIVE RESPONSE TO ALCOHOL&quot;" target="&quot;BRAC LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Changes in BrAC levels significantly influence subjective responses, including sedation and stimulation, which are analyzed across genotypes and drug conditions."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUMBER OF DRINKING DAYS&quot;" target="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Together, these factors provide a comprehensive picture of participants' alcohol consumption patterns over time."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRINKS PER DRINKING DAY&quot;" target="&quot;ACTIVE CONTROL MEDICATION (CYPROHEPTADINE)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Participants receiving this control medication reported higher drinks per drinking day, especially when combined with specific genotypes like CT/CC in placebo conditions compared to olanzapine."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE (RS671)&quot;" target="&quot;ADH1B GENOTYPE (RS1229984)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both variants were considered together in analyses to understand their combined effects on drinking behavior and subjective alcohol responses."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE (RS671)&quot;" target="&quot;AUQ VALUES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"AUQ values influenced the results, indicating they are significant covariates with ALDH2's role in drinking variables."</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;ASN40 HOMOZYGOTE GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ALDH2 genotype in Asn40 homozygotes influences their alcohol consumption behavior, showing a different pattern compared to Asp40 carriers."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;NALTREXONE MEDICATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The effect of naltrexone on alcohol self-administration varies depending on the ALDH2 genotype, indicating differential responses based on genetic background."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;NICOTINE SMOKING STATUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Smoking status may interact with ALDH2 genotype to influence alcohol consumption patterns, though no significant interaction was found in this study."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL SELF-ADMINISTRATION BEHAVIOR&quot;" target="&quot;BRAC (BREATH ALCOHOL CONCENTRATION)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Changes in BrAC reflect the impact of alcohol self-administration behavior and are influenced by genetic factors such as ALDH2 genotype."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAILY ALCOHOL CONSUMPTION&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is a positive association between daily alcohol consumption and blood cortisol levels in both sexes before and after adjusting for various factors."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAILY ALCOHOL CONSUMPTION&quot;" target="&quot;GENETIC POLYMORPHISM (RS671)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs671 polymorphism significantly influences daily alcohol consumption, with GG genotype individuals drinking more than those with GA or AA genotypes."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL LEVELS&quot;" target="&quot;GENETICALLY PREDICTED ALCOHOL CONSUMPTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In men, genetically predicted daily alcohol intake positively influences blood cortisol level, while in women, there is no significant association."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISM (RS671)&quot;" target="&quot;CORTISOL METABOLISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"ALDH2 gene's rs671 polymorphism affects cortisol metabolism differently in men and women, indicating sex-specific physiological responses."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEN&quot;" target="&quot;WOMEN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Sex differences are observed in baseline characteristics of alcohol consumption and cortisol levels based on ALDH2 genotypes."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONFIDENCE INTERVAL (CI)&quot;" target="&quot;MENDELIAN RANDOMIZATION (MR)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CI provides a measure of the reliability of estimates from MR analyses, helping to establish the strength of association between genetically predicted alcohol consumption and cortisol levels."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;SLC2A9 VARIANT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs3733591 variant of SLC2A9 is significantly associated with increased risk for hyperuricemia, particularly in female subjects."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;SERUM CREATININE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals with hyperuricemia tend to have higher serum creatinine levels, indicating potential renal function impairment."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;TG LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Individuals diagnosed with hyperuricemia exhibit elevated triglyceride levels compared to the general population."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCG2 RS2231142&quot;" target="&quot;HYPERURICAEMIA (HUA)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ABCG2 gene variant rs2231142 significantly increases the risk of hyperuricaemia, particularly in individuals with cardiovascular risk factors."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC22A12 RS893006&quot;" target="&quot;SUA LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SLC22A12 gene variant rs893006 shows no significant association with sUA levels, except in male carriers of the C/C genotype."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVELS&quot;" target="&quot;GENETIC RISK SCORE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An individual's genetic risk score increases linearly with higher serum uric acid (sUA) levels."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVELS&quot;" target="&quot;TG LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High triglyceride (TG) levels are associated with higher serum uric acid (sUA) levels in individuals carrying the ABCG2 rs2231142 T allele."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR RISK FACTORS&quot;" target="&quot;HYPERURICAEMIA (HUA)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of cardiovascular risk factors such as obesity, hypertension, high TG and low HDL cholesterol levels significantly increases HUA risk in individuals with specific genetic variants."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICAEMIA (HUA)&quot;" target="&quot;LDL LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher low-density lipoprotein cholesterol (LDL) levels significantly increase HUA risk in both male and female carriers of the ABCG2 rs2231142 T allele."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICAEMIA (HUA)&quot;" target="&quot;HDL LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Lower high-density lipoprotein cholesterol (HDL) levels increase HUA risk in males but not significantly in females carrying the ABCG2 rs2231142 T allele."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2231142 T ALLELE&quot;" target="&quot;HYPERURICEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of the rs2231142 T allele is associated with an increased risk of hyperuricemia."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2231142 T ALLELE&quot;" target="&quot;URIC ACID METABOLISM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic factors, such as the presence of the rs2231142 T allele, can influence uric acid metabolism."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT ABCG2&quot;" target="&quot;SERUM URIC ACID LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants of the ABCG2 gene affect serum uric acid levels across both genders and populations."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LRP2 GENE&quot;" target="&quot;EGFR-DECREASING ALLELE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The LRP2 gene is associated with a specific allele variant that decreases estimated glomerular filtration rate, impacting kidney function."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 GENE&quot;" target="&quot;CKD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variants in the NFATC1 gene are linked to an increased risk of chronic kidney disease based on their impact on eGFR."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 GENE&quot;" target="&quot;129S6 MOUSE STRAIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The 129S6 mouse strain serves as a model for studying the regulation of NFATC1 gene expression under conditions of high salt intake and CKD."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR-DECREASING ALLELE&quot;" target="&quot;CKD&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A specific allele variant associated with a decrease in estimated glomerular filtration rate is strongly correlated with the risk for chronic kidney disease."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKD&quot;" target="&quot;UNCX GENE VARIANT (RS62435145)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The UNCX gene variant rs62435145 shows a strong association with increased risk of chronic kidney disease as indicated by its impact on eGFR."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKD&quot;" target="&quot;ALMS1 GENE (RS7587577)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The ALMS1 gene variant rs7587577 is linked to a significant risk of chronic kidney disease according to genome-wide studies."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKD&quot;" target="&quot;T2D AND T1D&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Diabetes types 2 and 1 are risk factors for chronic kidney disease and influence estimated glomerular filtration rate according to genetic studies."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PDILT-UMOD GENE VARIANTS (RS77924615)&quot;" target="&quot;CKD, EGFR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Variants within the PDILT-UMOD locus, notably rs77924615, impact both chronic kidney disease risk and estimated glomerular filtration rate."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1&quot;" target="&quot;RGS14&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both NFATC1 and RGS14 genes are influenced by variants at the SLC34A1 locus, showing correlation in gene expression regulation across tissues."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCKR P.PRO446LEU (RS1260326)&quot;" target="&quot;CARDIOVASCULAR DISEASE RISK&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The GCKR missense variant is associated with metabolic changes that increase the risk of cardiovascular diseases, such as CKD."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HDAC8 BINDING SITES&quot;" target="&quot;KIDNEY FUNCTION REGULATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Binding of HDAC8 to specific genomic regions may regulate kidney function and development through chromatin modification."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTONE DEACETYLASES (HDACS)&quot;" target="&quot;CYCLOSPORINE A&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Cyclosporine A targets NFATC1, which is downstream of HDAC8 activity in the immune response regulation."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IONIC REGULATION&quot;" target="&quot;SALT SENSITIVITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ability to regulate ion concentrations can influence an organism's sensitivity to dietary salt intake."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC34A1 VARIANTS&quot;" target="&quot;GENE EXPRESSION IN TISSUES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These variants are eQTLs for RGS14 and NFATC1 in multiple tissues, indicating their regulatory roles."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FETAL KIDNEY CELLS&quot;" target="&quot;GENOMIC REGULATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Studies on DHSs in fetal kidney cells suggest that these cells play a role in early gene regulation during development."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RENAL CORTICAL EPITHELIAL CELLS (HRCES)&quot;" target="&quot;GENE REGULATION MECHANISMS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"These cells indicate that DHSs play a crucial role in the posterior probability of driving association signals with eGFR."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGS14 VARIANTS&quot;" target="&quot;IMMUNE RESPONSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The gene RGS14, influenced by variants at SLC34A1 locus, is involved in immune responses and regulation."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOCO LOSS-OF-FUNCTION VARIANTS&quot;" target="&quot;SALT SENSITIVITY REGULATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These variants reduce expression of loco gene, improving survival under salt stress conditions in Drosophila."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOCO GENE&quot;" target="&quot;SALT STRESS RESISTANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The loco gene plays a role in conferring resistance against salt stress, especially evident in mutant strains of Drosophila when supplemented with NaCl."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOCO GENE&quot;" target="&quot;ISOGENIC CONTROLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"When compared with isogenic controls under non-NaCl conditions, loco mutants show no significant differences in viability, indicating the specific role of NaCl supplementation."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 PROTEIN&quot;" target="&quot;HIGH-SALT DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"NFATC1's renal mRNA expression significantly decreases after exposure to high-salt conditions, indicating a physiological response to environmental stress."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 PROTEIN&quot;" target="&quot;CHRONIC KIDNEY DISEASE (CKD)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Renal mRNA levels of NFATC1 are reduced during CKD, reflecting changes in kidney function and disease progression."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGS14 PROTEIN&quot;" target="&quot;HIGH-SALT DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Similar to NFATC1, RGS14 shows significant downregulation in its renal mRNA expression upon exposure to a high-salt diet."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGS14 PROTEIN&quot;" target="&quot;CHRONIC KIDNEY DISEASE (CKD)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression of RGS14 decreases with CKD, suggesting its involvement in the pathogenesis or response to chronic kidney disease."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-SALT DIET&quot;" target="&quot;RGS14 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Renal mRNA levels of RGS14 are significantly reduced after exposure to a high-salt diet, indicating its role in kidney dysfunction under stress conditions."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYBRID HETEROGENIC STRAINS&quot;" target="&quot;LOCO MUTANTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In hybrid heterogenic strains, loco mutants exhibit salt-resistance similar to their isogenic counterparts, excluding effects due to inbreeding depression."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKD MODEL&quot;" target="&quot;SUB-TOTAL NEPHRECTOMY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The procedure of sub-total nephrectomy induces chronic kidney disease in mice models, leading to alterations in renal mRNA expression of RGS14 and NFATC1 genes."</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAMPYLOBACTER INFECTIONS&quot;" target="&quot;QUINOLONE RESISTANCE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Infections caused by Campylobacter bacteria can exhibit genomic variants leading to quinolone resistance, affecting the course and treatment options of the disease."&lt;SEP&gt;"Infections caused by Campylobacter bacteria can have a genomic variant leading to quinolone resistance, significantly impacting the course and treatment of the disease."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;TRAVEL&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Foreign travel is associated with an increased prevalence of quinolone-resistant Campylobacter infections, indicating a link between environment and bacterial resistance patterns."&lt;SEP&gt;"Foreign travel is associated with an increased prevalence of quinolone-resistant Campylobacter infections, indicating a link between environmental factors and bacterial antibiotic resistance patterns."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Consuming poultry other than chicken or turkey increases the risk for quinolone-resistant Campylobacter infections, indicating dietary habits as a potential environmental factor influencing disease susceptibility."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;SWIMMING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Engaging in swimming is associated with an increased risk of acquiring quinolone-resistant C. jejuni infections, highlighting recreational activities as environmental factors contributing to disease prevalence."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;AGE GROUP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The age distribution among patients does not significantly affect the likelihood or severity of quinolone-resistant Campylobacter infections, suggesting that other factors such as travel and dietary habits play a more significant role in susceptibility."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;FLUOROQUINOLONES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The use of fluoroquinolone antibiotics is associated with the development of quinolone-resistant Campylobacter strains, indicating an important consideration for treatment and prevention strategies."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERYTHROMYCIN RESISTANCE&quot;" target="&quot;CAMPYLOBACTER JEJUNI&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Some Campylobacter jejuni and C. coli strains harbor genes that confer erythromycin resistance."</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. COLI AND C. JEJUNI INFECTIONS&quot;" target="&quot;DURATION OF ILLNESS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The duration of illness for patients infected with C. jejuni is significantly longer when the infection is quinolone-resistant compared to sensitive strains."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DURATION OF ILLNESS&quot;" target="&quot;C. JEJUNI AND C. COLI INFECTIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The duration of illness for patients infected with C. jejuni is significantly longer when the infection is quinolone-resistant compared to sensitive strains, highlighting the impact of antibiotic resistance on disease severity."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FLUOROQUINOLONES&quot;" target="&quot;CAMPYLOBACTERIOSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Fluoroquinolones are used to treat campylobacteriosis, but resistance against fluoroquinolones is a concern in clinical settings."</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAMPYLOBACTER JEJUNI&quot;" target="&quot;NALIDIXIC ACID RESISTANCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The nalidixic acid resistance variant is found within the genetic makeup of certain Campylobacter jejuni isolates."</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRESH POULTRY OTHER THAN CHICKEN AND TURKEY&quot;" target="&quot;DOMESTICALLY ACQUIRED QUINOLONE-RESISTANT INFECTIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Consumption of fresh poultry other than chicken and turkey is associated with a higher risk of domestically acquired quinolone-resistant Campylobacter infections."</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. COLI&quot;" target="&quot;RETAIL FOOD PRODUCTS AND BROILER CHICKENS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Isolates from retail food products, including chicken, turkey, pork, and broiler chickens, were compared with C. coli isolates for resistance patterns and origin analysis."</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RETAIL FOOD PRODUCTS AND BROILER CHICKENS&quot;" target="&quot;GEOGRAPHIC AREA AND TIME PERIOD&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The geographic area and time period of the samples from retail food products and broiler chickens are critical in determining potential sources of infection."</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS9534511&quot;" target="&quot;SOCIAL DISINHIBITION (RISK)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The minor allele for rs9534511 significantly increases the risk of social disinhibition."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4938056&quot;" target="&quot;HTR3B GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs4938056 is associated with the HTR3B gene, contributing to higher social disinhibition risks."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4938056&quot;" target="&quot;SOCIAL DISINHIBITION (RISK)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The minor allele for rs4938056 is associated with an increased risk of social disinhibition."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1998220&quot;" target="&quot;OPRM1 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"An intronic SNP (rs1998220) in the OPRM1 gene is significantly linked to an increased risk of social disinhibition."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1998220&quot;" target="&quot;RS9534511 AND RS4938056&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These SNPs are part of the group associated with an increased risk of social disinhibition, compared to protective effects shown by other SNPs."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OPRM1 GENE&quot;" target="&quot;RS3025971&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"An intronic SNP (rs3025971) in OPRM1 is significantly linked to an increased risk of social disinhibition."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1003921&quot;" target="&quot;KCNC1 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs1003921 located within KCNC1 is associated with higher levels of social disinhibition."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1003921&quot;" target="&quot;SOCIAL DISINHIBITION (PROTECTIVE)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The minor allele for rs1003921 strongly protects against social disinhibition."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KCNC1 GENE&quot;" target="&quot;RS12830955&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs12830955 located within KCNC1 is associated with higher levels of social disinhibition."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS16116&quot;" target="&quot;NPY GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A significant SNP (rs16116) downstream of the NPY gene impacts social disinhibition risk."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS16116&quot;" target="&quot;SOCIAL DISINHIBITION (PROTECTIVE)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The minor allele for rs16116 provides a protective effect against social disinhibition."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NPY GENE&quot;" target="&quot;RS16867458&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A significant SNP (rs16867458) downstream of the NPY gene impacts social disinhibition risks."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS16870286&quot;" target="&quot;LINC00518 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs16870286 in LINC00518 is linked to increased social disinhibition risks."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOCIAL DISINHIBITION SCORE&quot;" target="&quot;LINGUISTIC ACCULTURATION SCORE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher linguistic acculturation scores are significantly associated with increased levels of social disinhibition."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOCIAL DISINHIBITION SCORE&quot;" target="&quot;TAS AND DAS SCORES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The TAS and DAS scores were positively correlated with higher social disinhibition risk, indicating a significant physiological influence."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS16116, RS16870286, AND RS1003921&quot;" target="&quot;SOCIAL DISINHIBITION (PROTECTIVE)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These SNPs are associated with a protective effect against social disinhibition."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1998220, RS9534511, AND RS4938056&quot;" target="&quot;SOCIAL DISINHIBITION (RISK)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These SNPs are associated with an increased risk of social disinhibition."</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUROIMAGING STUDY ON BRAIN ACTIVATION &quot;" target="&quot;ALCOHOL USE DISORDER SCORE (AUDIT)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The AUDIT score correlates with brain activation in VMPFC during alcohol exposure in individuals with the CT genotype at rs2023239, indicating a link between genetic variation and addiction risk."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHORT-TERM EFFECTS OF ALCOHOL ON REWARD SENSITIVITY &quot;" target="&quot;BREATH ALCOHOL LEVELS &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Despite similar breath alcohol levels after consuming three drinks across different genotypes (TT vs CT/CC), individuals with the rs2023239 variant showed increased reward sensitivity, indicating a genetic influence independent of blood alcohol concentration."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAST-MONTH QUANTITY OF ALCOHOL USE &quot;" target="&quot;TOBACCO SMOKING &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both tobacco smoking and past-month quantity of alcohol use were considered as factors in the study but showed no significant differences related to genotypes at rs2023239, suggesting no confounding effects."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239 GENOMIC VARIANT - EXON REGION &quot;" target="&quot;CNR1 GENE &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genetic variant rs2023239 is located upstream of exon 3 in the CNR1 gene, suggesting its role as an alternative promoter affecting CB1 receptor expression."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUCLEUS ACCUMBENS (NACC) &quot;" target="&quot;VENTRAL TEGMENTAL AREA (VTA) &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both NAcc and VTA show differential activation between TT and CT genotypes, indicating a common pathway influenced by CNR1 gene variation in reward processing."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VENTRAL MIDBRAIN PREFRONTAL CORTEX (VMPFC) &quot;" target="&quot;VENTRAL TEGMENTAL AREA (VTA) &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Activation patterns in VMPFC and VTA indicate a shared pathway in reward processing affected by CNR1 gene variation, suggesting common neural mechanisms."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUDIT SCORE &quot;" target="&quot;AUQ SCORE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both AUDIT and AUQ scores measure aspects of alcohol use disorder severity and craving, with AUQ showing specific correlations with brain activation patterns in the OFC, indicating distinct genetic influences on subjective experiences."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CNR1&quot;" target="&quot;OLANZAPINE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Olanzapine interacts with the CNR1 pathway, affecting responses in individuals with specific genotypes to alcohol consumption."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OLANZAPINE&quot;" target="&quot;SELF-REPORTED HIGH&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The drug olanzapine interacts with self-reported high measures, showing different effects based on participant genotypes."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OLANZAPINE&quot;" target="&quot;DOPAMINE SYSTEM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Olanzapine interacts with the dopamine system, affecting neurotransmission and potentially altering responses related to alcohol reward in individuals with specific CNR1 genotypes."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLACEBO TREATMENT&quot;" target="&quot;CUE-ELICITED CRAVING&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Individuals receiving placebo treatment showed increased cue-elicited craving compared to those treated with olanzapine in the context of specific CNR1 genotypes."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLACEBO TREATMENT&quot;" target="&quot;CUE-ELICITED DRINKING BEHAVIOR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Individuals under placebo treatment exhibited heightened cue-elicited craving and drinking behavior, contrasting with outcomes observed when treated with olanzapine."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CB1 RECEPTOR BINDING LEVELS &quot;" target="&quot;MESOCORTICOLIMBIC NEUROCIRCUITRY &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CNR1 gene variants like rs2023239 affect mesocorticolimbic neurocircuitry by altering CB1 receptor levels, influencing drug-seeking behavior."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE (LPL)&quot;" target="&quot;CHYLOMICRONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"LPL hydrolyzes chylomicrons as part of its function in lipid metabolism."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE (LPL)&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Decreased activity of lipoprotein lipase leads to accumulation of triglycerides in the bloodstream, causing hypertriglyceridemia."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE (LPL)&quot;" target="&quot;GPIHBP1&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"GPIHBP1 is necessary for transporting LPL to capillary lumen where it can act on chylomicrons."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE (LPL)&quot;" target="&quot;CHYLOMICRON HYDROLYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The process of breaking down chylomicrons into free fatty acids and monoglycerides is catalyzed by LPL."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT&quot;" target="&quot;CHYLOMICRONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Dietary fat is packaged into chylomicrons for transport and processing by LPL."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHYLOMICRONS&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High levels of chylomicrons, particularly after meals rich in fats, can exacerbate hypertriglyceridiaemia due to inadequate hydrolysis by lipoprotein lipase."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPEMIA RETINALIS&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High triglyceride levels (&gt;2500 mg/dl) lead to lipemia retinalis, a condition characterized by white-colored retinal veins due to lipid deposition."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERUPTIVE XANTHOMAS&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"High levels of triglycerides in the blood lead to eruptive xanthomas as a clinical manifestation."&lt;SEP&gt;"Severe hypertriglyceridemia can trigger eruptive xanthomas in patients with LPL deficiency."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;FASTING LIPID PROFILE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Used to assess the severity of hypertriglyceridemia caused by lipid metabolism disorders like LPL deficiency."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;HYPERVISCOSITY SYNDROME&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Elevated triglycerides contribute to hyperviscosity syndrome leading to abdominal pain and gastrointestinal hemorrhage in LPL deficient patients."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;PANCREATITIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High levels of triglycerides increase the risk of developing pancreatitis, a condition often found in LPL-deficient individuals."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;MCT FAT SUPPLEMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Medium-chain triglyceride supplements provide an alternative source of energy without increasing triglyceride levels in patients managing hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;GEMFIBROZIL DRUG THERAPY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Gemfibrozil is used to reduce high triglyceride levels by inhibiting lipoprotein synthesis and upregulating HDL cholesterol production in patients with hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;ORLISTAT DRUG THERAPY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Orlistat reduces the absorption of dietary fats, thereby lowering triglyceride levels when combined with dietary restrictions for managing hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;INTRAMUSCULAR INTRODUCTION OF GAIN-OF-FUNCTION LPL VARIANT THERAPY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This therapy aims to increase lipase activity through the introduction of a gain-of-function variant, helping to lower triglyceride levels in patients with hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;DGAT1 INHIBITORS TREATMENT APPROACH&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Inhibiting DGAT1 reduces lipid synthesis during fat absorption, potentially lowering triglyceride levels and managing hypertriglyceridemia in LPL-deficient patients."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;VLDL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Elevated VLDL particles contribute significantly to hypertriglyceridemia due to insufficient breakdown by LPL in patients with LPL gene mutations."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENFAPORT LIPIL FORMULA&quot;" target="&quot;MEDIUM-CHAIN TRIGLYCERIDES (MCT) FAT CONTENT IN ENFAPORT LIPIL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The formula provides a high proportion of MCTs, reducing dependence on LPL for dietary fat metabolism."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOMOZYGOUS LPL DEFICIENCY&quot;" target="&quot;COMPOUND HETEROZYGOUS LPL DEFICIENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both conditions represent forms of LPL deficiency but differ in severity and genetic basis."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE PROTEIN&quot;" target="&quot;P.Q240H MUTATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The p.Q240H mutation alters the structure and function of the lipoprotein lipase protein, contributing to hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;ADVERSE EVENT SEVERITY&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Treatment with topiramate leads to a higher mean severity rating of adverse events compared to placebo, particularly among A-allele carriers."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;RS2832407*C-HOMOZYGOTES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Among patients with the *C-homozygous genotype, topiramate treatment significantly reduced heavy drinking days (HDDs), demonstrating high efficacy."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Among patients carrying the *A allele, topiramate had no discernible effect on reducing heavy drinking days (HDDs), indicating minimal efficacy."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2832407 GENOTYPE&quot;" target="&quot;HDDS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Patients with different genotypes for rs2832407 respond differently to topiramate treatment in terms of reducing heavy drinking days (HDDs)."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVERSE EVENT SEVERITY&quot;" target="&quot;RS2832407*C-HOMOZYGOTES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Patients with the *C-homozygous genotype showed a non-significant difference in adverse event severity compared to placebo."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVERSE EVENT SEVERITY&quot;" target="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Patients with the *A allele had significantly higher adverse event severity when treated with topiramate compared to placebo."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCB1 RS1045642 VARIANT&quot;" target="&quot;CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Patients with the ABCB1 variant at position rs1045642 reported more severe acute nausea than those without this variant."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCB1 RS1045642 VARIANT&quot;" target="&quot;HTR3B (RS45460698)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both ABCB1 variant at position rs1045642 and HTR3B variant at position rs45460698 were examined for their association with acute nausea severity."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2D6 INTERMEDIATE OR EXTENSIVE METABOLIZER PHENOTYPE&quot;" target="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Patients characterized as CYP2D6 intermediate or extensive metabolizers were likely to be treated with highly emetogenic chemotherapy regimens."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2D6 INTERMEDIATE OR EXTENSIVE METABOLIZER PHENOTYPE&quot;" target="&quot;CYP2D6 ACTIVITY SCORE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CYP2D6 activity score reflects the functional activity of patients with intermediate or extensive metabolizer phenotypes."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA&quot;" target="&quot;PALONOSETRON&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Most patients received palonosetron, but the medication did not prevent all cases of CTCAE grade 2 or above acute nausea."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA&quot;" target="&quot;HISTORY OF MORNING SICKNESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Patients with a history of morning sickness were more likely to report CTCAE grade 2 or above acute nausea."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DELAYED CINV (NAUSEA AND VOMITING)&quot;" target="&quot;DEXAMETHASONE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Despite being prescribed alongside dexamethasone, some patients still experienced delayed CINV following chemotherapy treatment."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOURS OF SLEEP BEFORE CHEMOTHERAPY&quot;" target="&quot;PATIENT-REPORTED SEVERITY OF ACUTE NAUSEA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Less sleep before chemotherapy was associated with more severe acute nausea reported by patients."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA&quot;" target="&quot;LOC100507600 LNCRNA&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Silencing of LOC100507600 results in a reduction of LCT mRNA levels, indicating its role in regulating the expression of LCT."</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 GENE&quot;" target="&quot;DNA MODIFICATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Different DNA modifications are observed within the MCM6 locus associated with lactase persistence or non-persistence alleles."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 GENE&quot;" target="&quot;LACTASE NON-PERSISTENCE (CC) INDIVIDUALS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The MCM6 gene influences lactase non-persistence in individuals with CC genotype via age-related DNA modifications."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C/T-13910 SNP&quot;" target="&quot;LACTASE PERSISTENCE/NON-PERSISTENCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This SNP affects lactose digestion ability through its impact on DNA modification patterns around the LCT gene, influencing lactase persistence status."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHROMOSOME 2, 9, 19&quot;" target="&quot;LCT GENE REGULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genomic regions within these chromosomes are critical for understanding the transcriptional regulation of the LCT gene across individuals with varying lactase persistence statuses."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTAG-CLICK METHOD&quot;" target="&quot;EPIGENETIC ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This method enables comprehensive epigenetic analysis by enriching unmodified DNA fractions for detailed investigation of DNA modification changes around key genes like the LCT gene."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENCE/DISEASE NON-PERSISTENCE&quot;" target="&quot;DNA METHYLATION CHANGES WITH AGE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Age-dependent changes in DNA methylation patterns within the LCT-MCM6 region influence lactose persistence or non-persistence."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENCE/DISEASE NON-PERSISTENCE&quot;" target="&quot;C/T-13910 SNP RS4988235 AND G/A-22018 SNP RS182549&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic variations at these SNPs are strongly associated with lactase persistence or non-persistence conditions."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT EXON 1&quot;" target="&quot;HISTONE MARKS (H3K4ME1 AND H3K27AC)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The LCT exon 1 region has high levels of H3K4me3 and H3K27ac, indicative of an active promoter state."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTONE MARKS (H3K4ME1 AND H3K27AC)&quot;" target="&quot;MCM6 EXON 17-3â² UTR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Enhancer activity marked by these histones is observed at this region, indicating regulatory roles for lactase expression."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT INTRON 5&quot;" target="&quot;LOC100507600 LNCRNA PROMOTER REGION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This intron region harbors the promoter for a long non-coding RNA, potentially influencing lactase gene expression regulation."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-13910 GENOMIC VARIANT&quot;" target="&quot;AGE-RELATED DNA MODIFICATIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This genomic variant is associated with specific patterns of DNA modification changes over the lifespan, influencing LCT expression differently based on genotype."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-13910 GENOMIC VARIANT&quot;" target="&quot;LACTASE PERSISTENCE (TT) INDIVIDUALS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with this variant showing persistence of lactose digestion capacity due to protective epigenetic mechanisms against DNA modification changes over time."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENCE (TT) INDIVIDUALS&quot;" target="&quot;LOC100507600 LNCRNA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals showing lactase persistence have a regulatory region that interacts with an antisense transcript modulating LCT mRNA levels positively."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED DNA MODIFICATIONS&quot;" target="&quot;MCM6 EXON 16&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The region within MCM6 shows significant differences in DNA methylation between different haplotypes with aging, impacting lactase activity regulation."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT ACTIVITY&quot;" target="&quot;EVOLUTIONARY CONSERVATION OF EPIGENETIC FACTORS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Regulation of LCT activity via epigenetics is conserved across mammals, indicating the importance of these mechanisms in developmental biology."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP -13910 TT GENOTYPE&quot;" target="&quot;LACTASE PERSISTENCE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP -13910 TT genotype is linked to lactase persistence, a genetic condition affecting lactose digestion into adulthood."</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCF BINDING SITE&quot;" target="&quot;DNA METHYLATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased DNA methylation inhibits CTCF binding at insulator sites, impacting tissue-specific gene expression."</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT PROMOTER ELEMENT&quot;" target="&quot;CRISPR-CAS9 SYSTEM&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CRISPR-Cas9 was used to delete intronic regions that include or interact with Lct promoter elements in mouse experiments."</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 PROTEIN&quot;" target="&quot;ENHANCER ELEMENTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MCM6 protein influences the function of enhancer elements within its introns, which regulate neighboring genes like LCT."</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENCE ALLELE (T)&quot;" target="&quot;RCC&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"While individuals with the T allele of rs4988235 show normal milk consumption patterns, there was no observed direct influence on RCC risk compared to other factors."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK CONSUMPTION&quot;" target="&quot;RCC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Consumption of milk is associated with an increased risk of renal cell carcinoma (RCC), despite no direct genetic link through rs4988235."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CZECH REPUBLIC&quot;" target="&quot;ROMANIA&quot;">
      <data key="d4">1.2</data>
      <data key="d5">"Contrary to Romania, the Czech Republic exhibits a strong association between milk consumption and RCC risk."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLAND&quot;" target="&quot;RUSSIA&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"Both Poland and Russia show intermediate frequencies of lactase persistence alleles (rs4988235), reflecting regional genetic diversity."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL11A&quot;" target="&quot;RS4671393&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The BCL11A gene includes rs4671393 SNP that correlates with elevated baseline, MTD, and delta HbF levels post-treatment."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL11A&quot;" target="&quot;RS11886868 &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The BCL11A gene includes rs11886868 SNP that shows association with MTD and delta HbF levels but not baseline."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS9402686 &quot;" target="&quot;HMIP-2 (OR HBS1L-MYB)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HMIP-2 gene includes rs9402686 SNP that also shows increased baseline and MTD HbF levels after treatment with hydroxyurea."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROXYUREA (HU)&quot;" target="&quot;HEMOGLOBIN F (HBF)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Hydroxyurea treatment increases HbF levels in patients, demonstrating a significant physiological impact on the disease state."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANC (ABSOLUTE NEUTROPHIL COUNT)&quot;" target="&quot;MEASURED PARAMETERS &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Absolute neutrophil count is one of the hematological parameters measured before or after hydroxyurea treatment to assess its impact on blood cell counts, though no correlations were found with these SNPs."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AT START OF HU TREATMENT (AGE)&quot;" target="&quot;REGRESSION MODELS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The age when patients begin hydroxyurea treatment is used as a covariate in regression models to correct for baseline and post-treatment hemoglobin F (HbF) levels."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOTYPES &quot;" target="&quot;BCL11A &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The BCL11A gene contains haplotypes that influence baseline and MTD HbF levels in patients treated with hydroxyurea, particularly the G-G-T reference haplotype vs. T-A-C variant."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOTYPES &quot;" target="&quot;HMIP-2 (OR HBS1L-MYB)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HMIP-2 gene has haplotypes including T-G, C-A, and T-A that influence baseline hemoglobin F levels post-hydroxyurea treatment."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMIP-2 SNP&quot;" target="&quot;MTD HBF&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The HMIP-2 SNP is associated with MTD HbF levels, but this association loses significance when corrected for baseline HbF."</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-A HAPLOTYPE&quot;" target="&quot;MTD HBF&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The C-A haplotype was originally associated with MTD HbF before correction for baseline HbF, indicating a potential influence on HbF levels."</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-A HAPLOTYPE&quot;" target="&quot;MAPBACTEREMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CD subjects carrying the C-A haplotype show a modest increase in MAPbacteremia presence but with lower association strength compared to other haplotypes."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE HBF&quot;" target="&quot;DELTA HBF&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Baseline HbF serves as the starting point from which delta HbF is measured, reflecting changes in HbF levels over time or due to interventions."</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMIP-2 (OR HBS1L-MYB)&quot;" target="&quot;RS9399137 &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HMIP-2 gene contains rs9399137 SNP, which is linked to increased baseline and MTD HbF levels post-HU treatment."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCA GENE&quot;" target="&quot;FANCONI ANEMIA (FA) DISEASE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mutations in FANCA can cause Fanconi anemia by disrupting DNA repair and genomic stability mechanisms."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.2574C&gt;G/P.SER858ARG MUTATION IN FANCA&quot;" target="&quot;FANCONI ANEMIA (FA) DISEASE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"This mutation is known to lead to Fanconi anemia by affecting the function of the FANCA protein."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCD2 PROTEIN MONOUBIQUITINATION DEFECT&quot;" target="&quot;FANCONI ANEMIA (FA) DISEASE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Deficiency in monoubiquitination of FANCD2 is a hallmark of Fanconi anemia, indicating impaired DNA repair function."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCONI ANEMIA (FA) DISEASE&quot;" target="&quot;UBE2T GENE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Mutations in UBE2T can cause Fanconi anemia by disrupting the ubiquitination process essential for FANCD2 activation."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCONI ANEMIA (FA) DISEASE&quot;" target="&quot;ENVIRONMENTAL FACTOR - DNA CROSSLINKING AGENTS (DEB AND MMC)&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Individuals with Fanconi anemia are hypersensitive to DNA cross-linking agents like DEB and MMC, leading to chromosomal breakage."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCONI ANEMIA (FA) DISEASE&quot;" target="&quot;FANCI PROTEIN MONOUBIQUITINATION DEFECT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The deficiency in FANCI monoubiquitination is an additional indication of disrupted Fanconi pathway caused by UBE2T mutations."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS&quot;" target="&quot;COMPOUND HETEROZYGOUS MUTATIONS IN UBE2T&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The presence of compound heterozygous mutations leads to protein deficiency observed specifically in fibroblast cells, indicating tissue-specific expression or recombination."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS&quot;" target="&quot;LYMPHOBLASTOID CELL LINE (LCL)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The contrast between normal UBE2T levels in LCLs and deficiency in fibroblasts suggests tissue-specific reversion or expression."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS&quot;" target="&quot;RNA SEQUENCING (RNA-SEQ)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"RNA-seq identified reduced UBE2T transcript levels in RA2627 fibroblasts, indicating the functional significance of UBE2T mutations."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS&quot;" target="&quot;RT-QPCR ANALYSIS OF UBE2T TRANSCRIPT LEVELS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"RT-qPCR confirmed reduced transcript levels, aligning with protein deficiency observed in fibroblasts."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T&quot;" target="&quot;WILD TYPE UBE2T EXPRESSION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Expression of wild type UBE2T rescues cellular hypersensitivity and restores physiological processes essential for DNA damage repair."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T&quot;" target="&quot;URD&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The RING domain of human proteins binds Ube2T while URD does not interact directly with it according to ITC data."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T EXPRESSION&quot;" target="&quot;FANCD2 MONOUBIQUITINATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"UBE2T expression restores monoubiquitination of FANCD2, a process crucial for the cellular response to DNA crosslinking damage."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T EXPRESSION&quot;" target="&quot;FANCI MONOUBIQUITINATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"UBE2T expression also restores FANCI monoubiquitination, indicating its role in DNA repair mechanisms."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T EXPRESSION&quot;" target="&quot;FANCD2 MONOUBIQUITINATION&quot;/&quot;FANCI MONOUBIQUITINATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Overexpression of wild type UBE2T restores physiological processes essential for DNA damage repair."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T EXPRESSION&quot;" target="&quot;RA2627 CELLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Introduction of wild type UBE2T expression rescues cellular hypersensitivity and restores DNA repair mechanisms, similar to normal cell lines (BJ)."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCONI ANEMIA-T SUBTYPE (FA-T)&quot;" target="&quot;UBE2T DEFICIENCY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Deficiency of UBE2T leads to Fanconi anemia subtype T due to impaired DNA repair processes."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RA2627 CELLS&quot;" target="&quot;MMC&quot;/&quot;DEB&quot;/&quot;CISPLATIN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Crosslinking agents cause cellular hypersensitivity in RA2627 fibroblasts due to impaired DNA repair mechanisms when UBE2T is deficient."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPS19 GENE&quot;" target="&quot;FRAMESHIFT MUTATION C.58DELG&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This frameshift mutation in the RPS19 gene leads to reduced protein levels due to NMD activation."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPS19 GENE&quot;" target="&quot;SPLICE SITE MUTATION C.1-1G&gt;A&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The splice site mutation affects RNA splicing, leading to exon 2 skipping and altered RPS19 expression."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MISSENSE MUTATION P.ARG62TRP&quot;" target="&quot;DBA PATIENTS GENES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This mutation contributes to the differential gene expression profile seen in DBA patients."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DERMAL FIBROBLASTS TRANSCRIPTOME&quot;" target="&quot;DBA PATIENTS GENES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The transcriptome alterations observed in dermal fibroblasts from DBA patients correspond to the list of differentially expressed genes identified by microarray analysis."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INGENUITY PATHWAYS ANALYSIS (IPA)&quot;" target="&quot;AMINOACYL-TRNA BIOSYNTHESIS PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"IPA analysis shows enrichment of this pathway among differentially expressed genes in DBA patients."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLYCINE SERINE AND THREONINE METABOLISM PATHWAY&quot;" target="&quot;DEATH RECEPTOR SIGNALING PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Both pathways are enriched among differentially expressed genes in DBA patients, suggesting a connection between metabolic regulation and cell death signaling."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY&quot;" target="&quot;RAR ACTIVATION PATHWAY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Enrichment of these pathways indicates potential immune system dysregulation due to RPS19 mutations."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN SYNTHESIS GENES (RP GENES)&quot;" target="&quot;CELL DEATH REGULATION GENES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The differential expression of RP genes and cell death regulation genes suggests a role in protein synthesis and apoptosis control affected by RPS19 mutations."</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RP GENES CLUSTER (RPL22, RPL27A, RPL29, ETC.)&quot;" target="&quot;LIPID METABOLISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Ribosomal protein genes are part of a cluster involved in lipid metabolism pathways."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RP GENES CLUSTER (RPL22, RPL27A, RPL29, ETC.)&quot;" target="&quot;CELLULAR DEVELOPMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Ribosomal protein genes are crucial for cellular development processes."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPID METABOLISM&quot;" target="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"These pathways are interconnected as lipid metabolism involves the transport of lipids across membranes."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMPD3&quot;" target="&quot;CCND2 (CYCLIN D2)&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Both genes were found to be up-regulated in DBA patients relative to controls, indicating their potential role in disease pathogenesis."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCND2 (CYCLIN D2)&quot;" target="&quot;CELL CYCLE REGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"CCND2 is involved in cell cycle regulation, particularly in promoting progression from G1 to S phase."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOD2 (SUPEROXIDE DISMUTASE 2)&quot;" target="&quot;TNFAIP3 (TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN 3)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both genes play roles in inflammatory responses and cancer progression, with SOD2 involved in antioxidant defense and TNFAIP3 regulating the NF-kappaB pathway."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOD2 (SUPEROXIDE DISMUTASE 2)&quot;" target="&quot;ANTIOXIDANT DEFENSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SOD2 plays a critical role in antioxidant defense mechanisms, protecting cells from oxidative damage."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP3 (TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN 3)&quot;" target="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"TNFAIP3 regulates inflammatory responses by controlling the NF-kappaB pathway."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMP (CARTILAGE OLIGOMERIC MATRIX PROTEIN)&quot;" target="&quot;ZIC1 (ZIC FAMILY MEMBER 1)&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"These genes are differentially expressed in DBA patients, with COMP involved in cartilage/bone development and ZIC1 in neural tube formation."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WARS (TRYPTOPHANYL-TRNA SYNTHETASE)&quot;" target="&quot;PROTEIN SYNTHESIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"WARS is involved in the process of protein synthesis by activating tryptophan for incorporation into proteins."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZIC1 (ZIC FAMILY MEMBER 1)&quot;" target="&quot;NEURAL TUBE FORMATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"ZIC1 plays a critical role in neural tube formation during embryonic development."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF GENE&quot;" target="&quot;RS6265 POLYMORPHISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The BDNF gene contains the rs6265 polymorphism which is associated with migraine susceptibility."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF GENE&quot;" target="&quot;RS2049046 POLYMORPHISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Another variant of the BDNF gene, rs2049046 (A/T), also influences the risk for developing migraines."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF GENE&quot;" target="&quot;CAUCASIAN POPULATION GROUPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The BDNF gene polymorphisms were studied in five different Caucasian population groups."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS6265 POLYMORPHISM&quot;" target="&quot;MIGRAINE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The polymorphism in the BDNF gene at position rs6265 is significantly associated with migraine susceptibility."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2049046 POLYMORPHISM&quot;" target="&quot;MIGRAINE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic variant rs2049046 (A/T) in the BDNF gene also shows a significant association with migraine occurrence."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS SCORE&quot;" target="&quot;STUDY QUALITY ASSESSMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The NOS score is used to evaluate the quality of studies included in the meta-analysis, ensuring high-quality results."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSORIASIFORM DERMATITIS&quot;" target="&quot;IL-17A, IFN-Î, IL-22, IL-36Î&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These cytokines exhibit altered expression patterns in paradoxical psoriasis compared to classical psoriasis, indicating their involvement in the disease's immune response.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSORIASIFORM DERMATITIS&quot;" target="&quot;EPIDERMAL HYPERPLASIA WITH PARAKERATOSIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Histological changes characterized by hyperplasia and parakeratosis are typical in the skin lesions of patients experiencing paradoxical psoriasiform dermatitis.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDCA2+ PDCS, CD15+ NEUTROPHILS, C-KIT/CD117+ MAST CELLS, CD68+ MACROPHAGES AND MONOCYTES&quot;" target="&quot;INNATE IMMUNITY CELLS INFILTRATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These cell populations are part of the innate immunity that significantly infiltrates paradoxical psoriasiform lesions compared to classical psoriasis.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PBMCS&quot;" target="&quot;IL-27 EFFECTS STUDY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Human peripheral blood mononuclear cells are used to assess how different IL-27 variants affect IRF1 and STAT1 transcript levels, providing insight into gene regulation mechanisms."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL23R (RS11209026)&quot;" target="&quot;DISEASE, PARADOXICAL PSORIASIFORM REACTIONS TO ANTIâTNFS &quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The SNP IL23R (rs11209026) has been previously associated with paradoxical psoriasiform reactions to anti-TNF treatments."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL23R (RS72676067)&quot;" target="&quot;HS PATIENTS &quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The SNP IL23R (rs72676067) was detected in patient 2 of the HS patients."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL23R (RS1004819)&quot;" target="&quot;HS PATIENTS &quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The SNP IL23R (rs1004819) was detected in patient 1 of the HS patients."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)&quot;" target="&quot;DRWD DOMAIN STRUCTURE (DMFANCL)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The human URD and the DRWD domain of Drosophila share structural similarities but differ in secondary structure elements, particularly with an intermediary position for the N-terminal lobe of the human domain."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)&quot;" target="&quot;E2 UBC ENZYME STRUCTURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Structural similarity between the C-terminal lobe of the URD and E2 enzymes, especially in RWD folds for the C-terminal lobe, suggests potential evolutionary or functional relationships."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)&quot;" target="&quot;VERTEBRATE FANCLS FEATURE (ELEMENT SWAP)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The unique structure of human URD represents a key difference from Drosophila DRWD due to vertebrate-specific element swap, placing the N-terminal lobe in an intermediary position."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYSTEINE IN URD N-TERMINAL LOBE (URD)&quot;" target="&quot;THIOESTER CHARGE ASSAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The thioester charge assay revealed that despite structural similarity to catalytic cysteines of E2 enzymes, the cysteine in the human FANCL central domain's N-terminal lobe does not form a thioester bond with ubiquitin."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC CORE BETWEEN LOBES OF HUMAN FANCL CENTRAL DOMAIN AND DMDRWD DOMAINS&quot;" target="&quot;SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The hydrophobic core conservation between human URD and Drosophila DRWD indicates a conserved structural interaction, despite differences in surface exposure suggesting evolutionary adaptation for vertebrate systems."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC CORE BETWEEN LOBES OF HUMAN FANCL CENTRAL DOMAIN AND DMDRWD DOMAINS&quot;" target="&quot;INTERACTION RESIDUES BETWEEN LOBES (HUMAN URD VS DMDRWD)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"While specific interaction residues vary, the hydrophobic core between lobes is highly conserved in human URD compared to Drosophila DRWD."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)&quot;" target="&quot;HYDROPHOBIC PATCHES ON HUMAN FANCL CENTRAL DOMAIN (URD)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Additional hydrophobic patches on the human URD compared to Drosophila suggest potential for differential interactions required in vertebrate systems, reflecting differences observed in surface conservation analysis."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)&quot;" target="&quot;CONSERVATION OF FANCL PROTEINS (VERTEBRATE VS INVERTEBRATE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Comparative analysis highlights differences in surface conservation and hydrophobic patches between vertebrate URD and invertebrate DRWD, indicative of unique interaction patterns."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T CATALYTIC CYSTEINE RESIDUE (UBIQUITIN-CONJUGATING ENZYME)&quot;" target="&quot;CATALYTIC CYSTEINE IN URD N-TERMINAL LOBE (URD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Structural similarity but functional difference, with the cysteine residue in human FANCL central domain unable to form thioester bonds similar to Ube2Tâs catalytic cysteine."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SURFACE CONSERVATION COMPARISON DETAILS (URD VS DMDRWD)&quot;" target="&quot;HYDROPHOBIC EXPOSURE PATCHES (URD N-TERMINAL LOBE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Additional surface hydrophobic patches on human URD suggest differential interaction requirements compared to Drosophila DRWD, reflecting evolutionary adaptations."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;Î-MEANDER PATCH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Î²-meander patch is part of the structural features on the URD contributing to its function."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;ELECTROSTATIC POTENTIAL OF SURFACE URD VS DMDRWD&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Distinct electrostatic potential differences between human URD and Drosophila DRWD indicate functional variations in protein-protein interactions."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCI&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The URD protein interacts with FANCI, a key component in DNA repair mechanisms."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The URD protein also interacts with FANCD2, another critical element of the Fanconi anemia pathway."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RING DOMAIN&quot;" target="&quot;FANCI&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Experiments show that the hydrophobic patches on the C-terminal lobe of the RING domain are necessary for binding FANCI."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RING DOMAIN&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Similar to FANCI, mutations in the hydrophobic patches on the RING domain reduce its interaction with FANCD2."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RING DOMAIN&quot;" target="&quot;HYDROPHOBIC GROOVE ON C-TERMINAL DOMAIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Mutations in hydrophobic patches on the C-terminal lobe affect binding affinity with FANCI and FANCD2, suggesting their importance for substrate interaction."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCI&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"FANCI and FANCD2 proteins interact in substrate binding, indicating a molecular interaction required for proper function in DNA repair pathways."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCI&quot;" target="&quot;L248A/F252A/L254A/I265A MUTANT URD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The mutant L248A/F252A/L254A/I265A of URD shows reduced binding affinity with FANCI, indicating a critical role for specific residues in protein-protein interactions."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCI&quot;" target="&quot;W212A/L214A MUTANT URD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The W212A/L214A mutant of URD behaves similarly to wild type in substrate binding assays with FANCI, suggesting that certain mutations do not affect binding."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCD2&quot;" target="&quot;L248A/F252A/L254A/I265A MUTANT URD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The mutant L248A/F252A/L254A/I265A of URD shows reduced binding affinity with FANCD2, similar to its interaction with FANCI."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCD2&quot;" target="&quot;W212A/L214A MUTANT URD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The W212A/L214A mutant of URD behaves similarly to wild type in substrate binding assays with FANCD2, similar to its interaction with FANCI."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS351855 (GLY388ARG)&quot;" target="&quot;COLESEVELAM TREATMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This genomic variant is associated with differential treatment responses to colesevelam, affecting AC t1/2 and GC24."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS4975017&quot;" target="&quot;COLESEVELAM TREATMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Differential effects of colesevelam on CT are observed in the presence of this genomic variant, impacting GC24 values significantly."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS17618244 (ARG728GLN)&quot;" target="&quot;COLESEVELAM TREATMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"This genetic variation shows numerical but not statistically significant differential responses to colesevelam, affecting AC t1/2 and GC24."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM TREATMENT&quot;" target="&quot;AC T1/2 (AREA UNDER CURVE TIME 1/2)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The AC t1/2 is influenced by genetic variations in FGFR4 and KLB, showing differential effects of colesevelam treatment."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM TREATMENT&quot;" target="&quot;GC24 (GLYCEMIC CONTROL 24 HOURS)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The GC24 level changes depending on the presence of certain genetic variations under colesevelam treatment, indicating differential metabolic effects."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS376618&quot;" target="&quot;HWE ASSESSMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This genomic variant failed to satisfy Hardy-Weinberg equilibrium in the study."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROL PATIENTS&quot;" target="&quot;HWE ASSESSMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genotypes of healthy control patients were used to assess Hardy-Weinberg equilibrium for candidate SNPs."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL BA (BILE ACIDS)&quot;" target="&quot;SERUM C4&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased levels of serum C4 are associated with elevated stool bile acid excretion in IBS-D patients."&lt;SEP&gt;"There is a significant correlation between serum C4 levels and stool bile acid excretion in IBS-D patients."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL BA (BILE ACIDS)&quot;" target="&quot;FGFR4 RS1966265&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant FGFR4 rs1966265 is marginally associated with stool BA levels, suggesting a role in bile acid synthesis or excretion."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM C4&quot;" target="&quot;FGFR4 RS1966265&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant FGFR4 rs1966265 is marginally associated with stool BA but not serum C4, indicating a potential influence on bile acid metabolism."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS17618244&quot;" target="&quot;FGFR4 RS351855, FGFR4 RS376618&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variants KLB rs17618244 and other FGFR4 SNPs were tested but showed no significant associations with serum C4 or stool BA."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI, STOOL BA (BILE ACIDS)&quot;" target="&quot;FGF19 LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher BMI is correlated with higher serum C4 levels and total stool bile acids, indicating a relationship between metabolic status and FGF19 regulation."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;K48-LINKED UB2 &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FAAP20 can bind to K48-linked diubiquitin chains, indicating non-specific binding preference."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;M1-LINKED UB2 &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FAAP20 interacts with M1-linked diubiquitin chains, demonstrating non-specific binding capability."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;K63-LINKED UB2 (K63-UB2)&quot;" target="&quot;FAAP20-UBZ&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The FAAP20-UBZ protein specifically interacts with K63-linked Ub2, as shown by its crystal structure and biochemical experiments."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CENTRAL Î-HELIX (RESIDUES 160â173)&quot;" target="&quot;K63 OF DISTAL UB &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The central Î±-helix in FAAP20-UBZ interacts specifically with the K63 residue on the distal ubiquitin molecule."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILE44 PATCH (OF UB)&quot;" target="&quot;FAAP20-UBZ&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The Ile44-centered hydrophobic patch in ubiquitin is crucial for interaction with FAAP20's UBZ domain."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ (RESIDUES 143â180)&quot;" target="&quot;K48-LINKED UB2 &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FAAP20-UBZ can bind K48-linked diubiquitin chains."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ (RESIDUES 143â180)&quot;" target="&quot;M1-LINKED UB2 &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FAAP20-UBZ can interact with M1-linked diubiquitin chains."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN (UB)&quot;" target="&quot;FAAP20-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Ubiquitin interacts with FAAP20-UBZ through specific residues, contributing to the binding and recruitment of FAAP20 to DNA damage sites."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN (UB)&quot;" target="&quot;WRNIP1-UBZ&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Specific residues on WRNIP1-UBZ interact with Ubiquitin to facilitate the binding and localization of WRNIP1 to DNA damage sites."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN (UB)&quot;" target="&quot;RAD18-UBZ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Similar to WRNIP1, specific residues on RAD18-UBZ interact with Ubiquitin for binding and recruitment to DNA damage sites."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN (UB)&quot;" target="&quot;POLÎ-UBZ&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Unlike other UBZ proteins, PolÎ·-UBZ interacts uniquely with Ubiquitin, suggesting a different role in cellular processes compared to WRNIP1 and RAD18."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN (UB)&quot;" target="&quot;NEMO-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Specific residues on NEMO-UBZ interact differently from other UBZ proteins with Ubiquitin, indicating unique roles in cellular processes."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN (UB)&quot;" target="&quot;PRO398-LYS399 IN NEMO-UBZ AND GLU636-LYS637 IN POLÎ-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These residues on NEMO-UBZ and PolÎ·-UBZ interact uniquely with ubiquitin contributing to different binding mechanisms."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISOTHERMAL TITRATION CALORIMETRY (ITC)&quot;" target="&quot;BINDING AFFINITY MEASUREMENT &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"ITC measures equilibrium dissociation constants for protein-protein interactions, such as PolÎ· UBZ with ubiquitin."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TWO SHORT Î STRANDS &quot;" target="&quot;CLASSICAL UBZ FOLD &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Typically present in classical UBZ folds but absent in FAAP20-UBZ structure."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEU8, ILE44, VAL70, THR66, HIS68 (OF UB)&quot;" target="&quot;HYDROPHOBIC INTERACTIONS &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Residues and their aliphatic portions involved in hydrophobic interactions with FAAP20-UBZ."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;ILE44-CENTERED HYDROPHOBIC PATCH OF UB&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The hydrophobic patch on ubiquitin interacts with FAAP20-UBZ to facilitate binding and localization."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ICL SITES&quot;" target="&quot;DNA DAMAGE REPAIR PROCESS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of ICL sites indicates a need for DNA repair processes, where proteins like FAAP20-UBZ play crucial roles in recruitment and repair."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILE44-CENTERED HYDROPHOBIC PATCH OF UB&quot;" target="&quot;LEU8, VAL70, THR66, HIS68 OF UB&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These residues contribute to the hydrophobic patch on ubiquitin that interacts with FAAP20-UBZ."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILE44-CENTERED HYDROPHOBIC PATCH OF UB&quot;" target="&quot;PRO21-VAL22 IN THE Î-LOOP OF WRNIP1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The residues in the Î²-loop contribute to interactions with Ile44 on ubiquitin facilitating binding and localization."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILE44-CENTERED HYDROPHOBIC PATCH OF UB&quot;" target="&quot;C-TERMINAL LOOP OF FAAP20-UBZ&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The C-terminal loop in FAAP20 interacts specifically with residues on ubiquitin facilitating binding and localization."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASP37 IN WRNIP1 Î-HELIX AND ASP177 IN C-TERMINAL LOOP OF FAAP20&quot;" target="&quot;ARG42 IN UBIQUITIN (UB)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These residues interact with Arg42 on ubiquitin to facilitate binding and localization."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLÎ-UBZ (PDB CODE: 2I5O)&quot;" target="&quot;UB&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"PolÎ·-UBZ binds Ub in a manner similar to FAAP20-UBZ, suggesting conserved critical residues for interaction."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UB&quot;" target="&quot;WRNIP1-UBZ (PDB CODE: 2JVX)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The interaction between WRNIP1-UBZ and Ub involves the Î²-loop, distinct from FAAP20-UBZ and PolÎ·-UBZ."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UB&quot;" target="&quot;FAAP20-UBZ (PDB CODE: 2I5O)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"FAAP20-UBZ interacts with Ub through residues in the Î±-helix, showing similarity to Rabex5-MIU and distinctiveness from NEMO-UBZ."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UB&quot;" target="&quot;VPS27-UIM (PDB CODE: 1Q0W)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The interaction between Vps27-UIM and Ub is similar in critical residues to Rabex5-MIU, suggesting convergent evolution of the motif."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UB&quot;" target="&quot;RABEX5-MIU (PDB CODE: 2C7M AND 2FIF)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The interaction between Rabex5-MIU and Ub shares critical binding residues with FAAP20-UBZ, indicative of convergent evolution."&lt;SEP&gt;"The interaction between Rabex5-MIU and Ub shares critical residues with FAAP20-UBZ, indicative of convergent evolution."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WRNIP1-UBZ (PDB CODE: 2JVX)&quot;" target="&quot;Î-LOOP (IN UBZ DOMAINS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Î²-loop in WRNIP1-UBZ interacts with Ub via specific residues that are different from those of NEMO-UBZ."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ (PDB CODE: 2I5O)&quot;" target="&quot;MIU (MOTIF INTERACTING WITH UBIQUITIN)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The MIU motif shares critical binding residues with FAAP20-UBZ and Rabex5-MIU, indicating convergent evolution."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ (PDB CODE: 2I5O)&quot;" target="&quot;Î-HELIX (IN UBZ/UIM/MIU STRUCTURES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Î±-helix in FAAP20-UBZ interacts with Ub through residues that are conserved and critical for binding, showing similarity to Rabex5-MIU."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VPS27-UIM (PDB CODE: 1Q0W)&quot;" target="&quot;UIM (UB-INTERACTING MOTIF)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The UIM motif interacts with Ub similarly to Vps27-UIM in critical residues, despite opposite polarity."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCA INTERACTION STUDIES &quot;" target="&quot;GST-PULLDOWN ASSAY &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"GST-pulldown technique used to investigate binding interactions between FAAP20 and FANCA."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7775228&quot;" target="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The frequency of the minor 'C' allele at rs7775228 is higher among CD patients than controls, indicating a potential risk association with the disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2187668&quot;" target="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of the minor 'T' allele at rs2187668 is significantly higher in CD patients, suggesting a strong risk factor for developing Crohnâs disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQ2.5 HAPLOTYPE&quot;" target="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The homozygous HLA-DQ2.5 haplotype is more prevalent in CD patients, contributing to the genetic risk of developing Crohnâs disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQ8 HAPLOTYPE&quot;" target="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The heterozygous DQ8 haplotypes are highly frequent among CD patients and contribute significantly to the genetic predisposition for Crohnâs disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;RS7454108&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs7454108 does not show a significant difference between CD patients and controls, indicating it is not a strong risk factor for the disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;HOMOZYGOUS HLA-DQ2.2 HAPLOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The homozygous HLA-DQ2.2 haplotype is more frequent in controls than CD patients, suggesting its potential protective role against developing Crohnâs disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;DQ8/DQX HAPLOTYPES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The higher frequency of DQ8/DQX haplotype in CD patients compared to controls indicates its significant contribution as a risk factor for the disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;CHRONIC DIARRHEA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A common symptom of Crohnâs disease characterized by prolonged diarrhea, often lasting several weeks or longer due to inflammation and altered bowel function."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;ABDOMINAL PAIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Localized abdominal pain is a frequent clinical manifestation in CD patients, reflecting the site of gastrointestinal inflammation and involvement."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;ANOREXIA&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Loss of appetite or disinterest in food is commonly observed in CD patients due to systemic responses to chronic inflammation affecting the digestive system."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;ABDOMINAL DISTENSION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Swelling of the abdomen, often linked with bowel obstruction or excessive gas accumulation, is a notable symptom seen in Crohnâs disease patients due to intestinal blockages and inflammation."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;HAPLOTYPE COMBINATION T-G&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This haplotype combination between PTPN2:rs478582 and PTPN22:rs2476601 was more frequent in healthy controls, suggesting a protective role or reduced disease risk."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;PTPN2 TRANSCRIPT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The transcript level of PTPN2 is higher in healthy controls compared to CD patients, indicating a protective role of normal expression levels."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;DEMOGRAPHIC PROFILE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The demographic profile, including age and sex distributions, is compared between healthy controls and HIV-infected individuals to understand genetic associations."</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;TLR7 HAPLOTYPES (RS179008 AND RS179009)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The control group's haplotype distribution is compared with HIV-infected individuals to assess genetic associations in TLR7 gene."</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE THYROIDITIS&quot;" target="&quot;CHRONIC ECZEMA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both chronic eczema and autoimmune thyroiditis can be outcomes of immune dysregulation in STAT5B deficient individuals.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1128503 (ABCB1)&quot;" target="&quot;GRADE 3â4 ANEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs1128503 variant in ABCB1 is significantly associated with grade 3-4 anemia."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12762549 (ABCC2)&quot;" target="&quot;GRADE 3â4 ANEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs12762549 variant in ABCC2 is significantly associated with grade 3-4 anemia."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS363717 (ABCA1)&quot;" target="&quot;GRADE 3â4 ANEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs363717 variant in ABCA1 is significantly associated with grade 3-4 anemia."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS11615 (ERCC1)&quot;" target="&quot;GRADE 3â4 ANEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs11615 variant in ERCC1 is significantly associated with grade 3-4 anemia."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4986910 (CYP3A4)&quot;" target="&quot;THROMBOCYTOPENIA GRADE 3â4&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs4986910 variant in CYP3A4 is significantly associated with thrombocytopenia grade 3-4."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2074087 (ABCC1)&quot;" target="&quot;ERYTHROPOIETIN-STIMULATING AGENTS (ESAS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs2074087 variant in ABCC1 is significantly associated with the use of ESAs."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2073337 (ABCC2)&quot;" target="&quot;COLONY-STIMULATING FACTORS (CSFS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs2073337 variant in ABCC2 is significantly associated with the use of CSFs."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1695 (GSTP1)&quot;" target="&quot;COLONY-STIMULATING FACTORS (CSFS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs1695 variant in GSTP1 is significantly associated with the use of CSFs."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1799793 (ERCC2)&quot;" target="&quot;PROGRESSION-FREE INTERVAL (PFI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs1799793 variant in ERCC2 is significantly associated with PFI."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3814879 (TGFBR2)&quot;" target="&quot;RADIATION PNEUMONITIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs3814879 variant in TGFBR2 is associated with an increased risk for severe radiation pneumonitis."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7156029 (HLA-DQB1)&quot;" target="&quot;RESPONSE TO IMMUNOTHERAPY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs7156029 variant in HLA-DQB1 is correlated with the response to immunotherapy."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS113498797 (MYH6)&quot;" target="&quot;ATRIAL FIBRILLATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs113498797 variant in MYH6 increases the risk of atrial fibrillation."</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1799793 (ERCC2 Gâ&gt;âA)&quot;" target="&quot;PLATINUM-FREE INTERVAL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant rs1799793 in ERCC2 gene is significantly correlated with platinum-free interval (PFI) survival."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12762549 (ABCC2 Aâ&gt;âG)&quot;" target="&quot;ABCC2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ABCC2 gene harbors a significant genomic variant, rs12762549, which affects platinum-free interval (PFI) survival."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12762549 (ABCC2 Aâ&gt;âG)&quot;" target="&quot;PLATINUM-FREE INTERVAL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant rs12762549 in ABCC2 gene is significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS6104 (SERPINB2 Câ&gt;âG)&quot;" target="&quot;SERPINB2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SERPINB2 gene harbors a significant genomic variant, rs6104, which affects platinum-free interval (PFI) survival."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS6104 (SERPINB2 Câ&gt;âG)&quot;" target="&quot;PLATINUM-FREE INTERVAL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant rs6104 in SERPINB2 gene is significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 Gâ&gt;âA VARIANT CARRIERS (GG)&quot;" target="&quot;AGE AT DIAGNOSIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The effect of the ERCC2 G&gt;A variant on survival duration is less pronounced when only age at diagnosis is considered compared to a fully adjusted model."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 Gâ&gt;âA VARIANT CARRIERS (GG)&quot;" target="&quot;FIGO STAGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FIGO stage, along with other factors, influences the survival advantage observed in GG carriers of rs1799793 in ERCC2 gene."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 Gâ&gt;âA VARIANT CARRIERS (GG)&quot;" target="&quot;TUMOR GRADE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The tumor grade is a factor that, when adjusted for, reveals the significant advantage of GG carriers in terms of platinum-free interval compared to other genotypes."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 Gâ&gt;âA VARIANT CARRIERS (GG)&quot;" target="&quot;RESIDUAL DISEASE AFTER DEBULKING SURGERY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The amount of residual disease after surgery, when adjusted for alongside other factors like ERCC2 genotype, influences patient prognosis and survival outcomes."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 Gâ&gt;âA VARIANT CARRIERS (AA/GA)&quot;" target="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with AA or GA genotype in rs1799793 have a significant disadvantage in platinum-free interval compared to GG carriers, indicating worse survival outcomes."</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UMPS GENE&quot;" target="&quot;DE NOVO DELETION ON CHROMOSOME 3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The UMPS gene is part of a de novo deletion on chromosome 3, which may contribute to the patient's phenotype due to loss of function of multiple genes."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UMPS GENE&quot;" target="&quot;C.302DELA IN I4&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individual I4 harbors a variant (c.302delA) within the UMPS gene, leading to premature stop codon and loss of normal protein function."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UMPS GENE&quot;" target="&quot;C.385G&gt;T IN I7 AND S7&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals I7 and their healthy brother S7 share a maternally inherited variant (c.385G&gt;T) within the UMPS gene leading to loss of protein function."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UMPS GENE&quot;" target="&quot;C.224C&gt;A IN PEDIGREE 2 FAMILY MEMBERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A heterozygous missense alteration (c.224C&gt;A) found across multiple members of pedigree 2 within the UMPS gene, potentially pathogenic."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UMPS GENE&quot;" target="&quot;C.689G&gt;A AND C.688C&gt;T IN I6 AND I7&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Maternally inherited missense alterations (c.689G&gt;A and c.688C&gt;T) found within the UMPS gene leading to changes that are predicted to be pathogenic."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UMPS GENE&quot;" target="&quot;HIGH-DENSITY GENE-CENTRIC ARRAY CGH TESTING&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Testing method used to exclude copy number variations in the UMPS gene, particularly for individuals I4, 6 and 7."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.302DELA IN I4&quot;" target="&quot;PROTEIN TRUNCATION OR NONSENSE-MEDIATED MRNA DECAY (NMD)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The variant c.302delA leads to premature stop codon and triggers protein truncation/NMD leading to loss of function."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.385G&gt;T IN I7 AND S7&quot;" target="&quot;PROTEIN TRUNCATION OR NONSENSE-MEDIATED MRNA DECAY (NMD)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The variant c.385G&gt;T leads to premature stop codon and triggers protein truncation/NMD leading to loss of function."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.224C&gt;A IN PEDIGREE 2 FAMILY MEMBERS&quot;" target="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PROGRAMS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Predictive software indicates the variant c.224C&gt;A is potentially pathogenic within UMPS gene."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.689G&gt;A AND C.688C&gt;T IN I6 AND I7&quot;" target="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PROGRAMS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Predictive software indicates missense alterations (c.689G&gt;A and c.688C&gt;T) within UMPS gene are potentially pathogenic."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGF-SS1 (RS1800469 C/T)&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The T allele in the TGF-Ã1 gene is associated with a significantly higher risk of CRC."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 (RS4073 T/A)&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant association between the polymorphism in the promoter region of IL-8 and CRC was found."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 (RS1800896 A/G)&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The G allele in IL-10 is associated with reduced risk of developing colorectal cancer."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 (RS1179251 C/G)&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The G allele in rs1179251 in IL-22 is associated with increased risk of CRC, but not significantly."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 (RS2227485 C/T)&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant association was found between the polymorphism in IL-22 and the occurrence of CRC."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 (RS17855750 T/G)&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of the GG genotype for rs17855750 in IL-27 is associated with reduced risk of CRC."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER (CRC)&quot;" target="&quot;IL-22 GENE (RS1179251 C/G)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs1179251 C/G polymorphism in IL-22 gene is associated with a decreased risk of developing CRC but lacks strong statistical significance."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER (CRC)&quot;" target="&quot;IL-27 GENE (RS17855750 T/G)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The G allele in IL-27 gene shows protective effects against colorectal cancer development, though the association is weak."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRC&quot;" target="&quot;T ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The T allele showed a slightly lower frequency in CRC patients compared to controls, but this did not reach statistical significance (p=0.161, OR=0.68).")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 GENE (RS1800896 A/G)&quot;" target="&quot;IL-8 GENE (RS4073 T/A)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic variants of IL-8 and IL-10 both contribute to immune system modulation, with IL-10 showing a more pronounced effect on CRC risk reduction."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 GENE (RS1800896 A/G)&quot;" target="&quot;TGF-SS1 GENE (RS1800469 C/T)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both TGF-Ã1 and IL-10 genes have polymorphisms studied for CRC risk, with contrasting outcomes: increased risk in TGF-Ã1, reduced risk in IL-10."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONTROL GROUP VS CRC PATIENTS&quot;" target="&quot;T ALLELE FREQUENCY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A lower frequency of the T allele was observed in CRC patients compared to the control group but did not reach statistical significance.")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSLP GENE&quot;" target="&quot;ASTHMA SUSCEPTIBILITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TSLP gene contributes to asthma susceptibility through genetic variations such as SNPs."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (RS1898671)&quot;" target="&quot;EX-SMOKERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Smoking history affects the association of SNP rs1898671 in TSLP with increased risk for asthma."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (RS1898671)&quot;" target="&quot;NEVER-SMOKERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There is no significant association between SNP rs1898671 and asthma risk among never-smokers."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA SUSCEPTIBILITY&quot;" target="&quot;TSLP HAPLOTYPE (GAGGGCAAAG)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This specific haplotype within the TSLP gene is linked with increased risk of developing asthma after adjusting for covariates."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMATIC PATIENTS&quot;" target="&quot;LUNG FUNCTION TESTS (FEV1, FVC)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Lower lung function tests results such as FEV1 and FVC were observed in asthmatic patients compared to healthy controls."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMATIC PATIENTS&quot;" target="&quot;TOTAL IGE LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher total IgE levels are associated with asthma cases, indicating increased immune system activity."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMATIC PATIENTS&quot;" target="&quot;ATOPIC STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of atopy is more common among asthmatic patients compared to the control group."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-REPORTED RACE/ETHNICITY INFORMATION&quot;" target="&quot;POPULATION STRATIFICATION ADJUSTMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Race/ethnicity information is used to adjust for potential biases in genetic association studies."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 GENE&quot;" target="&quot;PTPN2 TRANSCRIPT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The transcript level of the PTPN2 gene is regulated by genetic variants like SNP rs478582, leading to lower expression in CD patients compared to healthy controls."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 GENE&quot;" target="&quot;RS1893217&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The PTPN2 gene is associated with rs1893217, a SNP linked to reduced efficacy of anti-CTLA-4 therapy in metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 GENE&quot;" target="&quot;ANTI-CTLA-4 TREATMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The response rate for anti-CTLA-4 treatment is influenced by genetic variations within the PTPN2 gene, particularly rs1893217."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 GENE&quot;" target="&quot;RS2476601&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The PTPN22 gene is associated with the SNP rs2476601, which though not significant in CD, shows a different haplotype distribution when combined with rs478582 from PTPN2."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;CD (CROHN'S DISEASE)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The SNP rs478582 in the PTPN2 gene is significantly associated with Crohn's disease, indicating its potential role in the etiology of CD."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;PREDISPOSITION TO CD&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The SNP rs478582 in the PTPN2 gene increases predisposition to Crohn's Disease due to altered expression levels and allele frequencies."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2476601&quot;" target="&quot;CD (CROHN'S DISEASE)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Although not directly significant, haplotype analysis suggests a combined effect with PTPN2:rs478582 influencing Crohn's disease risk."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2476601&quot;" target="&quot;PREDISPOSITION TO CD&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Although not directly significant, rs2476601 in the PTPN22 gene can contribute to Crohn's Disease predisposition when combined with rs478582."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD (CROHN'S DISEASE)&quot;" target="&quot;HAPLOTYPE COMBINATION C-G&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The haplotype combination of heterozygous/major alleles for rs478582 and rs2476601 is significantly higher in CD subjects, indicating a potential genetic risk factor."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD (CROHN'S DISEASE)&quot;" target="&quot;HAPLOTYPE COMBINATION C-A&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The haplotype combination of heterozygous/major alleles for rs478582 and the minor/heterozygous or minor allele for rs2476601 is significantly higher in CD compared to healthy controls, indicating a strong genetic risk factor."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD (CROHN'S DISEASE)&quot;" target="&quot;PTPN2 GENE EXPRESSION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The expression level of the PTPN2 gene is significantly lower in CD patients compared to healthy controls, indicating its role in disease susceptibility."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;CD AVERAGE RELATIVE GENE EXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The relative gene expression is lower among CD subjects with heterozygous or minor alleles in PTPN2:rs478582 compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;IFN-Î GENE EXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The relative gene expression of IFN-Î³ is higher among CD subjects with heterozygous or minor alleles in PTPN2:rs478582 compared to those with normal alleles."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;MAP INFECTION SUSCEPTIBILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The susceptibility to MAP infection is higher among CD subjects with heterozygous or minor alleles in PTPN2:rs478582 compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;T-CELL PROLIFERATION RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variants like PTPN2:rs478582 impact the T-cell proliferation response in CD subjects."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;PTPN2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant rs478582 is located within the PTPN2 gene."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD AVERAGE RELATIVE GENE EXPRESSION&quot;" target="&quot;PTPN22:RS2476601&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The relative gene expression of the PTPN22 protein is not affected by heterozygous or minor alleles in PTPN22:rs2476601."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Î GENE EXPRESSION&quot;" target="&quot;PTPN2 GENE EXPRESSION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Combined effect of MAPbacteremia and specific SNPs (PTPN2 or PTPN22) can increase the expression level of IFN-Î³ compared to subjects without these factors."&lt;SEP&gt;"The higher IFN-Î³ gene expression is correlated with lower relative gene expression of PTPN2 in CD subjects carrying specific alleles."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Î GENE EXPRESSION&quot;" target="&quot;PTPN2:RS478582 AND PTPN22:RS2476601 SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of specific genetic variants (SNPs in PTPN2 or PTPN22) combined with MAPbacteremia leads to increased IFN-Î³ expression."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22:RS2476601&quot;" target="&quot;MAP INFECTION SUSCEPTIBILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The susceptibility to MAP infection is increased among CD subjects with heterozygous or minor alleles in PTPN22:rs2476601 compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22:RS2476601&quot;" target="&quot;GA ALLELES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The GA alleles in PTPN22:rs2476601 are associated with MAPbacteremia presence, particularly compared to healthy controls."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22:RS2476601&quot;" target="&quot;PTPN22&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant rs2476601 is located within the PTPN22 gene."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 GENE EXPRESSION&quot;" target="&quot;CD SUBJECTS WITH MINOR ALLELES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CD subjects carrying heterozygous or minor alleles in PTPN2:rs478582 have significantly lower gene expression compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 GENE EXPRESSION&quot;" target="&quot;MAP INFECTION SUSCEPTIBILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Subjects with altered PTPN2 gene expression due to genomic variants have increased susceptibility to MAP infection."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 GENE EXPRESSION&quot;" target="&quot;MAPBACTEREMIA PRESENCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"CD subjects with MAPbacteremia have significantly lower relative gene expression levels of PTPN2 compared to healthy controls, irrespective of MAP presence status."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 GENE EXPRESSION&quot;" target="&quot;CD SUBJECTS WITH MINOR ALLELES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression of PTPN22 is not affected by heterozygous or minor alleles in CD subjects but shows lower overall expression compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 GENE EXPRESSION&quot;" target="&quot;RS2476601 RISK VARIANT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs2476601 risk variant influences PTPN22 gene expression, altering the function of LYP protein variants and contributing to disease risk."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TC ALLELES&quot;" target="&quot;MAPBACTEREMIA&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"CD subjects carrying the TC or CC alleles of PTPN2:rs478582 exhibit a higher prevalence of MAPbacteremia than those with normal TT alleles."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC ALLELE&quot;" target="&quot;MAPBACTEREMIA&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The minor CC allele in PTPN2:rs478582 is linked to an increased risk of MAPbacteremia compared to heterozygous or normal genotypes."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPBACTEREMIA&quot;" target="&quot;C-G HAPLOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CD subjects with the C-G haplotype (combination of alleles in PTPN2:rs478582 and PTPN22:rs2476601) are more likely to have MAPbacteremia than healthy controls."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPBACTEREMIA&quot;" target="&quot;T-A HAPLOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The T-A haplotype in CD subjects is linked with a moderate increase in the presence of MAPbacteremia compared to healthy controls, though less pronounced than the C-G haplotype."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPBACTEREMIA&quot;" target="&quot;T-CELL FUNCTIONALITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of MAPbacteremia affects T-cell functionality, indicating an immune system response in CD patients."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL PROLIFERATION RESPONSE&quot;" target="&quot;PHA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Treatment with PHA significantly increases the T-cell proliferation response in both CD and healthy control subjects."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL FUNCTIONALITY&quot;" target="&quot;MAP PPD-LIKE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Stimulation by MAP PPD-like enhances T-cell functionality, particularly in CD patients with MAPbacteremia."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1D NON-RISK ALLELE (LYP-620R)&quot;" target="&quot;RISK ALLELE (LYP-620W)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The T1D non-risk allele LYP-620R and the risk allele LYP-620W differ in their impact on T cell signaling pathways, with LYP-620R being more effective at modulating TCR-induced calcium flux and MAPK/ERK activity."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCR SIGNALING PATHWAY&quot;" target="&quot;CA2+ FLUX&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Calcium flux is a downstream event in the TCR signaling pathway that affects cell functions such as gene expression and proliferation."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCR SIGNALING PATHWAY&quot;" target="&quot;LYP-620R&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Overexpression of LYP-620R affects TCR signaling and expression of activation markers on T cells."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCR SIGNALING PATHWAY&quot;" target="&quot;ANTI-CD3 AND ANTI-CD28 STIMULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Stimulates TCR signaling, leading to activation and cytokine production in T-cells."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCR SIGNALING PATHWAY&quot;" target="&quot;K562 AAPCS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Artificial APCs are used in experiments to study TCR signaling and its regulation by different factors."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERK SIGNALING PATHWAY&quot;" target="&quot;ACTIVATION MARKERS ON T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MAPK/ERK pathway, initiated by pERK signaling following TCR ligation, regulates the surface expression of activation markers on T cells."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT OF PTPN22&quot;" target="&quot;MEMORY TCONV CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Expression analysis of the PTPN22 transcript reveals its role in maintaining memory T cell function and differentiation state."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT OF PTPN22&quot;" target="&quot;TREGS (REGULATORY T CELLS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The regulation of PTPN22 expression is crucial for the suppressive activity of regulatory T cells, impacting their role in immune tolerance."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYCLONAL ACTIVATION&quot;" target="&quot;BICISTRONIC CONSTRUCTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Upon polyclonal activation, bicistronic constructs are used to introduce specific genetic modifications into activated T cells for studying gene function."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LENTIVIRUS TRANSDUCTION&quot;" target="&quot;EGFP (ENHANCED GREEN FLUORESCENT PROTEIN)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Lentiviral transduction often includes the use of eGFP as a reporter to monitor transduction efficiency and expression of therapeutic genes."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD25&quot;" target="&quot;IL-2&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Net accumulation of IL-2 is a function of activation-induced secretion and consumption via the upregulated CD25 receptor."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 R620W VARIANT&quot;" target="&quot;PROLIFERATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Overexpression of the PTPN22 variant influences T-cell proliferation negatively."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;TRESP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Overexpression of LYP-620R significantly repressed the proliferation and activation of T helper responder cells (Tresps)."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;TRESP PROLIFERATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Overexpression of LYP-620R significantly represses the proliferation of T helper responder cells (Tresps)."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620W&quot;" target="&quot;T CONVOLUTIONAL CELLS (TCONV)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This variant is deficient in its ability to downregulate activation in Tconv compared to LYP-620R."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620W&quot;" target="&quot;TREG SUPPRESSION CAPACITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The overexpression of LYP-620W variant slightly increased the suppressive capacity of regulatory T cells compared to controls."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH1 SIGNATURE&quot;" target="&quot;IFNÎ&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Despite being part of the Th1 signature, IFNÎ³ secretion is not altered by PTPN22 variants according to experimental results."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROLIFERATION&quot;" target="&quot;PMA AND IONOMYCIN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Used as a means to induce proliferation regardless of the presence or absence of PTPN22 variants."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-4, IL-5, IL-9, IL-10, AND IL-13&quot;" target="&quot;CYTOKINE PANEL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These cytokines together form a panel of markers used to assess Th2-mediated immune responses."</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFNÎ&quot;" target="&quot;LYP VARIANTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The secretion of IFNÎ³ was not altered by the overexpression of LYP variants, suggesting that its production may be independent of PTPN22 gene regulation in this context."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREG&quot;" target="&quot;LYP-620W VARIANT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Overexpressed LYP-620W in Tregs slightly increased their suppressive capacity compared to controls, indicating an intrinsic impact on regulatory function."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE DISORDERS&quot;" target="&quot;RS2476601 RISK VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs2476601 risk variant is associated with an increased risk for autoimmune disorders due to its influence on PTPN22 gene expression and function of LYP variants."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFP&quot;" target="&quot;CELL TRACKING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Enhanced green fluorescent protein (eGFP) is used to track and differentiate cells such as transduced Tregs from untransduced cells for studying their functions like proliferation and suppression capacity."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 RISK VARIANT&quot;" target="&quot;TREG-MEDIATED SUPPRESSION CAPACITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The PTPN22 risk variant may alter Treg-mediated suppression capacity, influencing disease risk in autoimmune disorders."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN&quot;" target="&quot;CAR T CELLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The 4-1BB co-stimulatory domain enhances the activity, expansion, and persistence of CAR T cells in vitro."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC49 HUMANIZED SCFV&quot;" target="&quot;TAG72-BBÎ CAR T CELLS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CC49 humanized scFv specifically recognizes TAG72 on ovarian cancer cell lines, enabling the TAG72-BBÎ¶ CAR to mediate tumor cell killing."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD3Î CYTOLYTIC DOMAIN&quot;" target="&quot;CAR T CELLS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The CD3Î¶ domain is critical for signaling and activating CAR T cells against targeted antigens such as TAG72 on cancer cells."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELLS&quot;" target="&quot;CD19T&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Tracking of CAR T cell expansion and persistence during manufacturing and clinical use is facilitated by the expression of CD19t on these cells."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER CELL LINES&quot;" target="&quot;TAG72-BBÎ CAR T CELLS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"TAG72-BBÎ¶ CAR T cells specifically target ovarian cancer cell lines expressing the TAG72 antigen for killing activity."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER CELL LINES&quot;" target="&quot;TAG72 EXPRESSION LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Measurement of TAG72 expression levels on ovarian cancer cell lines is critical for evaluating the efficacy of TAG72-targeted CAR T cells."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;SKOV3 CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CAR T cells do not show significant tumor killing activity against SKOV3 cells due to their lack of surface TAG72 antigen."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;OVCAR8 CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Similarly, OVCAR8 cells are not targeted by TAG72-BBÎ¶ CAR T cells as they do not express sufficient levels of the TAG72 antigen."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;COV362.4 CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CAR T cells exhibit minimal tumor killing activity against COV362.4 cells due to low expression of surface TAG72 antigen."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;OVCAR3 CELLS&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"CAR T cells target and eliminate OVCAR3 cells that express the TAG72 antigen in tumor models."&lt;SEP&gt;"High levels of TAG72 on OVCAR3 cells make them highly susceptible targets for TAG72-BBÎ¶ CAR T cell-mediated killing activity."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;OV90 CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"OV90 cells with very high surface TAG72 expression are effectively targeted and killed by TAG72-BBÎ¶ CAR T cells."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;LS174T COLON CANCER LINE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"LS174T colon cancer line serves as a positive control in experiments demonstrating the specificity of TAG72-BBÎ¶ CAR T cell-mediated tumor killing."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;OVARIAN CANCER XENOGRAFT MODELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CAR T cells are used in xenograft models to study their efficacy against ovarian cancer."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;TUMOR RECURRENCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CAR T cells targeting the TAG72 antigen can lead to tumor recurrence through antigen escape mechanisms."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR T CELLS&quot;" target="&quot;OV90 TUMOR MODEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The OV90 tumor model demonstrates the impact of TAG72-BBÎ¶ CAR T cells on tumor growth and recurrence over time, indicating potential escape mechanisms."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOLUBLE TAG72 ANTIGEN SHEDDING&quot;" target="&quot;TUMOR KILLING ABILITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Shedding of soluble TAG72 minimally impacts the ability of TAG72-BBÎ¶ CAR T cells to kill tumor cells expressing this antigen."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBÎ CAR CONSTRUCT&quot;" target="&quot;DPBMCS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The TAG72-BBÎ¶ CAR construct is introduced into dPBMCs to generate CAR T cells targeting ovarian cancer cells expressing TAG72."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVCAR8 CELLS&quot;" target="&quot;MUC1 ANTIGEN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The OVCAR8 cell line is used to study MUC1 expression patterns in ovarian cancer cells, which contributes to understanding resistance mechanisms."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRAPERITONEAL DELIVERY&quot;" target="&quot;ANTI-TUMOR ACTIVITY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Regional intraperitoneal delivery of CAR T cells exhibits potent anti-tumor activity, extending survival in ovarian cancer ascites-bearing mice compared to systemic delivery."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SYSTEMIC INTRAVENOUS DELIVERY&quot;" target="&quot;TUMOR GROWTH&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Compared with regional i.p. delivery, systemic i.v. delivery shows limited anti-tumor efficacy and less prolonged control over tumor growth."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-TUMOR ACTIVITY&quot;" target="&quot;REPEAT DOSING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Repeat dosing of TAG72-BBÎ¶ CAR T cells over the course of a month provides more durable control of tumors compared with single dose treatments in aggressive cancer models."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER XENOGRAFT MODELS&quot;" target="&quot;MUC1 ANTIGEN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Expression and study of MUC1 in xenograft models contribute to understanding resistance mechanisms in ovarian cancer treatment."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72 ANTIGEN&quot;" target="&quot;MUC1 ANTIGEN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both TAG72 and MUC1 antigens play roles in ovarian cancer, showing heterogeneity and potential escape mechanisms following CAR T cell therapy."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELL THERAPY&quot;" target="&quot;TUMOR HETEROGENEITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Resistance to CAR T cell therapy can be driven by the genetic diversity within tumors, leading to antigen escape and recurrence."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23&quot;" target="&quot;RS12441227&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This SNP is the most significant variant at the THSD4-UACA-TLE3 locus, contributing notably to FEV1/FVC variance in Hutterites."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C10ORF11 GENE ON CHROMOSOME 10Q22.3&quot;" target="&quot;FEV1/FVC&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A genomic variant near the C10orf11 gene has been linked to FEV1/FVC, providing evidence for its influence on lung function."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL23-CCL18 LOCUS ON CHROMOSOME 17Q12&quot;" target="&quot;FEV1/FVC&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This genomic variant is significantly associated with FEV1/FVC in Hutterites, indicating a role in respiratory health regulation."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PITPNC1 LOCUS ON CHROMOSOME 17Q24.2&quot;" target="&quot;FEV1/FVC&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The PITPNC1 gene region shows association with FEV1/FVC, highlighting its importance in lung function."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAF1B LOCUS ON CHROMOSOME 21Q22.13&quot;" target="&quot;FEV1/FVC&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A genomic variant near CHAF1B is significantly associated with FEV1/FVC, particularly significant when excluding asthmatic individuals."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL37 GENE ON CHROMOSOME 2Q13&quot;" target="&quot;FEV1&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"An SNP downstream of IL37 is associated with FEV1 in Hutterites, suggesting genetic influence on expiratory lung function."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASXL3 LOCUS ON CHROMOSOME 18Q12.1&quot;" target="&quot;FVC&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This intronic variant has a significant association with FVC among Hutterite subjects, impacting measures of forced vital capacity."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FEV1/FVC&quot;" target="&quot;HERITABILITY (H2/H2)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The heritabilities indicate that substantial genetic variation influences FEV1/FVC ratios in Hutterites."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FEV1/FVC&quot;" target="&quot;GWAS STUDY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The GWAS study aims to identify genetic factors influencing FEV1/FVC in Hutterites.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Î-DEFENSIN GENES CLUSTER 1-3&quot;" target="&quot;CCL18 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Î²-defensin genes are significantly connected to the CCL18 gene in the GRAIL analysis.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Î-DEFENSIN GENES CLUSTER 1-3&quot;" target="&quot;CCL23-CCL18 LOCUS SNP&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A SNP at CCL23-CCL18 locus is functionally connected to Î²-defensin gene clusters in the GRAIL analysis.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CXCL12 GENE&quot;" target="&quot;TNFRSF13B GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The CXCL12 and TNFRSF13B genes show significant functional connections according to the GRAIL analysis.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CXCL12 GENE&quot;" target="&quot;CCL23-CCL18 LOCUS SNP&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The same SNP at the CCL23-CCL18 locus also connects with CXCL12 according to functional analyses.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THSD4-UACA-TLE3 LOCUS SNPS&quot;" target="&quot;UACA GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The UACA gene is located within the same locus as significant SNPs identified in the GWAS study.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THSD4-UACA-TLE3 LOCUS SNPS&quot;" target="&quot;TLE3 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The TLE3 gene is located within the THSD4-UACA-TLE3 locus where replicated GWAS findings were reported.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C10ORF11 LOCUS SNPS&quot;" target="&quot;C10ORF11 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variants at the C10orf11 locus did not show functional connections to other genes in the study, but were replicated.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS STUDY&quot;" target="&quot;GRAIL ALGORITHM&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The GRAIL algorithm was used to analyze data from the GWAS study for functional gene connections.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4&quot;" target="&quot;RS231775&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The rs231775 variant within the CTLA4 gene is significantly associated with PBC susceptibility."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4&quot;" target="&quot;RS231725&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Similarly, the rs231725 variant of CTLA4 also shows a significant association with PBC risk."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231775&quot;" target="&quot;PBC&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The genetic variant rs231775 increases susceptibility to primary biliary cholangitis (PBC)."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231725&quot;" target="&quot;PBC&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Similarly, the genetic variant rs231725 also increases risk for PBC."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3087243&quot;" target="&quot;PBC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs3087243 does not show an association with primary biliary cholangitis susceptibility."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS5742909&quot;" target="&quot;PBC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Likewise, the genetic variant rs5742909 is found to be non-significantly associated with PBC risk."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3087243 POLYMORPHISM&quot;" target="&quot;PBC SUSCEPTIBILITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The polymorphism rs3087243 within CTLA4 does not influence the risk of primary biliary cholangitis (PBC)."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS5742909 POLYMORPHISM&quot;" target="&quot;PBC SUSCEPTIBILITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Similarly, the polymorphism rs5742909 within CTLA4 is not associated with PBC risk."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RANDOM-EFFECTS MODEL&quot;" target="&quot;HETEROGENEOUS STUDIES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Preferred for meta-analysis when there is significant variability among study results."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRIMARY BILIARY CHOLANGITIS SUSCEPTIBILITY&quot;" target="&quot;CTLA4 VARIANTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The susceptibility to PBC varies based on specific genetic variants within the CTLA4 gene, affecting immune system regulation."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY ANALYSES&quot;" target="&quot;META-ANALYSIS STABILITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Conducted to ensure the stability of meta-analysis results when individual studies or assumptions about study effects are omitted."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PUBLICATION BIAS EVALUATION&quot;" target="&quot;RESEARCH INTEGRITY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Ensures that the conclusions drawn from the meta-analysis are not skewed by publication bias, maintaining research integrity and validity."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT6 PROTEIN&quot;" target="&quot;CIS-REGULATORY SNP (EQTL) FOR STAT6 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variants have an impact on the transcriptional activity and expression levels of STAT6, crucial for T cell differentiation."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STX2 GENE (SYNTAXIN 2)&quot;" target="&quot;CIS-REGULATORY SNP (EQTL) FOR STX2 GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Expression regulation of syntaxin 2 is modulated by genetic variants, impacting intracellular vesicle transport in T cells."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 GENE EXPRESSION REGULATION&quot;" target="&quot;CTLA4 POLYMORPHISM CT60A/G (RS3087243)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The polymorphism CT60 is associated with reduced CTLA4 mRNA expression and increased risk of autoimmune diseases in CD4+ T cells."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 GENE EXPRESSION REGULATION&quot;" target="&quot;(AT)N REPEAT POLYMORPHISM IN THE 3âUTR OF CTLA4&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Length variation in this repeat region influences mRNA levels of CTLA4, impacting autoimmune responses."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 GENE EXPRESSION REGULATION&quot;" target="&quot;ALTERNATIVE SPLICING&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Genetic control over CTLA4 includes alternative splicing patterns specific to CD4+ T cells that influence its function in immune regulation."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION OF CTLA4 GENE LOCUS&quot;" target="&quot;CTLA4 POLYMORPHISM CT60A/G (RS3087243)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Differential methylation near the second exon of CTLA4, inversely correlated with gene expression levels due to the presence of CT60 polymorphism."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 POLYMORPHISM CT60A/G (RS3087243)&quot;" target="&quot;T1D AND RA-ASSOCIATED VARIANTS (E.G., RS231775, RS3087243)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"These variants are in strong LD with CTLA4 polymorphisms that affect gene expression and disease risk."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1D&quot;" target="&quot;MTOR SIGNALING PATHWAY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variants that affect the mTOR signaling pathway contribute to Type 1 Diabetes risk by influencing gene functions in CD4+ T cells."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1131017&quot;" target="&quot;RPS26&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SNP rs1131017, located near RPS26, is associated with significant eQTL effects on this gene's expression in T cells."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANS-EQTL&quot;" target="&quot;IL27 GENE REGION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A trans-eQTL analysis of the IL27 region revealed that genetic variants influence IRF1 and STAT1 expression, linked to a reduced risk for Type 1 Diabetes."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4788084[T]&quot;" target="&quot;STAT1 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP rs4788084[T] is associated with decreased expression levels of the STAT1 gene in CD4+ T cells, contributing to lower risk for Type 1 Diabetes."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL27RA&quot;" target="&quot;GP130 (IL6ST)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Together, IL27RA and gp130 form a receptor complex necessary for the signal transduction pathway activated by IL-27 binding."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1&quot;" target="&quot;STAT1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression levels of IRF1 and STAT1 are strongly correlated, suggesting a functional relationship where one gene may influence the expression or activity of the other."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL27RA, GP130 (RECEPTOR COMPLEX)&quot;" target="&quot;IL-27 CYTOKINE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The IL-27 cytokine binds to the receptor complex composed of IL27RA and gp130, leading to activation of downstream signaling pathways in cells."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBI3&quot;" target="&quot;IL27&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"EBI3 acts as a subunit of the heterodimeric cytokine IL-27, which binds to its receptor complex consisting of IL27RA and gp130."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBI3&quot;" target="&quot;IL-27 CYTOKINE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"EBI3 forms a heterodimer with p28 (IL37) or IL-27beta subunit to form the cytokines IL-27 and IL-35, which bind to specific receptors for signaling."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERFERON-STIMULATED RESPONSE ELEMENTS (ISRE)&quot;" target="&quot;STAT1/STAT3 PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Binding of STAT1 or STAT3 dimers to ISREs initiates transcriptional regulation of interferon-responsive genes such as IRF1 and STAT1."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEK293 CELLS&quot;" target="&quot;IL-27 TRANSFECTION EXPERIMENT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Human embryonic kidney 293 cells are used to produce and study IL-27 protein variants (Leu119 and Pro119) in the context of their effects on IRF1 and STAT1 expression."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL27 SNP RS181206[G]&quot;" target="&quot;IRF1, STAT1 EXPRESSION LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genetic variant IL27 SNP rs181206[G] is associated with decreased expression of IRF1 and STAT1 genes in CD4+ T cells."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4073 GENOMIC VARIANT&quot;" target="&quot;ASTHMA RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Carrying the homozygous TT genotype at rs4073 increases asthma susceptibility, indicating a strong genetic link to disease risk."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 PROTEIN&quot;" target="&quot;IL-8 MRNA TRANSCRIPT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression level of IL-8 protein correlates with mRNA levels in serum and PBMCs, impacting immune responses."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;IL-8 SERUM LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Elevated IL-8 levels are observed in patients with asthma compared to controls, suggesting a role in disease pathogenesis."&lt;SEP&gt;"Elevated levels of IL-8 in serum correlate with the presence and severity of asthma."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MODERATE-SEVERE ASTHMA&quot;" target="&quot;MILD ASTHMA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The severity of asthma correlates with higher levels of IL-8 protein and mRNA expression, indicating an inflammatory component in severe cases."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"For ASAH1, the kernel machine method using a linear kernel outperforms the min test when the causal SNPs have moderate linkage disequilibrium with typed SNPs."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;IBS KERNEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"When testing for the effect of the ASAH1 gene, the IBS kernel demonstrates higher empirical power compared to other methods like linear kernel or min test.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;EPISTASIS (INTERACTIONS BETWEEN GENES)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The presence of epistatic interactions can impact the power and accuracy of genetic tests like IBS kernel when studying ASAH1 gene effects.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;" target="&quot;FGFR2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The performance of the kernel machine method exceeds that of the min test in regions within FGFR2 with high linkage disequilibrium but is comparable in weak LD regions."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST&quot;" target="&quot;NAT2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The single SNP-based min test shows higher power than the kernel machine method for NAT2 gene in scenarios where a single true casual SNP is highly correlated with one of the typed SNPs."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST&quot;" target="&quot;LINEAR KERNEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both the linear kernel and min test suffer from substantial power loss when studying genetic effects, indicating they are less effective in certain scenarios than IBS kernels.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B GENE&quot;" target="&quot;GENETIC VARIANTS (SNPS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In the HLA-B gene, incorporating information about minor allele frequency into the weighted IBS kernel can upweight rare alleles and increase power for SNPs with lower MAF."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT (RS2523608)&quot;" target="&quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"When rs2523608, a SNP with higher MAF, is causal, the weighted IBS kernel downweights its common allele effect.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS KERNEL&quot;" target="&quot;EMPIRICAL POWER&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"In various scenarios, the IBS kernel demonstrates higher empirical power compared to linear or min tests for detecting gene effects.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL SNP (RS2523608)&quot;" target="&quot;MAF&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The minor allele frequency of rs2523608 influences its role as a causal variant in genetic studies.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL SNP (RS2523608)&quot;" target="&quot;LD STRUCTURE (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The LD structure between rs2523608 and other SNPs influences the performance of genetic tests in detecting its effect.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1893217&quot;" target="&quot;ANTI-CTLA-4 TREATMENT RESPONSE RATE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The presence of the minor allele G in rs1893217 is associated with a reduced likelihood of response to anti-CTLA-4 treatment."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1893217&quot;" target="&quot;PTPN2 GENE REGION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP rs1893217 is located within the genomic region containing PTPN2 and affects response to anti-CTLA-4 therapy."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1893217&quot;" target="&quot;METASTATIC MELANOMA PATIENTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of rs1893217 influences the efficacy of anti-CTLA-4 treatment in metastatic melanoma patients."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;IL2-IL21 LOCUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The IL2-IL21 locus contains rs17388568, a significant SNP linked to increased efficacy of anti-PD-1 therapy in metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;ANTI-PD-1 TREATMENT RESPONSE RATE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The presence of the minor allele GA or AA in rs17388568 is associated with a higher likelihood of response to anti-PD-1 treatment."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;ALLERGY, COLITIS, TYPE 1 DIABETES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP rs17388568 is associated with increased risk for conditions like allergy, colitis and type 1 diabetes."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;IL2-IL21 GENOMIC LOCUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP rs17388568 is located within the genomic region containing IL2, ADAD1, and IL21 and affects response to anti-PD-1 therapy."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;METASTATIC MELANOMA PATIENTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of rs17388568 influences the efficacy of anti-PD-1 treatment in metastatic melanoma patients."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-CTLA-4 TREATMENT&quot;" target="&quot;METASTATIC MELANOMA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Anti-CTLA-4 treatment is used for the management of metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-CTLA-4 TREATMENT&quot;" target="&quot;IPILIMUMAB, TREMELIMUMAB&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Ipilimumab and tremelimumab are drugs used in anti-CTLA-4 treatment for metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-CTLA-4 TREATMENT&quot;" target="&quot;COMBINATION THERAPY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Anti-CTLA-4 is a component of combination therapy that was studied for its effect on patient response.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-PD-1 TREATMENT&quot;" target="&quot;IL2-IL21 LOCUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Response to anti-PD-1 therapy in metastatic melanoma patients is significantly influenced by genetic variations within the IL2-IL21 locus, particularly rs17388568."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-PD-1 TREATMENT&quot;" target="&quot;METASTATIC MELANOMA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Anti-PD-1 treatment is also used for the management of metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-PD-1 TREATMENT&quot;" target="&quot;NIVOLUMAB, PEMBROLIZUMAB&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Nivolumab and pembrolizumab are drugs used in anti-PD-1 treatment for metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-PD-1 TREATMENT&quot;" target="&quot;COMBINATION THERAPY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Anti-PD-1 treatment is another part of the combination therapy used in the study.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMBINATION THERAPY (ANTI-CTLA-4 AND ANTI-PD-1)&quot;" target="&quot;METASTATIC MELANOMA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This combination therapy targets both CTLA-4 and PD-1 pathways to treat metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METASTATIC MELANOMA&quot;" target="&quot;ICIS (IMMUNE CHECKPOINT INHIBITORS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"ICIs, including both anti-PD-1 and anti-CTLA-4 treatments, are used in the immunotherapy of metastatic melanoma."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SAMPLE SIZE&quot;" target="&quot;CONFIDENCE INTERVAL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A smaller sample size leads to wider confidence intervals, reducing the power to detect significant associations between SNPs and treatment response.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;MS RISK SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"EBNA2 binds chromatin at multiple sclerosis (MS) risk loci dependent on the MS risk allele."</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TRAF3&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"EBNA2 binds preferentially to the risk allele of TRAF3, leading to decreased expression of this gene at an MS risk locus.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;CD40&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"EBNA2 binds preferentially to the protective allele of CD40, resulting in relatively lower expression compared to B cells, despite being a risk gene.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TNFAIP8&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"EBNA2 alters allelic association with expression upon binding TNFAIP8 at an MS risk locus, affecting the gene's role in immune evasion.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TNFRSF1A&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"EBNA2 binds preferentially to the protective allele of TNFRSF1A, leading to lower expression compared to B cells at an MS risk locus.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TBX6&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The effect of EBNA2 on TBX6 alters relative allelic expression in LCLs compared to uninfected B cells, influencing gene function in immune evasion.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;RCOR1&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"EBNA2 binding and treatment with EBNA2-TAT alter the effect on RCOR1 expression, impacting relative allelic association at an MS risk locus.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;CLECL1&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"EBNA2 increases the expression of CLECL1 at an MS risk locus, altering gene function in immune evasion despite no genotype effect observed.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS RISK SNPS&quot;" target="&quot;EBV DNA COPY NUMBER&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variations at MS risk loci influence the stability of EBV DNA copy number within LCLs, affecting disease susceptibility."</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRAF3/RCOR1 SNP (RS1258869)&quot;" target="&quot;CD40 SNP (RS1883832)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"EBNA2 binds preferentially to both loci, indicating a role in MS risk regulation through allele-specific binding."</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP8 SNP (RS32658)&quot;" target="&quot;TBX6 SNP (RS3809627)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both genomic variants demonstrate protective effects when EBNA2 binds to the non-risk alleles, influencing gene expression and MS risk."</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2-TAT&quot;" target="&quot;LMP1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Treatment with EBNA2-TAT reduces LMP1 expression in lymphoblastoid cell lines (LCLs), indicating inhibition of EBV latency III growth program."</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRAF3 GENE EXPRESSION&quot;" target="&quot;TNFRSF1A GENE EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both genes show altered expression levels as a result of EBNA2 function inhibition, implicating their role in MS risk regulation."</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS RISK LOCI&quot;" target="&quot;ALLELIC ASSOCIATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Allelic association at MS risk loci can be altered due to the influence of EBNA2 and treatment effects on gene expression.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBV LATENCY III PROGRAM&quot;" target="&quot;LMP1 AND LMP2 SIGNALLING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The EBV latency III program involves molecular interactions with LMP1 and LMP2 signalling, which are influenced by EBNA2 interaction with MS risk genes.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOST IMMUNE EVASION&quot;" target="&quot;EBNA2/RISK GENE INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The effect of EBNA2 on expression at risk loci is postulated to increase host immune evasion through regulation of these risk genes in the latency III program.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COX-2 GENE POLYMORPHISM (RS20417)&quot;" target="&quot;ITGA2 GENE POLYMORPHISM (RS1126643)&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Both rs20417 and rs1126643 are genetic factors associated with increased risk of aspirin insensitivity, but they differ in their effects across ethnic groups."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COX-2 GENE POLYMORPHISM (RS20417)&quot;" target="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The COX-2 gene polymorphism rs20417 is significantly associated with aspirin insensitivity, contributing to the condition's genetic risk."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COX-2 GENE POLYMORPHISM (RS20417)&quot;" target="&quot;CAD (CORONARY ARTERY DISEASE)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Differences in CAD prevalence contribute to heterogeneity for the association between rs20417 and aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ITGA2 GENE POLYMORPHISM (RS1126643)&quot;" target="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The ITGA2 gene polymorphism rs1126643 confers a high risk for aspirin insensitivity, especially under the dominant model."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ITGA2 GENE POLYMORPHISM (RS1126643)&quot;" target="&quot;CAD (CORONARY ARTERY DISEASE)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The presence of CAD explains a significant part of heterogeneity for the association between rs1126643 and aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COX-1 GENE POLYMORPHISM (RS3842787)&quot;" target="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The COX-1 gene polymorphism rs3842787 does not show a significant association with aspirin insensitivity, indicating no substantial genetic risk."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ITGA2B GENE POLYMORPHISM (RS20118426)&quot;" target="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The ITGA2B gene polymorphism rs20118426 does not significantly contribute to the risk of aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643&quot;" target="&quot;AVERAGED PLATELET NUMBER&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Averaged platelet number was found to be a significant source of heterogeneity for rs1126643, indicating an interaction between averaged platelet count and the genomic variant."</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B GENE&quot;" target="&quot;HOMOZYGOUS NONSENSE MUTATION C.1892G&gt;A, P.W631*&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The STAT5B gene harbors a homozygous nonsense mutation leading to a truncated protein with reduced function and expression."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B GENE&quot;" target="&quot;STAT5B VARIANT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The STAT5B gene harbors a loss-of-function variant that influences CD8+ T cell homeostasis."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B GENE&quot;" target="&quot;CD4+ MEMORY T CELLS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Despite the presence of the STAT5B variant, CD4+ memory T cells remain within normal ranges."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B GENE&quot;" target="&quot;CD8+ TEMRA CELLS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Elevations in CD8+ TEMRA cells during infancy are linked to STAT5B deficiency, which normalizes around age 7."&lt;SEP&gt;"Elevations of CD8+ TEMRA cells during infancy normalize around age 7, indicating a developmental impact of STAT5B deficiency."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOMOZYGOUS NONSENSE MUTATION C.1892G&gt;A, P.W631*&quot;" target="&quot;WILD-TYPE FLAG-STAT5B (F-STAT5B WT)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The wild-type protein contrasts with the mutant protein in expression and function following GH treatment."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOMOZYGOUS NONSENSE MUTATION C.1892G&gt;A, P.W631*&quot;" target="&quot;TRANSCRIPT OF STAT5B GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The transcript is affected by the mutation leading to a truncated protein."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOMOZYGOUS NONSENSE MUTATION C.1892G&gt;A, P.W631*&quot;" target="&quot;SRC HOMOLOGY 2 (SH2) DOMAIN AND TRANSACTIVATION DOMAIN (TAD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The mutation eliminates the SH2 domain and TAD of STAT5B protein."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD-TYPE FLAG-STAT5B (F-STAT5B WT)&quot;" target="&quot;GROWTH HORMONE (GH)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"GH stimulates phosphorylation and nuclear localization of the wild-type STAT5B protein, which is impaired in the mutant protein."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD-TYPE FLAG-STAT5B (F-STAT5B WT)&quot;" target="&quot;GH RECEPTOR (GHRS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"GH receptors are used to assess functional capacity of wild-type STAT5B in comparison with mutant form."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD-TYPE FLAG-STAT5B (F-STAT5B WT)&quot;" target="&quot;NUCLEAR LOCALIZATION &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Nuclear localization is observed for wild-type protein but impaired for the mutant protein following GH treatment."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)&quot;" target="&quot;SEVERE SHORT STATURE, HEIGHT SDS â6.5, â5.06, AND â4.7 &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Treatment with rhIGF-1 was initiated to address the severe short stature condition in the siblings."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEVERE SHORT STATURE, HEIGHT SDS â6.5, â5.06, AND â4.7 &quot;" target="&quot;NK CELLS &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Reduced NK cells in STAT5B deficient siblings contribute to immune impairments."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE THYROIDITIS &quot;" target="&quot;SEVERE POST-NATAL GROWTH FAILURE &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The autoimmune thyroiditis diagnosis is part of the broader clinical presentation of post-natal growth failure among the siblings."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE THYROIDITIS &quot;" target="&quot;REACTIVE AIRWAY DISEASE &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both diseases are part of the broader clinical presentation including atopic conditions."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B&quot;" target="&quot;LOF STAT5B VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The LOF variant of the STAT5B gene leads to a reduction in the expression and function of the STAT5B protein.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GH STIMULATION&quot;" target="&quot;PHOSPHORYLATION/NUCLEAR TRANSLOCATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"GH stimulation typically results in phosphorylation and nuclear translocation of STAT5B, but this process is impaired by the LOF variant.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NK CELLS&quot;" target="&quot;STAT5B GENE EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Impaired expression or function of STAT5B leads to reduced numbers and function of NK cells in deficient individuals.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;B CELLS&quot;" target="&quot;IGE LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased immunoglobulin production by B cells, particularly IgE, is associated with elevated serum levels leading to allergic conditions such as chronic eczema and reactive airway disease.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THYMIC T CELL PRODUCTION&quot;" target="&quot;PERIPHERAL DESTRUCTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"In STAT5B deficient individuals, either thymic production or peripheral destruction may account for reduced numbers of mature T cells.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT THYMIC EMIGRANTS (RTE)&quot;" target="&quot;TREG FUNCTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Evaluation of RTEs helps assess the function and maintenance of regulatory T cells in STAT5B deficient patients over time.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEMORY CD8+ T CELLS&quot;" target="&quot;NAIVE T CELLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Young STAT5B deficient siblings exhibit dysregulated memory CD8+ T cells with reduced naÃ¯ve subsets and elevated memory/activation phenotypes.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B VARIANT&quot;" target="&quot;CD8+ TEM CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The STAT5B variant influences the proportion and activation status of CD8+ TEM cells over time."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B VARIANT&quot;" target="&quot;CD8+ TEMRA CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Elevations in CD8+ TEMRA cell percentages during infancy are linked to the STAT5B variant, which normalizes by age 4."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ TEM CELLS&quot;" target="&quot;LOF MUTATION IN STAT5B&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"No significant alterations were observed in the proportion of CD4+ TEM cells despite STAT5B mutation."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ TEM CELLS&quot;" target="&quot;LOF MUTATION IN STAT5B&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increases in CD8+ TEM cell proportions with age suggest an important role for the STAT5B variant in T cell homeostasis."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B DEFICIENCY&quot;" target="&quot;CD8+ MEMORY T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Patients with STAT5B deficiency have elevated proportions of CD8+ memory T cells from infancy onwards, indicating a critical role for the STAT5B variant in CD8+ T cell homeostasis."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ MEMORY T CELLS&quot;" target="&quot;LOF MUTATION IN STAT5B&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"No alterations were observed in the proportion of CD4+ memory T cells, indicating that STAT5B mutation does not affect this cell subset."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1 GENE&quot;" target="&quot;LINKAGE DISEQUILIBRIUM (LD)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The HLA-DRB1 gene's alleles show linkage disequilibrium with other genetic markers contributing to immune responses and disease susceptibility."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1 GENE&quot;" target="&quot;ALLELE CARRIER STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Determining the allele carrier status for the HLA-DRB1 gene is crucial in predicting immune responses and disease susceptibility."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS28383172&quot;" target="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SNP rs28383172 is used to predict the carrier status of this specific haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS28383172&quot;" target="&quot;HAPLOTYPE TAGGING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SNP rs28383172 is used as a marker for haplotype tagging, aiding in the prediction of HLA-DRB1*07:01âDQA1*02:01âDQB1*02:02 carrier status."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS28383172&quot;" target="&quot;NEGATIVE PREDICTIVE VALUE (NPV)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Determining the NPV of SNP rs28383172 helps assess its reliability for excluding false negatives in predicting HLA-DRB1*07:01 carrier status."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;SNP RS2395182&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"rs2395182 is a SNP involved in predicting the carrier status of this specific haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;SNP RS4713586&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"rs4713586 is a SNP used in predicting the carrier status of this specific haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;SNP RS7775228&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"rs7775228 is a SNP involved in predicting the carrier status of this specific haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;HLA-DQA1 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HLA-DQA1 gene contributes to the formation of this specific haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype is a genetic variant that affects the risk of E. coli ASP hypersensitivity.")&lt;SEP&gt;"The presence of this haplotype increases the risk for E. coli ASP hypersensitivity.")</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS7775228&quot;" target="&quot;SPECIFICITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Measuring specificity for SNP rs7775228 aids in determining its reliability in predicting the HLA-DRB1*07:01âDQA1*02:01âDQB1*02:02 haplotype carrier status."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQA1 GENE&quot;" target="&quot;POSITIVE PREDICTIVE VALUE (PPV)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The PPV of HLA-DQA1 gene markers is crucial for determining the accuracy of predicting haplotypes in populations."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE&quot;" target="&quot;POLYMORPHISM RS179008 AND RS179009&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The TLR7 gene contains specific polymorphisms (rs179008, rs179009) that are associated with different disease susceptibilities in HIV-infected individuals compared to healthy controls."</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE&quot;" target="&quot;TLR7 (RS179008)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TLR7 gene includes the rs179008 polymorphism which was studied in the context of HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE&quot;" target="&quot;TLR7 (RS179009)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TLR7 gene also includes the rs179009 polymorphism, examined for its influence on HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYMORPHISM RS179008 AND RS179009&quot;" target="&quot;HIV DISEASE STAGES&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The presence of specific TLR7 gene polymorphisms is linked with different stages of HIV disease, showing a significant reduction in early to advanced stages compared to healthy controls."</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOBACCO AND ALCOHOL CONSUMPTION&quot;" target="&quot;TLR7 GENE POLYMORPHISM RS179008 AND RS179009&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Consumption of tobacco or alcohol does not significantly alter the distribution patterns of TLR7 gene polymorphisms in HIV-infected individuals."</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE CD4 COUNTS&quot;" target="&quot;TLR7 GENE POLYMORPHISM RS179008 AND RS179009&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CD4 counts at the baseline correlate with TLR7 gene polymorphisms, indicating a role in immune response during HIV infection."</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 (RS179009)&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The TLR7 rs179009 polymorphism is also studied in the context of HIV disease progression, similarly not identified as a standalone risk factor."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AND SEX&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Age and sex were examined for their correlation with HIV disease progression through multivariate logistic regression analysis but did not emerge as significant independent factors."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOBACCO USAGE&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The use of tobacco was analyzed in relation to its potential impact on HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOBACCO USAGE&quot;" target="&quot;ALCOHOL USAGE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both tobacco and alcohol usage were analyzed as potential lifestyle factors affecting HIV disease progression together."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL USAGE&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Alcohol usage was considered as one of the factors influencing HIV disease progression through logistic regression analysis."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4 COUNTS&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Baseline CD4 counts were correlated with HIV disease progression in the study but did not stand out as independent risk factors."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV DISEASE PROGRESSION&quot;" target="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This analysis was conducted to determine factors influencing HIV disease progression, including genetic and lifestyle factors."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;HLA-A*02:01&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ALK R1275Q mutation forms a nonamer (GMAQDIYRA) that binds to HLA-A*02:01 with significant binding affinity."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NRAS Q61K&quot;" target="&quot;HLA-A*01:01&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The NRAS mutation Q61K generates a neoepitope (ILDTAGKEEY) that binds to HLA-A*01:01 with significant binding affinity."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;ALK R1275Q NEOEPITOPE (DECAMER)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The HLA-B*15:01 protein binds the ALK R1275Q decamer peptide, facilitating immune recognition and response."</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;NONAMER PEPTIDE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The nonamer peptide forms less stable complexes with HLA-B*15:01 compared to the decamer peptide due to fewer interactions and more surface exposure."</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;DECAMER PEPTIDE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The decamer peptide binds strongly to HLA-B*15:01, forming stable complexes that are recognized by TCRs, enhancing immune response against cancer cells expressing the ALK mutation."</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;SELF-PEPTIDE (ARDIYRASY)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The self-peptide ARDIYRASY is poorly bound by HLA-B*15:01, suggesting it may not trigger an immune response due to structural incompatibilities."</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;ALK NEOEPITOPES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Similar to HLA-A*01:01, HLA-B*15:01 can also form stable p/MHC complexes with ALK-derived peptides and present them to T cells."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAQDIYRASY AND AQDIYRASYY&quot;" target="&quot;AQDIYRASY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both MAQDIYRASY and AQDIYRASYY are neoepitopes derived from ALK R1275Q, but AQDIYRASY has better binding affinity to HLA-B*15:01 compared to its parental self-antigen."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-A*02:01&quot;" target="&quot;GMAQDIYRA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The nonamer GMAQDIYRA derived from ALK R1275Q binds to HLA-A*02:01, demonstrating the interaction between neoepitopes and HLAs in diverse settings."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-A*01:01&quot;" target="&quot;NRAS Q61K NEOEPITOPE ILDTAGKEEY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The NRAS mutation generates a neoepitope (ILDTAGKEEY) that binds to HLA-A*01:01, suggesting its potential role in immunotherapy."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-A*01:01&quot;" target="&quot;DECAMER PEPTIDE AQDIYRASYY (PDB ID 6AT9)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The decamer peptide forms a stable complex with HLA-A*01:01, which is crucial for its presentation to T cells."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-A*01:01&quot;" target="&quot;TCRS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The HLA-A*01:01 molecule presents peptides in a way that can activate TCRs, leading to an immune response."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUROBLASTOMA (NBL)&quot;" target="&quot;PROTECT SOFTWARE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ProTECT software is used for the identification of neoepitope-generating mutations in neuroblastoma tumors, aiding in therapeutic development."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUROBLASTOMA (NBL)&quot;" target="&quot;ZNF717 Q716 MUTATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ZNF717 mutation is recurrent in neuroblastomas, highlighting its significance in the disease pathology."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUROBLASTOMA (NBL)&quot;" target="&quot;F1174L/I/C MUTATIONS IN ALK &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These mutations indicate genetic diversity within the neuroblastoma cohort and may serve as potential therapeutic targets."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:03&quot;" target="&quot;ARDIYRASYY AND ARDIYRASY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"HLA-B*15:03 binds to both ARDIYRASYY and ARDIYRASY with scores of 2.2% and 4.7%, respectively, indicating its role in immune recognition."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P/MHC COMPLEX STABILITY&quot;" target="&quot;PROTECT SOFTWARE ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In vitro analysis of p/MHC complexes stability provides insights into therapeutic target validation for neuroblastoma mutations."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK NEOEPITOPES&quot;" target="&quot;TCRS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"TCRs recognize the ALK-derived peptides presented by MHC molecules, initiating an immune response against cancer cells expressing these epitopes."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;DECAMER PEPTIDE AQDIYRASYY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The nonamer and decamer peptides display distinct conformations within the HLA-B*15:01 binding groove due to their differing lengths and anchor residues."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIFFERENTIAL SCANNING FLUORIMETRY (DSF)&quot;" target="&quot;HLA-B*15:01 BINDING COMPLEXES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"DSF is used to measure the kinetic stability of p/MHC complexes formed by HLA-B*15:01 and neoepitopes, indicating thermal stabilities."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPSTEINâBARR VIRUS&quot;" target="&quot;HLA-B*15:01 BINDING MOTIF&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Peptides derived from EpsteinâBarr virus follow established binding motifs for HLA-B*15:01, similar to those of ALK neoepitopes."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 (UBE2M)&quot;" target="&quot;HLA-B*15:01 BINDING MOTIF&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Peptides from UBE2M also fit the established binding motifs for HLA-B*15:01, akin to those of ALK-derived peptides."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SARS CORONAVIRUS&quot;" target="&quot;HLA-B*15:01 BINDING MOTIF&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Peptides from SARS coronavirus follow established binding motifs for HLA-B*15:01, consistent with patterns observed in ALK neoepitopes."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCRS (T-CELL RECEPTORS)&quot;" target="&quot;ALK NEOEPITOPES BOUND TO HLA-B*15:01&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The interaction between TCRs and the p/MHC complexes formed by ALK-derived peptides bound to HLA-B*15:01 mediates immune recognition."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEOEPITOPES&quot;" target="&quot;Î2M (BETA-2-MICROGLOBULIN)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The binding of neoepitopes to Î²2m is crucial for the formation of stable MHC class I complexes."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCRS (T CELL RECEPTORS)&quot;" target="&quot;HLA-B*15:01/DECAMER PEPTIDE COMPLEX&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"TCRs recognize the HLA-B*15:01 complexed with ALK R1275Q decamer peptide, initiating an immune response against cancer cells."</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA ALLELES&quot;" target="&quot;THERMAL STABILITY OF DECAMER COMPLEX WITH HLA-A*01:01&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Refolding experiments confirm the stability and structural integrity of decamer peptide complexes formed with high-frequency HLA alleles like HLA-A*01:01.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PEPTIDES&quot;" target="&quot;ROSETTA COMPARATIVE MODELING CALCULATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Rosetta modeling is used to predict binding of peptides with HLAs, providing insights into peptide/HLA interactions and stability.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PEPTIDES&quot;" target="&quot;IN VITRO REFOLDING EXPERIMENTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Refolding experiments confirm the structural stability of peptide/HLA complexes formed with nonamer and decamer peptides from ALK mutation.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01 STRUCTURE&quot;" target="&quot;HLA-A*01:01 STRUCTURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Similarities in X-ray structures between HLA-B*15:01 and HLA-A*01:01, aiding in the structural modeling of peptide/HLA interactions.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-THROUGHPUT APPROACH FOR PEPTIDE/HLA INTERACTIONS&quot;" target="&quot;NONAMER AND DECAMER ALK PEPTIDES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The high-throughput approach was applied to evaluate binding of nonamer and decamer peptides with a wide array of HLA alleles.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER AND DECAMER ALK PEPTIDES&quot;" target="&quot;HLA-B*15:84 ALLELE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The HLA-B*15:84 allele shows strong binding with decamer peptides, as indicated by low binding energy predictions.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING ENERGY PREDICTIONS&quot;" target="&quot;KULLBACKâLEIBLER SEQUENCE LOGO&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Predicted binding energies correlate with sequence features revealed by the Kullback-Leibler logo, aiding in understanding peptide/MHC interactions.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING ENERGY PREDICTIONS&quot;" target="&quot;MOCK POLYALA HLA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The mock polyAla HLA serves as a negative control for binding energy predictions, revealing higher binding energies compared to natural alleles.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KULLBACKâLEIBLER SEQUENCE LOGO&quot;" target="&quot;POLAR CONTACTS IN MHC BINDING GROOVE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The sequence logo highlights preferred residues involved in polar contacts within the HLA binding groove, contributing to strong peptide/MHC interactions.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECAMER PEPTIDE AQDIYRASYY (PDB ID 6AT9)&quot;" target="&quot;POLAR CONTACTS WITHIN MHC GROOVE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Specific polar contacts between the peptide and residues in the MHC groove contribute to the stability of the complex formed with HLA-A*01:01."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPARÎ PROTEIN&quot;" target="&quot;RXRÎ PROTEIN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The protein product of PPARÎ³ interacts molecularly with RXRÎ± to regulate gene expression involved in lipid metabolism and inflammation.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS74420772&quot;" target="&quot;IGM ANTI-PC&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The SNP rs74420772 is associated with IgM anti-PC measurement in one of the GWAS studies."&lt;SEP&gt;"This SNP is associated with IgM anti-PC measurement in one of the GWAS studies."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643-G&quot;" target="&quot;GRAMD1B GENE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The GRAMD1B gene overlaps a linkage disequilibrium block containing the leading SNP rs35923643-G."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643-G&quot;" target="&quot;IGM ANTI-PC&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The rs35923643-G variant has a significant effect size on IgM anti-PC levels, indicating its role in the measurement."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643-G&quot;" target="&quot;GENERAL IMMUNOGLOBULIN LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The rs35923643-G variant shows significant association with IgM levels, indicating its role in the physiological process of general immunoglobulin regulation."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRAMD1B GENE&quot;" target="&quot;RS735665-A&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The GRAMD1B gene is in close proximity to SNP rs735665-A which shows association with CLL risk."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665-A&quot;" target="&quot;CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The SNP rs735665-A is recognized as the top risk allele for CLL based on GWAS meta-analysis results."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC&quot;" target="&quot;SNPS IN 1P31.3 AND 11Q24.1&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genomic variants (specific SNPs) identified in the GWAS meta-analysis are significantly associated with IgM anti-PC levels."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC&quot;" target="&quot;CLL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There is an association between Chronic Lymphocytic Leukemia (CLL) and IgM anti-PC levels, indicating potential biological relevance to disease progression or diagnosis."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC&quot;" target="&quot;RS35923643&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs35923643 is suggested to be a candidate influencing the IgM anti-PC levels in relation to CLL, though direct causality needs further investigation."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;DNASEI HYPERSENSITIVITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs35923643 is also found in regions marked by DNaseI hypersensitivity, suggesting its location within open chromatin regions active for transcription."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;IGM ANTI-PC AND CLL PHENOTYPIC ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs35923643 is suggested to be a candidate for influencing the phenotypic association between IgM anti-PC levels and Chronic Lymphocytic Leukemia (CLL)."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPTION FACTOR BINDING SITES&quot;" target="&quot;RUNX3 BINDING MOTIF&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The region around rs35923643 contains binding sites for multiple transcription factors, with RUNX3 showing a strong signal particularly at this locus."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RUNX3 BINDING MOTIF&quot;" target="&quot;SNP RS35923643 BINDING IMPACT ON RUNX3&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP rs35923643 alters the predicted affinity of RUNX3 to bind DNA, potentially affecting gene regulation."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC AND CLL PHENOTYPIC ASSOCIATION&quot;" target="&quot;STRATIFIED COX PROPORTIONAL HAZARDS MODEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The statistical model indicates no significant association between IgM anti-PC levels and incident CLL risk, suggesting that the relationship is complex or influenced by other factors."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
  </graph>
</graphml>
